{
  "id": 97,
  "title": "Effects of Resistance Training on Body Composition and Function in Older Women With Sarcopenic Obesity (Korean Cohort)",
  "authors": "Lee Y-H et al.",
  "year": 2007,
  "doi": "NR",
  "journal": null,
  "rating": 4.0,
  "tags": [
    "older_women",
    "sarcopenic_obesity",
    "Korean_population"
  ],
  "population": {
    "training_status": "RCT_RT_only",
    "sample_size": 79
  },
  "sections": {
    "abstract": "Excessive abdominal obesity, coupled with a decline in muscle mass and physical \nfunction that is exacerbated by sedentary living, contributes substantively to the disease and \ndisability common to our aging population. The Senior Study, a randomized controlled trial \ndesigned to investigate the health benefits associated with performing resistance exercise (RE), \naerobic exercise (AE), or a combination of both exercise modalities (RAE) for six months in the \nabsence of caloric restriction, was conducted on otherwise healthy but abdominally obese, \nsedentary men (n=57) and women (n=79) between the ages of 60 and 80. \n The purpose of the first manuscript (Chapter 3) was to compare the effects of exercise \nmodality on visceral obesity and insulin resistance in the Senior Study. All exercise groups \nsignificantly reduced total abdominal and visceral fat (P<0.05) and waist circumference \n(P<0.001), which measure explained 30% of the variance in total abdominal fat changes \n(P<0.001). AE and RAE improved insulin sensitivity (P<0.05), but the RE group did not (P>0.1). \nThe greatest insulin sensitivity increase was observed within the RAE group (48% increase, \nP<0.001). \n The purpose of the second manuscript (Chapter 4) was to evaluate the effects of \nexercise modality on cardiorespiratory and functional fitness in the Senior Study. AE and RAE \nincreased cardiorespiratory fitness (P<0.001), whereas RE did not (P>0.1). All exercise groups \nimproved functional fitness performance (P<0.001), but age- and sex-specific percentile ranking \nimprovement within RAE was greater than AE (P<0.01). RE and RAE significantly increased \nskeletal muscle (P<0.01), predominantly in the upper body, while AE did not (P=1.0). AE and \nRAE reduced total fat (P<0.001). Both fat loss and muscle gain were independent predictors of \nimprovements in functional fitness (P<0.05). \n The findings from these studies demonstrate conclusively that a combined resistance and \naerobic exercise program without caloric restriction is an optimal strategy for the therapeutic \nreduction of health risk in abdominally obese men and women. While each exercise modality \noffers distinct benefits and remains a viable option for needs-based exercise prescription, the \n ii\n\n \ncombination was associated with the greater simultaneous improvements to body composition, \ninsulin resistance, and cardiorespiratory and functional fitness than either resistance or aerobic \nexercise alone. \nKey words: Exercise modality, obesity, visceral fat, skeletal muscle, disability, elderly \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n iii\n\n \nCo-Authorship \n \n Writing of the manuscripts contained within this dissertation (Chapters 3 and 4) and all \nstatistical analyses were performed by Lance E. Davidson. Critical revisions for important \nintellectual content were provided by Dr. Robert Ross. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n iv\n\n \nAcknowledgements \n \n Although I consider this dissertation and the successful completion of the Senior Study \nupon which it is based a considerable personal accomplishment, precious little of it would have \nmaterialized without the dedicated efforts and support of numerous colleagues and friends. First \nand foremost, I thank Bob Ross for his inspired conception and design of the study, for his \nwillingness to entrust the management of this mammoth five-year, federally-funded project to an \neager but wet-behind-the-ears graduate student, and for his unfailing loyalty as an advisor, \nmentor, and friend to me as I earned what I deem a top-notch education experiencing the highs \nand lows inherent to conducting an intervention trial. \n Thanks also to Drs. Hudson and Kilpatrick, Tammy, Cindy, and the whole medical team \nat the Hotel Dieu and Kingston General Hospitals who donated time, energy, expertise, and often \nbent over backward to ensure quality assessment of the senior participants. Thanks to Ann-\nMarie, Shelley, and Amanda for their enthusiasm and frequent encouragement to the seniors and \nto me. A special thanks to my fellow graduate students, Jen, Peter, Kate, So Jung, Suzy, \nMeghan, and Travis -- many of whom endured long hours of monitoring, testing and analysis for \nthe project over the years. And certainly thanks to Dr. Miu Lam, who patiently answered my \nquestions as I struggled through multiple imputation modeling in the intent-to-treat analysis. \n My undying gratitude is extended to the personalities in the trenches: my friends, the \nseniors, who often battled the elements en route to the lab, sacrificing well-deserved leisure time \nwith no remuneration save a sometimes unrecognized enhancement of health and the promised \ncontribution to science. To those for whom this new habit of exercise opened a door to a life full \nof purposeful activity and vigor, thank you for inspiring me and those around you. For those who \nleft shoes in the lab at the end of six months with a vow to get back to an “easy” retirement, I am \nawed by your sacrifice to keep a commitment. To Erin, Claire, Mika, and Nicole whose daily \nencouragement and friendship kept the seniors engaged, and to the participants who took me in \nas family and literally made Kingston “home” for me, I thank you. I could not have done this \nwithout all of you. \n v\n\n \n Finally, I owe a debt of appreciation to my sweetheart, Amiee, and my two adorable girls, \nEmma and Rhea, for following me over a continent and even across international borders, waiting \nendlessly for me to come home, and donating countless hours of “Daddy time” to this dream of a \ncompleted doctoral dissertation. \n vi\n\n \nTable of Contents \n \nAbstract......................................................................................................................................... ii \nCo-Authorship..............................................................................................................................iv \nAcknowledgements ......................................................................................................................v \nTable of Contents ........................................................................................................................vii \nList of Tables ...............................................................................................................................xii \nList of Figures .............................................................................................................................xiii \nList of Abbreviations ...................................................................................................................xiv \nChapter 1. General",
    "introduction": "...................................................................................................1 \nChapter 2. Literature Review ........................................................................................................3 \n2.1.0. Introduction.........................................................................................................................3 \n2.1.1. The Aging Body ..............................................................................................................3 \n2.2.0. Methodologies for Measuring Body Composition...............................................................6 \n2.2.1. Measurement of Fat........................................................................................................6 \n2.2.2. Measurement of Muscle ...............................................................................................11 \n2.3.0. Health Risk Associated with Age-Related Body Composition Changes..........................14 \n2.3.1. Obesity and Age-Related Health Risk..........................................................................15 \n2.3.1.1. Health Risks of Abdominal Obesity........................................................................15 \n2.3.1.2. Health Risks of Excessive Visceral Adiposity ........................................................16 \n2.3.1.3. Health Risks of Ectopic Lipid Storage....................................................................19 \n2.3.2. Sarcopenia and Functional Impairment........................................................................20 \n2.3.2.1. Prevalence of Sarcopenia in Aging........................................................................21 \n2.3.2.2. Functional Impairment with Muscle Loss...............................................................22 \n2.3.3. Simultaneous Obesity and Sarcopenia ........................................................................24 \n2.4.0. Treating Age-Related Health Risk through Lifestyle Intervention ....................................25 \n2.4.1. Treatment of Obesity in the Elderly ..............................................................................26 \n2.4.2. Treatment of Sarcopenia in the Elderly ........................................................................35 \n vii\n\n \n2.4.3. Exercise Modalities for Treatment of Sarcopenic Obesity............................................36 \n2.5.0. Summary ..........................................................................................................................38 \nChapter 3. First Manuscript ........................................................................................................40 \nABSTRACT ................................................................................................................................41 \nINTRODUCTION........................................................................................................................42",
    "methods": "..................................................................................................................................44 \nParticipants .............................................................................................................................44 \nDietary Assessment................................................................................................................44 \nExercise Regimen...................................................................................................................45 \nMeasurement of Body Composition .......................................................................................46 \nMeasurement of Cardiorespiratory Fitness ............................................................................46 \nMeasurement of Insulin Sensitivity and Glucose Tolerance...................................................47 \nStatistical Analysis ..................................................................................................................47",
    "results": "...................................................................................................................................48 \nAdherence to the Exercise and Diet Regimen........................................................................48 \nBaseline Characteristics and Gender Differences..................................................................48 \nAnthropometric Variables .......................................................................................................48 \nTotal Fat and Total Subcutaneous Fat ...................................................................................49 \nAbdominal Fat.........................................................................................................................49 \nSkeletal Muscle.......................................................................................................................49 \nInsulin Sensitivity ....................................................................................................................49 \nCardiorespiratory Fitness........................................................................................................50",
    "discussion": ".............................................................................................................................51 \nACKNOWLEDGEMENTS...........................................................................................................55 \nChapter 4. Second Manuscript ...................................................................................................61 \nABSTRACT ................................................................................................................................62 \nINTRODUCTION........................................................................................................................63 \nMETHODS..................................................................................................................................64 \n viii\n\n \nParticipants .............................................................................................................................64 \nDietary Assessment................................................................................................................64 \nExercise Regimen...................................................................................................................65 \nMeasurement of Cardiorespiratory Fitness ............................................................................66 \nMeasurement of Functional Fitness .......................................................................................66 \nMeasurement of Body Composition .......................................................................................66 \nStatistical Analysis ..................................................................................................................67 \nRESULTS ...................................................................................................................................68 \nBaseline Characteristics and Gender Differences..................................................................68 \nDietary Intake..........................................................................................................................68 \nExercise Programs .................................................................................................................68 \nAnthropometric Variables .......................................................................................................69 \nCardiorespiratory Fitness........................................................................................................69 \nFunctional Fitness...................................................................................................................69 \nSkeletal Muscle.......................................................................................................................70 \nTotal Fat..................................................................................................................................70 \nAssociations between Muscle, Fat, and Functional Performance..........................................70 \nDISCUSSION .............................................................................................................................71 \nACKNOWLEDGEMENTS...........................................................................................................75 \nChapter 5. General Discussion...................................................................................................83 \nSummary and",
    "conclusions": "........................................................................................................87 \nReferences....................................................................................................................................88 \nAppendices.................................................................................................................................105 \n7.1.0. Senior Study Manual of Procedures...............................................................................106 \n7.1.1. Introduction .................................................................................................................106 \n7.1.2. Key Personnel ............................................................................................................106 \n7.1.3. Recruitment Strategies ...............................................................................................110 \n7.1.4. Screening of participants ............................................................................................112 \n ix\n\n \n7.1.5. Orientation meetings...................................................................................................114 \n7.1.6. Nutritional meetings....................................................................................................116 \n7.1.7. Randomization............................................................................................................118 \n7.1.8. Assessments ..............................................................................................................119 \n7.1.8.1. Anthropometrics...................................................................................................119 \n7.1.8.2. Functional fitness .................................................................................................122 \n7.1.8.3. Glucose tolerance ................................................................................................126 \n7.1.8.4. Cardiorespiratory fitness test (VO2max) ..............................................................128 \n7.1.8.5. Magnetic resonance imaging ...............................................................................136 \n7.1.8.6. Magnetic resonance spectroscopy ......................................................................138 \n7.1.8.7. Computed tomography.........................................................................................139 \n7.1.8.8. Hyperinsulinemic Euglycemic Clamp...................................................................146 \n7.1.8.9. Bioelectrical Impedance.......................................................................................150 \n7.1.8.10. Basal Metabolic Rate and Clamp Calorimetry ...................................................152 \n7.1.8.11. Blood Pressure...................................................................................................154 \n7.1.8.12. Blood Lipids / Blood Gases................................................................................155 \n7.1.9. Exercise Interventions ................................................................................................157 \n7.1.9.1. Aerobic Exercise ..................................................................................................158 \n7.1.9.2. Resistance Exercise.............................................................................................159 \n7.1.10 Data Management .....................................................................................................162 \n7.1.11 Results Packages......................................................................................................165 \n7.1.12. Statistical Analyses...................................................................................................166 \n7.1.13. Procedural Appendices.............................................................................................168 \nAppendix 1: Newspaper Advertisements ..........................................................................169 \nAppendix 2: Promotional Articles Written by Senior Participants .....................................173 \nAppendix 3: Study Poster..................................................................................................176 \nAppendix 4: Promotional Article by Pat Galasso ..............................................................178 \nAppendix 5: PowerPoint Presentation Used for Orientation Meetings .............................180 \n x\n\n \nAppendix 6: Orientation Meeting Information Sheet .........................................................186 \nAppendix 7: Informed Consent..........................................................................................188 \nAppendix 8: Medical Questionnaire ..................................................................................201 \nAppendix 9: Daily Dietary Record .....................................................................................210 \nAppendix 10: Goals for Nutrition Sessions .......................................................................212 \nAppendix 11: Anthropometric Data Collection Form.........................................................215 \nAppendix 12: Functional Fitness Test Data Sheet............................................................218 \nAppendix 13: Heart Rate Record for Graded Maximal Exercise Test ..............................220 \nAppendix 14: VO2max Summary Data Sheet ...................................................................222 \nAppendix 15: Whole Body MRI Acquisition Protocol ........................................................224 \nAppendix 16: MRI Script File.............................................................................................227 \nAppendix 17: MRI Script Record.......................................................................................229 \nAppendix 18: MRI Partial Volume Anomalies Guide.........................................................231 \nAppendix 19: MRI Tissue Area and Whole Body Volume Calculations............................234 \nAppendix 20: CT Requisition Form ...................................................................................236 \nAppendix 21: Clamp Data Sheet.......................................................................................238 \nAppendix 22: Blood Gases and Lipid Profile Requisition Forms ......................................241 \nAppendix 23: Medical Outcomes Survey -- SF-36............................................................244 \nAppendix 24: Informed Consent for Hoffmann-LaRoche Study........................................251 \nAppendix 25: Aerobic Exercise Session Record...............................................................257 \nAppendix 26: Resistance Exercise Session Record.........................................................259 \nAppendix 27: Results Package for Participants................................................................261 \nAppendix 28: Results Package Letters for Physicians......................................................275 \nAppendix 29: SAS Code for Intent-to-Treat Analysis........................................................280 \nAppendix 30: Multiple Imputations Output for Changes in Body Weight ..........................284 \n7.2.0. Associated Appendix: Liver Fat Methodology Paper .....................................................292 \n7.3.0. List of Publications and Abstracts ..................................................................................298 \n \n xi\n\n \nList of Tables \n \nChapter 2 \nTable 1. Methods for measuring whole body and/or regional fat as a health outcome .................. 8\nTable 2. Methods for measuring skeletal muscle size/mass as a health outcome in the \nelderly .............................................................................................................................12 \nTable 3. Effect of aerobic exercise on whole body fat and health outcomes in the elderly: \nrandomized controlled trials............................................................................................27 \nTable 4. Effect of aerobic exercise on whole body fat and health outcomes in the elderly: \nother study designs ........................................................................................................28 \nTable 5. Effect of resistance exercise on whole body fat and health outcomes in older \nmen and women .............................................................................................................29 \nTable 6. Effect of aerobic exercise on abdominal fat and health outcomes in elderly men \nand women .....................................................................................................................32 \nTable 7. Effect of resistance exercise on abdominal fat and health outcomes in elderly \nmen and women .............................................................................................................33 \n \nChapter 3 \nTable 1. Subject characteristics at baseline..................................................................................56 \nTable 2. Changes in selected morphologic, metabolic and fitness variables ............................... 57 \n \nChapter 4 \nTable 1. Subject characteristics at baseline..................................................................................76 \nTable 2. Changes in selected anthropometric, cardiorespiratory and functional fitness \nvariables over 6 months of treatment .............................................................................77 \nTable 3. Associations between changes in muscle, fat, and functional performance \nImprovement...................................................................................................................78 \n xii\n\n \n \nList of Figures \n \nChapter 2 \nFigure 1. Age-related changes in visceral and subcutaneous adipose tissue................................ 4 \n \nChapter 3 \nFigure 1. Participant flow diagram ................................................................................................58 \nFigure 2. Changes in abdominal fat and associated waist circumference.................................... 59 \nFigure 3. Percent changes in muscle, visceral fat, and insulin sensitivity .................................... 60 \n \nChapter 4 \nFigure 1. Participant flow diagram ................................................................................................79 \nFigure 2. Changes in age- and sex-specific ranking on four functional fitness tests.................... 80\nFigure 3. Percent changes in cardiorespiratory and functional fitness, total muscle and \nfat with exercise modality..............................................................................................81 \nFigure 4. Functional fitness performance by muscle and fat change tertile groups ..................... 82\n \n \n \n \n \n \n \n \n \n xiii\n\n \nList of Abbreviations \n \nACSM American College of Sports Medicine \nANCOVA Analysis of covariance \nANOVA Analysis of variance \nASAT Abdominal subcutaneous adipose tissue \nADP Air displacement plethysmography \nBIA Bioelectrical impedance \nBMI Body mass index \nCIHR Canadian Institutes of Health Research \nCRP C-reactive protein \nCT Computed tomography \nDEXA Dual energy x-ray absorptiometry \nFFA Free fatty acids \nFFT Functional Fitness Tests \nHDH Hotel Dieu Hospital \nHDL High density lipoproteins \nHealth ABC Health, aging, and body composition study \nHOMA Homeostasis model assessment \nHRmax Maximal heart rate \nHRR Heart rate reserve \nHU Hounsfield units \nHydro Hydrostatic weighing \nIL-6 Interleukin-6 \nIMCL Intramyocellular triglyceride \nIR Insulin resistance \nIVNA In vivo neutron activation \nKGH Kingston General Hospital \n xiv\n\n \nL4-L5 Intervertebral space between the 4th and 5th lumbar vertebrae \nLDL low-density lipoproteins \nMRI Magnetic resonance imaging \nMRS Magnetic resonance spectroscopy \nNHANESIII Third national health and nutrition survey \nOGTT Oral glucose tolerance test \nPPAR-γ Peroxisome proliferator-activator receptor-γ \nRSMI Relative skeletal muscle index \nSI Sensitivity index \nSMI Skeletal muscle index \nTC Total cholesterol \nTNF-α Tumor necrosis factor-α \nT12-L1 Intervertebral space between 12th thoracic and 1st lumbar vertebrae \nVAT Visceral adipose tissue \nVCO2 Rate of carbon dioxide expired \nVO2max Rate of oxygen consumed during maximal exercise \nVO2peak Peak rate of oxygen consumed during exercise \nWC Waist circumference \nWHO World Health Organization \nWHR Waist-to-hip ratio \n \n \n xv\n\n \nChapter 1. General Introduction \n \n Obesity, especially abdominal obesity, is a predominant phenotype of the aging \nCanadian. The prevalence of obesity throughout North America has increased dramatically in \npast decades such that now a clear majority of men and women over 65 are considered \nabdominally obese.1 Of particular concern is that with aging, an expanding waistline represents a \ndisproportionate increase in visceral adipose tissue -- an established independent predictor of \nmorbidity2, 3 and mortality,4 and a major contributor to disease states common in the elderly and \nwhich add significantly to the burden of health care.5 Furthermore, the sedentary lifestyle that is \noften associated with an abdominally obese profile exacerbates age-related muscle loss, which \nprecipitates declining muscle function and an increased incidence of disability.6-8 \n Although clinicians routinely prescribe weight reduction programs for younger obese \nadults, uncertainty exists regarding the appropriate strategy for obesity reduction in the elderly. \nBecause weight loss, especially that attained through caloric restriction, is commonly associated \nwith lean tissue loss concurrent with fat reduction,9-13 purposeful weight loss may not be an ideal \nprescription for an older patient in whom declining muscle mass may compromise mobility and \nfunctional capacity, and even lead to metabolic morbidity.14 Evidence compiled from numerous \nstudies shows that while weight loss induced by exercise alone may be modest in comparison to \nthat obtained through caloric restriction, exercise training may provide a stimulus for preservation \nof skeletal muscle while mobilizing energy from risk-laden abdominal adiposity.10 \n While a reasonable prescription for health risk reduction in the elderly may be to focus on \nexercise alone, some uncertainty exists as to which modality of exercise yields optimal benefits. \nWhereas a program of progressive resistance exercise may have a profound effect on muscle \nmass, strength, and functional capacity, the energy expended per session may not be sufficient \nfor reducing abdominal obesity and its associated metabolic risk. On the other hand, the energy \nexpenditure of aerobic exercise may stimulate a more substantial reduction of abdominal obesity \nand metabolic risk, yet fail to provide the increased muscle mass and functional capacity typical \nof resistance exercise. Since either modality offers unique outcomes desirable for sedentary, \n1 \n\n \nabdominally obese older persons, it is likely that the optimal exercise prescription would be one \nthat incorporates both modalities. Indeed, currently-accepted exercise recommendations for the \nelderly acknowledge the benefits of both modalities and encourage a combination approach.15 \nHowever, nearly absent from the literature are supporting studies which compare the independent \neffects of aerobic or resistance exercise against a program which combines the two exercise \nmodalities. \n In the two manuscripts contained in chapters 3 and 4, we report the independent and \ncombined effects of resistance and aerobic exercise on abdominal obesity and insulin resistance, \nmuscle mass and functional fitness in abdominally obese, sedentary older adults. With a tightly-\ncontrolled, randomized study design, we compared the effects of exercise modality using “gold \nstandard” methodologies to measure the morphological, metabolic, and functional adaptations \nthat underlie modest, exercise-induced weight loss. A novel aspect of our study design is our \ninvestigation of the effects of exercise, independent of caloric restriction, and a pragmatic \napproach to exercise prescription that is consistent with consensus recommendations. Our \npurpose in performing this trial, hereafter referred to as the Senior Study, was to provide empirical \ndata to support an improved therapeutic strategy for the prevention and treatment of abdominal \nobesity, the reduction of health risk, and improved physical function in older men and women. \n \n2 \n\n \nChapter 2. Literature Review \n \n2.1.0. Introduction \n Fundamental to the aging process are the morphological changes that occur within the \nhuman body during later decades of life. Beneath the graying hair and wrinkles that are generally \nassociated with the “golden years,” aging often brings a myriad of medical maladies that hamper \nquality of life and lead to increased disability, dependent living, and eventual death. Although \nmedicine has made unprecedented progress over less than a century toward developing \nremedies and risk reduction practices, accounting for much of the over 30% increase of life \nexpectancy in the United States16 and Canada,17 the resultant lifespan extension has brought to \nthe forefront a new wave of senescence-related medical conditions, many of which are \nexacerbated by poor lifestyle choices. The challenge for today’s seniors is not simply living long \nenough, but striving for healthy aging: a lifestyle that includes independence from disease states \nand disability. This review discusses current methodologies employed to measure body \ncomposition for the purpose of assessing age-related health risk, details the health risks of a \nsedentary lifestyle in aging, and then compares effectiveness of lifestyle-based intervention \nstrategies employed to improve health and quality of life in the elderly. \n \n2.1.1. The Aging Body \n The human body experiences subtle changes in morphology as it ages. Data from \nseveral classic cross-sectional population studies indicate that body weight and body mass index \n(BMI; weight in kilograms divided by height in centimeters squared) gradually increase through \nadulthood, peak at approximately 60 years, and then decline.18, 19 This decline in weight could be \nattributed to the increased early mortality rate of obese persons,20, 21 effectively “thinning” the \nsurviving population as it ages. Prospective studies, however, generally confirm the cross-\nsectional results, indicating that beyond 60 years of age, body weight and BMI are either \nmaintained or tend to decrease.22, 23 Sometimes these decreases in weight over time in the \nelderly are misconstrued as an arrest in the progression of obesity, and, for many who have been \n3 \n\n \nindoctrinated in the woes of weight gain, weight loss is considered an indication of improved \nhealth. With a closer look at the subtle changes occurring in various tissues in the aging body, \nhowever, one realizes that weight loss in the elderly may have deleterious health outcomes, \ndepending on which tissue is waning. \n Two major tissues in the body change in opposite directions with age: adipose tissue and \nskeletal muscle. Whole body adipose tissue or fat mass generally continues to increase over \ntime,24 and that increase has been measured at a rate of approximately 7.5% per decade in older \nmen and women.25 Age-related fat mass changes do not appear to be uniform throughout the \nbody, since decreases of 17% in subcutaneous fat thickness are observed with concomitant \nincreases in total body fat mass and waist girth over a decade.26 A longitudinal study in 1300 \nSwedish women also demonstrated a progressive, approximately 0.7 cm per year increase in \nwaist circumference, even in the oldest participants.27 Studies conducted using computed \ntomography (CT) have demonstrated that this progressive increase in abdominal girth indicates \ngrowth of the intra-abdominal or visceral fat depot, which increases significantly with age in men \nand women despite reductions in subcutaneous fat.28-30 Figure 1 illustrates how concomitant \nchanges in visceral and abdominal subcutaneous fat may result in the same waist circumference \nin a 60-year-old versus an 80-year-old man. \n \naFigure 1. Age-related changes in visceral and subcutaneous adipose tissue \n \n \n60 year old male \n106 cm waist \n137 cm2 visceral fat \n269 cm2 subcutaneous fat \n80 year old male \n106 cm waist \n309 cm2 visceral fat \n174 cm2 subcutaneous fat \n4 \n\n \nFurther investigations into regional fat deposition using CT and magnetic resonance imaging \n(MRI) have determined that aging is associated with concomitant increases in the amount of fat \nstored within metabolically active tissues such as muscle31 and liver.32 Fatty infiltration of lean \ntissue and growth of abdominal adiposity alongside thinning subcutaneous fat layers represents a \nprogressive shift of lipid in the body from its “normal” storage depot toward “ectopic” storage of \nlipid: a phenomenon called lipodystrophy, describing the body’s inability to develop adequate \nadipose tissue mass to store lipid. The lipodystrophy of aging is associated with marked \nincreases in metabolic risk.33 \n With lipid storage progressively increasing with age, how might one explain an observed \nmaintenance or even reduction of weight over time in an elderly population? A major contributor \nto age-related weight reduction is a phenomenon called “sarcopenia,” a term coined by Irwin \nRosenberg in 1988 to describe the steady, involuntary decline in skeletal muscle mass that \noccurs with aging.34 Significant muscle loss is generally reported to begin occurring somewhere \nin the 5th decade of life and accelerate through old age.35 Men usually carry more muscle than \nwomen in younger years, and the subsequent loss of that muscle is more rapid than women later \nin life.36 Regardless of gender, the difference between young and old subjects is primarily seen in \nlower-body muscle.36 Since muscle mass contributes substantially to overall body mass, \nparticularly in men, sarcopenic reductions in skeletal muscle are at least partly responsible for \nobserved weight and BMI declines in the elderly: perhaps even in spite of continued fat \naccumulation. Whereas metabolic health risk and disease are often linked to excessive obesity \nand lipodystrophy, insufficient skeletal muscle is also laden with its own debilitating \nconsequences. That both phenomena progress simultaneously in the aging body is indeed a \ncause for concern, and presents a unique challenge for intervention. \n The sections that follow will discuss the current methods available for measuring the \nsubtle changes in body composition that occur with age, identify the health risks associated with \nage-related lipodystrophy and sarcopenia, and then discuss appropriate lifestyle modifications \ndesigned to reverse the progression of disease and disability in older men and women. \n \n5 \n\n \n2.2.0. Methodologies for Measuring Body Composition \n For the purpose of acquainting the reader with the methods used in the literature for \nassessment of body composition in the elderly, this section will discuss and compare the various \ntechniques available for quantification of fat and muscle, respectively, and describe their utility in \ncharacterizing obesity and sarcopenia in aging humans. \n \n2.2.1. Measurement of Fat \n As interest in obesity escalates, methods of body composition assessment have also \nrapidly advanced, illuminating the intricacies of regional fat deposition and the lipodystrophy of \naging. The measurement of fat has progressed from simple weight-by-height estimates to in-vivo \nwhole body imaging for tissue identification. As described above, an inherent part of the aging \nprocess is a progressive reduction in fat-free mass and an increase in the ratio between fat and \nfat-free mass. Body mass index (BMI), a simple measure of weight that accounts for standing \nheight, is a measure that is commonly used to assess health risk in younger populations because \nof its strong relationship with obesity. Since stature and skeletal muscle mass decrease while fat \ndeposition is maintained or continues to increase in the aging population, weight and BMI are not \nas accurate health and mortality risk assessment tools for the elderly as compared to \nmeasurements of body composition.37, 38 Currently there are no internationally-accepted \nthresholds for overweight and obesity by BMI specific to older men and women. Rather, it is \nwidely accepted that various measures of fat distribution have greater predictive power for health \nrisk assessment in aging, either coupled with or at the exclusion of BMI.39, 40 An extensive review \nof the history and development of numerous body composition measures has recently been \npublished,41 and the reader is directed there for in-depth descriptions of the historical \ndevelopment and use of each measurement method. However, with regards to the assessment \nof fat in the elderly, a comparison of various techniques and their relative advantages and \ndisadvantages for use in aging research is found in Table 1. \n Because fat deposition changes with aging and the known health risk associated with \nexcessive accumulation of abdominal obesity, methods capable of quantifying changes in \n6 \n\n \n7 \nregional adiposity have the greatest utility for assessing fat-dependent health risk in the elderly. \nHence, of the measures listed in Table 1, those which simply assess whole body volume have \nless clinical relevance in elderly populations. In previous decades, hydrostatic weighing was \nconsidered the gold standard method for determining whole body volume, a variable that can be \nused with body weight to determine whole body density, from which body fat percentage can be \nderived with various equations.42, 43 Some of the technical limitations inherent to this method with \nthe elderly are that difficulties may arise when the subject is particularly buoyant as a result of \nhigher body fat stores and reduced muscle mass, and problems with compliance to protocol often \noccur when an elderly subject is required to expel as much air as possible from the lungs while \nunderwater. Another alternative for whole body volume assessment is air displacement \nplethysmography, an alternative to underwater assessment that employs air chambers and \nadiabatic pressure to assess whole body volume. Three-dimensional body scanning, by laser \nrefraction technology or by dual digital photography, is an emerging method of obtaining whole \nbody volume, especially on oversized individuals. The utility of three-dimensional imaging is still \nunknown, as body composition validation studies have not yet shown to reliably compare with \nHydro,\n44, 45 but as the technology develops, it may potentially rival both Hydro and air \ndisplacement plethysmography due to its ability to obtain accurate abdominal or appendicular \ncircumference data to describe regional fat distribution as part of the data acquisition process. \nOther anthropometric measures of regional girth, namely waist circumference, waist-to-hip ratio, \nand abdominal sagittal diameter are less expensive methods and have been more frequently \nused in the literature to describe the unique obesity characteristics of aging. \n Several imaging techniques allow viewing of specific tissues that underlie circumferences \nand body volumes. Dual-energy x-ray absorptiometry (DEXA) is one that uses a low x-ray \ndosage to obtain a whole-body image and is capable of differentiating fat and lean mass by the \nrelative density of appendicular and truncal regions. Some limitations to DEXA assessment of \nwhole body fat have been documented, especially when comparing machines from different \nmanufacturers46, 47 or from pencil- and fan-beam technologies,48-50 but overall, this method is \nconsidered reliable, repeatable, and reasonably accurate. Although not an imaging technique, \n\n \n Disadv es \n \n \naTable 1. Methods for measuring whole body and/or regional fat as a health outcome \n \nTechnique Measured Quantity \nWhole \nBody Regional Advantages antag\nMRI Cross-sectional fat quantification Yes Yes Most accurate and repeatable; \nquantifies internal fat depots; \nnon-hazardous; “gold standard” \nVery expensive and time-\nconsuming \nMRS Lipid content of various lean \ntissues \nNo Yes Actual quantification of \nmuscle/liver fat \nVery expensive and time-\nconsuming \nCT Cross-sectional fat quantification; \nattenuation of x-ray energy \nestimates lipid content of lean \ntissues \nNo Yes Most accurate and repeatable; \nquantifies internal fat depots; \nqualitative muscle/liver fat \nassessment \nExpensive; radiation exposure \nDEXA Relative attenuation of two x-ray \nenergies \nYes Yes Fairly accurate and repeatable Minimal radiation exposure; fair \nassessment of total abdominal fat \nUltrasound Adipose tissue depth No Yes Distinguishes between visceral \nand subcutaneous depots \nNot widely used as a health \noutcome \n3D body \nscanning \nBody surface area/volume; \ncircumferences \nYes Yes Regional girth measurements in \naddition to body volume \nNew technology; not widely used \nADP Whole body volume Yes No More tolerable than underwater \nweighing \nAge-specific % body fat estimates \nnot yet developed \nHydro Whole body volume and density Yes No Widely used in early studies Expelling lung air underwater \nintolerable for some subjects \nBioelectrical \nimpedance \nResistance and reactance of an \nalternating electrical current \nthrough body tissues \nYes Yes Inexpensive and widely used Poor assessment of total \nabdominal fat; questionable \nreliability \nSkinfolds Thickness of a fold of \nsubcutaneous fat \nYes Y s e Site-specific regional\nmeasurement of subcutaneous \nfat \nCertain regions difficult to assess \nwith increasing obesity; between-\ntester reliability relatively low \nWaist \ncircumference \nAbdominal girth No Yes Correlates well with visceral fat \nvolume \nCombines visceral and \nsubcutaneous \nWaist-to-hip \nratio \nRatio of abdomen to hip/buttocks \ngirth \nNo Yes Indicates upper- versus lower-\nbody fat; wide use in earlier \npopulation studies \nRatio sometimes fails to capture \nrisk changes \nAbdominal \nsagittal diameter \nDistance between anterior and \nposterior trunk at iliac crest \nNo Yes Correlates well with visceral fat \nvolume \nNot as easily obtained as waist \ncircumference \nAbbreviations: MRI(S) = magnetic resonance imaging (spectroscopy); CT = computerized tomography; DEXA = dual-energy x-ray \nabsorptiometry; Hydro = hydrodensitometry or underwater weighing; ADP = air displacement plethysmography. \n\n\n \nbioelectrical impedance is another method that differentiates between fat and fat-free mass by \nmeasuring resistance and reactance of water-containing tissues of the body as an alternating \nelectrical current passes through it. Various prediction equations for whole body fat mass have \nbeen derived from aging populations with DEXA as a reference.51-54 Because most bioelectrical \nimpedance equipment is inexpensive and portable, this method has gained popularity for use in \nepidemiological studies as well as for clinical and commercial facilities. Impedance tends to \npredict body composition well on a population level, but some have questioned its ability to \npredict body composition change on an individual level.55 \n Imaging methods such as computed tomography (CT) and magnetic resonance imaging \n(MRI) are considered the most accurate and repeatable methods for in-vivo quantification of \nwhole body obesity and have the added benefit of differentiating between and quantifying various \ninternal fat depots. The two methods differ primarily in the manner in which the images are \nobtained. While both acquire cross-sectional images throughout the body, providing a view of \ninternal lean and adipose tissue, acquisition of these images by CT requires ionizing radiation, \nwhich deters the use of CT for quantification of fat other than in specific regions of the body. On \nthe other hand, MRI acquisition does not deliver any harmful radiation, but uses the interaction \nbetween hydrogen nuclei within bodily tissues and the magnetic fields created by the MRI \nsystem’s instrumentation to generate a cross-sectional image of the body. The absence of \nradiation exposure in MRI increases its clinical utility and makes it the method of choice for whole \nbody quantification of adipose tissue. Acquisition costs, availability, and time required to analyze \nthe images prohibit use of MRI in larger epidemiological studies, however. \n Although both CT and MRI were initially used to quantify the cross-sectional area of \nadipose tissue depots, they can also be used for in-vivo measurement of lipid deposition in lean \ntissue. Excessive lipid stored in tissues other than subcutaneous adipose tissue can be referred \nto as ectopic fat, meaning that its location is somewhere other than the customary site for most \nlipid deposition, namely subcutaneous fat. Several metabolically important ectopic fat depots \nhave been shown to be independent risk factors for disease3, 56, 57 and can be measured using \nMRI and/or CT technology. Two examples of ectopic depots are skeletal muscle and liver. \n9 \n\n \nTraditionally, fat accumulation in these two tissues was measured by biopsy. However, biopsies \nmay be painful58 and impart additional risk of bleeding and other complications that may result in \nhospitalization or possible death.59 Magnetic resonance spectroscopy, using the same machinery \nas MRI, is able to quantify lipid content in specific regions of lean tissue, and can differentiate \nbetween intra- and extramyocellular lipid in that region.60 This technology is being used with \nincreasing frequency in the literature to quantify lipid content of liver and skeletal muscle, and has \nbeen used in elderly subjects.32 \n Computed tomography may also be used to indicate the lipid deposition in skeletal \nmuscle and liver. Measuring the extent of attenuation of x-ray particles as they pass through \nspecific tissues, CT can detect the extent of lipid infiltration in lean tissue by virtue of the lean \ntissue’s density. Not a quantitative method for measuring lipid content, CT assesses lean tissue \nquality, and has been used in studies linking liver61 and muscle62 lipid levels to metabolic risk. \nAlthough the accessibility and ease of acquisition is much greater in CT than magnetic resonace \nspectroscopy, CT imaging still delivers measurable radiation exposure to subjects, which again \nlimits this method for frequent or repeated measurements. Until recently, studies measuring liver \nfat were left to their own devices in determining the amount and location of chest images to \nacquire a suitable image of liver for analysis. Also the location of specific regions of interest \nseemed to produce variable attenuation results.63 Our research group at Queen’s University, \nusing data collected at the Cooper Institute in Dallas, Texas, produced a methodology paper that \nproposed a novel approach to CT liver acquisition.64 Using 437 full-abdomen image sets of male \nand female subjects characterized by a wide range of age and obesity, we determined that the \noptimal image location for obtaining a simultaneous liver and spleen image in our sample was the \nintervertebral space between the 12th thoracic and 1st lumbar vertebrae (T12-L1). We also \nassessed the mean attenuation of liver and spleen in 8 different regions, respectively, for the \npurpose of determining optimal areas for placement of regions of interest. Because of the relative \nuniformity of density found throughout the liver, we proposed that attenuation of the whole liver \nvisible on a single T12-L1 image, instead of using regions of interest, was the optimal approach \nfor reducing analytical bias. This work established a procedure for liver fat acquisition that \n10 \n\n \n11 \nminimizes radiation exposure and provides a uniform approach to liver analysis.64 A full copy of \nthis published manuscript is found as an appendix in section 7.2.0. of this dissertation. \n In summary, an array of whole body and regi onal fat assessment tools are available for \nuse with elderly subjects. The lipodystrophy of aging can be gauged by measures as simple as \nwaist circumference, but radiological methods can quantify the different adipose tissue depots \notherwise undetectable by circumferences. Furthermore, imaging technology allows for in vivo \nanalysis of ectopic lipid deposition in metabolically active tissues like liver and muscle. \n \n2.2.2. Measurement of Muscle \n Measurement of body composition is often cons idered in reference to the health risk of \nobesity in younger populations, but a major contributor to the disability of aging is a reduced \nmuscle mass, or sarcopenia. In aging studies, the quantity of muscle is a good indicator of \nmuscle strength and thus, is a good indirect measure of functional capacity and health. Similar to \nobesity, a variety of skeletal muscle measurement methods are available for use in studies with \nelderly subjects. Several comprehensive reviews have detailed the advantages and \ndisadvantages of each muscle measurement method.41, 65, 66 A brief summary of these \nmeasurements follows to acquaint the reader with the methodologies commonly used to assess \nthe health risk associated with sarcopenia. Table 2 provides a synopsis of the measurement \nmethods discussed in this section. \n As mentioned in the previous section on obesity, skeletal muscle mass cannot be \nmeasured directly by simple weight or BMI. In aging, however, observed declines in weight often \nindicate sarcopenic reductions in muscle mass. Thus, a very low BMI imparts an increased risk \nin older men and women, especially when controlling for waist circumference.40 For similar \nreasons, the hip component of the waist-to-hip ratio may indicate gluteal muscle mass, which \nmay explain the inverse association between hip circumference and health or disability risk. \nAppendicular circumferences, especially a triceps circumference with correction for skinfold \nthickness, were used widely in the literature for decades. The accuracy of this method was \n\n \n Disadv es Disadv es \n \n \nbTable 2. Methods for measuring skeletal muscle size/mass as a health outcome in the elderly \n \nMethods for measuring skeletal muscle size/mass as a health outcome in the elderly \nTechnique Technique Measured Quantity Measured Quantity \nWhole \nBody\nWhole \nBody RegionalRegional AdvantagesAdvantages antagantag\n \n \n \nMRI Cross-sectional muscle size \nquantification; volume \nconversion to mass \nYes Yes Most accurate and repeatable; \nquantifies regional and whole \nbody muscle; non-hazardous; \n“gold standard” \nVery expensive and time-\nconsuming \nCT Cross-sectional muscle size \nquantification \nNo Yes Most accurate and repeatable; \nquantifies regional muscle \nExpensive; radiation exposure \nDEXA Relative attenuation of two x-ray \nenergies \nYes Yes Fairly accurate and repeatable Minimal radiation exposure \nWhole-body \ncounting/IVNA \nTotal body nitrogen \nTotal body potassium \nYes No Noninvasive; minimal age or \ngender dependencies in \nprediction \nHigh cost; restricted availability; \nvariability in muscle estimation \nBioelectrical \nimpedance \nResistance and reactance of an \nalternating electrical current \nthrough body tissues \nYes Yes Inexpensive and widely used Variability in results on the \nindividual level \nCircumferences Hips and appendicular girth, \nsometimes corrected for skinfold \nfat \nNo Yes Indicates upper- versus lower-\nappendicular muscle; used widely \nin early literature \nEstimation error increases with \nincreasing obesity \nAbbreviations: MRI(S) = magnetic resonance imaging (spectroscopy); CT = computerized tomography; DEXA = dual-energy x-ray \nabsorptiometry; IVNA = in vivo neutron activation. \n \n \n \n \n \n \n \n\n\n \n \nexamined in comparison to CT cross-sectional area of muscle at mid-humerus, and was found to \noverestimate muscle by 15-20% in normal weight individuals.67 Even with revised, sex-specific \nequations that took into account humeral bone mass, the intra-individual error of circumferences \nwas large and increased in those with higher body weights.68 While circumferences give an \nindication of muscle mass, the inaccuracy associated with this measurement method, especially \nwhen monitoring subtle age-related declines in muscle mass, may undermine its utility in \nintervention studies. \n Bioelectrical impedance was discussed earlier as a measure of whole body fat mass, yet \nin reality, bioelectrical impedance systems measure the voltage drop across a measured tissue \nbed, and since fat mass is a poor conductor of electricity, fat-free mass and total body water are \nthe variables more directly assessed by this method. Because age-related changes in whole \nbody muscle composition, which is the major appendicular conductor, impede the flow of \nelectricity independent of muscle volume, age-specific formulas are required for appropriate \nbioelectrical impedance associations in older adults.69 Indeed, prediction equations have been \nproposed for fat- free mass in the elderly such that bioelectrical impedance can be used as a \nviable measure of lean tissue in this age group.52, 53, 70 However, some limitations still exist \nregarding variation of results on an individual level.55 \n Whole body counting and in-vivo neutron analysis are methods which were developed as \na by-product of nuclear-based industrial testing of accidental radiation exposure in laboratory \nsettings. Either by detecting the naturally occurring radioactive potassium-40 isotope or by \nactivating various elements contained in human fat-free mass by neutron stream, these methods \ndetermine fat-free body mass with high correlations to DEXA and little need to apply age-\ndependent formulas.66 Availability of and access to this technology, however, is limited. \n Both whole body fat and lean tissues can be estimated in the elderly using DEXA. An \nadded convenience to using this method in elderly populations is that it is the method of choice \nfor osteoporosis screening -- a test that should be performed regularly, especially in \npostmenopausal women. Despite a low level of exposure to ionizing radiation inherent to x-ray \ntechnology, use of the DEXA is considered to estimate lean tissue mass well in the elderly.66 \n13 \n\n \n For reasons similar to those stated in the obesity measurement section, MRI and CT \nremain the methods of choice for quantifying muscle size. Using region-specific cross-sectional \nimages, researchers can differentiate between fat, lean, and skeletal muscle tissue. Both MRI \nand CT have been used to obtain a single cross-sectional image of mid-thigh to estimate skeletal \nmuscle quantity or adaptations to change. However, radiation exposure limits use of CT for more \nthan single-slice or regional composition measures. Imaging and subsequent quantification of \nwhole body skeletal muscle by MRI is possible by various multiple-image protocols.71, 72 Using a \nwhole-body, multiple-image approach, researchers are not only able to quantify skeletal muscle \nvolume, but also organ, bone, and the various adipose tissue depots as described above. \nAlthough the cost and time-consuming analysis of MRI assessment of skeletal muscle remains \nprohibitive for large-scale studies, acquisition time is decreasing73 and machines are becoming \nmore prevalent. \n As a summary of the methods available for use in the study of muscle size in the elderly, \nseveral stand out for different reasons. First, bioelectrical impedance machines can be \npurchased relatively inexpensively and give an indication of changes in total muscle volume, \nalbeit with potential for variability in results. Second, whole-body DEXA scanning is growing in \npopularity, and couples a reliable measure of appendicular muscle mass with capacity for bone \ndensitometry. Third, while expensive, MRI provides the most accurate and repeatable \nrepresentation of skeletal muscle mass available, and can be considered the “gold standard” of \nin-vivo body composition measurement techniques. \n \n2.3.0. Health Risk Associated with Age-Related Body Composition Changes \n Advances in body composition assessment permit the characterization of the \nlipodystrophy of aging and introduce methodologies capable of monitoring sarcopenic \nprogression. These measures help investigators more clearly define the disease states and \ndisability associated with aging. The following section on health risk in the elderly will discuss \ncurrent knowledge with respect to age-related health risk as it is associated with regional lipid \ndeposition and sarcopenia. \n14 \n\n \n \n2.3.1. Obesity and Age-Related Health Risk \n Obesity is a global health problem due to its increasing prevalence74-76 and its association \nwith morbidity and mortality from multiple chronic diseases.77 The steep rise in overweight and \nobesity in Canada,76 as in other industrialized nations,18, 78, 79 has been referred to as nothing less \nthan “epidemic,” perhaps owing to the increased incidence of cardiovascular disease, \nhypertension, diabetes, dyslipidemia, metabolic syndrome, gall stones, osteoarthritis, sleep \napnea, and certain forms of cancer that have all been linked to overweight and obesity, as \nmeasured by body mass index.80, 81 Risk of developing features in this extensive list of \ndebilitating diseases is exacerbated in the obese elderly.82 Considering that 1 in 4 Canadians \nbetween the ages of 65 and 74 now has a BMI that exceeds 30 kg/m2,83 it is little wonder that \nalthough seniors comprise less than 15% of the Canadian population, they now account for a \nthird of the nation’s health care expenditure.84 In a prospective cohort study using questionnaires \nfrom over 17,000 healthy middle-aged men and women with a wide range of BMI, 26-year follow-\nup data showed a significant inverse-graded association between BMI and perceived health \nstatus or quality of life for those who were obese earlier in life.85 Elevated mid-life BMI also \nincreased later-life health care expenditures.86 Within this same cohort, those who were obese at \nbaseline assessment had a higher risk of hospitalization and mortality from heart disease and \ndiabetes during the 26 years than those who were normal weight.87 Clearly, a lifetime of obesity \naffects health risk and quality of life in later years. \n \n 2.3.1.1. Health Risks of Abdominal Obesity \n Substantial evidence has established overweight and obesity as risk factors for \ndeveloping heart disease and diabetes, yet not every person with excess weight presents with \nmetabolic abnormalities. Certainly, regional fat deposition is not homogeneous throughout the \npopulation; two major whole-body obesity phenotypes have been likened to the characteristic \nshapes of fruits, with “pear-shaped” individuals having thinner waists and fatter hips while “apple-\nshaped” individuals are characterized by rounder abdomens and reduced hip and leg \n15 \n\n \ncircumferences. Apple-shaped people often possess greater metabolic disease and mortality risk \nthan those with thinner waists.2, 88, 89 The notion that body fat topography affects metabolic \nfunction was introduced in the literature over half a century ago by a French professor named \nJean Vague, who noted that patients with increased fat deposition in the truncal region were more \nlikely to display the metabolic abnormalities of obesity than those whose fat resided \npredominantly on hips and thighs.90 Because of the increased health risk associated with \nabdominal obesity, and since waist circumference is a measure of abdominal girth, waist \ncircumference is becoming increasingly recognized as an indicator of metabolic risk. Indeed, \nsome studies have now shown that waist circumference may be a better predictor of risk than \nBMI for myocardial infarction,91 type 2 diabetes,89 medical care costs,5 and all-cause mortality.92, \n93 The mounting evidence supporting the importance of abdominal obesity in the prediction of \nchronic disease and mortality has led to the incorporation of waist circumference instead of BMI \nfor the clinical identification of the metabolic syndrome:94 a cluster of metabolic abnormalities that \nalso includes elevated levels of plasma triglycerides, cholesterol, blood pressure, and fasting \nglucose.95 The focus of attention on centrally-located fat is further evident in the International \nDiabetes Foundation’s adoption of even lower waist circumference cutpoints to identify risk, while \ninstituting those thresholds as mandatory requirements for diagnosis of metabolic syndrome.96 \nOverall obesity carries with it substantial health risk, yet central deposition of fat may be a key \nfactor in the development of obesity-related co-morbidities. It is well established that the aging \nbody progressively shifts lipid away from subcutaneous stores (on hips, legs, and arms) and \ndeposits it centrally. This lipodystrophy may explain some of the increased metabolic risk that \nemerges in the elderly as opposed to younger adults with comparable BMI.97 \n \n 2.3.1.2. Health Risks of Excessive Visceral Adiposity \n The predictive power of waist circumference on health risk is thought to be linked to \nexcessive visceral adipose tissue deposition, a centrally-located fat depot that is consistently \nreported to mirror changes in insulin resistance and other obesity-related co-morbidities \nindependent of other adipose tissue depots.98 Indeed, abdominal girth is often used as an \n16 \n\n \nanthropometric surrogate for visceral adiposity because it estimates that specific fat depot better \nthan BMI, weight, or waist-to-hip ratio.99 Wide inter-individual variation in the ratio of \nsubcutaneous to visceral fat in the abdomen, however, limits the prediction of visceral fat by waist \ncircumference to about 35 to 50% of the variance explained (see Figure 1).100, 101 Nevertheless, \nsince waist circumference seems to predict both visceral adiposity and metabolic risk, it is logical \nto presume that visceral fat may be linked to the development of metabolic risk. Investigation of \nthis notion through radiological quantification of abdominal adipose depots in elderly subjects \nconfirms that visceral fat, not abdominal subcutaneous fat, is a common denominator in all \nfeatures of the metabolic syndrome.102 Furthermore, reduction of the visceral fat depot by \nsurgical removal or through weight loss is associated with a marked improvement in insulin \nsensitivity103, 104 and plasma lipid profile,105 whereas surgical reduction of abdominal \nsubcutaneous fat through liposuction has no effect on insulin sensitivity or other cardiovascular \nrisk factors.106 The visceral adipose depot is clearly linked to increased metabolic risk, and is an \nestablished independent predictor of morbidity2, 3 and mortality.4 These associations are of \nparticular importance to seniors, who by virtue of the aging process, experience a \ndisproportionate increase in visceral fat compared to abdominal subcutaneous fat for a given \nwaist circumference. \n While it is well established that measuring visceral adiposity is helpful in predicting health \nrisk, the mechanisms by which visceral fat affects metabolic profile are yet unknown. In fact, \nwhether visceral fat plays a causal role in elevated health risk or is simply a side effect of \nupstream metabolic dysfunction is still intensely debated.107, 108 For years, the prevailing theory \nfor the relationship between metabolic dysfunction and visceral fat was simply its proximity to the \nliver; in conditions of excessive abdominal adiposity, hypertrophied visceral adipocytes become \nresistant to the antilipolytic effects of insulin,109 and increased the flux of free fatty acids into the \nportal vein, which drains directly into the liver. The overabundance of free fatty acids presented \nthe liver directly from visceral adipocytes were thought to overwhelm hepatic metabolic \nprocesses, causing an increase in hepatic glucose production, decreased degradation of \napolipoprotein B, and increased secretion of lipid-laden lipoproteins.110 Significant doubt was \n17 \n\n \ncast on the portal theory, however, when Nielsen et al.111 observed the relative contribution of \nportally-delivered free fatty acids (FFA) from visceral and systemic sources. In obese subjects, \nonly 20-25% of portally-delivered FFA was of visceral origin, and that percentage was even lower \n(5-10%) in lean subjects.111 Additionally, the contribution of visceral lipolysis to total systemic \nFFA availability was less than 5%:111 certainly insufficient stimulus to create the lipotoxic \nenvironment thought to be responsible for either β-cell dysfunction or peripheral insulin \nresistance.108 \n Another perhaps more plausible explanation for an altered metabolic profile in the \nviscerally obese is that adipose tissue also has many endocrine functions, and is known to \nrelease numerous proinflammatory molecules such as tumor necrosis factor-α (TNF-α), \ninterleukin-6 (IL-6), and C-reactive protein (CRP). Cross-sectional studies have shown that \nelevated plasma levels of these systemic inflammatory markers are associated with insulin \nresistance and type 2 diabetes mellitus,112-117 and now longitudinal studies confirm that elevated \nlevels of TNF-α, CRP and IL-6 predict the development of type 2 diabetes118-122 and mortality.123, \n124 Elevated plasma CRP may also better predict myocardial infarction than traditional risk factor \nestimates.125 One protein inversely associated with increasing obesity is adiponectin, an \nadipose-derived molecule that improves insulin signaling and provides protection against \natherosclerosis.126 Abdominally obese persons, especially those with high visceral fat \ndistribution, are often characterized by increased proinflammatory markers TNF-α, IL-6, and \nCRP, and have reduced circulating adiponectin.127 Although not dramatically, plasma levels of \nthese inflammatory markers also increase with age, such that they contribute independently to \nmorbidity and mortality, even after controlling for lifestyle factors and obesity.123 Since visceral \nadipose tissue is known to release 2 to 3 times the amount of IL-6 than subcutaneous adipose \ntissue,128 it stands to reason that the progressive increase of visceral adiposity in aging may \ninfluence inflammatory pathways. However, because both visceral obesity and inflammatory \nprocesses occur simultaneously, it is yet unclear which risk factor precedes the other. \n \n18 \n\n \n2.3.1.3. Health Risks of Ectopic Lipid Storage \n Perhaps because the visceral adipose tissue depot seems to correlate more highly to \nmetabolic risk than other depots, subcutaneous adipose tissue is frequently overlooked as a \nsignificant player in the development of disease, when in fact, more than a few studies have \nshown that peripheral subcutaneous fat has a protective effect against the development of \nobesity’s co-morbidities.129-134 The inverse relationship between subcutaneous fat and metabolic \nrisk seems paradoxical because metabolic disease usually increases proportionally to the degree \nor severity of obesity. By definition, lipodystrophy is a failure to develop adequate adipose tissue \nmass, resulting in lipid deposition in tissues other than the intended or metabolically favorable site \nfor storage.135 Subcutaneous adipose tissue is considered a “metabolically favorable site” for \nlipid storage, and under normal conditions, has the capacity to buffer lipid excess. In the \nlipodystrophy of aging, however, and for reasons not yet understood, the subcutaneous adipose \ntissue mass diminishes, and when available lipid exceeds the storage capacity of the \nsubcutaneous fat mass, lipid is deposited in “ectopic” regions such as liver, heart, and skeletal \nmuscle.136 The visceral fat depot also appears to be a metabolically unfavorable site for \nexcessive lipid deposition, and its growth may similarly be a marker of an upstream failure of \nsubcutaneous adipose to appropriately deal with excessive fatty acid flux.98 The mechanism by \nwhich thiazolidinediones operate supports this notion of metabolic dysfunction occurring when \nperipheral subcutaneous adipocytes reach filling capacity. Thiazolidinediones are medications \nwhich signal subcutaneous adipocyte cell division by binding to peroxisome proliferator-activator \nreceptor-γ (PPAR-γ), and thus reverse the lipodystrophic limitation of subcutaneous capacity by \ncreating more adipocytes for lipid storage. What results is a reduction of circulating FFA,137 \nredistribution of lipid from the visceral to subcutaneous depots,138-140 decreased fatty liver and \nskeletal muscle triglyceride content141, 142 and an improvement in hepatic and peripheral insulin \nsensitivity.141, 142 \n Metabolically active lean tissue is not incapable of storing some lipid. Most lean tissues \nmaintain a small reserve of intracellular lipid for use as immediate energy and for repairing cell \nmembranes. When faced with a constant barrage of FFA, however, these lean tissues are \n19 \n\n \ninfiltrated with excessive lipid, become insulin resistant, lose capacity to function normally, and \neventually develop overt disease.143 In the liver, lipid accumulation is referred to as hepatic \nsteatosis, or “fatty liver.” Hepatic steatosis results in hepatic insulin resistance and elevated liver \nenzymes, and is related to the development of type 2 diabetes independent of obesity.3 \n Under normal conditions, skeletal muscle also has a small reserve of intramyocellular \nlipid available for energy production in oxidative pathways. With aging and inactivity, skeletal \nmuscle has a decreased proportion of oxidative fibers and increased intramyocellular lipid. \nDespite increased availability of lipid within the myocyte, carnitine palmitoyltransferase remains \nthe rate limiting step in the metabolism of fatty acyl-CoA,144 and the transfer of long-chain lipid \nmolecules into the mitochondria limits clearance or oxidation of intramyocellular lipid. \nSubsequent accumulation of intramyocellular lipid negatively affects peripheral insulin sensitivity \nand muscle glucose transport,145 and independently predicts incidence of the metabolic syndrome \nin elderly subjects.2 \n Regardless of the mechanisms, accumulation of lipid in either visceral depot or lean \ntissue results in increased incidence of morbidity and mortality and must be prevented or treated \nin the elderly to avoid costly metabolic and lifestyle consequences. \n \n2.3.2. Sarcopenia and Functional Impairment \n The term sarcopenia was defined earlier as the steady and involuntary decline in skeletal \nmass that occurs with aging.34 Not a rapidly-developing syndrome seen in more severe muscle \nwasting diseases caused by starvation, human immunodeficiency syndrome or the cachexia of \ncongestive heart or renal failure, sarcopenia is more insidious in nature: acting as an underlying \nplayer in age-related disease and disability.146 Its definition has grown to encompass such elicit \ncauses as decrements in peripheral nervous system innervation, altered hormonal status, \ninflammatory effects, and altered caloric and protein intake.35 These additional contributors to \ngeneral skeletal muscle atrophy combine to explain much of the functional impairment, frailty, and \ndisability commonly seen in older adults.147 Not considered a diseased state, per se, the \nsequelae of disabling conditions which accompany clinical sarcopenia and undermine \n20 \n\n \nindependent living are cause for concern and should motivate prevention and treatment \nmeasures in the aging population.148 Fortunately for the elderly, physical activity is a modifiable \nbehavior associated with benefits that sometimes surpass existing pharmacological disease \ntreatments.149 The following sections will discuss in greater detail the prevalence and health toll \nof sarcopenia. \n \n2.3.2.1. Prevalence of Sarcopenia in Aging \n The prevalence of sarcopenia is difficult to quantify because its development is gradual, \nand there is truly no threshold level of lean tissue or skeletal muscle mass loss beyond which \nfunctional impairment dramatically increases. To dichotomize a continuous variable like age-\nrelated muscle loss is extremely difficult when some muscle loss is considered a natural \nphenomenon of aging, and when there is no simple and reliable anthropometric method of \nquantifying lean tissue. Various arbitrary thresholds have been proposed, however, and are \ncurrently widely used in population studies that employ imaging techniques capable of quantifying \nlean tissue or muscle mass. Through a population-based study conducted in New Mexico and \nusing data from the Rosetta study150 of healthy young adults as a reference, Baumgartner and \ncollegues151 collected appendicular muscle mass data by DEXA in elderly Hispanics and non-\nHispanic whites. Having no clinical definition for sarcopenia, the authors determined that muscle \nmass 2 standard deviations below the mean of the Rosetta population classified a subject as \nsarcopenic. Since individuals vary widely in skeletal structure, and a larger frame requires \ngreater total skeletal muscle to accomplish a similar functional task, a relative skeletal muscle \nindex was proposed using appendicular skeletal muscle in kilograms divided by height in meters \nsquared.151 The results of this study showed sarcopenia at a prevalence of 13.5% and 23.1% in \nwhite men and women, respectively, 65-69 years of age. This prevalence climbed steadily every \nhalf-decade through the over-80 group, within which 52.6% of men and 43.2% of women had a \nrelative skeletal muscle index that was 2 standard deviations below the sex-specific mean \nstandard provided by a younger population. Other epidemiological studies have since been \nconducted in various regions of the United States,8, 152-154 Europe,155, 156 and Asia,157 using either \n21 \n\n \nrelative skeletal muscle index or a similar skeletal muscle index (skeletal muscle mass divided by \ntotal body mass, multiplied by 100) and standard deviation approach, yielding a similar \nincreasing, age-dependent prevalence. These results, however, may be underestimates of the \ntrue population prevalence, as most studies only use healthy, non-institutionalized elderly \nsubjects. Despite various limitations of the research to date, the message is clear: muscle loss \noccurs increasingly in the later decades of life, and a high percentage of our oldest old face an \natrophy that would classify them as sarcopenic with reference to declining muscle mass. \n Recent work by Janssen et al.158 has questioned the wisdom of arbitrary cutpoints with \nreference solely to statistical deviation from “normal” muscle mass in younger populations, \nsuggesting that cutpoints be made in relation to sarcopenia-induced disability. Using bioelectrical \nimpedance data from the Third National Health and Nutrition Survey (NHANES III), these \nresearchers examined the relationships between whole body mass estimates (indexed for height) \nand relative ability to perform activities of daily living. Receiver operating characteristics analyses \nof physical disability and skeletal muscle mass were used to derive three categories of disability \nrisk.158 From these analyses, cutpoints for moderately increasing and high disability risk were \ndeveloped, creating new classifications based on disability standards: moderate (6.75 to 5.76 \nkg/m2 in women, 10.75 to 8.51 kg/m2 in men) and severe sarcopenia (<5.75 and <8.50 in men \nand women, respectively). Interestingly, previous sarcopenia cutpoints established by a 2 \nstandard deviation variation from young Rosetta Study subjects151 varied only slightly from these \ndisability-based cutpoints for severe sarcopenia, yet still proved less predictive of physical \ndisability.158 By the new definitions, it was estimated that 35% of older Americans have moderate \nsarcopenia, and 10% have a severe degree of sarcopenia.158 \n \n2.3.2.2. Functional Impairment with Muscle Loss \n The true clinical importance of sarcopenia is revealed when declining muscle mass \ntranslates into a loss of strength and capacity for work, or ultimately renders a person unable to \naccomplish the tasks of daily living. Quite literally, humans need a certain amount of muscle just \nto survive; earlier studies indicate that losing 40% of baseline lean mass is fatal.159, 160 Loss of \n22 \n\n \nmuscle strength due to declining muscle mass is probably the most important detrimental effect of \nsarcopenia. Regardless of body weight and build, those who lack physical strength have higher \nmortality risk161 and activities of daily life become increasingly more difficult. Ronenn Roubenoff, \na leader in the field of sarcopenic research, suggests162 that as sarcopenic seniors become \nweaker, greater effort is required to accomplish ordinary tasks, and the more difficult ones are \neventually abandoned. This pattern of increasing disuse is self-perpetuating, as the foregone \nactivities no longer provide stimulus for muscle maintenance. A vicious cycle of inactivity \ncontinues into disability, dependent living, and death. The previously-mentioned New Mexico \nstudy affirmed that sarcopenic men have 3.6 times higher risk of physical disability, while women \nhad 4.1 higher rates, even after adjustment for age and a host of other possible confounders.151 \nIn this study, odds ratios for abnormalities in gait and balance, use of a cane or walker, recent \nfalls, or having a history of bone fractures were all significantly greater in sarcopenic seniors.151 \n While the results from cross-sectional studies attest to the high risk of physical disability \nwith sarcopenic levels of muscle mass,8, 151, 152, 158 longitudinal study designs describe which \ncharacteristic precedes the other. Two recent longitudinal studies have investigated the \ndevelopment of mobility limitations and disability. Visser et al.,163 from the Health, Aging, and \nBody Composition (Health ABC) Study, tracked an aging cohort of over 3000 men and women \n(ages 70-79) over a period of 2.5 years, measuring CT axial thigh images for muscle size and \ndegree of fat infiltration. After control for lifestyle and health factors, men who had the smallest \ncross-sectional mid-thigh skeletal muscle area were 90% more likely to report increases in \ndifficulty walking a quarter mile or climbing 10 steps over that time period, while women were \n68% more likely, in comparison to their peers with the largest mid thigh muscle area. These \ninvestigators also included a measure of muscle strength in their analysis, and as expected, \nfound that the relationship between muscle size and mobility limitations was indeed mediated by \nmuscle strength. Muscle fat infiltration, as measured by muscle attenuation, was another \nindependent predictor of decreased mobility.163 \n Ian Janssen,164 using data from over 5000 older men and women in the Cardiovascular \nHealth Study, examined the relationship between muscle mass as measured by bioelectrical \n23 \n\n \nimpedance and disability scores eight years later as indicated by self-reported increases in \ndifficulty performing daily tasks. When the sarcopenia cutpoints Janssen and colleagues had \nearlier established158 were applied, it was found that only the men and women with severe \nsarcopenia had a greater likelihood of developing disability than their counterparts with normal \nlevels of muscle mass, and that increased likelihood for disability was only 27% greater.164 \n Although both of the two recent longitudinal studies showed sarcopenia preceding \nincreased disability rates, neither reported rate increases of the magnitude reported in cross-\nsectional studies.8, 151, 152, 158 This observation should not be construed as evidence refuting the \nrelationship between sarcopenia and disability. On the contrary and as noted earlier, a self-\nperpetuating cycle of inactivity and muscle weakening suggests a bi-directional influence of either \nof these two health indicators on the other, and thus it might be expected that a temporal \nrelationship between sarcopenia and disability would be difficult to establish. \n \n2.3.3. Simultaneous Obesity and Sarcopenia \n Until this point in this review, the health risks of obesity and sarcopenia have been \ndiscussed independently. In reality, both phenomena occur simultaneously in the human body as \na result of aging, and not only are they difficult to measure independent of one another, but the \nmetabolic risks and disabling characteristics associated with progression of either condition are \nexacerbated when both are manifest. \n Richard Baumgartner, the lead investigator for the New Mexico Elderly Health Study, \ncharacterized a group of over 1000 seniors by measured or estimated body fat and appendicular \nskeletal muscle mass. Using the cutpoints for sarcopenia he had earlier established (>2 standard \ndeviations from the mean of representative young adults),151 and a median body fat percent of the \nstudy sample, he divided his subjects into four groups: normal, obese, sarcopenic, or sarcopenic \nobese. Of the four, the sarcopenic obese group was much more likely to be misclassified by \npopulation-based obesity indicators such as body mass index and waist-to-hip ratio, and had \nsignificantly lower grip strength relative to body weight, indicating progress toward functional \ndisability. Serum testosterone and insulin-like growth factor were both elevated in men with \n24 \n\n \nsarcopenic obesity, and elevated serum leptin was characteristic of the sarcopenic obese, \nregardless of gender. Furthermore, although either sarcopenia or obesity alone were associated \nwith significant increases in odds ratios for developing three or more physical disabilities, those \nwho were classified as sarcopenic obese had double and even triple the odds ratios (8.72 and \n11.98 for men and women, respectively) for disability than they might have had with only obesity \nor sarcopenia, when all were compared to their normal counterparts. Further research is needed \nto discover the true prevalence of sarcopenic obesity on a population level, but the evidence from \nthis study suggests that a simultaneous diagnosis of obesity and sarcopenia results in a \nsynergistic effect of the negative consequences associated with each disease, resulting in a \nmarked propensity for metabolic disease and disability. \n \n2.4.0. Treating Age-Related Health Risk through Lifestyle Intervention \n Although clinicians routinely prescribe obesity reduction programs that include caloric \nrestriction for younger obese adults, uncertainty exists regarding whether this is an appropriate \nstrategy for obesity reduction in the elderly. The principal concern with using caloric restriction as \na method of inducing weight loss in the elderly is that senescence is associated with progressive \nreductions in muscle mass.36, 162 While caloric restriction may be effective for reduction of risk-\nladen adiposity, diet-induced weight loss is associated with decrements in skeletal muscle size11, \n13, 165-167 and strength:167 perhaps injurious side effects for older persons whose muscle mass is \nalready compromised.8 Thus, the viscerally obese and muscle-deficient older patient presents \nthe clinician with a dual challenge for which a dietary treatment traditionally prescribed younger \nadults may not be optimal. Understandably, prescriptions for health risk reduction should be \nmade on a case-by-case basis, using an approach that maximizes chances for successful \nimprovements and incorporates the personal preferences or relative abilities of each senior, and \nproper management of nutrition should be a fundamental component of any lifestyle intervention. \nIn order to ascertain the effects of exercise in a lifestyle intervention independent of caloric \nrestriction, however, the following section will provide a summary of evidence to date supporting \nphysical activity alone as a lifestyle modification designed to provide optimal health benefit to \n25 \n\n \n26 \npreviously sedentary, abdominally obese seniors. Comparisons of the effects of aerobic and \nresistance exercise will be made for the treatment of obesity, sarcopenia, and then for sarcopenic \nobesity. \n \n2.4.1. Treatment of Obesity in the Elderly \n Several studies have investigated the indepe ndent effects of aerobic or resistance \nexercise on whole body fat in the elderly. A summary of the studies to date which report whole \nbody obesity and associated health outcome changes as a result of performing aerobic exercise \nin the elderly is provided in Tables 3 and 4. In an attempt to investigate the independent effect of \naerobic exercise on overall obesity and health, studies were included in these two tables if whole-\nbody obesity measurements were performed on healthy, non-diabetic older (age exceeding 60 \nyears) men and women before and after an intervention that included aerobic exercise \nindependent of diet or other modifications. The first thing to notice about this collection of studies \nis that many of them are relatively recent. Whether due to technological improvements in \nmeasurement techniques (increased availability of DEXA for whole body measurement instead of \nhydrostatic weighing) or a recent increase in public awareness of health risk reduction in the \naging population, the previous paucity of obesity reduction studies using aerobic exercise as a \nsole treatment strategy in the elderly has accumulated good evidence in recent years to create a \nclearer picture of the effects of aerobic exercise on whole body fatness. Most,\n168-174 but not all \nstudies,175, 176 report that participation in at least a moderate-intensity aerobic exercise program 3 \nto 5 days per week induces a significant reduction in body fat over time in the elderly. All studies \nreporting a decrease in whole body fat content show a concomitant improvement in insulin \nresistance, as measured either by Bergman’s minimal model,177 homeostasis model assessment \n(HOMA),178 or hyperinsulinemic, euglycemic clamp technique.179 In these studies, maximal \noxygen consumption on a graded exercise test to exhaustion (VO2max) invariably improved. \nInteresting to note, however, are the studies which failed to see a whole body fat reduction, yet \nobserved beneficial metabolic outcomes. In the recent studies by Coker et al.\n175 and DiPietro et \n\n \ncTable 3. Effect of aerobic exercise on whole body fat and health outcomes in the elderly: randomized controlled trials \n \nFirst \nauthor Year \nStudy \ntype \nDuration\n(weeks) # Sex\nAge \n(years)\nExercise \ndescription \nBody \ncomp \nmethod\nBody \nfat \n∆ \nMetabolic \nhealth \noutcomes \nHealth \noutcome \n∆ \nCoker175 2006 RCT 12 7 M/F 70±2 MI (50% VO2max), \n1000 kcal/wk \nDEXA -- VO2max \nIR by clamp \n↑ \n-- \n 7 M/F 73±2 HI (75% VO2max), \n1000 kcal/wk \nDEXA \n \n \n \n \n \n-- VO2max \nIR by clamp \n↑ \n↓ \nDiPietro176 2006 RCT 39 9 F 73±3 MI (65% VO2max), \n1200 kcal/wk \nDEXA -- VO2peak \nIR by clamp \n-- \n-- \n 9 F 72±3 HI (80% VO2max), \n1200 kcal/wk \nDEXA -- VO2peak \nIR by clamp \n-- \n↓ \nFrank170 \nIrwin171 \n2005 RCT 52 87 F 61±7 MI (60-75% VO2max) \n45 min, 4 d/wk \n(some RE suggested) \nDEXA ↓ VO2max \nIR by HOMA \nGlucose, Trig \nInsulin, Leptin \n↑ \n↓ \n-- \n↓ \nEvans173 2001 RCT 39 18 F 66±3 MI (70-85% HRmax) \n30 min, 3 d/wk \nDEXA ↓ VO2max ↑ \nDengel180 1996 RCT 43 10 M 60±2 MI (65-85% HRR) Hydro -- VO2max \nIR by clamp \nOGTT glucose \nOGTT insulin \n↑ \n↓ \n-- \n↓ \nHersey181 1994 RCT 26 16 M/F 72±2 MI (75-85% HRR) \n35-45 min, 3 d/wk \nSkinfolds ↓ VO2max \nOGTT glucose \nOGTT insulin \nLipid profile \n↑ \n↓ \n↓ \n-- \nAbbreviations: RCT = randomized controlled trial; # = number of subjects; M = male; F = female; RE = resistance \nexercise; MI = moderate intensity exercise, HI = high intensity exercise, VO2max = maximal oxygen consumption; \nVO2peak = peak oxygen consumption; HRmax = maximal heart rate; HRR = heart rate reserve; kcal/wk = kilocalories \nexpended per week; min = minutes; d/wk = days per week; DEXA = dual energy x-ray absorptiometry; Hydro = \nhydrostatic weighing; ∆ = exercise-induced change over intervention period; IR = insulin resistance; clamp = \nhyperinsulinemic, euglycemic clamp; HOMA = homeostasis model assessment; OGTT = oral glucose tolerance test; Trig \n= triglycerides. \n \n\n \n \ndTable 4. Effect of aerobic exercise on whole body fat and health outcomes in the elderly: other study designs \n \nFirst \nauthor Year \nStudy \ntype \nDuration\n(weeks) # Sex\nAge \n(years) Exercise description \nBody \ncomp \nmethod\nBody \nfat \n∆ \nMetabolic health \noutcomes \nHealth \noutcome \n∆ \nO’Leary172 2006 NR 12 16 M/F 63±1 MI (85% HRmax) \n60 min, 5 d/wk \nHydro ↓ VO2max \nOGTT \nLeptin \nAdiponectin, TNFα \n↑ \n↓ \n↓ \n-- \nFerrara169 2006 NR 26 9 M 63±1 MI (75-80% HRR) \n45-50 min, 3 d/wk \nDEXA ↓ \n \n \n \n \nVO2max \nIR by clamp \nGlucose, Insulin \n↑ \n↓ \n-- \nEvans168 2005 RNC 39 10 M/F 80±3 HI (83% VO2peak) \n58 min, 3 d/wk \nDEXA ↓ VO2peak \nOGTT SI \nTC, LDL \nHDL, Trig \n↑ \n↑ \n↓ \n-- \nKohrt182 1992 NR 27 93 M/F 65±2 HI (80% VO2max) \n46 min, 4 d/wk \nHydro ↓ \n \nNone\nSchwartz183 1991 RNC 27 15 M 68±6 HI (85% HRR) \n45 min, 5 d/wk \nHydro ↓ VO2max ↑ \nKahn174 1990 NR 26 13 M 68.6 HI (80-85% HRR) \n45 min, 5 d/wk \nHydro ↓ VO2max \nIR by minimal model \n↑ \n↓ \nAbbreviations: NR = not randomized; RNC = randomized, but no control group; # = number of subjects; M = male; F = \nfemale; RE = resistance exercise; MI = moderate intensity exercise, HI = high intensity exercise, VO2max = maximal \noxygen consumption; VO2peak = peak oxygen consumption; HRmax = maximal heart rate; HRR = heart rate reserve; min \n= minutes; kcal/wk = kilocalories expended per week; d/wk = days per week; DEXA = dual energy x-ray absorptiometry; \nHydro = hydrostatic weighing; ∆ = exercise-induced change over intervention period; IR = insulin resistance; clamp = \nhyperinsulinemic, euglycemic clamp; HOMA = homeostasis model assessment; OGTT = oral glucose tolerance test; SI = \nsensitivity index; TNFα = tumor necrosis factor, α; TC = total cholesterol; L(H)DL = low (high) density lipoprotein; Trig = \ntriglycerides. \n \n\n \n \n \neTable 5. Effect of resistance exercise on whole body fat and health outcomes in older men and women \n \nFirst \nauthor Year \nStudy \ntype \nDuration\n(weeks) # Se x\nAge \n(years)\nExercise \ndescription \nBody \ncomp \nmethod \nBody \nfat \n∆ \nMetabolic \nhealth \noutcomes \nHealth \noutcome \n∆ \nFerrara169 2006 NR 26 13 M 63±1 6 exercises, DEXA -- \n1 set UB, 2 sets LB,\n8-12 reps, 3 d/wk \nVO2max \nIR by clamp \nGlucose, Insulin\n-- \n↓ \n-- \nBinder184 2005 RCT 13 53 M/F 83±4 6 exercises, 3 sets, \n8-12 reps, 3 d/wk \nDEXA -- \n \n26 \nHydro -- \nNone \nHunter185 2002 NR 26 14\n12\nM \nF \n68±4 \n66±4 \n11 exercises, 2 sets,\n10 reps, 3 d/wk \nADP ↓ Non e\nRyan186 2001 NR 11\n10\nM \nF \n70±1 \n69±1 \n11 exercises, \n1 set UB, 2 sets LB, \n15 reps, 3 d/wk \nDEXA -- IR by clamp \nGlucose, Insulin\nLeptin in M \nLeptin in F \n-- \n-- \n↓ \n-- \nTrueth187 1995 NR 16 14 F 67±1 12 exercises, 2 sets\n12 reps, 3 d/wk \nVO2max \nLipid Profile \n-- \n-- \nTrueth188 1994 NR 16 13 M 60±4 14 exercises, 2 sets\n15 reps, 3 d/wk \nDEXA \nHydro \n↓ \n↓ \nVO2max -- \nHersey181 1994 RCT 26 17 M/F 72±2 10 exercises, 1 set \n8-12 reps, 3 d/wk \nSkinfolds -- VO2max \nOGTT glucose \nOGTT insulin \nLipid profile \n-- \n-- \n-- \n-- \nAbbreviations: RCT = randomized controlled trial; NR = not randomized; RNC = randomized, but no control \ngroup; # = number of subjects; M = male; F = female; RE = resistance exercise; d/wk = days per week; UB = \nupper body exercises; LB = lower body exercises; reps = repetitions; VO2max = maximal oxygen consumption; \nDEXA = dual energy x-ray absorptiometry; Hydro = hydrostatic weighing; ADP = air displacement \nplethysmography; ∆ = exercise-induced change over intervention period; OGTT = oral glucose tolerance test; IR \n= insulin resistance; clamp = hyperinsulinemic, euglycemic clamp; Ins = fasting plasma insulin; HbA1c = \nglycosylated hemoglobin. \n \n \n\n\n \n \nal.,176 higher intensities of aerobic exercise induced significant improvements in insulin sensitivity, \nwhile lower intensities did not, despite equivalent energy expenditure during exercise and an \nabsence of whole body fat loss in either group over a substantial intervention period. While a \npossible explanation for the lack of observed whole body fat change may be the low subject \nnumbers in either study, it is also possible that fat mobilization may be preferentially reduced in a \nregion-specific way during aerobic exercise such that significant regional fat changes could be \noccurring that are not detected by whole body measurement methods, and these changes could \nexplain, or at least be correlated with the health benefits of exercise. \n A similar collection of studies showing the effect of resistance exercise on whole body fat \nand health outcomes is shown in Table 5. Comparative inspection of these tables reveals \ninteresting trends that highlight the difference between aerobic and resistance exercise in their \nrelative ability to reduce whole body obesity and affect change in health-related outcomes. The \nfirst notable difference between aerobic and resistance exercise is that with the exception of only \none non-randomized study, resistance exercise did not induce a significant change in whole body \nfat. Furthermore, no body composition study has observed a change in VO2max, and only one of \nthree studies report improvements in insulin resistance as a result of resistance exercise training. \nAlso of note is the relative paucity of randomized controlled trials using elderly subjects; a \nmajority of the studies to date lack randomization or a control group. In fact, the only randomized \ncontrolled trial in this population investigated body composition, but did not measure any \nmetabolic outcomes. \n A limitation to studying whole body obesity changes, especially in older men and women, \nis that measures of whole body fat may not be sensitive to regional deposition changes. \nPursuant to the notion that adiposity in the elderly is characterized by a shift toward abdominal \nregions, and that significant health risk is associated with visceral fat accumulation, it is \nreasonable to argue that treatment strategies intended to reduce health risk in aging should \nfocus predominantly on the reduction of abdominal fat depots and measure them for resultant \nchange. Intervention trials performed in the elderly (mean age exceeding 60 years) wherein \n30 \n\n \n31 \nmeasures of abdominal adiposity were specifically reported are summarized for aerobic and \nresistance exercise in Tables 6 and 7, respectively. \n Similar to Tables 3 and 4, the research summarized in Table 6 provides evidence of fat \nreduction with aerobic exercise training in older men and women, yet not all studies agree. Of \nnotable exception are the randomized controlled trials conducted by DiPietro et al.189 and Dengel \net al.,180 which failed to observe exercise-induced abdominal fat changes over 4 and 10 months, \nrespectively, while reporting significant improvements in cardiorespiratory fitness and insulin \nsensitivity measures. While both trials contained relatively few subjects and the latter relied on \nonly waist-to-hip ratio, a rather crude measure of central adiposity, they comprise a majority of \nthe few randomized controlled trials investigating abdominal change in a senior population. The \nremaining randomized controlled trial, the results of which are reported by both Frank et al.170 \nand Irwin et al.,171 contains many more subjects than the other two randomized controlled trials \ncombined and finds a small yet significant change in abdominal fat depots accompanying \nmeaningful fitness and metabolic improvements. Although the other studies in Table 4 either \nlack randomized design\n169, 172, 182 or a comparative control group,183 all demonstrate significant \nreductions in abdominal adipose tissue depots with concomitant health risk improvements in \nfitness and metabolic outcomes for senior men and women who train aerobically. \n While the results of trials investigating the e ffect of resistance training on abdominal fat in \nthe elderly (shown in Table 6) are also not unanimous, they stand in stark contrast to the results \nof aerobic exercise trials, with fully half of the studies failing to report significant reductions in \nabdominal adiposity,169, 184, 186 including the only two trials which reported significant \nimprovements in metabolic health outcomes: decreased insulin resistance169 and decreased \nplasma leptin levels in men.186 Furthermore, all but one of the trials were of non-randomized \ndesign, which brings into question the biases introduced regarding subject self-selection. The \nonly randomized controlled trial investigating resistance exercise and changes in regional fat \ndeposition in the elderly did not observe a change in abdominal adiposity, nor was any metabolic \nvariable measured concurrently.\n\n \nfTable 6. Effect of aerobic exercise on abdominal fat and health outcomes in elderly men and women \n \nFirst \nauthor Year \nStudy \ntype \nDuration\n(weeks) # Sex\nAge \n(years) Exercise description \nAbdominal \nassessment \nmethod \nFat \n∆ \nMetabolic health \noutcomes \nHealth \noutcome \n∆ \nO’Leary172 2006 NR 12 16 M/F 63±1 MI (85% HRmax) \n60 min, 5 d/wk \nVAT by CT \nASAT by CT\n \n↓ \n↓ \nVO2max \nOGTT \nLeptin \nAdiponectin, TNFα \n↑ \n↓ \n↓ \n-- \nFerrara169 2006 NR 26 9 M 63±1 MI (75-80% HRR) \n45-50 min, 3 d/wk \nVAT by CT \nASAT by CT\nWC \n-- \n↓ \n-- \nVO2max \nIR by clamp \nGlucose, Insulin \n↑ \n↓ \n-- \nFrank170 \nIrwin171 \n \n2005 \n2003 \nRCT 52 87 F 61±7 MI (60-75% VO2max) \n45 min, 4 d/wk \n(some RE suggested) \nVAT by CT \nASAT by CT\nWC \n↓ \n↓ \n↓ \nVO2max \nIR by HOMA \nGlucose, Trig \nInsulin, Leptin \n↑ \n↓ \n-- \n↓ \nDiPietro189 1998 RCT 17 9 M/F 72±1 MI (60-75% HRmax) VAT by CT \nASAT by CT\nWC, WHR \n \n-- \n-- \n-- \n \nVO2peak \nPlasma FFA \nOGTT glucose \nOGTT insulin \n↑ \n↓ \n↓ \n↓ \nDengel180 1996 RCT 43 10 M 60±2 MI (65-85% HRR) WHR -- VO2max \nIR by clamp \nOGTT glucose \nOGTT insulin \n↑ \n↓ \n-- \n↓ \nKohrt182 1992 NR 27 93 M/F 65±2 HI (80% VO2max) \n46 min, 4 d/wk \nWC ↓ \n \nNone \nSchwartz183 1991 RNC 27 15 M 68±6 HI (85% HRR) \n45 min, 5 d/wk \nVAT by CT \nASAT by CT\nChest by CT\nWC \n↓ \n↓ \n↓ \n↓ \nVO2max ↑ \nAbbreviations: RCT = randomized controlled trial; NR = not randomized; RNC = randomized, but no control group; # = number of \nsubjects; M = male; F = female; RE = resistance exercise; MI = moderate intensity exercise, HI = high intensity exercise, VO2max = \nmaximal oxygen consumption; HRmax = maximal heart rate; HRR = heart rate reserve; min = minutes; kcal/wk = kilocalories \nexpended per week; d/wk = days per week; VAT = visceral adipose tissue; ASAT = abdominal subcutaneous adipose tissue; CT = \ncomputed tomography; WC = waist circumference; WHR = waist-to-hip ratio; ∆ = exercise-induced change over intervention period; \nIR = insulin resistance; clamp = hyperinsulinemic, euglycemic clamp; HOMA = homeostasis model assessment; OGTT = oral \nglucose tolerance test; TNFα = tumor necrosis factor, α; Trig = triglycerides. \n \n\n \n \n \ngTable 7. Effect of resistance exercise on abdominal fat and health outcomes in elderly men and women \n \nFirst \nauthor Year \nStudy \ntype \nDuration\n(weeks) # Se x\nAge \n(years) Exercise description \nAbdominal \nassessment \nmethod \nFat \n∆ \nMetabolic health \noutcomes \nHealth \noutcome \n∆ \nFerrara169 2006 NR 26 13 M 63±1 6 exercises, \n1 set UB, 2 sets LB, \n8-12 reps, 3 d/wk \nVAT by CT \nASAT by CT\nWC \n-- \n-- \n-- \nVO2max \nIR by clamp \nGlucose, Insulin \n-- \n↓ \n-- \nBinder184 2005 RCT 13 53 M/F 83±4 6 exercises, 3 sets, \n8-12 reps, 3 d/wk \nVAT by MRI\nASAT by MRI\n-- \n-- \nNone \nHunter185 2002 NR 26 14 M \n \n68±4 \n \n11 exercises, 2 sets, \n10 reps, 3 d/wk \nVAT by CT \nASAT by CT\n-- \n-- \nNone \n 12 F 66±4 11 exercises, 2 sets, \n10 reps, 3 d/wk \nVAT by CT \nASAT by CT\n↓ \n↓ \nNone \nRyan186 2001 NR 26 11\n10\nM \nF \n70±1 \n69±1 \n11 exercises, \n1 set UB, 2 sets LB, \n15 reps, 3 d/wk \nDEXA trunk -- IR by clamp \nGlucose, Insulin \nLeptin in M \nLeptin in F \n-- \n-- \n↓ \n-- \nTrueth187 1995 NR 16 14 F 67±1 12 exercises, 2 sets \n12 reps, 3 d/wk \nVAT by CT \nASAT by CT\nWC, WHR \n↓ \n-- \n-- \nVO2max \nLipid Profile \n-- \n-- \nTrueth188 1994 NR 16 13 M 60±4 14 exercises, 2 sets \n15 reps, 3 d/wk \nDEXA trunk \nWC \n↓ \n-- \nVO2max -- \nAbbreviations: RCT = randomized controlled trial; NR = not randomized; RNC = randomized, but no control group; # = number of \nsubjects; M = male; F = female; RE = resistance exercise; d/wk = days per week; UB = upper body exercises; LB = lower body \nexercises; DEXA = dual energy x-ray absorptiometry; VAT = visceral adipose tissue; ASAT = abdominal subcutaneous adipose tissue; \nCT = computed tomography; MRI = magnetic resonance imaging; WC = waist circumference; WHR = waist-to-hip ratio;∆ = exercise-\ninduced change over intervention period; VO2max = maximal oxygen consumption; IR = insulin resistance; clamp = hyperinsulinemic, \neuglycemic clamp. \n \n \n \n\n\n \n Of the studies summarized in Tables 6 and 7, only one recently-published study \ncompares groups of aerobic and resistance exercisers and their comparative body composition \nchanges across time in the same trial. In this study conducted by Ferrara and colleagues,169 two \ngroups of older men were created by non-random assignment and performed either aerobic or \nresistance exercise three days per week for 6 months while adjusting calorie intake for weight \nmaintenance throughout the intervention period. Despite a design that required recovery of \nexercise-induced energy expenditure through dietary means, aerobic exercisers lost a small but \nsignificant amount of body weight, while the resistance exercisers gained. Consistent with the \nresults of other studies, aerobic training resulted in a 6.2% reduction of whole body fat mass, \nmeasured by DEXA, which was matched by a 7% abdominal subcutaneous fat loss, measured by \nCT.169 Visceral adipose tissue did not change enough to achieve significance, which would have \nbeen an unexpected finding in middle-aged men and women due to reports of preferential \nreductions of VAT with aerobic exercise.11, 190 However, studies conducted in the elderly are \nequivocal in their findings, with some showing significant reductions in visceral adipose tissue170-\n172 while others fail to observe a change.189 \n The equivocal nature of the results to date regarding the comparative effects of aerobic \nor resistance exercise on body composition and reduction of health risk in older men and women \nreinforces the need for continued research. A few trends in the literature are noteworthy, \nhowever. First, aerobic training, especially of higher intensity, generally results in significant \nreductions in whole body fat and abdominal adipose tissue depots, and those changes \naccompany significant improvements in aerobic fitness and insulin sensitivity. Second, resistance \ntraining appears to be less effective at mobilizing the adipose tissue depots that are usually \nassociated with age-related decreases in insulin sensitivity, and does not appear to improve \naerobic capacity. While these generalized statements comparing aerobic or resistance exercise \ncan be made with reference to various results available in current literature, there are currently no \nrandomized controlled trials that simultaneously test these two exercise modalities for their \nindependent effects on total or regional adiposity, nor has any such trial also investigated the \n 34\n\n \nresultant metabolic changes that occur when previously sedentary abdominally obese seniors \nembark on either type of exercise program. \n \n2.4.2. Treatment of Sarcopenia in the Elderly \n Inherent to the argument that weakness perpetuates inactivity (and vice versa) is the \nreverse notion that purposeful training of skeletal muscle serves to maintain its size and strength \nover time, which will also improve activity and mobility. Indeed, a well-known cross-sectional \nstudy in elderly master weightlifters has shown that participation in resistance weight training 3 \ndays a week for at least 12 years showed a maintenance of muscle mass and strength that was \ncomparable to youthful controls.191 Interestingly, elderly master swimmers (who perform a \npredominantly aerobic activity) measured in that same study displayed comparatively significant \ndecrements in muscle strength and size over 12 years.191 This study and others192, 193 that have \ninvestigated the physically active elderly versus their sedentary, age-matched peers suggest that \nno other exercise modality yields the same muscle-maintaining benefits as resistance exercise. \nBenefits of training are also not limited to the lifetime fitness enthusiasts. Sedentary and even \nfrail elderly have experienced significant muscle hypertrophy as a result of resistance exercise: \nmany with as short an intervention period as 12 weeks of progressive resistance training.194 \n Multiple reviews have been published in recent years summarizing the literature on the \neffects of resistance exercise training on elderly subjects.149, 194-196 It should be noted that despite \nthe seeming wealth of available data, many trials failed to control for confounding variables or do \nnot report with sufficient detail the specifics of intervention such that summary statements can be \nmade regarding the effect of resistance exercise on various outcome measures.195, 196 However, \nan overriding theme throughout the studies was a significant strength improvement, especially in \nleg extensors.149, 194-196 Lower-limb strength gains were reported relatively uniformly across the \nstudies with significant improvements in gait speed and the ability to stand up from a chair or \nseated position.195 These seemingly simple and practical outcome measures of walking speed or \ngetting in and out of a chair represent improvements in lifestyle afforded by increased muscle \nstrength and or power, and their utility is proven by the ease at which seniors are able to carry out \n 35\n\n \nthe activities of daily life.197 Thus, it is now widely accepted that resistance training 2 to 3 days \nper week will lead to strength and muscle mass increases in the elderly, insomuch that the \nAmerican College of Sports Medicine recommends strength training as an integral part of \nphysical activity programming for older adults, and in particular, for frail seniors who stand to \nderive the most benefit from improvements in muscle mass or strength.15 \n \n2.4.3. Exercise Modalities for Treatment of Sarcopenic Obesity \n Granted that only a small portion of the elderly population would be classified as \nsarcopenic obese by clinical standards, a majority of older men and women choose a sedentary \nlifestyle that predisposes them to escalating obesity and muscular atrophy. Despite ample \nevidence that aerobic exercise is an effective strategy for obesity reduction and that resistance \nexercise can be used to maintain and even restore functional capacity by increasing muscle mass \nin the elderly, only a third of people over 75 and half of seniors between 65 and 74 engage in any \nleisure time physical activity at all.198 Which avenue should a practitioner take when prescribing a \nprogram of physical activity to a sedentary, senior population with an expanding waistline and \nmuscle mass deteriorating from disuse? Is it aerobic exercise or resistance exercise which holds \nthe most benefits for this population? \n Owing to the specificity of training effects, a combination of the two modalities has been \nadvocated for optimal physical function and health in the elderly.15, 199-201 Interestingly, although \nthese exercise recommendations are based on decades of research, few studies have been \nconducted in the elderly which directly compare the effects of aerobic or resistance exercise in \nthe same exercise trial and employ measures that capture the relative benefits of each modality \nas they affect major health outcomes. The non-randomized exercise trial by Ferrara et al.169 was \nthe first to provide insight into the comparative insulin sensitivity and abdominal adaptations of an \naerobic or resistance training in older, obese men. The authors reported significant strength \ngains were observed in both upper and lower body muscle groups in resistance exercisers by \ncomparison to those in the aerobic group, despite no significance in appendicular lean tissue \nmass or mid-thigh skeletal muscle area.169 \n 36\n\n \n Several studies to date have documented substantial strength, endurance, and even \nmetabolic improvements associated with a combined program of aerobic and resistance training \nin the elderly.202-207 However, only one trial to date provides measures of aerobic capacity, \nmuscular strength, and associated functional fitness change in a direct comparison between an \naerobic exercise only, resistance exercise only, and a combination of the two exercise modalities \nin a group of previous-sedentary senior men and women. This randomized controlled design \nemployed by Wood and colleagues208 identified the independent treatment effect of both aerobic \nand resistance exercise as compared to control while also considering whether one modality may \ninterfere with the benefits of the other when attempted concurrently. \n The notion of one exercise modality interfering with the expected outcomes of another in \na combined exercise training program has been investigated in studies with younger adults. \nWhile some studies report an impaired strength development when aerobic exercise is combined \nwith an existing resistance training program,209-212 others do not observed a compromise in \nrelative strength gains.202, 208, 213, 214 On the other hand, no study has yet shown that adding \nresistance training to an aerobic program interferes with improvements in aerobic endurance.202, \n211, 212 The study by Wood et al.208 responds to the possible interference of aerobic training on \nstrength gains by reducing the weekly volume of aerobic and resistance exercise in the combined \ngroup to match the volume performed by either modality alone. The results of this 12-week study \nshowed no interference of aerobic exercise on strength or functional fitness gains when the \nmodalities were combined.208 In fact, the combined group outperformed the other exercise \ngroups on strength and agility scores obtained by functional fitness testing.208 \n The results of this randomized controlled trial support the recommendations set forth by \nthe American College of Sports Medicine (ACSM) position panel on exercise for older adults,15 \nand seemingly provide answers to the questions regarding which modality or combination of \nexercises is most beneficial for functionality and strength in seniors approaching sarcopenic \nobesity. However, several questions still remain unanswered. First, the study by Wood et al.208 \nfailed to provide any measures of skeletal muscle mass and obesity, or more specifically, \nabdominal adiposity changes that may have occurred as a result of exercise intervention. \n 37\n\n \nSecond, although blood pressure was monitored, no other meaningful metabolic parameters were \ninvestigated which are known to be highly related to physical function, health, and disability such \nas insulin resistance or plasma markers of inflammation or disease. Lastly, the subjects \ncomposing each intervention group were of mixed gender, masking any possible gender-specific \nresponses to exercise that may have driven the relationships found in the results. Despite its \nlimitations, this study provides intriguing evidence that a combination of aerobic and resistance \nexercise improves functionality in seniors better than either exercise modality alone, and should \nbe employed as a therapeutic strategy to prevent the onset of disability in the elderly. \n \n2.5.0. Summary \n As a natural part of the aging process, but exacerbated by inactivity, abdominal obesity \naccumulates and appendicular muscle mass declines. Visceral fat deposition brings with it a host \nof debilitating metabolic diseases, including insulin resistance and dyslipidemia. Sarcopenia \nreduces functional capacity, threatens dependency on others, and increases risk of mortality. \nSimultaneous presentation of both conditions, a state termed sarcopenic obesity, results in a \nsynergistic compounding of metabolic and disability risk. Aerobic training reduces whole body \nand abdominal adiposity, but has not been shown as an effective method of restoring muscle \nmass. Resistance training results in muscle hypertrophy even in the frail elderly and restores \nability to perform activities of daily living, yet is not a potent stimulus for obesity reduction. It is \nthought that a combination of aerobic and resistance exercise should provide seniors with a \ntherapeutic strategy that is tailored to the specific body compositional and functional needs of \naging. However, only one randomized controlled trial to date has investigated the independent \nand combined effects of these two exercise modalities as they relate to strength and functional \nimprovements in the elderly. Absent from the literature are randomized controlled trials \ninvestigating the separate and combined effects of aerobic and resistance exercise on visceral \nand subcutaneous adiposity, muscle mass, insulin resistance, or other metabolic outcomes in \nseniors. The effect of gender on these relationships has also not been directly investigated. The \n 38\n\n \nresults of trials investigating the type of lifestyle modification that provides most benefit to seniors \ncurrently on the pathway toward sarcopenic obesity are required. \n The Senior Study responds to the paucity of data in the literature regarding the \ntherapeutic use of exercise for the reduction of health risk in the elderly. Using a well-controlled, \nrandomized design in an abdominally obese elderly population, the Senior Study investigates the \neffects of exercise using gold standard methodologies for determination of muscle mass, total \nand visceral fat, and insulin resistance. A novel aspect of the design is that the effects of aerobic \nexercise, resistance exercise, or a combination of the two modalities are observed and compared \nin the absence of caloric restriction. The results of this investigation provide the basis for \nimproved therapeutic strategies for the prevention and treatment of abdominal obesity, reduction \nof health risk, and improvement of physical function in older men and women.\n 39\n\n \n \n \n \n \n \n \nChapter 3. First Manuscript \n \n \nEffects of Exercise Modality on Visceral Fat, Skeletal Muscle and Insulin Resistance in \nObese Older Men and Women: A Randomized Controlled Trial \n 40\n\n \nABSTRACT \nCONTEXT: Aging is associated with marked increases in visceral obesity and associated insulin \nresistance concurrent with decreases in skeletal muscle mass and functional capacity. The \noptimal exercise modality for simultaneous treatment of abdominal obesity, insulin resistance and \nloss of muscle mass is unknown. \nOBJECTIVES: To compare the effects of a six-month program of aerobic and/or resistance \nexercise without caloric restriction on changes in visceral fat, skeletal muscle, and insulin \nresistance in obese older men and women. \nDESIGN: Randomized controlled trial. \nSETTING: Queen’s University Exercise Physiology Laboratory. \nPARTICIPANTS: 136 sedentary, abdominally obese older (60-79 years) men and women. \nINTERVENTION: Six months of progressive whole-body resistance exercise (RE), aerobic \nexercise (AE), a combination of the two modalities (RAE) or non-exercise control (C). \nMEASUREMENTS: Whole body skeletal muscle and total and visceral fat were quantified by \nwhole body magnetic resonance imaging. Insulin sensitivity was assessed by hyperinsulinemic \neuglycemic clamp. \nRESULTS: Total abdominal and visceral fat were reduced in all exercise groups compared to \ncontrols (P<0.01). Muscle mass increased in RE and RAE groups by comparison to both AE and \ncontrols (P<0.05). Insulin sensitivity increased in AE and RAE groups (P<0.05), but not RE \n(P>0.8), by comparison to controls. The insulin sensitivity increase within the RAE group was \nalso greater than RE (P<0.001).",
    "conclusion": "In abdominally obese older men and women, the combination of resistance and \naerobic exercise is the optimal treatment strategy for reducing abdominal obesity and associated \ninsulin resistance concurrent to increases in skeletal muscle mass. \nKey Words: exercise, aging, visceral fat, insulin resistance \n 41\n\n \nINTRODUCTION \n The prevalence of abdominal obesity in older men and women is already high and \nincreasing.1 Of particular concern is that with aging, an expanding waistline represents a \ndisproportionate increase in visceral adipose tissue, an established independent predictor of \nmorbidity2, 3 and mortality.4 The increase in visceral adipose tissue with aging is at least partially \nresponsible for the current epidemic of type 2 diabetes,215 a disease that contributes substantially \nto the burden of health care in the United States.216 \n Diet-induced weight loss has been the cornerstone of a lifestyle-based treatment for \nobesity and its related chronic diseases.82 While this strategy may effectively reduce abdominal \nobesity and related insulin resistance,107, 217 weight loss induced by caloric restriction alone is also \nassociated with decrements in skeletal muscle size11, 13, 165-167 and strength.167 For the elderly, a \nloss of skeletal muscle mass and strength is a detriment to functional capacity and increases the \nlikelihood of disability.8 Thus, a viscerally obese and muscle-deficient older patient presents a \ndual challenge to the clinician and raises questions as to the optimal treatment strategy for \nreducing abdominal obesity concurrent with a preservation and/or increase in skeletal muscle \nmass. \n Although exercise is commonly associated with a decrease in abdominal fat and an \nincrease in muscle, there is some uncertainty as to which modality of exercise is most beneficial \nfor the reduction of metabolic risk in older adults. Performing aerobic exercise in the absence of \ncaloric restriction has been shown to maintain muscle size and strength despite a significant \nreduction in body weight and obesity167 and improves insulin resistance, likely through the \nmechanism of visceral fat reduction.171, 172 Resistance exercise increases muscle mass and \nfunctional capacity in the elderly,218 and has been shown to reduce visceral fat in several non-\nrandomized trials.185, 187 It has been suggested that combining the two exercise modalities is the \noptimal treatment strategy for health risk reduction.15, 199-201 However, absent from the literature \nare randomized controlled trials comparing the independent and combined effects of aerobic and \nresistance exercise on visceral obesity and insulin resistance in elderly subjects. \n 42\n\n \n We performed a randomized controlled trial to establish the independent and combined \neffects of resistance and aerobic exercise on abdominal and visceral fat, insulin resistance, and \nskeletal muscle in abdominally obese older men and women. Our goal was to evaluate \nmodalities of exercise that were consistent with consensus guidelines and to implement them in \nthe absence of caloric restriction with the intent to produce a modest, exercise-induced weight \nloss that would be associated with substantial improvements in all three outcomes. \n 43\n\n \nMETHODS \nParticipants \nNon-smoking, sedentary, overweight senior men and women, 60 to 80 years of age were \nrecruited from the Kingston, Ontario, Canada region. Inclusion criteria required a waist \ncircumference of >102 cm in men and >88 cm in women and stable weight (±2 kg) for six months \nprior to study entry. Potential participants were excluded if they reported a history of heart \ndisease, stroke, diabetes or any condition that would prevent them from engaging in an exercise \nstudy; currently dieting or intent to diet; or if they were already engaging in two or more planned \nexercise sessions per week. Blood pressure and lipid-lowering medications were allowed if \nmaintained throughout the trial. All participants received medical clearance from a personal \nphysician and signed an informed consent in accordance with ethical guidelines of Queen’s \nUniversity. \n Eligible participants were allocated by computer-generated, sex-stratified random \nassignment into a non-exercise control or one of three exercise training groups: resistance \nexercise (RE), aerobic exercise (AE), or a combination of resistance and aerobic exercise (RAE). \nRandomized group assignment was issued upon completion of a majority of baseline \nassessments, and was not revealed to those conducting baseline tests. Of the 136 men and \nwomen randomized, nineteen did not complete their assigned six-month treatment (Figure 1). \nDiscontinuation due to musculoskeletal pain was due primarily to arthritis or involved a joint \ninjured prior to participation. Those who did not complete the trial did not differ significantly in any \nbaseline anthropometric variable from those who completed (P>0.10). \nDietary Assessment \nDuring the baseline period, participants were taught by a nutritionist to continue a weight-\nmaintenance calorie intake while recording their daily consumption of self-selected foods. A \nhealthy balance of macronutrients (approximately 55% carbohydrate, 15% protein, and 30% fat) \nwas encouraged, and body weight was monitored for approximately four weeks to ensure that \ndaily calorie targets were appropriate for weight maintenance. During the intervention, \nparticipants were required to maintain calorie levels determined at baseline unless weight change \n 44\n\n \nexceeded that predicted by exercise-induced energy expenditure. All participants attended nine \none-hour seminars in which the nutritionist taught healthy food selection and preparation. \nParticipants continued to keep and analyze detailed daily food records throughout the duration of \nthe study (approximately 29 weeks). The nutritionist regularly reviewed records to assure \ncompliance to established weight maintenance calorie targets, and upon completion of the study, \nanalyzed two representative weeks of records (week 4 and week 20 of the \nintervention) by a computerized program (Food Processor, ESHA Research, Salem, Oregon) to \nassess accuracy of calculated results. \nExercise Regimen \nAerobic and resistance exercise interventions were consistent with consensus \nrecommendations for exercise-related health benefits15 in older adults. All exercise sessions \nwere by appointment and supervised within the facilities of the corresponding author. \nParticipants randomized into either the RE or RAE group performed resistance training 3 \ndays per week. For each training session, the following nine exercises were performed: chest \npress, leg extension, shoulder raise, leg flexion, superpullover or lat pulldown (latissimus dorsi), \ntriceps extension, biceps curl, abdominal crunch, and modified pushups. Subjects performed one \nset of between eight and fifteen repetitions to volitional fatigue for all exercises during each \nsession. The weight lifted was increased when fifteen repetitions was exceeded. Relative \nstrength increases were assessed by subtracting the weight lifted in the 4th week from the final \nweek in the training, and expressed as a percentage of the 4th week’s weight. \nThose randomized to the AE group performed thirty minutes of moderate-intensity \nexercise (brisk walking or light jogging between 60 to 75% of peak oxygen uptake or 75 to 85% \nmaximal heart rate), with five minutes designated for warm up and cool down, respectively, for a \ntotal of forty minutes on motorized treadmills, five days per week. Exercise intensity was \nmonitored every five minutes using an automated heart rate monitor (Polar Oy, Kempele, \nFinland). Energy expenditure during the exercise program was determined using the heart rate \nand oxygen uptake data obtained from the baseline graded exercise test, which was adjusted \nusing the results from a subsequent graded exercise test performed in the second month of \n 45\n\n \nexercise. Participants in the RAE group performed the aerobic exercise protocol only three days \nper week in addition to the resistance exercise protocol. \nMeasurement of Body Composition \n Anthropometric measurements were taken at baseline and during the last week of \nintervention. Barefoot standing height was obtained to the nearest 0.1 cm using a wall-mounted \nstadiometer. Body mass was measured on a balance scale calibrated to the nearest 0.1 kg with \nparticipants dressed in standard T-shirts and shorts. Waist circumference was obtained in a \nstanding position using the average of two measures within 1.0 cm at the superior edge of the \niliac crest. \n Total and regional muscle mass and total fat mass were measured by magnetic \nresonance imaging (MRI) in a whole-body assessment protocol established elsewhere.12 Images \nwere obtained by a General Electric, 1.5-T magnet at baseline and follow-up. Once acquired, the \nMRI data were transferred to a stand-alone workstation for analysis using specially-designed \ncomputer software (Tomovision, Montreal, QC, Canada), the procedures for which have been \ndescribed elsewhere.12, 219 Volume units (liters) of tissues were converted to mass units \n(kilograms) multiplying the volumes by an assumed constant density for adipose tissue (0.92 \nkg/L) and fat-free skeletal muscle (1.04 kg/L).220 Visceral and abdominal subcutaneous tissue \nmasses were calculated using five equally-spaced cross-sectional images from five centimeters \nbelow to twenty centimeters above the L4-L5 intervertebral space. \nMeasurement of Cardiorespiratory Fitness \n Cardiorespiratory fitness (Peak VO2) was determined using a graded maximal treadmill \ntest that employed a constant walking speed, progressive increases in treadmill grade, and the \nuse of standard open-circuit spirometry techniques (SensorMedics, Yorba Linda, CA) at baseline, \nduring the 2nd month of exercise, and in the final week of intervention. Peak VO2 was attained \nwhen the subject reached volitional fatigue and at least two of the following three criteria were \nachieved: no increase in VO2 despite further increases in treadmill grade, a respiratory exchange \nratio in excess of 1.10, and a heart rate exceeding 85% of age-predicted maximum (208 - 0.7 x \nage).221 \n 46\n\n \n \nMeasurement of Insulin Sensitivity and Glucose Tolerance \n Insulin sensitivity was assessed by 3-hour hyperinsulinemic euglycemic clamp according \nto standard laboratory procedures we have described previously,190 with the exception that the \nelderly participants slept the previous night at their homes before being conveyed to the hospital \nwith minimal arousal at 5:15 a.m. Upon arrival, they were instructed to relax or sleep in bed until \ntesting commenced at 7:30 a.m. Post-intervention insulin sensitivity was assessed between 36-\n48 hours after the final exercise session. \n Glucose tolerance was measured a by 2-hour glucose tolerance test after a 12-hour fast \naccording to standard laboratory procedures previously published.190 Those participants whose \nplasma glucose levels exceeded 11.1 mmol/L at 120 minutes were considered diabetic and \nexcluded from the study. \nStatistical Analysis \n The effect of intervention was evaluated by intent-to-treat analysis. Subjects for whom \nfollow up data were unavailable were included in a multiple imputations procedure that estimated \nthe missing data values randomly based on the multivariate normal distribution of the data within \neach gender-specific intervention group.222 Analysis of variance (ANOVA) was used to determine \ndifferences between means of the treatment groups at baseline. Treatment-related changes in \noutcomes were adjusted for baseline values in an analysis of covariance (ANCOVA). The \nANCOVA model was extended to include gender and treatment-by-gender interaction to \ndetermine whether the effects of treatment varied by gender. Tukey post hoc tests with \nadjustment for multiple comparisons were performed to determine the differences between \ninterventions. Regression analysis was performed to determine the relationship between the \nchanges in abdominal fat and changes in waist circumference. P values of <0.05 were \nconsidered significant. All analyses were performed using SAS software, version 9.1 (SAS \nInstitute, Cary, NC). \n 47\n\n \nRESULTS \nAdherence to the Exercise and Diet Regimen \n Average attendance at the exercise sessions was 91±9% and did not vary significantly by \ngender or by exercise group (P>0.3). Aerobic exercise intensity did not differ between the AE \nand RAE groups (average exercise heart rate was 80% of maximum in both groups). \nCompliance to resistance exercise was manifest by significant strength gains. The RE and RAE \ngroups improved whole body strength by 46 and 48%, respectively. Relative strength gains did \nnot differ by group (P>0.2). \nSixty-six percent of participants completed more than 80% of their daily food intake \nrecords over the 6 month intervention. An additional 25% completed records at a rate of \napproximately two to three days per week. Computer analysis of a subset of 80 subjects verified \nself-reported results and confirmed that the total calorie and fat content of the diet did not change \nfrom the 4th to the 20th week of intervention and were not different from nutritional \nrecommendations (P>0.2). \nBaseline Characteristics and Gender Differences \n Subject characteristics at baseline are given in Table 1. The study sample was 98% \nCaucasian. Thirty-three percent of the sample was medicated for control of blood pressure; 19% \nwas taking lipid-lowering medications. While men were different from women for many baseline \ncharacteristics, there were no significant differences between randomized groups within each \ngender for any baseline variable (P>0.05). With the exception of a greater magnitude of total and \nvisceral fat reduction in men than women in the AE group only (P<0.05), men and women \nperforming the same exercise treatments did not differ significantly in their response to exercise \n(P>0.05), and thus all treatment-induced changes were shown collapsed across gender. \nAnthropometric Variables \nBody weight and body mass index (BMI) were reduced in the AE (-3.2±0.4%) and RAE (-\n2.8±0.4%) groups by comparison to both RE and controls (P<0.01), but did not differ from each \nother (P>0.8) (Table 2). The reduction in body weight and BMI within the RE group was not \nsignificant compared to controls (P>0.1). \n 48\n\n \n Waist circumference was reduced in all exercise groups by comparison to controls \n(P<0.001). The reduction within the AE group was greater than RE (P<0.05), but not RAE \n(P>0.9), which was not different from RE (P>0.1). Collapsed across groups, waist circumference \nexplained 30% of the variance in the changes in total abdominal fat volume (P<0.001). \nTreatment changes for both abdominal fat and waist circumference are shown in Figure 2. \nTotal Fat and Total Subcutaneous Fat \n Total fat was reduced in the AE and RAE groups (P<0.05) by comparison to both RE and \ncontrols, but were not different from each other (P>0.7) (Table 2). Total fat did not change in the \nRE group compared to controls (P=0.1). Subcutaneous fat was reduced in the AE and RAE \ngroups (P<0.01), but not RE (P>0.1) by comparison to controls. The reduction within the RAE \ngroup was greater than RE (P<0.01), but not AE (P>0.4). \nAbdominal Fat \n Total abdominal fat was reduced in all exercise groups compared to controls (P<0.05) \n(Table 2). The reduction did not differ between groups (P>0.1). Abdominal subcutaneous fat \nwas reduced in AE and RAE groups (P<0.01), but not RE (P>0.1), by comparison to controls. \nThe reduction was not different between AE and RAE (P=1.0). Visceral fat was reduced in all \nexercise groups compared to controls (P<0.01). The reduction did not differ between groups \n(P>0.2). \nSkeletal Muscle \n Skeletal muscle mass increased in the RE and RAE groups (P<0.05) by comparison to \nboth AE and controls, but were not different from each other (P>0.8) (Table 2). Skeletal muscle \nmass did not change in the AE group compared to controls (P=1.0). \nInsulin Sensitivity \n Insulin sensitivity increased in the AE and RAE groups (P<0.05), but not RE (P>0.8) by \ncomparison to controls (Table 2). The increase within the RAE group was greater than RE \n(P<0.001), but not AE (P>0.2). Percent increases in insulin sensitivity by exercise modality and \ncorresponding muscle and visceral fat changes are shown in Figure 3. \n \n 49\n\n \nCardiorespiratory Fitness \n Cardiorespiratory fitness increased in AE and RAE groups by comparison to both RE \n(P<0.05) and controls (P<0.001), but did not differ from each other (P=1.0) (Table 2). \nCardiorespiratory fitness did not change within the RE group compared to controls (P>0.1). \n 50\n\n \nDISCUSSION \n The primary finding of this trial is that independent of gender, the combination of \nresistance and aerobic exercise is the optimal treatment strategy for reducing abdominal obesity \nand associated insulin resistance concurrent with increases in skeletal muscle mass. However, it \nis also important that aerobic exercise alone was associated with a substantial reduction in \nvisceral fat and insulin resistance and a preservation of skeletal muscle mass, and that resistance \nexercise was associated with a reduction in abdominal obesity concurrent with an increase in \nskeletal muscle mass. These findings offer options for clinicians who seek lifestyle-based \ntreatment options for abdominally obese older men and women at substantially increased risk of \ndiabetes and functional impairment. \n Absent from the literature are randomized controlled trials comparing the extent to which \naerobic exercise, resistance exercise, or the combination of those two modalities reduce visceral \nfat independent of caloric restriction in older subjects. Previous trials that have investigated the \nindependent effects of aerobic exercise alone on visceral fat in older subjects,171, 189, 223 report \nequivocal findings. In a study conducted by Irwin et al.,171 87 older women exercised aerobically \n3.5 days per week for 12 months, yielding a 6.9% decrease in visceral fat. An earlier study by \nDiPietro et al.189 reported no change in visceral fat, perhaps owing to a small sample size and \nshorter treatment duration. Both of these trials failed to measure or control dietary intake, which, \nif slightly increased over the intervention period, may have masked exercise-induced energy \nexpenditure. Weiss and Holloszy223 observed a 36% reduction in visceral fat following one year \nof aerobic exercise in 18 men and women. In that study, the authors rigorously controlled dietary \nintake to ensure a 16-20% increase in expenditure was achieved throughout the intervention. \nAlthough the energy expended during aerobic exercise training was likely substantially less in our \ntrial, our results support the observations of Weiss and Holloszy,224 demonstrating with twice the \nnumber of subjects a significant reduction of visceral fat as a result of aerobic exercise. \n This is the first randomized controlled trial to report a significant reduction in visceral fat \nby resistance exercise alone in the elderly. Only one previous randomized trial in seniors, \nconducted in frail subjects over 78 years of age, reported no change in visceral fat as a result of \n 51\n\n \n12 weeks of progressive resistance training.184 It is possible that the short duration of the trial \ncoupled with the extreme age or frailty of the subjects may have resulted in insufficient energy \nexpenditure to reduce visceral fat significantly. Our findings extend previous work by providing a \ncomparison of visceral fat changes induced by both aerobic or resistance exercise in the absence \nof caloric restriction, and offer novel evidence in support of a combined modality approach for the \nreduction of visceral fat. \n To our knowledge, this is the first trial to compare the effects of exercise modality on \ninsulin sensitivity using the hyperinsulinemic euglycemic clamp method in older subjects. An \nearlier trial by Dengel et al.180 found that 10 months of aerobic exercise increased insulin \nsensitivity by 22% in 10 older men compared to controls. A larger trial by Frank et al.170 also \nshowed significant improvement in insulin sensitivity compared to controls using the HOMA \nmethod in 87 older women who performed aerobic exercise for a year. Although our results are \nconsistent with the available randomized controlled trials investigating insulin sensitivity \nadaptations to aerobic exercise, the literature is not as well established regarding the effect of \nresistance exercise. Hersey et al.181 conducted a 6-month randomized controlled trial in 52 older \nmen and women, and reported that aerobic, not resistance exercise, improved fasting insulin and \nglucose tolerance compared to controls. The lack of a significant insulin sensitivity increase \nobserved in our RE group confirms these results, yet the combination of resistance and aerobic \nexercise provided added insulin sensitivity benefit in comparison to aerobic exercise alone. That \nresistance exercise decreased visceral fat significantly while not improving insulin sensitivity \npoints to mechanisms other than visceral fat as contributors to insulin resistance, possibly by \nlipotoxicity in muscle and/or liver that may not be modified by resistance training in the absence of \naerobic exercise.225, 226 More research is needed to determine the mechanisms underlying the \ndifferences in insulin sensitivity adaptations between exercise modalities. \n An exercise-induced reduction in visceral fat of the magnitude observed in this study, \nespecially when accompanied by maintenance or even increases in skeletal muscle, has \nimportant clinical implications for elderly men and women. It demonstrates that healthy body \ncompositional adaptations can occur without caloric restriction and in the absence of substantial \n 52\n\n \nweight loss. Specifically, while reducing body weight less than 3%, RAE participants experienced \na significant reduction in visceral fat and regained muscle mass equivalent to five years’ worth of \n“normal” age-related muscle loss, as estimated by a cross-sectional analysis of similar-aged men \nand women.36 Certainly exercise alone, especially when combining resistance and aerobic \nexercise, is associated with marked reductions in visceral obesity and insulin resistance without \nnecessitating caloric restriction. \n These observations challenge the dogma that weight loss and caloric restriction need be \nthe cornerstone of a lifestyle-based intervention, especially in the elderly. Indeed, if weight loss \nor BMI reduction were the sole indicators of health improvement and success in our participants, \nthe efforts of the RE group would have been considered unsuccessful despite significant changes \nin muscle mass and abdominal obesity. The use of waist circumference as a clinical measure of \nsuccessful obesity reduction may provide a clearer picture of progress to the clinician and to \nseniors whose exercise efforts may have induced meaningful body compositional changes while \ntheir BMI remained relatively constant. Given the concern of many clinicians that caloric \nrestriction may be associated with malnutrition and loss of muscle mass, these results have vast \nclinical importance, and support the notion that measures of abdominal obesity such as waist \ncircumference should become a standard clinical tool for the assessment of changes in obesity-\nrelated health risk. \n It is important to highlight that the exercise prescriptions in this trial were consistent with \ncurrent recommendations for exercise in the elderly.15 The high compliance rate of our previously \nsedentary participants attests to the feasibility of the exercise prescriptions. That aerobic \nfrequency was reduced from 5 days a week to 3 days when combined with resistance exercise \nfurther enhanced the palatability of the combined modality intervention for our senior participants \nand coincides with literature-supported evidence for an optimal exercise prescription in this age \ngroup.218 The aerobic intensity maintained in daily exercise sessions by the participants was \ngenerally not considered burdensome, with a majority of the participants walking and only a few \njogging in later stages of intervention. Although the commencement of and sustained compliance \n 53\n\n \nto these exercise recommendations was well-tolerated by our participants, further research is \nneeded to determine their effectiveness when recommended by health care providers. \n In summary, our findings provide unequivocal support for a combined resistance and \naerobic exercise program without caloric restriction as an optimal strategy for the simultaneous \nimprovement of muscle mass, visceral fat, and insulin sensitivity in abdominally obese seniors. \nHowever, both aerobic and resistance exercise alone offer unique and meaningful health \nbenefits. These observations provide the basis for an improved therapeutic strategy for the \ntreatment of health risk associated with abdominal obesity and muscle loss in senior men and \nwomen: findings that apply directly to more than half of Americans over 65 years of age.1 This \nevidence upholds consensus exercise guidelines and should encourage health care providers to \npromote exercise as a meaningful preventive measure for the development of diabetes and \ndisability in seniors. \n 54\n\n \n 55\nACKNOWLEDGEMENTS \n This work was supported by a research grant from the Canadian Institutes of Health \nResearch to Robert Ross. We thank the study participants for their outstanding contribution to \nthe success of the study; our nutritionists and project coordinators, Ann-Marie Kungl, Shelley \nAtkinson, and Amanda McDougall; and expert technical assistance from Cyndi Little, Tammy \nScott-Zelt, and others of our medical team from the Kingston General and Hotel Dieu Hospitals; \nand finally Dr. Miu Lam for his biostatistical advice in performing the intent-to-treat analysis. The \nfunding agencies had no role in the analysis or interpretation of the data or in the decision to \nsubmit the report for publication. \n\n \n \nhTable 1. Subject characteristics at baseline \n Women Men\n \nControl Resistance \nExercise \nAerobic \nExercise \nResistance \n& Aerobic \nExercise \n Control Resistance \nExercise \nAerobic \nExercise \nResistance \n& Aerobic \nExercise \nMeasured variables \n \n(n=17)\n \n(n=21) (n=20) (n=21) (n=11)\n \n(n=15) (n=17) (n=14)\n \nAnthropometric \n \n \n \n \n \n \n \n \n \n \n \nAge (yrs) 67 (4) 68 (4) 69 (7) 67 (5) 67 (4) 67 (6) 69 (6) 67 (5) \nBody mass index (kg/m2) 30.4 (3.2) 30.0 (3.4) 29.2 (3.7) 29.5 (3.0) 30.5 (2.0) 30.1 (2.6) 29.9 (3.0) 31.1 (3.1) \nWaist circumference (cm) 104.9 (7.4) 104.3 (8.5) 104.2 (10.4) 102.8 (9.6) * 112.8 (5.3) \n \n111.0 (5.4) 113.0 (7.9) 114.1 (8.3) \n \nMagnetic Resonance Imaging \nSkeletal muscle (kg) 20.6 (2.6) 19.9 (2.5) 19.3 (3.6) 19.0 (2.1) * 29.5 (3.7) 32.2 (4.1) 30.3 (3.6) 30.0 (3.6) \nTotal fat (kg) 38.1 (7.5) 36.4 (6.8) 34.9 (7.2) 34.9 (6.8) * 34.0 (6.1) 31.5 (4.5) 33.0 (9.2) 34.9 (6.8) \n Subcutaneous fat (kg) 31.7 (6.7) 30.3 (5.7) 28.6 (6.2) 29.0 (6.3) * 24.3 (4.5) 21.4 (3.3) 22.7 (7.9) 24.5 (5.6) \nTotal abdominal fat (kg) 8.5 (2.0) 7.8 (1.8) 7.6 (2.2) 7.5 (1.5) * 9.0 (1.6) 8.2 (1.4) 8.9 (2.5) 9.1 (2.1)\n Visceral fat (kg) 2.7 (1.0) 2.5 (1.0) 2.6 (1.0) 2.3 (0.7) * 4.3 (1.3) 4.6 (1.1) 4.6 (0.9) 4.7 (1.1)\n Abdominal subcutaneous fat (kg) 5.9 (1.5) 5.3 (1.1) 5.0 (1.5) 5.1 (1.2) * 4.6 (0.9) \n \n3.6 (0.7) 4.3 (2.2) 4.4 (1.4) \n \nMetabolic \nFasting glucose (mmol/L) 4.7 (0.5) 4.7 (0.4) 4.8 (0.7) 4.2 (0.9) 4.7 (0.4) 4.8 (0.5) 4.8 (0.6) 4.8 (0.06) \n2-hr glucose tolerance (mmol/L) 6.7 (1.3) 7.6 (2.0) 7.3 (1.6) 6.7 (2.0) 6.1 (1.5) 7.0 (1.6) 7.6 (1.8) 6.7 (1.8) \nFasting insulin (pmol/L) 67.6 (41.5) 79.4 (46.6) 58.8 (30.6) 51.6 (25.0) 75.2 (61.4) 66.9 (24.3) 76.2 (32.9) 81.0 (31.3) \nInsulin sensitivity (M/I) 4.4 (1.6) 3.4 (1.6) 4.4 (2.0) 4.9 (2.2) * 3.7 (1.5) \n \n3.2 (1.5) 3.1 (1.6) 2.7 (1.4)\n \nCardiorespiratory fitness \nVO2max (L/min) 1.7 (0.3) 1.7 (0.3) 1.7 (0.3) 1.8 (0.4) * 2.6 (0.4) 2.6 (0.5) 2.5 (0.4) 2.7 (0.5) \nVO2max (mL•kg-1•min-1) \n \n21.1 (2.6) 21.0 (3.9) 21.8 (3.1) 23.5 (5.2) * 28.3 (5.3) \n \n27.8 (5.2) 26.9 (4.0) 28.1 (6.1) \nData are presented as group means (SD). \nM/I = rate of glucose uptake per unit of plasma insulin per kg skeletal muscle (mg•L/pmol•min-1•kg-1muscle x 100). \n. * Baseline means in men are significantly different from women (p<0.05)\n \n\n \n \nrol Resis cise rol Resis cise \n \n \n \niTable 2. Changes in selected morphologic, metabolic and fitness variables \n \nChanges in selected morphologic, metabolic and fitness variables \nContCont tance Exercise tance Exercise Aerobic ExerAerobic Exer Resistance & Resistance & \nAerobic Exercise Aerobic Exercise \n \nMeasured variables )] [n=30 )] )] [n=33 )] \n \n[n=24(28\n \n(36 [n=30(37 (35\n \nAnthropometric \n \n \n \n \n \n \nBody weight (kg) 0.3 (-0.4 to 1.0) -0.6 (-1.4 to 0.1) -2.8 (-3.4 to -2.1)*† -2.3 (-3.0 to -1.7)*† \nBody mass index (kg/m2) 0.1 (-0.2 to 0.3) -0.3 (-0.5 to -0.0) -0.9 (-1.2 to -0.7)*† -0.8 (-1.1 to -0.6)*† \nWaist circumference (cm) -0.3 (-1.3 to 0.7) -3.2 (-4.1 to -2.2)* -5.1 (-6.0 to -4.2)*† -4.6 (-5.5 to -3.7)* \n \nMagnetic Resonance Imaging \nSkeletal muscle (kg) -0.0 (-0.4 to 0.3) 0.8 (0.5 to 1.1)*‡ -0.0 (-0.3 to 0.3) 0.7 (0.4 to 0.9)*‡ \nTotal fat (kg) -0.5 (-1.2 to 0.3) -1.6 (-2.3 to -1.0) -3.0 (-3.7 to -2.3)*† -3.4 (-4.0 to -2.7)*† \nSubcutaneous fat (kg) -0.3 (-0.9 to 0.3) -1.2 (-1.7 to -0.7) -1.9 (-2.4 to -1.3)* -2.4 (-2.9 to -1.9)*† \nTotal abdominal fat (kg) -0.0 (-0.3 to 0.2) -0.5 (-0.7 to -0.3)* -0.8 (-1.0 to -0.6)* -0.8 (-1.0 to -0.6)* \n Visceral fat (kg) 0.0 (-0.1 to 0.2) -0.2 (-0.4 to -0.1)* -0.4 (-0.5 to -0.4)* -0.4 (-0.5 to -0.3)* \n Abdominal subcutaneous fat (kg) -0.0 (-0.2 to 0.1) -0.2 (-0.4 to -0.1) -0.4 (-0.5 to -0.3)* -0.4 (-0.5 to -0.3)* \n \nMetabolic \nFasting Insulin -2.0 (-10.6 to 6.5) -6.7 (-14.5 to -1.1) -10.0 (-18.6 to -1.0) -10.5 (-17.7 to -3.3) \nInsulin Sensitivity 0.1 (-0.3 to 0.5) 0.3 (-0.1 to 0.7) 0.9 (0.4 to 1.3)* 1.3 (0.9 to 1.7)*† \n \nCardiorespiratory Fitness \nVO2max (mL•kg-1•min-1) \n \n-1.2 (-0.3 to 0.2) 0.8 (-0.6 to 2.2) 4.2 (2.6 to 5.7)*† 3.8 (2.6 to 5.1)*† \n \nData are presented as group mean differences (95% confidence intervals). \nM = male; F = female; [n = number of participants completed (participants used in intent-to-treat analysis)]. \n* Significant treatment differences (pre vs. post) compared with control (p<0.05). \n† Significant treatment differences (pre vs. post) compared with resistance exercise (p<0.05). \n<0.05). ‡ Significant treatment differences (pre vs. post) compared with aerobic exercise (p\n\n \nbFigure 1. Participant flow diagram \n \nPersons who responded to media or other contact (n=1876) \nPersons who met screening criteria (n=272) \nMen \nControl \n(n=11) \nResistance\nExercise \n(n=15) \nPersons not \nrandomized \n(n=136) \nAerobic \nExercise \n(n=17) \nResistance \n& Aerobic \nExercise \n(n=14) \nDiscontinued: 1 lost interest \nDiscontinued: 1 lost interest; 2 had \nknee/arthritis pain; 1 died (myo-\ncardial infarct unrelated to study) \nRandomized \n(n=57) \nCompleted (n=10) \nIntent-to-treat \nanalysis (n=11) \nCompleted (n=10) \nIntent-to-treat \nanalysis (n=15) \nCompleted (n=13) \nIntent-to-treat \nanalysis (n=17)\nCompleted (n=14) \nIntent-to-treat \nanalysis (n=14)\nDiscontinued: 2 lost interest; 2 had \nshoulder/elbow pain; 1 moved \nControl \n(n=17) \nResistance\nExercise \n(n=21) \nAerobic \nExercise \n(n=20) \nResistance \n& Aerobic \nExercise \n(n=21) \nDiscontinued: 1 dissatisfied with \ngroup assignment; 1 had sickness-\nrelated weight loss; 1 dieted \nDiscontinued: 1 lost interest; 1 had \nknee/arthritis pain; 1 had back pain \nRandomized \n(n=79) \nCompleted (n=14) \nIntent-to-treat \nanalysis (n=17)\nCompleted (n=20) \nIntent-to-treat \nanalysis (n=21)\nCompleted (n=17) \nIntent-to-treat \nanalysis (n=20)\nCompleted (n=19) \nIntent-to-treat \nanalysis (n=21)\nDiscontinued: 1 had a death in the \nfamily \nDiscontinued: 1 lost interest; 1 had \nknee arthritis pain \nUnable to commit to 6 month program (n=99) \nUnwilling/unable to undergo testing procedures (n=13) \nPhysically unable to exercise (n=18) \nDiagnosed diabetic during baseline testing (n=6) \nWomen \n 58\n\n \ncFigure 2. Changes in abdominal fat and associated waist circumference \n \n \n \n \n \nC = control; RE = resistance exercise; AE = aerobic exercise; RAE = resistance and aerobic \nexercise \n* Significant treatment differences (pre vs. post) compared with control (p<0.05). \n† Significant treatment differences (pre vs. post) compared with resistance exercise (p<0.05). \n‡ Significant treatment differences (pre vs. post) compared with aerobic exercise (p<0.05). \n \n 59\n\n \ndFigure 3. Percent changes in muscle, visceral fat, and insulin sensitivity \n \n \nC = control; RE = resistance exercise; AE = aerobic exercise; RAE = resistance and aerobic \nexercise \n* Significant treatment differences (pre vs. post) compared with control (p<0.05). \n† Significant treatment differences (pre vs. post) compared with resistance exercise (p<0.05). \n‡ Significant treatment differences (pre vs. post) compared with aerobic exercise (p<0.05). \n \n 60\n\n \n \n \n \n \n \n \nChapter 4. Second Manuscript \n \n \n \nInfluence of Exercise Modality on Cardiorespiratory and Functional Fitness in Older Men \nand Women: A Randomized Controlled Trial \n 61\n\n \nABSTRACT \nCONTEXT: Low cardiorespiratory fitness and decreased muscular strength are trademarks of \naging, but can be modified with exercise. The optimal exercise modality or combination of \nmodalities to be used as a treatment strategy to prevent physical disability in the elderly is still \nunknown. \nOBJECTIVES: The primary objective was to examine the effects of aerobic and/or resistance \nexercise on cardiorespiratory and functional fitness. A secondary objective was to determine the \nextent to which changes in skeletal muscle and fat mass are related to functional performance in \npreviously sedentary, abdominally obese older men and women. \nDESIGN: Randomized controlled trial. \nSETTING: Queen’s University Exercise Physiology Laboratory. \nPARTICIPANTS: 136 sedentary, abdominally obese older (60-79 years) men and women. \nINTERVENTION: Six months of progressive whole-body resistance exercise (RE), aerobic \nexercise (AE), a combination of the two modalities (RAE) or non-exercise control. \nMEASUREMENTS: Cardiorespiratory fitness (CRF) was assessed using a graded maximal \nexercise test. Four physical tests were used to assess functional fitness. Whole body skeletal \nmuscle and fat were quantified by magnetic resonance imaging. \nRESULTS: CRF increased in the AE and RAE groups by comparison to both RE and controls. \nFunctional fitness improved significantly in all groups versus controls (P<0.001). Improvement in \nthe RAE group was greater than AE (P<0.01) but not RE (P>0.1). Muscle mass increased in RE \nand RAE groups by comparison to both AE and controls (P<0.05). Total fat was reduced in AE \nand RAE groups by comparison to both RE and controls (P<0.05). Both muscle gain and fat loss \nsignificantly and independently predicted improvements in functional fitness. \nCONCLUSION: The combination of resistance and aerobic exercise is the optimal treatment \nstrategy for simultaneous improvement of cardiorespiratory and functional fitness. \nKey Words: aging, sarcopenia, obesity, fitness, aerobic exercise, resistance exercise \n 62\n\n \nINTRODUCTION \n Over 46% of elderly Americans report no leisure time physical activity:227 a lifestyle \nchoice that, coupled with accelerated age-related declines in muscle strength and \ncardiorespiratory fitness,228, 229 increases dramatically the likelihood of physical disability.7, 230 \nAlthough it is clear that resistance exercise reverses age-related declines in muscle mass and \nstrength,218, 231 and that aerobic exercise improves cardiorespiratory fitness in elderly men and \nwomen,232 the relative effects of resistance exercise on cardiorespiratory fitness and aerobic \nexercise on muscle mass and strength are not well understood. Uncertainty also remains \nregarding the efficacy of a combined aerobic and resistance training program for improving \nstrength, functional ability and cardiorespiratory fitness in older adults. \n Despite widely-accepted guidelines recommending that older adults incorporate both \naerobic and resistance exercise into their daily activity,15 only one randomized controlled trial has \ncompared a combined modality program with aerobic and resistance exercise alone on strength, \ncardiorespiratory and functional fitness outcomes. Wood et al.208 observed that a combined \nresistance and aerobic program resulted in strength gains similar to resistance exercise alone, \nand cardiorespiratory improvements similar to aerobic alone, with a synergistic effect of the two \nmodalities on functional fitness.208 While the results of Wood and colleagues provide promising \nevidence for an optimal exercise prescription for disability prevention in the elderly, the sample \nsize was small, duration of treatment was short, dietary intake was not reported, the influence of \ngender was not considered, and intent-to-treat analyses were not performed. \n In this study we compared 6 months of resistance and aerobic exercise combined to \neither modality alone in a large group of abdominally obese elderly men and women. To help \nisolate the effects of exercise modality on the primary outcomes, participants were asked to \nmaintain calorie intake throughout the intervention. We hypothesized that the combination of \naerobic and resistance exercise would induce significant improvements in functional performance \nand cardiorespiratory fitness compared to either modality alone. Ancillary aims were to \ninvestigate whether modality-driven outcomes differed by gender and whether exercise-induced \nchanges in muscle and fat mass contributed to functional performance. \n 63\n\n \nMETHODS \nParticipants \nNon-smoking, sedentary, overweight senior men and women 60 to 80 years of age were \nrecruited from the Kingston, Ontario, Canada region. Inclusion criteria required a waist \ncircumference of >102 cm in men and >88 cm in women and stable weight (±2 kg) for six months \nprior to study entry. Potential participants were excluded if they reported a history of heart \ndisease, stroke, diabetes or any condition that would prevent them from engaging in an exercise \nstudy; currently dieting or intent to diet; or if they were already engaging in two or more planned \nexercise sessions per week. Blood pressure and lipid-lowering medications were allowed if \nmaintained throughout the trial. All participants received medical clearance from a personal \nphysician and signed an informed consent in accordance with ethical guidelines of Queen’s \nUniversity. \n Eligible participants were allocated by computer-generated, sex-stratified random \nassignment into a non-exercise control or one of three exercise training groups: resistance \nexercise (RE), aerobic exercise (AE), or a combination of resistance and aerobic exercise (RAE). \nRandomized group assignment was issued upon completion of a majority of baseline \nassessments, and was not revealed to those conducting baseline tests. Of the 136 men and \nwomen randomized, nineteen did not complete their assigned six-month treatment (Figure 1). \nThose who discontinued participation due to musculoskeletal pain complained primarily of \narthritis, previous joint injuries, or discomfort not directly attributable to the exercise requirements. \nThose who did not complete the trial did not differ significantly in any baseline anthropometric \nvariable from those who completed (P>0.10). \nDietary Assessment \nDuring the baseline period, participants were taught by a nutritionist to continue a weight-\nmaintenance calorie intake while recording their daily consumption of self-selected foods. A \nhealthy balance of macronutrients (approximately 55% carbohydrate, 15% protein, and 30% fat) \nwas encouraged, and body weight was monitored for approximately four weeks to ensure that \ndaily calorie targets were appropriate for weight maintenance. During the intervention, \n 64\n\n \nparticipants were required to maintain calorie levels determined at baseline unless weight change \nexceeded that predicted by exercise-induced energy expenditure. All participants attended nine \none-hour seminars in which a nutritionist taught healthy food selection and preparation. \nParticipants continued to keep and analyze detailed daily food records throughout the duration of \nthe study (approximately 29 weeks). The nutritionist regularly reviewed records to assure \ncompliance to established weight maintenance calorie targets, and upon completion of the study, \nanalyzed two representative weeks of records (week 4 and week 20 of the \nintervention) by a computerized program (Food Processor, ESHA Research, Salem, Oregon) to \nassess accuracy of calculated results. \nExercise Regimen \nAerobic and resistance exercise interventions were consistent with consensus \nrecommendations for exercise-related health benefits15 in older adults. All exercise sessions \nwere by appointment and supervised within the facilities of the corresponding author. \nParticipants randomized into either the RE or RAE group performed progressive \nresistance exercises 3 days per week. For each training session, the following nine exercises \nwere performed: chest press, leg extension, shoulder raise, leg flexion, superpullover or lat \npulldown (latissimus dorsi), triceps extension, biceps curl, abdominal crunch, and modified \npushups. Subjects performed one set of between eight and fifteen repetitions to volitional fatigue \nfor all exercises during each session. The weight lifted was increased when fifteen repetitions \nwas exceeded. \nThose randomized to the AE group performed thirty minutes of moderate-intensity \nexercise (brisk walking or light jogging between 60 to 75% of peak oxygen uptake or 75 to 85% \nmaximal heart rate), with five minutes designated for warm up and cool down, respectively, for a \ntotal of forty minutes on motorized treadmills, five days per week. Exercise intensity was \nmonitored every five minutes using an automated heart rate monitor (Polar Oy, Kempele, \nFinland). Energy expenditure during the exercise program was determined using the heart rate \nand oxygen uptake data obtained from the baseline graded exercise test, which was adjusted \nusing the results from a subsequent graded exercise test performed in the second month of \n 65\n\n \nexercise. Participants in the RAE group performed the aerobic exercise protocol only three days \nper week in addition to the resistance exercise protocol. \nMeasurement of Cardiorespiratory Fitness \n Cardiorespiratory fitness (Peak VO2) was determined using a graded maximal treadmill \ntest that employed a constant walking speed and the use of standard open-circuit spirometry \ntechniques (SensorMedics, Yorba Linda, CA) at baseline, during the 2nd month of exercise, and in \nthe final week of intervention. Peak VO2 was attained when the subject reached volitional fatigue \nand at least two of the following three criteria were achieved: no increase in VO2 despite further \nincreases in treadmill grade, a respiratory exchange ratio in excess of 1.10, and a heart rate \nexceeding 85% of age-predicted maximum (208 - 0.7 x age).221 \nMeasurement of Functional Fitness \n Status of physical function was evaluated using four of the six tests from the functional \nfitness test battery designed by Rikli and Jones,197 consisting of items designed to assess the \nphysiological parameters associated with independent living in older adults: thirty-second chair \nstand, arm curl, two-minute step, and 8-foot up-and-go. The remaining two tests evaluated \nflexibility outcomes were not directly targeted by our exercise intervention: stretching was \nencouraged, but not required following each exercise session. Performance on the four \nfunctional tests was evaluated not only by raw scores, but by changes in percentile rankings \nwhen compared to age- and gender-specific normative values from a representative older \npopulation of over 7,000 older subjects who completed the same battery of tests.233 An overall \nfunctional fitness improvement score was derived using a mean percentile ranking increase from \nall four strength and agility tests. \nMeasurement of Body Composition \n Anthropometric measurements were taken at baseline and during the last week of \nintervention. Barefoot standing height was obtained to the nearest 0.1 cm using a wall-mounted \nstadiometer. Body mass was measured on a balance scale calibrated to the nearest 0.1 kg with \nparticipants dressed in standard T-shirts and shorts. Circumference measures were obtained in a \nstanding position using the average of two measures within 1.0 cm: thigh at the midpoint between \n 66\n\n \ninguinal crease and the proximal edge of the patella; hip at the greatest protrusion of the buttocks \nas viewed from the side; waist at the superior edge of the iliac crest. \n Total and regional muscle mass and total fat mass were measured by magnetic \nresonance imaging (MRI) in a whole-body assessment protocol established elsewhere.12 Images \nwere obtained by a General Electric, 1.5-T magnet at baseline and follow-up. Once acquired, the \nMRI data were transferred to a stand-alone workstation for analysis using specially-designed \ncomputer software (Tomovision, Montreal, QC, Canada), the procedures for which have been \ndescribed elsewhere.12, 219 Volume units (liters) of tissues were converted to mass units \n(kilograms) multiplying the volumes by an assumed constant density for adipose tissue (0.92 \nkg/L) and fat-free skeletal muscle (1.04 kg/L).220 Skeletal muscle was divided into upper and \nlower-body segments at the L4-L5 intervertebral space. \nStatistical Analysis \n The effect of intervention was evaluated by intent-to-treat analysis. Subjects for whom \nfollow up data were unavailable were included in a multiple imputations procedure that estimated \nthe missing data values randomly based on the multivariate normal distribution of the data within \neach gender-specific intervention group. Analysis of variance (ANOVA) was used to determine \ndifferences between means of the treatment groups at baseline. Treatment-related changes in \noutcomes were adjusted for baseline values in an analysis of covariance (ANCOVA). The \nANCOVA model was extended to include gender and treatment-by-gender interaction to \ndetermine whether any treatment effects varied by gender. Tukey post hoc tests with adjustment \nfor multiple comparisons were performed to determine differences between randomized groups. \nRegression analysis tested the independent associations of fat and muscle changes to functional \nfitness changes. Fat and muscle tertile group comparisons were made by ANCOVA controlling \nfor baseline, age, and gender with Tukey adjustment for multiple comparisons. P values of <0.05 \nwere considered significant. All analyses were performed using SAS software, version 9.1 (SAS \nInstitute, Cary, NC). \n 67\n\n \nRESULTS \nBaseline Characteristics and Gender Differences \n The study sample was 98% Caucasian. Thirty-three percent of the sample (24 of 57 \nmen; 21 of 79 women) was medicated for control of blood pressure; 19% (11 of 57 men; 15 of 79 \nwomen) was taking lipid-lowering medications. While there were differences in baseline values \nbetween men and women, randomly-assigned groups within each gender did not differ \nsignificantly (P>0.05), and baseline characteristics are shown collapsed across group in Table 1. \nMen and women did not differ in response to exercise modality for any of the physical or \nfunctional fitness variables, with the single exception of a greater total fat reduction in men \n(4.4±0.5 kg) than women (1.7±0.4 kg) within the aerobic exercise group only (P=0.04). \nAccordingly, mean changes for all variables are shown collapsed across gender (Table 2). \nDietary Intake \n Approximately 66% of participants completed more than 80% of their daily food intake \nrecords over the 24-week intervention. An additional 25% completed records at a rate of \napproximately two to three days per week. Computer analysis of a subset of 80 subjects verified \ncalculated results and confirmed that the total calorie and fat content of the diet was not different \nfrom nutritional recommendations, and did not change from the 4th to the 20th week of intervention \n(P>0.2). \nExercise Programs \n Average attendance at all exercise sessions was 91±9% and did not vary significantly by \ngender or by exercise group (P>0.3). Aerobic exercise intensity did not differ between the AE \nand RAE groups (average exercising heart rate was 80% of maximum in both groups, regardless \nof gender). Men expended more energy during each aerobic exercise session (354±58 kcal) than \ndid women (245±47 kcal) (P<0.001), but within gender, AE and RAE did not differ in energy \nexpenditure per treadmill session (P>0.2). \n Compliance to resistance exercise was evidenced by significant strength gains in both \nmen and women. The RE and RAE groups improved upper body strength by 39% in men; in \nwomen, the RE and RAE groups increased by 40% and 46%, respectively. Men increased lower \n 68\n\n \nbody strength by 59% and 62% in the RE and RAE groups, respectively; women increased by \n62% in both RE and RAE groups. Percent strength gains did not differ by gender or between RE \nand RAE (P>0.2). \nAnthropometric Variables \nBody weight and body mass index (BMI) were reduced in the AE and RAE groups \n(P<0.01) by comparison to both RE and controls, but did not differ from each other (P>0.8) (Table \n2). The reduction in body weight and BMI within the RE group was not significant compared to \ncontrols (P>0.1). \nCardiorespiratory Fitness \n Absolute cardiorespiratory fitness (expressed in L/min) increased in the AE and RAE \ngroups (P<0.001), but not RE (P>0.1), by comparison to controls (Table 2). The increase within \nthe AE group was greater than RE (P<0.05), but not RAE (P>0.9). When expressed relative to \nbody weight (milliliters of oxygen per kg body weight per minute), cardiorespiratory fitness \nincreased in AE and RAE groups by comparison to both RE (P<0.05) and controls (P<0.001). \nThe RE group did not increase compared to controls (P>0.1) \nFunctional Fitness \n Performance on the four functional fitness tests improved significantly in all exercise \ngroups compared to controls (P<0.01) (Table 2). Improvements within the RAE group were \ngreater than the AE group on chair stands, arm curls and the 2-minute step test (P<0.05), but \nwere not greater than AE on the 8-foot up-and-go (P>0.3). The AE and RE groups did not differ \nfrom each other on any functional fitness test (P>0.5), nor did RAE differ from RE (P>0.05). \nImprovements in age- and sex-specific percentile rankings compared to a reference population \nare shown in Figure 2. The mean percentile ranking increase from the four functional fitness \ntests was greater in the RAE group compared to AE (P<0.01), but not RE (P>0.1) (Figure 2e). \nPercent change in percentile rankings are shown by randomized group as they coincide with \nchanges in cardiorespiratory fitness, skeletal muscle, and total fat in Figure 3. \n \n \n 69\n\n \nSkeletal Muscle \n Both whole body and upper body skeletal muscle mass increased in the RE and RAE \ngroups (P<0.05) by comparison to AE and controls, but RE and RAE were not different from each \nother (P>0.8) (Table 2). Muscle mass did not change in the AE group compared to controls \n(P=1.0). Lower body skeletal muscle mass did not increase significantly in any of the exercise \ngroups compared to controls (P>0.2). \nTotal Fat \n Total fat was reduced in the AE and RAE groups (P<0.05) by comparison to both RE and \ncontrols, but were not different from each other (P>0.7) (Table 2). Total fat did not change in the \nRE group compared to controls (P=0.1). \nAssociations between Muscle, Fat, and Functional Performance \n Collapsed across groups, changes in muscle mass and total fat were significantly \nassociated with corresponding changes in performance on all four functional fitness tests, albeit \nin opposite directions (n=121, P<0.05). Both fat loss and muscle gain were independent \npredictors of improvements in functional fitness, but fat loss was a stronger predictor in all but the \n8-foot up-and-go test (Table 3). Figure 4 further illustrates the relationship between changes in \nfunctional performance and muscle and total fat change using groups defined by high, middle, or \nlow muscle and total fat change. On all four functional fitness tests, mean improvement on \nperformance was greater in subjects in the highest tertile of fat loss and muscle gain compared to \nthose in the lowest tertile in both tissues (P<0.05) (Figure 4). \n 70\n\n \nDISCUSSION \n The primary finding of this study was that performing aerobic and resistance exercise for \n6 months produced optimal improvements in functional performance and cardiorespiratory fitness \nin previously sedentary, abdominally obese senior men and women. Performing aerobic exercise \nalone was associated with a similar increase in cardiorespiratory fitness but lesser functional \nfitness benefit, while resistance exercise alone did not significantly increase cardiorespiratory \nfitness but improved functional performance similarly when compared to the combined exercise \ngroup. Regardless of modality, however, exercise produced significant and meaningful \nimprovements in functional performance compared to controls. All exercise-induced \ncardiorespiratory and functional fitness changes occurred independent of gender. That these \nobservations were derived from exercise strategies that are consistent with consensus guidelines \nreinforce the clinical utility of the findings and offer the clinician alternatives for the prevention and \ntreatment of disability in the elderly. \n Our primary observation that a combination of aerobic and resistance exercise resulted in \noptimal cardiorespiratory and functional fitness outcomes supports the findings of Wood et al.,208 \nwhich demonstrated in a smaller sample of elderly men and women that the strength and \ncardiorespiratory fitness adaptations attained by either aerobic or resistance exercise were not \nattenuated when the two modalities were combined. While some previous randomized trials in \nyounger subjects have reported an “interference” effect of modality-specific adaptations,210, 212 our \nfindings and those of Wood et al.208 demonstrate that not only are the strength gains achieved by \nelderly subjects performing resistance exercise alone, and the cardiorespiratory improvements \nattained consequent to aerobic training alone not affected when combined with the other \nmodality, but a synergistic enhancement of functional performance is achieved with simultaneous \nresistance and aerobic training. A possible explanation for the lack of interference in these two \nstudies with elderly subjects is that in both cases, aerobic exercise session frequency was \nreduced to three instead of five or more sessions per week, which allows for adequate \nrecuperation from muscle damage caused by resistance training, especially muscle groups used \nin both exercise modalities.218 Although a recent meta-analysis recommends a resistance \n 71\n\n \nexercise frequency of two days per week to obtain full muscle recovery in the elderly, specifically \nin older women,234 our results show no significant compromise in strength or muscle hypertrophy \nwith a frequency of three days per week during six months of combined training. \n Whereas the strength and functional fitness benefits of resistance exercise are well \nestablished,218 the benefits regarding cardiorespiratory fitness are unclear.196 Other randomized \ncontrolled trials have investigated the effects of resistance exercise alone on cardiorespiratory \nfitness outcomes in elderly subjects. Vincent et al.235 compared 6 months of high and low \nintensity resistance training to controls, and found that both intensities increased cardiorespiratory \nfitness significantly by over 20%. Using a training protocol similar to Vincent’s high intensity \nprogram, Hersey et al.181 compared six months of resistance exercise to aerobic exercise, and \nobserved a 20% increase in cardiorespiratory fitness with aerobic exercise and no improvement \nin the resistance group. The resistance training protocols of both previous trials match ours in \nintensity and duration, yet our results support Hersey et al.181 and contradict those of Vincent et \nal.235 One plausible explanation for differences between these trials is the possible variance in \nsubjects’ participation in free-living physical activity, which has been documented to increase \nconcurrent to longer-duration resistance training programs,236 but was not quantified or reported \nto be controlled in these studies. \n This is the first randomized controlled trial to compare modality-specific adaptations in \nboth muscle and fat and how they relate to functional fitness improvements in the elderly. Visser \net al.237 demonstrated in a large cross-sectional study that both low muscle mass and high body \nfat are related to poor physical function. The significant differences in muscle and fat change \nbetween treatments, shown in Figure 3, demonstrate the distinct physical adaptations that are \nassociated with either aerobic or resistance exercise. That functional fitness improvement \nappears to be greatest in modalities that induce the greatest concurrent changes in muscle and \nfat implies that these adaptations independently contribute to enhanced performance. Indeed, we \nexamined further the associations between functional performance and body compositional \nchange and found that both fat loss and muscle gain significantly and independently predicted \nperformance improvement, such that the subjects who lost more fat and gained more muscle \n 72\n\n \nwere more likely to enhance functional performance (Figure 4). These findings highlight the \nimportance of simultaneously developing muscle and reducing fat in seniors to prevent functional \ndecline. \n Consensus exercise guidelines for older adults already recommend participation in both \naerobic and resistance exercise for optimal health benefits.15 For the clinician wishing to \npersonalize exercise prescription for a variety of elderly patients, however, the results from this \nstudy provide evidence to support more than one viable treatment option. An obese older patient \nmay choose to focus on the cardiorespiratory fitness-enhancing, fat-reducing, morbidity-\ncompressing benefits associated with aerobic exercise, for example, while a frailer senior may \nprefer the muscle hypertrophy and strength benefits that a resistance-only program provides. \nUnderstanding that resistance exercise alone may have minimal effects on cardiorespiratory \nfitness, and that aerobic exercise alone may not yield the maximal functional fitness benefit \nwithout resistance exercise provides a framework upon which informed treatment decisions can \nbe made. Regardless of preference, significant functional fitness benefits can be achieved with \neither exercise modality alone. However, our results clearly show that the combination of \nresistance and aerobic exercise provides an optimal assembly of cardiorespiratory and functional \nfitness benefits, due in part to its favorable influence on both muscle and fat mass. \n A notable limitation to our study may be our exclusion of non-abdominally obese seniors. \nThough our sample represents a majority of the aging population in North America, our \nconclusions regarding the relative benefits of exercise modalities in this sample may not apply to \nelderly populations with substantial anthropometric differences from our sample. Furthermore, an \nevaluation of the effect of race on study outcomes was not possible with our predominantly \nCaucasian sample of elderly men and women. Also, this study compared the efficiency of \nexercise modality programs which contained aerobic or resistance components, and did not \nassess the results of a program in which resistance exercise is modified to incorporate aerobic \nattributes. Circuit training, for example, may or may not produce the same results achieved by \nour combined aerobic and resistance exercise program. Further research is required to assess \nthe comparative utility of such modifications. \n 73\n\n \n In conclusion, the findings of our study present unequivocal evidence that the \ncombination of resistance and aerobic exercise, performed according to consensus \nrecommendations, is the optimal treatment strategy for simultaneous improvement of \ncardiorespiratory and functional fitness in abdominally obese older adults. However, substantive \nbody compositional and functional fitness benefits were associated with either exercise modality \nalone. These observations provide the clinician with options for needs-based exercise \nprescriptions for the prevention of disability in the elderly. \n 74\n\n \nACKNOWLEDGEMENTS \n This work was supported by a research grant from the Canadian Institutes of Health \nResearch to Robert Ross. We extend sincere thanks to the study participants as well as to the \nsupport personnel who made this work possible. We are grateful for the efforts of our nutritionists \nand project coordinators, Ann-Marie Kungl, Shelley Atkinson, and Amanda McDougall, and the \nradiology technicians at Kingston General Hospital. Also a special thanks to Dr. Miu Lam for his \nbiostatistical advice in performing the intent-to-treat analysis. \n 75\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \njTable 1. Subject characteristics at baseline \n \nMen \n(n=57) \n \nWomen \n(n=79) \n \nAnthropometrics \nAge, yr 67.7 (5.1) 67.7 (5.1) \nWaist Circumference, cm 112.7 (6.9) 104.0 (9.0)* \nBody Mass Index, kg/m2 30.4 (2.7) 29.7 (3.3) \nBody weight, kg 94.6 (10.6) 78.7 (10.1)* \n \nCardiorespiratory Fitness \nVO2max (L/min) 2.6 (0.5) 1.7 (0.3)* \nVO2max (mL•kg-1•min-1) 27.7 (5.1) 21.9 (4.0)* \n \nFunctional Fitness \nChair Stands, reps in 30 seconds 15.4 (3.6) 12.5 (3.4)* \n Percentile Ranking 50.6 (24.3) 40.0 (25.7)* \nArm curls, reps in 30 seconds 19.8 (3.8) 15.3 (3.4)* \n Percentile Ranking 62.0 (23.0) 49.4 (22.5)* \nSteps in place, reps in 2 minutes 113.1 (15.1) 90.5 (19.1)* \n Percentile Ranking 71.0 (24.5) 52.7 (24.5)* \n8-foot up-and-go, seconds 4.1 (0.6) 5.2 (0.8)* \n Percentile Ranking 75.4 (12.9) 61.6 (18.7)* \n \nMagnetic Resonance Imaging \nTotal Muscle Mass, kg 30.6 (3.8) 19.7 (2.8)* \n Upper Body Muscle, kg 12.6 (1.8) 7.4 (1.1)* \n Lower Body Muscle, kg 18.0 (2.2) 12.3 (1.8)* \nTotal Fat Mass, kg 33.3 (7.0) 36.0 (7.0)* \n \nValues as presented as Mean (SD). \n* Women are significantly different from men, P<0.05. \n \n 76\n\n \n \nkTable 2. Changes in selected anthropometric, cardiorespiratory and functional fitness variables over 6 \nmonths of treatment \n \n Control Resistance \nExercise Aerobic Exercise Resistance \n& Aerobic Exercise\nMeasured variables [n=24(28)] [n=30(36)] [n=30(37)] [n=33(35)] \n \nAnthropometric \nBody weight (kg) 0.3 (-0.4 to 1.0) -0.6 (-1.4 to 0.1) -2.8 (-3.4 to -2.1)*† -2.3 (-3.0 to -1.7)*† \nBody mass index (kg/m2) 0.1 (-0.2 to 0.3) -0.3 (-0.5 to -0.0) -0.9 (-1.2 to -0.7)*† -0.8 (-1.1 to -0.6)*† \n \nCardiorespiratory fitness \nVO2max (L/min) -0.1 (-0.2 to 0.0) 0.0 (-0.1 to 0.2) 0.3 (0.2 to 0.4)*† 0.2 (0.1 to 0.3)* \nVO2max (mL•kg-1•min-1) -1.8 (-2.5 to 0.2) 0.8 (-0.6 to 2.2) 4.2 (2.6 to 5.7)*† 3.8 (2.6 to 5.1)*† \n \nFunctional fitness \nChair stands (repetitions) 0.4 (-0.7 to 1.5) 4.2 (3.1 to 5.3)* 3.9 (2.9 to 4.8)* 6.1 (5.0 to 7.2)*‡ \nArm curls (repetitions) 0.1 (-1.6 to 1.7) 6.5 (4.9 to 8.0)* 5.1 (3.8 to 6.4)* 8.1 (6.5 to 9.7)*‡ \n2-minute step (steps) 1.8 (-2.8 to 6.4) 19.7 (15.0 to 24.4)* 16.7 (12.8 to 20.6)* 27.3 (22.9 to 31.7)*‡\n8-foot up-and-go (seconds) -0.1 (-0.2 to 0.1) -0.6 (-0.7 to -0.4)* -0.4 (-0.6 to -0.3)* -0.6 (-0.8 to -0.4)* \n \nMagnetic Resonance Imaging \nSkeletal muscle (kg) -0.0 (-0.4 to 0.3) 0.8 (0.5 to 1.1)*‡ -0.0 (-0.3 to 0.3) 0.7 (0.4 to 0.9)*‡ \n Upper body muscle (kg) -0.1 (-0.3 to 0.2) 0.7 (0.3 to 1.1)*‡ -0.5 (-0.9 to -0.2) 0.6 (0.2 to 0.9)*‡ \n Lower body muscle (kg) 0.0 (-0.4 to 0.5) 0.5 (0.1 to 0.9) 0.3 (-0.1 to 0.7) 0.2 (-0.2 to 0.5) \nTotal fat (kg) -0.5 (-1.2 to 0.3) -1.6 (-2.3 to -1.0) -3.0 (-3.7 to -2.3)*† -3.4 (-4.0 to -2.7)*† \n \nData are presented as group mean differences (95% confidence intervals). \n* Significant treatment differences (pre vs. post) compared with control (p<0.05). \n† Significant treatment differences (pre vs. post) compared with resistance exercise (p<0.05). \n‡ Significant treatment differences (pre vs. post) compared with aerobic exercise (p<0.05). \n \n \n77\n\n \n \nlTable 3. Associations between changes in muscle, fat, and functional performance improvement \n Skeletal Muscle \nChanges \nTotal Fat \nChanges \nCombined \nChanges \nFunctional Fitness Test R2 P-value R2 P-value R2 P-value \n \nChair stands (repetitions) 0.038* 0.04 0.093*† <0.001 0.149 <0.001 \nArm curls (repetitions) 0.057* 0.01 0.095*† <0.001 0.175 <0.001 \n2-minute step (steps) 0.039* 0.03 0.093*† <0.001 0.151 <0.001 \n8-foot up-and-go (seconds) 0.058*† 0.01 0.037* 0.04 0.110 <0.001 \n \n* Change independently predicts functional fitness change. \n† Stronger predictor of functional fitness change. \n \n \n \n \n \n78\n\n \neFigure 1. Participant flow diagram \nPersons who responded to media or other contact (n=1876) \nPersons who met screening criteria (n=272) \nMen \nControl \n(n=11) \nResistance\nExercise \n(n=15) \nPersons not \nrandomized \n(n=136) \nAerobic \nExercise \n(n=17) \nResistance \n& Aerobic \nExercise \n(n=14) \nDiscontinued: 1 lost interest \nDiscontinued: 1 lost interest; 2 had \nknee/arthritis pain; 1 died (myo-\ncardial infarct unrelated to study) \nRandomized \n(n=57) \nCompleted (n=10) \nIntent-to-treat \nanalysis (n=11) \nCompleted (n=10) \nIntent-to-treat \nanalysis (n=15) \nCompleted (n=13) \nIntent-to-treat \nanalysis (n=17) \nCompleted (n=14) \nIntent-to-treat \nanalysis (n=14) \nDiscontinued: 2 lost interest; 2 had \nshoulder/elbow pain; 1 moved \nControl \n(n=17) \nResistance\nExercise \n(n=21) \nAerobic \nExercise \n(n=20) \nResistance \n& Aerobic \nExercise \n(n=21) \nDiscontinued: 1 dissatisfied with \ngroup assignment; 1 had sickness-\nrelated weight loss; 1 dieted \nDiscontinued: 1 lost interest; 1 had \nknee/arthritis pain; 1 had back pain \nRandomized \n(n=79) \nCompleted (n=14) \nIntent-to-treat \nanalysis (n=17) \nCompleted (n=20) \nIntent-to-treat \nanalysis (n=21) \nCompleted (n=17) \nIntent-to-treat \nanalysis (n=20) \nCompleted (n=19) \nIntent-to-treat \nanalysis (n=21) \nDiscontinued: 1 had a death in the \nfamily \nDiscontinued: 1 lost interest; 1 had \nknee arthritis pain \nUnable to commit to 6 month program (n=99) \nUnwilling/unable to undergo testing procedures (n=13) \nPhysically unable to exercise (n=18) \nDiagnosed diabetic during baseline testing (n=6) \nWomen \n \n \n \n \n \n79\n\n \nfFigure 2. Changes in age- and sex-specific ranking on four functional fitness tests \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nC = control; RE = resistance exercise; AE = aerobic exercise; RAE = resistance and aerobic \nexercise \n* Significant treatment differences (pre vs. post) compared with control (p<0.05). \n† Significant treatment differences (pre vs. post) compared with resistance exercise (p<0.05). \n‡ Significant treatment differences (pre vs. post) compared with aerobic exercise (p<0.05). \n \n \n80\n\n \ngFigure 3. Percent changes in cardiorespiratory and functional fitness, total muscle and fat with \nexercise modality \n \nC = control; RE = resistance exercise; AE = aerobic exercise; RAE = resistance and aerobic \nexercise \n* Significant treatment differences (pre vs. post) compared with control (p<0.05). \n† Significant treatment differences (pre vs. post) compared with resistance exercise (p<0.05). \n‡ Significant treatment differences (pre vs. post) compared with aerobic exercise (p<0.05). \n \n \n81\n\n \nhFigure 4. Functional fitness performance by muscle and fat change tertile groups \n \n∆ = change; -∆ = inverted change scores; High = highest tertile of muscle or fat change; \nMid = middle tertile of muscle or fat change; Low = lowest tertile of muscle or fat change; \nsec = seconds; min = minutes. \n* Tertile mean is greater than low-fat low-muscle change tertile (p<0.05). \n† Tertile mean is greater than mid-fat low-muscle change tertile (p<0.05). \n‡ Tertile mean is greater than low-fat mid-muscle change tertile (p<0.05). \n \n \n \n82\n\n \nChapter 5. General Discussion \n \n The results from these two manuscripts establish that independent of gender and without \ncaloric restriction, performing a combination of aerobic and resistance exercise over a period of 6 \nmonths results in marked improvements in body composition, insulin resistance and functional \ncapacity, and may be considered an optimal treatment strategy for the reduction of metabolic risk \nand functional disability in the elderly. However, either aerobic or resistance exercise alone \nprovides distinct body compositional, metabolic, and functional benefits, offering viable exercise \nmodality options to clinicians seeking lifestyle-based prevention and treatment for the diabetes \nand functional impairment commonly observed in abdominally obese older men and women. \n The message to clinicians regarding the therapeutic treatment of older men and women \nis clear. The dogma that caloric restriction is fundamental for the reduction of health risk in \nabdominally obese seniors has now been challenged. Through moderate exercise alone \nconsistent with consensus guidelines and with minimal weight loss, older adults may enjoy a \nsubstantive reduction in abdominal obesity and related insulin resistance, a marked increase in \ncardiorespiratory fitness, and muscle hypertrophy concurrent with total fat loss resulting in a \nreversal of the functional impairment commonly associated with aging. This evidence and the \nencouraging clinical message it provides is relevant to a majority of older adults. \n The Senior Study provides conclusive evidence confirming the efficacy of exercise as a \nfundamental part of a therapeutic strategy to reduce health risk in abdominally obese senior men \nand women. Indeed, the use of a rigorously-controlled randomized design, criterion \nmeasurement methodology, well-managed exercise facilities and motivating support staff to \nensure compliance to the study protocol, strengthens our findings and elevates the quality of \nresearch so that dissemination of our interpretation of the results can be more widespread. The \ncontrolled attributes of a laboratory setting, although essential to establishing the efficacy of a \ntreatment strategy, do not provide information regarding the success of that intervention when \napplied within the everyday living environment of the elderly in the absence of an “obligation” to \ncomply with an imposed research protocol. Essentially, our results provide a clear message of \n \n \n83\n\n \nthe efficiency of exercise in providing substantial health benefit, but in so doing, are unable to \nspeak to the effectiveness of physical activity. Would the marked physical and functional \nimprovements we observed in each of the exercise treatment groups have materialized without \nsupervision of exercise and constant external motivation to continue? \n One method of testing the applicability of a successful laboratory protocol in a home-\nbased environment is to continue observation of participants for a period of time after the \nstructured laboratory intervention. Dunstan et al.238 conducted a 1-year trial in older diabetic men \nand women in which 6 months of supervised gym-based resistance exercise and dietary \nintervention was followed by 6 months of unsupervised home-based diet and resistance exercise. \nThe improvement in glycemic control observed after the first 6 months was abolished under a \nhome-based resistance exercise program, with the authors citing a reduced volume and intensity \nof exercise and other non-compliance issues as possible explanations for the lack of success at \nhome.238 Another randomized trial by the same research group compared a year of home-based \nresistance exercise to similar training performed in a community fitness and recreation center, \nboth of which were prefaced by two months of observed exercise in a laboratory setting.239 \nAgain, the home-based exercise program failed to provide significant glycemic control while the \ncommunity-based exercisers at least maintained the glycemic benefits they derived from the 2-\nmonth laboratory training.239 Investigations have been conducted comparing various other \nmodalities of exercise and physical activity interventions, many of which report that home-based \nexercise programs are not as effective as center-based or observed exercise.240-243 However, \nthere is some evidence that, assuming sustained compliance over longer intervention periods, \nhome-based programs may produce similar results to structured or observed exercise244, 245 and \nfurther research is needed to establish their long-term effectiveness.246 \n From the research cited above regarding the comparative effectiveness of observed or \ncommunity-based versus home-based exercise programs, coupled with the observation that \nmany of the seniors sought to exercise together during the program and some even arranged to \ncontinue an exercise routine with their fellow participants after they concluded the study, it \nappears that a key component for successful maintenance of an exercise program is social \n \n \n84\n\n \nsupport. A need for social interaction within this demographic may be answered by group \nparticipation in physical activity, and may satisfy innate social desires while providing substantial \nhealth benefits. \n Interest in whether these exercise interventions are sustainable in a “real world” \nenvironment stems from observations of the Senior Study participants as they attempted to \ntransition their newly-developed lifestyle of physical activity into an old framework fraught with \nsedentary habits. Their responses to the cessation of our laboratory program varied \nsubstantially, with some concluding the study hopeful and excited to continue physical activity in \nother surroundings, some doubtful and fearful that they couldn’t sustain a physically active \nlifestyle without daily external motivation, and others just glad to have one less thing to worry \nabout in their busy, yet sedentary lifestyles. With such variation in attitudes toward a lifestyle that \nincludes physical activity, even within our sample of seniors who successfully became “physically \nfit” though completing 6 months of sustained exercise, it is no wonder that such high rates of \nphysical inactivity prevail in the elderly population. \n In other seniors for whom the commencement of exercise is not conveniently facilitated \nthrough joining an exercise intervention trial, starting a new exercise program may be difficult \nwithout the encouragement of a health care provider. It was our impression when obtaining \nmedical consent for the subjects’ participation in the study that most primary care physicians were \nfully supportive of their patients’ involvement in a lifestyle-based intervention designed to improve \nphysical and metabolic function, yet perhaps lacked the time, information, or resources to \nadequately prescribe that kind of intervention for their patients without resorting to an existing \nprogram. Fostering good communication with health care providers and making available options \nfor implementing viable lifestyle-based treatments for at-risk elderly patients will facilitate the \nadvocacy of the medical community, which will likely increase the success rate of seniors who \nwish to improve their health through exercise. \n Disseminating to clinicians our recommendation for the optimal treatment strategy for \nabdominal obesity and age-related muscle decline is only one step toward implementation of \nexercise in seniors whom the message would most benefit. Further research is required to \n \n \n85\n\n \ndetermine the effectiveness of exercise recommendations when advocated by primary care \nphysicians, and to determine an environment in which seniors are best able to sustain regular \nphysical activity. \n \n \n \n86\n\n \nSummary and Conclusions \n \n Aging is associated with a progressive accumulation of abdominal fat and an accelerated \ndecline in muscle mass and strength, which are associated with substantially increased risk of \nmetabolic disease and functional disability. These studies establish that performing a \ncombination of resistance and aerobic exercise without caloric restriction and in accordance to \nconsensus guidelines is an optimal treatment strategy for abdominally obese older men and \nwomen. The distinct benefits associated with each modality combine to produce a simultaneous \nreduction in obesity and muscle hypertrophy associated with marked improvements in insulin \nsensitivity and cardiorespiratory and functional fitness. That substantial benefits were associated \nwith only moderate exercise-induced weight loss challenges the dogma that caloric restriction and \nweight loss need be the cornerstone of a lifestyle-based strategy for health risk reduction in the \nelderly. Rather, the notion of tracking waist circumference instead of weight changes as a clinical \ntool for assessment of exercise-induced changes in abdominal obesity is reinforced. While these \ndata support a combination of resistance and aerobic exercise as the optimal treatment strategy \nin abdominally obese older adults, more research is needed to determine the effectiveness of this \nexercise prescription when advocated by physicians and conducted in a non-laboratory setting. \n \n \n \n \n87\n\n \nReferences \n \n \n1. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing Trends in Waist Circumference and \nAbdominal Obesity among U.S. Adults. Obesity (Silver Spring). Jan 2007;15(1):216-224. \n2. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, \nand the metabolic syndrome in older men and women. Arch Intern Med. Apr 11 \n2005;165(7):777-783. \n3. Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat \nare independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol \nMetab. Jun 2003;284(6):E1065-1071. \n4. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an \nindependent predictor of all-cause mortality in men. Obesity (Silver Spring). Feb \n2006;14(2):336-341. \n5. Cornier MA, Tate CW, Grunwald GK, Bessesen DH. Relationship between waist \ncircumference, body mass index, and medical care costs. Obes Res. Nov \n2002;10(11):1167-1172. \n6. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE. Sarcopenic \nobesity predicts instrumental activities of daily living disability in the elderly. Obes Res. \nDec 2004;12(12):1995-2004. \n7. Di Francesco V, Zamboni M, Zoico E, et al. Relationships between leisure-time physical \nactivity, obesity and disability in elderly men. Aging Clin Exp Res. Jun 2005;17(3):201-\n206. \n8. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in \nolder persons is associated with functional impairment and physical disability. J Am \nGeriatr Soc. May 2002;50(5):889-896. \n9. Berentzen T, Sorensen TI. Effects of intended weight loss on morbidity and mortality: \npossible explanations of controversial results. Nutr Rev. Nov 2006;64(11):502-507. \n10. Garrow JS, Summerbell CD. Meta-analysis: effect of exercise, with or without dieting, on \nthe body composition of overweight subjects. Eur J Clin Nutr. Jan 1995;49(1):1-10. \n11. Ross R, Dagnone D, Jones PJ, et al. Reduction in obesity and related comorbid \nconditions after diet-induced weight loss or exercise-induced weight loss in men. A \nrandomized, controlled trial. Ann Intern Med. Jul 18 2000;133(2):92-103. \n12. Ross R, Rissanen J, Pedwell H, Clifford J, Shragge P. Influence of diet and exercise on \nskeletal muscle and visceral adipose tissue in men. J Appl Physiol. Dec 1996;81(6):2445-\n2455. \n13. Janssen I, Ross R. Effects of sex on the change in visceral, subcutaneous adipose tissue \nand skeletal muscle in response to weight loss. Int J Obes Relat Metab Disord. Oct \n1999;23(10):1035-1046. \n14. Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res. Jun \n2004;12(6):887-888. \n \n \n88\n\n \n15. American College of Sports Medicine Position Stand. Exercise and physical activity for \nolder adults. Med Sci Sports Exerc. Jun 1998;30(6):992-1008. \n16. Arias E. United States life tables, 2003. Natl Vital Stat Rep. Apr 19 2006;54(14):1-40. \n17. Statistics Canada. Life expectancy at birth, by sex, by province. \nhttp://statcan.ca/l01/cst01/health26.htm. (Accessed January 2007). \n18. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of \noverweight and obesity among US children, adolescents, and adults, 1999-2002. Jama. \nJun 16 2004;291(23):2847-2850. \n19. Kuskowska-Wolk A, Rossner S. Body mass distribution of a representative adult \npopulation in Sweden. Diabetes Res Clin Pract. 1990;10 Suppl 1:S37-41. \n20. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, Jr. Body-mass index and \nmortality in a prospective cohort of U.S. adults. N Engl J Med. Oct 7 1999;341(15):1097-\n1105. \n21. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N \nEngl J Med. Sep 14 1995;333(11):677-685. \n22. Kannel WB, Gordon T, Castelli WP. Obesity, lipids, and glucose intolerance. The \nFramingham Study. Am J Clin Nutr. Jun 1979;32(6):1238-1245. \n23. Fogelholm M, Kujala U, Kaprio J, Sarna S. Predictors of weight change in middle-aged \nand old men. Obes Res. Aug 2000;8(5):367-373. \n24. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. Aug 2001;2(3):141-147. \n25. Hughes VA, Frontera WR, Roubenoff R, Evans WJ, Singh MA. Longitudinal changes in \nbody composition in older men and women: role of body weight change and physical \nactivity. Am J Clin Nutr. Aug 2002;76(2):473-481. \n26. Hughes VA, Roubenoff R, Wood M, Frontera WR, Evans WJ, Fiatarone Singh MA. \nAnthropometric assessment of 10-y changes in body composition in the elderly. Am J \nClin Nutr. Aug 2004;80(2):475-482. \n27. Noppa H, Andersson M, Bengtsson C, Bruce A, Isaksson B. Longitudinal studies of \nanthropometric data and body composition. The population study of women in \nGotenberg, Sweden. Am J Clin Nutr. Jan 1980;33(1):155-162. \n28. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of \nabdominal fat content by computed tomography. Am J Clin Nutr. Jul 1982;36(1):172-177. \n29. Kotani K, Tokunaga K, Fujioka S, et al. Sexual dimorphism of age-related changes in \nwhole-body fat distribution in the obese. Int J Obes Relat Metab Disord. Apr \n1994;18(4):207-202. \n30. Zamboni M, Armellini F, Harris T, et al. Effects of age on body fat distribution and \ncardiovascular risk factors in women. Am J Clin Nutr. Jul 1997;66(1):111-115. \n31. Goodpaster BH, Carlson CL, Visser M, et al. Attenuation of skeletal muscle and strength \nin the elderly: The Health ABC Study. J Appl Physiol. Jun 2001;90(6):2157-2165. \n \n \n89\n\n \n32. Cree MG, Newcomer BR, Katsanos CS, et al. Intramuscular and liver triglycerides are \nincreased in the elderly. J Clin Endocrinol Metab. Aug 2004;89(8):3864-3871. \n33. Beaufrere B, Morio B. Fat and protein redistribution with aging: metabolic considerations. \nEur J Clin Nutr. Jun 2000;54 Suppl 3:S48-53. \n34. Rosenberg IH. Summary Comments. Am J Clin Nutr. 1989;50:1231-1233. \n35. Doherty TJ. Invited review: Aging and sarcopenia. J Appl Physiol. Oct 2003;95(4):1717-\n1727. \n36. Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in \n468 men and women aged 18-88 yr. J Appl Physiol. Jul 2000;89(1):81-88. \n37. Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal \nguidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med. \nMay 14 2001;161(9):1194-1203. \n38. Wassertheil-Smoller S, Fann C, Allman RM, et al. Relation of low body mass to death \nand stroke in the systolic hypertension in the elderly program. The SHEP Cooperative \nResearch Group. Arch Intern Med. Feb 28 2000;160(4):494-500. \n39. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal \nobesity with multiple health outcomes in older women: the Iowa Women's Health Study. \nArch Intern Med. Jul 24 2000;160(14):2117-2128. \n40. Janssen I, Katzmarzyk PT, Ross R. Body mass index is inversely related to mortality in \nolder people after adjustment for waist circumference. J Am Geriatr Soc. Dec \n2005;53(12):2112-2118. \n41. Mattsson S, Thomas BJ. Development of methods for body composition studies. Phys \nMed Biol. Jul 7 2006;51(13):R203-228. \n42. Siri W. The gross composition of the body. In: Tobias C, Lawrence J, eds. Advances in \nBiological and Medical Physics. New York: Academic; 1956. \n43. Brozek J, Grande F, Anderson JT, Keys A. Densitometric Analysis of Body Composition: \nRevision of Some Quantitative Assumptions. Ann N Y Acad Sci. Sep 26 1963;110:113-\n140. \n44. Wang J, Gallagher D, Thornton JC, Yu W, Horlick M, Pi-Sunyer FX. Validation of a 3-\ndimensional photonic scanner for the measurement of body volumes, dimensions, and \npercentage body fat. Am J Clin Nutr. Apr 2006;83(4):809-816. \n45. Wells JC, Douros I, Fuller NJ, Elia M, Dekker L. Assessment of body volume using three-\ndimensional photonic scanning. Ann N Y Acad Sci. May 2000;904:247-254. \n46. Genton L, Karsegard VL, Zawadynski S, et al. Comparison of body weight and \ncomposition measured by two different dual energy X-ray absorptiometry devices and \nthree acquisition modes in obese women. Clin Nutr. Jun 2006;25(3):428-437. \n47. Genton L, Hans D, Kyle UG, Pichard C. Dual-energy X-ray absorptiometry and body \ncomposition: differences between devices and comparison with reference methods. \nNutrition. Jan 2002;18(1):66-70. \n \n \n90\n\n \n48. Tothill P, Hannan WJ, Wilkinson S. Comparisons between a pencil beam and two fan \nbeam dual energy X-ray absorptiometers used for measuring total body bone and soft \ntissue. Br J Radiol. Feb 2001;74(878):166-176. \n49. Ellis KJ, Shypailo RJ. Bone mineral and body composition measurements: cross-\ncalibration of pencil-beam and fan-beam dual-energy X-ray absorptiometers. J Bone \nMiner Res. Oct 1998;13(10):1613-1618. \n50. Soriano JM, Ioannidou E, Wang J, et al. Pencil-beam vs fan-beam dual-energy X-ray \nabsorptiometry comparisons across four systems: body composition and bone mineral. J \nClin Densitom. Fall 2004;7(3):281-289. \n51. Sun SS, Chumlea WC, Heymsfield SB, et al. Development of bioelectrical impedance \nanalysis prediction equations for body composition with the use of a multicomponent \nmodel for use in epidemiologic surveys. Am J Clin Nutr. Feb 2003;77(2):331-340. \n52. Genton L, Karsegard VL, Kyle UG, Hans DB, Michel JP, Pichard C. Comparison of four \nbioelectrical impedance analysis formulas in healthy elderly subjects. Gerontology. Nov-\nDec 2001;47(6):315-323. \n53. Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C. Single prediction equation for \nbioelectrical impedance analysis in adults aged 20--94 years. Nutrition. Mar \n2001;17(3):248-253. \n54. Roubenoff R, Baumgartner RN, Harris TB, et al. Application of bioelectrical impedance \nanalysis to elderly populations. J Gerontol A Biol Sci Med Sci. May 1997;52(3):M129-136. \n55. Piers LS, Soares MJ, Frandsen SL, O'Dea K. Indirect estimates of body composition are \nuseful for groups but unreliable in individuals. Int J Obes Relat Metab Disord. Sep \n2000;24(9):1145-1152. \n56. Tiikkainen M, Tamminen M, Hakkinen AM, et al. Liver-fat accumulation and insulin \nresistance in obese women with previous gestational diabetes. Obes Res. Sep \n2002;10(9):859-867. \n57. Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma \nfree fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. \nDiabetes. Jul 2001;50(7):1612-1617. \n58. Castera L, Negre I, Samii K, Buffet C. Pain experienced during percutaneous liver biopsy. \nHepatology. Dec 1999;30(6):1529-1530. \n59. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, \nmethods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by \nthe British Society of Gastroenterology and the Royal College of Physicians of London. \nGut. Mar 1995;36(3):437-441. \n60. Boesch C, Slotboom J, Hoppeler H, Kreis R. In vivo determination of intra-myocellular \nlipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med. \nApr 1997;37(4):484-493. \n61. Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG. Liver fat, serum \ntriglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black \nmen with NIDDM. Int J Obes Relat Metab Disord. Dec 1995;19(12):846-850. \n \n \n91\n\n \n62. Goodpaster BH, Thaete FL, Kelley DE. Thigh adipose tissue distribution is associated \nwith insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr. Apr \n2000;71(4):885-892. \n63. Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 \ndiabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J \nPhysiol Endocrinol Metab. Oct 2003;285(4):E906-916. \n64. Davidson LE, Kuk JL, Church TS, Ross R. Protocol for measurement of liver fat by \ncomputed tomography. J Appl Physiol. Mar 2006;100(3):864-868. \n65. Lee RC, Wang ZM, Heymsfield SB. Skeletal muscle mass and aging: regional and whole-\nbody measurement methods. Can J Appl Physiol. Feb 2001;26(1):102-122. \n66. Heymsfield SB, Nunez C, Testolin C, Gallagher D. Anthropometry and methods of body \ncomposition measurement for research and field application in the elderly. Eur J Clin \nNutr. Jun 2000;54 Suppl 3:S26-32. \n67. Heymsfield SB, Olafson RP, Kutner MH, Nixon DW. A radiographic method of quantifying \nprotein-calorie undernutrition. Am J Clin Nutr. Mar 1979;32(3):693-702. \n68. Heymsfield SB, McManus C, Smith J, Stevens V, Nixon DW. Anthropometric \nmeasurement of muscle mass: revised equations for calculating bone-free arm muscle \narea. Am J Clin Nutr. Oct 1982;36(4):680-690. \n69. Nunez C, Gallagher D, Grammes J, et al. Bioimpedance analysis: potential for measuring \nlower limb skeletal muscle mass. JPEN J Parenter Enteral Nutr. Mar-Apr 1999;23(2):96-\n103. \n70. Baumgartner RN, Heymsfield SB, Lichtman S, Wang J, Pierson RN, Jr. Body \ncomposition in elderly people: effect of criterion estimates on predictive equations. Am J \nClin Nutr. Jun 1991;53(6):1345-1353. \n71. Ross R, Leger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by \nMRI: relationship with anthropometric variables. J Appl Physiol. Feb 1992;72(2):787-795. \n72. Shen W, Wang Z, Tang H, et al. Volume estimates by imaging methods: model \ncomparisons with visible woman as the reference. Obes Res. Feb 2003;11(2):217-225. \n73. Ross R. Magnetic resonance imaging provides new insights into the characterization of \nadipose and lean tissue distribution. Can J Physiol Pharmacol. Jun 1996;74(6):778-785. \n74. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among \nUS adults, 1999-2000. Jama. Oct 9 2002;288(14):1723-1727. \n75. Belanger-Ducharme F, Tremblay A. Prevalence of obesity in Canada. Obes Rev. Aug \n2005;6(3):183-186. \n76. Katzmarzyk PT. The Canadian obesity epidemic: an historical perspective. Obes Res. Jul \n2002;10(7):666-674. \n77. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large \nprospective cohort of persons 50 to 71 years old. N Engl J Med. Aug 24 2006;355(8):763-\n778. \n \n \n92\n\n \n78. York DA, Rossner S, Caterson I, et al. Prevention Conference VII: Obesity, a worldwide \nepidemic related to heart disease and stroke: Group I: worldwide demographics of \nobesity. Circulation. Nov 2 2004;110(18):e463-470. \n79. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of \nthe obesity epidemic in the United States, 1991-1998. Jama. Oct 27 1999;282(16):1519-\n1522. \n80. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing \ncommon chronic diseases during a 10-year period. Arch Intern Med. Jul 9 \n2001;161(13):1581-1586. \n81. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on \ncardiovascular disease: a statement for professionals from the American Heart \nAssociation Council on Nutrition, Physical Activity, and Metabolism: endorsed by the \nAmerican College of Cardiology Foundation. Circulation. Nov 2 2004;110(18):2952-2967. \n82. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and \nObesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. Sep \n1998;6 Suppl 2:51S-209S. \n83. Tjepkema M. Adult obesity. Statistics Canada Health Reports. August 2006;17(3):9-25. \n84. Health Canada. Economic Burden of Illness in Canada, 1998. http://www.phac-\naspc.gc.ca/publicat/ebic-femc98/index.html. (Accessed January 2007). \n85. Daviglus ML, Liu K, Yan LL, et al. Body mass index in middle age and health-related \nquality of life in older age: the Chicago heart association detection project in industry \nstudy. Arch Intern Med. Nov 10 2003;163(20):2448-2455. \n86. Daviglus ML, Liu K, Yan LL, et al. Relation of body mass index in young adulthood and \nmiddle age to Medicare expenditures in older age. Jama. Dec 8 2004;292(22):2743-\n2749. \n87. Yan LL, Daviglus ML, Liu K, et al. Midlife body mass index and hospitalization and \nmortality in older age. Jama. Jan 11 2006;295(2):190-198. \n88. Kanaya AM, Vittinghoff E, Shlipak MG, et al. Association of total and central obesity with \nmortality in postmenopausal women with coronary heart disease. Am J Epidemiol. Dec \n15 2003;158(12):1161-1170. \n89. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity \nand overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. Mar \n2005;81(3):555-563. \n90. Vague J. Sexual differentiation, a factor affecting the forms of obesity. . Presse Méd. \n1947;30:339-340. \n91. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in \n27,000 participants from 52 countries: a case-control study. Lancet. Nov 5 \n2005;366(9497):1640-1649. \n92. Bigaard J, Frederiksen K, Tjonneland A, et al. Waist circumference and body composition \nin relation to all-cause mortality in middle-aged men and women. Int J Obes (Lond). Jul \n2005;29(7):778-784. \n \n \n93\n\n \n93. Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC. A \ncomparison of body mass index, waist-hip ratio and waist circumference as predictors of \nall-cause mortality among the elderly: the Rotterdam study. Int J Obes Relat Metab \nDisord. Nov 2001;25(11):1730-1735. \n94. Executive Summary of The Third Report of The National Cholesterol Education Program \n(NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol \nIn Adults (Adult Treatment Panel III). Jama. May 16 2001;285(19):2486-2497. \n95. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition. \nLancet. Sep 24-30 2005;366(9491):1059-1062. \n96. International Diabetes Federation. The IDF consensus worldwide definition of the \nmetabolic syndrome. http://www.idf.org/webdata/docs/MetSyndrome_Final.pdf. \n(Accessed March 3, 2007). \n97. Bryhni B, Jenssen TG, Olafsen K, Eikrem JH. Age or waist as determinant of insulin \naction? Metabolism. Jul 2003;52(7):850-857. \n98. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. Dec 14 \n2006;444(7121):881-887. \n99. Rankinen T, Kim SY, Perusse L, Despres JP, Bouchard C. The prediction of abdominal \nvisceral fat level from body composition and anthropometry: ROC analysis. Int J Obes \nRelat Metab Disord. Aug 1999;23(8):801-809. \n100. Valsamakis G, Chetty R, Anwar A, Banerjee AK, Barnett A, Kumar S. Association of \nsimple anthropometric measures of obesity with visceral fat and the metabolic syndrome \nin male Caucasian and Indo-Asian subjects. Diabet Med. Dec 2004;21(12):1339-1345. \n101. Harris TB, Visser M, Everhart J, et al. Waist circumference and sagittal diameter reflect \ntotal body fat better than visceral fat in older men and women. The Health, Aging and \nBody Composition Study. Ann N Y Acad Sci. May 2000;904:462-473. \n102. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of \nthe National Cholesterol Education Program Adult Treatment Panel III criteria for the \nmetabolic syndrome. Diabetes. Aug 2004;53(8):2087-2094. \n103. Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin \nresistance. Diabetes. Jan 1999;48(1):94-98. \n104. Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance \nand glucose intolerance of aging: an adipokine-mediated process? Diabetes. Oct \n2002;51(10):2951-2958. \n105. Brochu M, Tchernof A, Turner AN, Ades PA, Poehlman ET. Is there a threshold of \nvisceral fat loss that improves the metabolic profile in obese postmenopausal women? \nMetabolism. May 2003;52(5):599-604. \n106. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action \nand risk factors for coronary heart disease. N Engl J Med. Jun 17 2004;350(25):2549-\n2557. \n107. Lebovitz HE, Banerji MA. Point: visceral adiposity is causally related to insulin resistance. \nDiabetes Care. Sep 2005;28(9):2322-2325. \n \n \n94\n\n \n108. Miles JM, Jensen MD. Counterpoint: visceral adiposity is not causally related to insulin \nresistance. Diabetes Care. Sep 2005;28(9):2326-2328. \n109. Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN. Extreme insulin resistance of \nthe central adipose depot in vivo. Diabetes. Mar 2002;51(3):755-761. \n110. Bergman RN, Kim SP, Hsu IR, et al. Abdominal obesity: role in the pathophysiology of \nmetabolic disease and cardiovascular risk. Am J Med. Feb 2007;120(2 Suppl 1):S3-8; \ndiscussion S29-32. \n111. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human \nobesity. J Clin Invest. Jun 2004;113(11):1582-1588. \n112. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor \nnecrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent \ndiabetes mellitus. Arterioscler Thromb Vasc Biol. Aug 1998;18(8):1199-1202. \n113. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy \nsubjects: associations with obesity, insulin resistance, and endothelial dysfunction: a \npotential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc \nBiol. Apr 1999;19(4):972-978. \n114. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes \nCare. Dec 1999;22(12):1971-1977. \n115. Festa A, D'Agostino R, Jr., Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic \nsubclinical inflammation as part of the insulin resistance syndrome: the Insulin \nResistance Atherosclerosis Study (IRAS). Circulation. Jul 4 2000;102(1):42-47. \n116. Frohlich M, Imhof A, Berg G, et al. Association between C-reactive protein and features \nof the metabolic syndrome: a population-based study. Diabetes Care. Dec \n2000;23(12):1835-1839. \n117. Temelkova-Kurktschiev T, Siegert G, Bergmann S, et al. Subclinical inflammation is \nstrongly related to insulin resistance but not to impaired insulin secretion in a high risk \npopulation for diabetes. Metabolism. Jun 2002;51(6):743-749. \n118. Barzilay JI, Abraham L, Heckbert SR, et al. The relation of markers of inflammation to the \ndevelopment of glucose disorders in the elderly: the Cardiovascular Health Study. \nDiabetes. Oct 2001;50(10):2384-2389. \n119. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, \nand risk of developing type 2 diabetes mellitus. Jama. Jul 18 2001;286(3):327-334. \n120. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor \nof risk for the development of diabetes in the West of Scotland Coronary Prevention \nStudy. Diabetes. May 2002;51(5):1596-1600. \n121. Festa A, D'Agostino R, Jr., Tracy RP, Haffner SM. Elevated levels of acute-phase \nproteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: \nthe insulin resistance atherosclerosis study. Diabetes. Apr 2002;51(4):1131-1137. \n122. Hanley AJ, Festa A, D'Agostino RB, Jr., et al. Metabolic and inflammation variable \nclusters and prediction of type 2 diabetes: factor analysis using directly measured insulin \nsensitivity. Diabetes. Jul 2004;53(7):1773-1781. \n \n \n95\n\n \n123. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. \nPredicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old \npeople. Clin Exp Immunol. Apr 2003;132(1):24-31. \n124. Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: \na magnificent pathway. J Gerontol A Biol Sci Med Sci. Jun 2006;61(6):575-584. \n125. Tsimikas S, Willerson JT, Ridker PM. C-reactive protein and other emerging blood \nbiomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol. Apr 18 \n2006;47(8 Suppl):C19-31. \n126. Gable DR, Hurel SJ, Humphries SE. Adiponectin and its gene variants as risk factors for \ninsulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis. \nOct 2006;188(2):231-244. \n127. Cote M, Mauriege P, Bergeron J, et al. Adiponectinemia in visceral obesity: impact on \nglucose tolerance and plasma lipoprotein and lipid levels in men. J Clin Endocrinol \nMetab. Mar 2005;90(3):1434-1439. \n128. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of \nobese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J \nClin Endocrinol Metab. Mar 1998;83(3):847-850. \n129. Snijder MB, Dekker JM, Visser M, et al. Trunk fat and leg fat have independent and \nopposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes \nCare. Feb 2004;27(2):372-377. \n130. Snijder MB, Visser M, Dekker JM, et al. Low subcutaneous thigh fat is a risk factor for \nunfavourable glucose and lipid levels, independently of high abdominal fat. The Health \nABC Study. Diabetologia. Feb 2005;48(2):301-308. \n131. Tanko LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity \nexhibits an independent dominant antiatherogenic effect in elderly women. Circulation. \nApr 1 2003;107(12):1626-1631. \n132. Okura T, Nakata Y, Yamabuki K, Tanaka K. Regional body composition changes exhibit \nopposing effects on coronary heart disease risk factors. Arterioscler Thromb Vasc Biol. \nMay 2004;24(5):923-929. \n133. Terry RB, Stefanick ML, Haskell WL, Wood PD. Contributions of regional adipose tissue \ndepots to plasma lipoprotein concentrations in overweight men and women: possible \nprotective effects of thigh fat. Metabolism. Jul 1991;40(7):733-740. \n134. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body \nadiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab. \nAug 2005;90(8):4573-4578. \n135. Rasouli N, Molavi B, Elbein SC, Kern PA. Ectopic fat accumulation and metabolic \nsyndrome. Diabetes Obes Metab. Jan 2007;9(1):1-10. \n136. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, \npathophysiology, and mechanisms. Am Heart J. Jan 2005;149(1):33-45. \n \n \n96\n\n \n137. Miyazaki Y, Glass L, Triplitt C, et al. Effect of rosiglitazone on glucose and non-esterified \nfatty acid metabolism in Type II diabetic patients. Diabetologia. Dec 2001;44(12):2210-\n2219. \n138. Miyazaki Y, Mahankali A, Matsuda M, et al. Improved glycemic control and enhanced \ninsulin sensitivity in type 2 diabetic subjects treated with pioglitazone. Diabetes Care. Apr \n2001;24(4):710-719. \n139. Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat \ndistribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab. Jun \n2002;87(6):2784-2791. \n140. Mori Y, Murakawa Y, Okada K, et al. Effect of troglitazone on body fat distribution in type \n2 diabetic patients. Diabetes Care. Jun 1999;22(6):908-912. \n141. Bajaj M, Suraamornkul S, Pratipanawatr T, et al. Pioglitazone reduces hepatic fat content \nand augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes. Jun \n2003;52(6):1364-1370. \n142. Mayerson AB, Hundal RS, Dufour S, et al. The effects of rosiglitazone on insulin \nsensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with \ntype 2 diabetes. Diabetes. Mar 2002;51(3):797-802. \n143. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids \nin the metabolic syndrome. Endocrinology. Dec 2003;144(12):5159-5165. \n144. Wolfe RR. Fat metabolism in exercise. Adv Exp Med Biol. 1998;441:147-156. \n145. Virkamaki A, Korsheninnikova E, Seppala-Lindroos A, et al. Intramyocellular lipid is \nassociated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and \nearly insulin signaling pathways in human skeletal muscle. Diabetes. Oct \n2001;50(10):2337-2343. \n146. Taaffe DR. Sarcopenia--exercise as a treatment strategy. Aust Fam Physician. Mar \n2006;35(3):130-134. \n147. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. May 1997;127(5 \nSuppl):990S-991S. \n148. Roubenoff R. Sarcopenia: effects on body composition and function. J Gerontol A Biol \nSci Med Sci. Nov 2003;58(11):1012-1017. \n149. Borst SE. Interventions for sarcopenia and muscle weakness in older people. Age \nAgeing. Nov 2004;33(6):548-555. \n150. Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: \neffects of age, gender, and ethnicity. J Appl Physiol. Jul 1997;83(1):229-239. \n151. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the \nelderly in New Mexico. Am J Epidemiol. Apr 15 1998;147(8):755-763. \n152. Melton LJ, 3rd, Khosla S, Crowson CS, O'Connor MK, O'Fallon WM, Riggs BL. \nEpidemiology of sarcopenia. J Am Geriatr Soc. Jun 2000;48(6):625-630. \n \n \n97\n\n \n153. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors \nof skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. \nDec 2002;57(12):M772-777. \n154. Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-\nConnor E. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J \nPrev Med. Oct 2003;25(3):226-231. \n155. Rolland Y, Lauwers-Cances V, Cournot M, et al. Sarcopenia, calf circumference, and \nphysical function of elderly women: a cross-sectional study. J Am Geriatr Soc. Aug \n2003;51(8):1120-1124. \n156. Tanko LB, Movsesyan L, Mouritzen U, Christiansen C, Svendsen OL. Appendicular lean \ntissue mass and the prevalence of sarcopenia among healthy women. Metabolism. Jan \n2002;51(1):69-74. \n157. Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ, 3rd. Prevalence of and risk factors for \nsarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci. Feb \n2005;60(2):213-216. \n158. Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skeletal muscle \ncutpoints associated with elevated physical disability risk in older men and women. Am J \nEpidemiol. Feb 15 2004;159(4):413-421. \n159. Kotler DP, Tierney AR, Wang J, Pierson RN, Jr. Magnitude of body-cell-mass depletion \nand the timing of death from wasting in AIDS. Am J Clin Nutr. Sep 1989;50(3):444-447. \n160. Tellado JM, Garcia-Sabrido JL, Hanley JA, Shizgal HM, Christou NV. Predicting mortality \nbased on body composition analysis. Ann Surg. Jan 1989;209(1):81-87. \n161. Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of \nall-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci. Oct 2002;57(10):B359-\n365. \n162. Roubenoff R. Origins and clinical relevance of sarcopenia. Can J Appl Physiol. Feb \n2001;26(1):78-89. \n163. Visser M, Goodpaster BH, Kritchevsky SB, et al. Muscle mass, muscle strength, and \nmuscle fat infiltration as predictors of incident mobility limitations in well-functioning older \npersons. J Gerontol A Biol Sci Med Sci. Mar 2005;60(3):324-333. \n164. Janssen I. Influence of sarcopenia on the development of physical disability: the \nCardiovascular Health Study. J Am Geriatr Soc. Jan 2006;54(1):56-62. \n165. Janssen I, Fortier A, Hudson R, Ross R. Effects of an energy-restrictive diet with or \nwithout exercise on abdominal fat, intermuscular fat, and metabolic risk factors in obese \nwomen. Diabetes Care. Mar 2002;25(3):431-438. \n166. Rice B, Janssen I, Hudson R, Ross R. Effects of aerobic or resistance exercise and/or \ndiet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care. May \n1999;22(5):684-691. \n167. Weiss EP, Racette SB, Villareal DT, et al. Lower extremity muscle size and strength and \naerobic capacity decrease with caloric restriction but not with exercise-induced weight \nloss. J Appl Physiol. Feb 2007;102(2):634-640. \n \n \n98\n\n \n168. Evans EM, Racette SB, Peterson LR, Villareal DT, Greiwe JS, Holloszy JO. Aerobic \npower and insulin action improve in response to endurance exercise training in healthy \n77-87 yr olds. J Appl Physiol. Jan 2005;98(1):40-45. \n169. Ferrara CM, Goldberg AP, Ortmeyer HK, Ryan AS. Effects of aerobic and resistive \nexercise training on glucose disposal and skeletal muscle metabolism in older men. J \nGerontol A Biol Sci Med Sci. May 2006;61(5):480-487. \n170. Frank LL, Sorensen BE, Yasui Y, et al. Effects of exercise on metabolic risk variables in \noverweight postmenopausal women: a randomized clinical trial. Obes Res. Mar \n2005;13(3):615-625. \n171. Irwin ML, Yasui Y, Ulrich CM, et al. Effect of exercise on total and intra-abdominal body \nfat in postmenopausal women: a randomized controlled trial. Jama. Jan 15 \n2003;289(3):323-330. \n172. O'Leary VB, Marchetti CM, Krishnan RK, Stetzer BP, Gonzalez F, Kirwan JP. Exercise-\ninduced reversal of insulin resistance in obese elderly is associated with reduced visceral \nfat. J Appl Physiol. May 2006;100(5):1584-1589. \n173. Evans EM, Van Pelt RE, Binder EF, Williams DB, Ehsani AA, Kohrt WM. Effects of HRT \nand exercise training on insulin action, glucose tolerance, and body composition in older \nwomen. J Appl Physiol. Jun 2001;90(6):2033-2040. \n174. Kahn SE, Larson VG, Beard JC, et al. Effect of exercise on insulin action, glucose \ntolerance, and insulin secretion in aging. Am J Physiol. Jun 1990;258(6 Pt 1):E937-943. \n175. Coker RH, Hays NP, Williams RH, et al. Exercise-induced changes in insulin action and \nglycogen metabolism in elderly adults. Med Sci Sports Exerc. Mar 2006;38(3):433-438. \n176. DiPietro L, Dziura J, Yeckel CW, Neufer PD. Exercise and improved insulin sensitivity in \nolder women: evidence of the enduring benefits of higher intensity training. J Appl \nPhysiol. Jan 2006;100(1):142-149. \n177. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr \nRev. Winter 1985;6(1):45-86. \n178. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. \nHomeostasis model assessment: insulin resistance and beta-cell function from fasting \nplasma glucose and insulin concentrations in man. Diabetologia. Jul 1985;28(7):412-419. \n179. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying \ninsulin secretion and resistance. Am J Physiol. Sep 1979;237(3):E214-223. \n180. Dengel DR, Pratley RE, Hagberg JM, Rogus EM, Goldberg AP. Distinct effects of aerobic \nexercise training and weight loss on glucose homeostasis in obese sedentary men. J \nAppl Physiol. Jul 1996;81(1):318-325. \n181. Hersey WC, 3rd, Graves JE, Pollock ML, et al. Endurance exercise training improves \nbody composition and plasma insulin responses in 70- to 79-year-old men and women. \nMetabolism. Jul 1994;43(7):847-854. \n182. Kohrt WM, Obert KA, Holloszy JO. Exercise training improves fat distribution patterns in \n60- to 70-year-old men and women. J Gerontol. Jul 1992;47(4):M99-105. \n \n \n99\n\n \n183. Schwartz RS, Shuman WP, Larson V, et al. The effect of intensive endurance exercise \ntraining on body fat distribution in young and older men. Metabolism. May \n1991;40(5):545-551. \n184. Binder EF, Yarasheski KE, Steger-May K, et al. Effects of progressive resistance training \non body composition in frail older adults: results of a randomized, controlled trial. J \nGerontol A Biol Sci Med Sci. Nov 2005;60(11):1425-1431. \n185. Hunter GR, Bryan DR, Wetzstein CJ, Zuckerman PA, Bamman MM. Resistance training \nand intra-abdominal adipose tissue in older men and women. Med Sci Sports Exerc. Jun \n2002;34(6):1023-1028. \n186. Ryan AS, Hurlbut DE, Lott ME, et al. Insulin action after resistive training in insulin \nresistant older men and women. J Am Geriatr Soc. Mar 2001;49(3):247-253. \n187. Treuth MS, Hunter GR, Kekes-Szabo T, Weinsier RL, Goran MI, Berland L. Reduction in \nintra-abdominal adipose tissue after strength training in older women. J Appl Physiol. Apr \n1995;78(4):1425-1431. \n188. Treuth MS, Ryan AS, Pratley RE, et al. Effects of strength training on total and regional \nbody composition in older men. J Appl Physiol. Aug 1994;77(2):614-620. \n189. DiPietro L, Seeman TE, Stachenfeld NS, Katz LD, Nadel ER. Moderate-intensity aerobic \ntraining improves glucose tolerance in aging independent of abdominal adiposity. J Am \nGeriatr Soc. Jul 1998;46(7):875-879. \n190. Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin \nresistance in women: a randomized controlled trial. Obes Res. May 2004;12(5):789-798. \n191. Klitgaard H, Mantoni M, Schiaffino S, et al. Function, morphology and protein expression \nof ageing skeletal muscle: a cross-sectional study of elderly men with different training \nbackgrounds. Acta Physiol Scand. Sep 1990;140(1):41-54. \n192. Alway SE, Coggan AR, Sproul MS, Abduljalil AM, Robitaille PM. Muscle torque in young \nand older untrained and endurance-trained men. J Gerontol A Biol Sci Med Sci. May \n1996;51(3):B195-201. \n193. Harridge S, Magnusson G, Saltin B. Life-long endurance-trained elderly men have high \naerobic power, but have similar muscle strength to non-active elderly men. Aging \n(Milano). Feb-Apr 1997;9(1-2):80-87. \n194. Porter MM. The effects of strength training on sarcopenia. Can J Appl Physiol. Feb \n2001;26(1):123-141. \n195. Latham NK, Bennett DA, Stretton CM, Anderson CS. Systematic review of progressive \nresistance strength training in older adults. J Gerontol A Biol Sci Med Sci. Jan \n2004;59(1):48-61. \n196. Hurley BF, Roth SM. Strength training in the elderly: effects on risk factors for age-related \ndiseases. Sports Med. Oct 2000;30(4):249-268. \n197. Rikli RE, Jones CJ. Development and validation of a functional fitness test for \ncommunity-residing older adults. Journal of Aging and Physical Activity. 1999;7:129-161. \n \n \n100\n\n \n198. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing \nepidemics of obesity and diabetes in the United States. Jama. Sep 12 \n2001;286(10):1195-1200. \n199. Mazzeo RS, Tanaka H. Exercise prescription for the elderly: current recommendations. \nSports Med. 2001;31(11):809-818. \n200. Hurley BF, Hagberg JM. Optimizing health in older persons: aerobic or strength training? \nExerc Sport Sci Rev. 1998;26:61-89. \n201. Tseng BS, Marsh DR, Hamilton MT, Booth FW. Strength and aerobic training attenuate \nmuscle wasting and improve resistance to the development of disability with aging. J \nGerontol A Biol Sci Med Sci. Nov 1995;50 Spec No:113-119. \n202. McCarthy JP, Agre JC, Graf BK, Pozniak MA, Vailas AC. Compatibility of adaptive \nresponses with combining strength and endurance training. Med Sci Sports Exerc. Mar \n1995;27(3):429-436. \n203. Cress ME, Buchner DM, Questad KA, Esselman PC, deLateur BJ, Schwartz RS. \nExercise: effects on physical functional performance in independent older adults. J \nGerontol A Biol Sci Med Sci. May 1999;54(5):M242-248. \n204. Fragnoli-Munn K, Savage PD, Ades PA. Combined resistive-aerobic training in older \npatients with coronary artery disease early after myocardial infarction. J Cardiopulm \nRehabil. Nov-Dec 1998;18(6):416-420. \n205. Meuleman JR, Brechue WF, Kubilis PS, Lowenthal DT. Exercise training in the \ndebilitated aged: strength and functional outcomes. Arch Phys Med Rehabil. Mar \n2000;81(3):312-318. \n206. Ferrara CM, McCrone SH, Brendle D, Ryan AS, Goldberg AP. Metabolic effects of the \naddition of resistive to aerobic exercise in older men. Int J Sport Nutr Exerc Metab. Feb \n2004;14(1):73-80. \n207. Verney J, Kadi F, Saafi MA, Piehl-Aulin K, Denis C. Combined lower body endurance and \nupper body resistance training improves performance and health parameters in healthy \nactive elderly. Eur J Appl Physiol. Jun 2006;97(3):288-297. \n208. Wood RH, Reyes R, Welsch MA, et al. Concurrent cardiovascular and resistance training \nin healthy older adults. Med Sci Sports Exerc. Oct 2001;33(10):1751-1758. \n209. Hickson RC. Interference of strength development by simultaneously training for strength \nand endurance. Eur J Appl Physiol Occup Physiol. 1980;45(2-3):255-263. \n210. Bell GJ, Syrotuik D, Martin TP, Burnham R, Quinney HA. Effect of concurrent strength \nand endurance training on skeletal muscle properties and hormone concentrations in \nhumans. Eur J Appl Physiol. Mar 2000;81(5):418-427. \n211. Hunter G, Demment R, Miller D. Development of strength and maximum oxygen uptake \nduring simultaneous training for strength and endurance. J Sports Med Phys Fitness. Sep \n1987;27(3):269-275. \n212. Kraemer WJ, Patton JF, Gordon SE, et al. Compatibility of high-intensity strength and \nendurance training on hormonal and skeletal muscle adaptations. J Appl Physiol. Mar \n1995;78(3):976-989. \n \n \n101\n\n \n213. Hakkinen K, Alen M, Kraemer WJ, et al. Neuromuscular adaptations during concurrent \nstrength and endurance training versus strength training. Eur J Appl Physiol. Mar \n2003;89(1):42-52. \n214. Nelson AG, Arnall DA, Loy SF, Silvester LJ, Conlee RK. Consequences of combining \nstrength and endurance training regimens. Phys Ther. May 1990;70(5):287-294. \n215. Despres JP. Is visceral obesity the cause of the metabolic syndrome? Ann Med. \n2006;38(1):52-63. \n216. Thorpe KE, Florence CS, Howard DH, Joski P. The impact of obesity on rising medical \nspending. Health Aff (Millwood). Jul-Dec 2004;Suppl Web Exclusives:W4-480-486. \n217. Bosello O, Zamboni M. Visceral obesity and metabolic syndrome. Obes Rev. May \n2000;1(1):47-56. \n218. Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. \nSports Med. 2004;34(5):329-348. \n219. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. \nCadaver validation of skeletal muscle measurement by magnetic resonance imaging and \ncomputerized tomography. J Appl Physiol. Jul 1998;85(1):115-122. \n220. Snyder WS, Cooke MJ, Mnassett ES, Larhansen LT, Howells GP, Tipton IH. Report of \nthe Task Group on Reference Man. Oxford: Pergamon; 1975. \n221. Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am \nColl Cardiol. Jan 2001;37(1):153-156. \n222. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. Mar 1999;8(1):3-15. \n223. Weiss EP, Holloszy JO. Improvements in body composition, glucose tolerance, and \ninsulin action induced by increasing energy expenditure or decreasing energy intake. J \nNutr. Apr 2007;137(4):1087-1090. \n224. Weiss EP, Racette SB, Villareal DT, et al. Improvements in glucose tolerance and insulin \naction induced by increasing energy expenditure or decreasing energy intake: a \nrandomized controlled trial. Am J Clin Nutr. Nov 2006;84(5):1033-1042. \n225. Delarue J, Magnan C. Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab \nCare. Mar 2007;10(2):142-148. \n226. Gill JM. Physical activity, cardiorespiratory fitness and insulin resistance: a short update. \nCurr Opin Lipidol. Feb 2007;18(1):47-52. \n227. Kruger J, Carlson SA, Buchner D. How active are older Americans? Prev Chronic Dis. Jul \n2007;4(3):A53. \n228. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, \nand quality in older adults: the health, aging and body composition study. J Gerontol A \nBiol Sci Med Sci. Oct 2006;61(10):1059-1064. \n229. Fleg JL, Morrell CH, Bos AG, et al. Accelerated longitudinal decline of aerobic capacity in \nhealthy older adults. Circulation. Aug 2 2005;112(5):674-682. \n \n \n102\n\n \n230. Wang BW, Ramey DR, Schettler JD, Hubert HB, Fries JF. Postponed development of \ndisability in elderly runners: a 13-year longitudinal study. Arch Intern Med. Nov 11 \n2002;162(20):2285-2294. \n231. Lambert CP, Evans WJ. Adaptations to aerobic and resistance exercise in the elderly. \nRev Endocr Metab Disord. May 2005;6(2):137-143. \n232. Hawkins S, Wiswell R. Rate and mechanism of maximal oxygen consumption decline \nwith aging: implications for exercise training. Sports Med. 2003;33(12):877-888. \n233. Rikli RE, Jones CJ. Functional fitness normative scores for community-residing older \nadults, ages 60-94. Journal of Aging and Physical Activity. 1999;7:162-181. \n234. Rhea MR, Alvar BA, Burkett LN, Ball SD. A meta-analysis to determine the dose \nresponse for strength development. Med Sci Sports Exerc. Mar 2003;35(3):456-464. \n235. Vincent KR, Braith RW, Feldman RA, Kallas HE, Lowenthal DT. Improved \ncardiorespiratory endurance following 6 months of resistance exercise in elderly men and \nwomen. Arch Intern Med. Mar 25 2002;162(6):673-678. \n236. Hunter GR, Wetzstein CJ, Fields DA, Brown A, Bamman MM. Resistance training \nincreases total energy expenditure and free-living physical activity in older adults. J Appl \nPhysiol. Sep 2000;89(3):977-984. \n237. Visser M, Kritchevsky SB, Goodpaster BH, et al. Leg muscle mass and composition in \nrelation to lower extremity performance in men and women aged 70 to 79: the health, \naging and body composition study. J Am Geriatr Soc. May 2002;50(5):897-904. \n238. Dunstan DW, Daly RM, Owen N, et al. Home-based resistance training is not sufficient to \nmaintain improved glycemic control following supervised training in older individuals with \ntype 2 diabetes. Diabetes Care. Jan 2005;28(1):3-9. \n239. Dunstan DW, Vulikh E, Owen N, Jolley D, Shaw J, Zimmet P. Community center-based \nresistance training for the maintenance of glycemic control in adults with type 2 diabetes. \nDiabetes Care. Dec 2006;29(12):2586-2591. \n240. Carmeli E, Sheklow SL, Coleman R. A comparative study of organized class-based \nexercise programs versus individual home-based exercise programs for elderly patients \nfollowing hip surgery. Disabil Rehabil. Aug 30 2006;28(16):997-1005. \n241. Savage P, Ricci MA, Lynn M, et al. Effects of home versus supervised exercise for \npatients with intermittent claudication. J Cardiopulm Rehabil. May-Jun 2001;21(3):152-\n157. \n242. Ashworth NL, Chad KE, Harrison EL, Reeder BA, Marshall SC. Home versus center \nbased physical activity programs in older adults. Cochrane Database Syst Rev. \n2005(1):CD004017. \n243. McCarthy CJ, Mills PM, Pullen R, et al. Supplementation of a home-based exercise \nprogramme with a class-based programme for people with osteoarthritis of the knees: a \nrandomised controlled trial and health economic analysis. Health Technol Assess. Nov \n2004;8(46):iii-iv, 1-61. \n \n \n103\n\n \n244. Smith KM, Arthur HM, McKelvie RS, Kodis J. Differences in sustainability of exercise and \nhealth-related quality of life outcomes following home or hospital-based cardiac \nrehabilitation. Eur J Cardiovasc Prev Rehabil. Aug 2004;11(4):313-319. \n245. van der Bij AK, Laurant MG, Wensing M. Effectiveness of physical activity interventions \nfor older adults: a review. Am J Prev Med. Feb 2002;22(2):120-133. \n246. Conn VS, Minor MA, Burks KJ, Rantz MJ, Pomeroy SH. Integrative review of physical \nactivity intervention research with aging adults. J Am Geriatr Soc. Aug 2003;51(8):1159-\n1168. \n \n \n \n \n104\n\n \n \n \n \n \n \n \nAppendices \n \n \n \n105\n\n \n7.1.0. Senior Study Manual of Procedures \n7.1.1. Introduction \n Inherent to successfully conducting intervention trials in humans is a need for strict \nadherence to a protocol that minimizes opportunities for bias, ensures proper treatment of \nparticipants, and provides uniformity in intervention and assessment. When I began as a new \ndoctoral student in Dr. Ross’s exercise physiology laboratory at Queen’s University, the Senior \nStudy had recently been awarded federal funding, and I was expected to begin learning the ropes \nof laboratory testing, establish study procedures, and recruit study participants as soon as \npossible. Fortunately, I began this effort in the wake of two other major intervention trials: a \nrecently-completed diet and exercise study in women, nicknamed the MRC women study; and the \nCaffeine study, an ongoing trial investigating insulin resistance in diabetics being directed by So \nJung Lee. With this immediate opportunity to learn assessments, I began compiling a personal \nlaboratory testing procedures manual, which I have used extensively as a reference and a \nteaching tool over the years of Senior Study data collection. The following manual of procedures \nexplains the behind-the scenes work of conducting a randomized controlled trial and provides \nstep-by-step instructions for carrying out recruitment, assessment, management, and data \nanalysis for the Senior Study. \n \n7.1.2. Key Personnel \n Essential to the study are the major decision makers. First and foremost, Dr. Robert \nRoss was the principal investigator and funding supervisor, and provided the final word on all \nmajor decisions regarding the study. In matters of a medical nature, he would consult Dr. Robert, \nHudson, who was head of the medical team and was also a co-investigator listed on the funded \ngrant. The medical team included doctors, nurses, and medical technicians as listed below, \nalong with their specific duties: \n1. Dr. Robert Hudson – Provided approval of medication use, attended a majority of clamp \nprocedures, signed imaging requisition forms, acted as liaison with participant physicians \n \n \n106\n\n \n2. Dr. Katherine Kilpatrick – Attended all maximal exercise tests, assisted in approval of \nparticipant medical questionnaires, was attending physician for 1/3 of all clamp tests \n3. Dr. Armita Rahmani – Attended clamp tests on occasion \n4. Tammy Scott-Zelt – Head clamp nurse, charge of inventory at Hotel Dieu hospital for \nblood draws and clamp procedure \n5. Lesley Rooke – Assistant clamp nurse, filled in on double clamp mornings \n6. Leann Cunningham – Assistant clamp nurse toward the end of the study \n7. Diana Hall – Consultant laboratory technician for proper handling of freezer samples \n8. Cindy Little – Head MRI technician, attended many whole-body MRI acquisitions, only \ntechnician trained to perform MRS procedure, trained her staff of technicians and \ndeveloped program for MRI scan acquisition on newly-acquired magnet partway through \ndata collection \n9. Joyce Devette-McPhail – Manager of CORELAB at KGH, which facility made possible \nblood specimen analysis for blood gases, lipids, insulin, and for liver and inflammatory \nmarkers \n \n Management of the study participants was made possible by a team of students and \nemployees in Dr. Ross’s laboratory. Over the 4-year data collection, we cycled through various \nproject staff which filled roles that were essential to the successful completion of the trial. I \nshared much of the day-to-day management of the study with a project coordinator: a vital \nmember of the team who often doubled as a study nutritionist. In chronological order of their \nemployment, the following served as project coordinators: \n1. Ann-Marie Kungl – Project coordinator of previous studies, aided in adapting an existing \nnutritional guidance package for Senior Study use, assisted in recruitment of subjects \nthrough arranging for advertisements and telephone screening, performed all nutritional \neducation sessions and monitored dietary intake records during first 1.5 years of the \nstudy, scheduled testing appointments, and arranged personnel for observation of \nexercising seniors. \n \n \n107\n\n \n2. Shelley Atkinson – Began as study nutritionist and developed the nutritional package to \naccommodate a greater mass of study participants, assumed role of project manager in \nAnn-Marie’s absence while continuing her role as study nutritionist, assisted extensively \nin study recruitment efforts, and aided me in providing feedback packages to seniors who \nhad completed. \n3. Amanda McDougall – Completed the study as project coordinator and nutritionist in \nShelley’s absence and performed detailed analysis of dietary records for a majority of \nparticipants. \n \n Most testing appointments were attended or performed by me personally for the first year \nof the study, but as the recruitment effort and volume of ongoing participants increased, I \ndelegated some of my testing responsibilities to other graduate students in the lab. The following \nis a list of graduate students and their involvement in testing procedures during the study: \n1. Jennifer Kuk – performed a majority of the senior women’s anthropometric and functional \nfitness assessments and attended MRI/MRS appointments on a rotational basis with \nother graduate students. \n2. Kate McMillan – performed anthropometric and functional fitness assessments on a few \nof the senior women, attended MRI/MRS on rotation with other graduate students, helped \nconduct VO2max tests for a year and a half, and upon completion of her Masters degree, \nhelped analyze MRI images. \n3. Peter Janiszewski – Conducted VO2max tests for 2 years, attended CT scan sessions \noften throughout that time, and attended MRI/MRS on rotation with other graduate \nstudents. \n4. SoJung Lee – performed anthropometric and functional fitness assessments on a few of \nthe senior women, and attended MRI/MRS and CT on rotation with other graduate \nstudents. \n \n \n108\n\n \n5. Meghan Watts – Assisted me with VO2max tests for a year, attended CT scan sessions \noften throughout that time, and attended MRI/MRS on rotation with other graduate \nstudents. \n6. Suzy Wong -- attended MRI/MRS on rotation with other graduate students. \n \n Each exercise session completed by the seniors was monitored by a graduate student, \nundergrad, or hired exercise monitor. During the first year or so of the study, while the Caffeine \nstudy was still underway, I monitored a majority of the resistance exercise sessions (which \nrequired the monitor to accompany the participant to the Queen’s exercise facilities downstairs) \nand shared the responsibility of upstairs monitoring with the other graduate students. \nOccasionally, undergrads seeking volunteer hours or even an hourly wage would stand in for the \nupstairs monitoring. Gradually, as recruitment accelerated, I trained some of the graduate \nstudents and a few trustworthy undergrads to help with the downstairs resistance sessions, and \nwe began to share the load of exercise monitoring relatively equally. During the 3rd year of the \nstudy, we decided to hire a part- to full-time graduated physical education student as a more \npermanent exercise monitor to ease the burden of monitoring from me and the other graduate \nstudents. It was mandatory that a graduate student was available in the event of an emergency, \nso each graduate student signed up for various hours throughout the week and made him/herself \neasily accessible to either fill in while the permanent exercise monitor was downstairs, or was \nable to assist if called on for an emergency. The laboratory purchased walkie-talkies to ensure \nquick communication, and often the graduate students were able to maintain their studies in their \nlaboratory offices while leaving the exercise monitor to interact with the seniors alone. \n The exercise monitor obviously played a pivotal role in motivating the exercising seniors, \nand we were fortunate enough to have consistently hired dedicated and energetic monitors for \nthis position. Our first official monitor was Erin Armitage, whose work ethic and love for the \nseniors set the stage for the others: Claire Kilgallon, Mika Johnson, and Nicole Bobbette. Each of \nthese monitors provided motivating encouragement to the exercisers, and was essential to the \nsuccess of the study during her respective tenure as part of our research team. \n \n \n109\n\n \n7.1.3. Recruitment Strategies \n Over the four years of recruitment, we tried numerous recruitment strategies to attract \neligible participants for the study. Listed below, in order of efficacy, are some of the methods we \nemployed: \n1. Newspaper advertisements – Our first wave of recruits was summoned by small \nadvertisements placed in a few of the local newspapers. These smaller advertisements \ncaught only the avid newspaper readers, and efficacy began to wane after the first surge \nof recruits called in. We maintained those smaller advertisements while trying other \nmeans until later in the study, when we became desperate for a response and went to \nlarger advertisements with pictures and testimonials of current participants. This latter \nmeans brought more calls than any other, and while expensive, was the single greatest \nrecruitment method. Examples of smaller and larger advertisements can be found in \nsection 7.1.13., Appendix 1. We also encouraged exercising seniors to submit short \npromotional articles to local publications, relating their feelings about participation in the \nstudy and encouraging other like-minded seniors to take part. Two participants, Bora \nHincer and Dr. Peter Froud, were eager to help and produced pieces for submission in \nThe Kingston’s Whig Standard and in online form for the Retirees Association of \nQueen’s, respectively (see section 7.1.13., Appendix 2). These promotional articles did \nnot generate as much response as the picture advertisements, however. \n2. Health fair booth – Another highly effective recruitment opportunity was posting an \ninformation booth at a health fair held by Christ’s Church in Kingston. A representative \nfrom the church contacted the School of Physical and Health Education, asking for \ngraduate students to display current research. No other graduate student in our school at \nthe time was half as interested as I was at interacting with the community, so I was \nallowed an entire booth space to attract senior recruits. One of the current exercisers, \nBob Wells, was eager to join me at the fair, and we had some very large and colorful \nposters made up for the occasion. We posted pictures of seniors exercising in the lab (all \nwith written permission, of course) and had a sign-up sheet available for eligible seniors \n \n \n110\n\n \nto indicate their interest in the study. Bob Wells was phenomenal: he talked up the \nprogram so well (even flexing his muscles for a few undecided seniors) that we went \naway with 30 or so names in only 4 hours worth of work! The power of a testimonial is \nsupreme. \n3. Posters – Early in the study, I created a flyer that became our trademark poster \nthroughout the study (see section 7.1.13., Appendix 3). We had it slightly enlarged, \nprinted in color on good-quality paper, and posted it in strategically-located places \nthroughout the community in hopes of attracting the senior eye. We posted in medical \nfacilities, malls, bookstores, libraries, churches, and Kingston’s senior centre: anywhere \nwe could get permission. Although we don’t have statistics on which poster had the most \nhits, I recall that one posted near a coffee shop in the Cataraqui Town Centre seemed to \nbring in more calls than any other over an extended period of time. \n4. Public speaking opportunities – Our first occasion to double a public speaking opportunity \nwith recruitment was when we arranged for Dr. Ross to speak as part of the “Learn and \nLinger” program at the Senior Centre in Kingston. We expected the opportunity to be a \nfruitful one, with Ann-Marie and I performing simple functional fitness tests afterwards so \nthat people could get to know us and hopefully respond to the recruitment flyers we were \nprepared to give them. Dr. Ross’s speech went very well and was extremely well \nreceived. However, due to a time conflict, we had to hurry away to another engagement \nimmediately after the presentation and fitness tests without leaving much time for further \nmingling. We received only one phone call resulting from that event; the subsequent \nwrite-up of the discourse in the Senior Centre monthly journal, Vista, was extremely \ncomplimentary, but was also of limited recruitment consequence (see article by Pat \nGalasso in section 7.1.13., Appendix 4). In time, however, we learned to make \nopportunities for one-on-one discussion with attendees, and public speaking became a \nworthwhile venture. Dr. Ross spoke at one more luncheon put on by Rotary \nInternational, and later I put together a PowerPoint presentation for a different rotary club \nluncheon and for two other invited church gatherings. \n \n \n111\n\n \n5. Word of mouth – A few of our participants were directed to the program by family \nmembers. Meetings with Rotary International, for example, were public speaking events \nwhich often made the grown children of seniors concerned for the health of their parents, \nwho would be given our pamphlets or number to call. With all of the foot travel that I did \nbetween the university and the two hospitals, I often stopped to talk with seniors fitting \nthe description of the study and asked them if they would be interested in becoming \ninvolved. That method alone brought in several successful participants. Sometimes \nstudy participants became so excited about the changes they had made that they \nrecruited their friends and colleagues. The effect of word of mouth recruitment is difficult \nto assess, especially later in the study, when recruits may have seen posters and \nadvertisements well before finally being approached by someone and invited to join the \nstudy. \n6. Radio and television – On two occasions, I was interviewed on local radio and television \nprograms, extolling the virtues of the study and expressing our need for participants. \nPrevious studies from our lab had had success with Dr. Ross targeting a younger \npopulation on the radio waves, but somehow this method did not seem as productive in \nthe Senior Study. One of our early participants, Beverly Spencer, was chosen as a \nsenior spotlight on a national cable network show. She was followed around by cameras \nas she explained her new lifestyle in the Senior Study; while the program was well-\nproduced and provided glowing praise for the study, these methods did not yield \nsubstantive recruiting results. \n \n7.1.4. Screening of participants \n Not everyone fits the criteria we are looking for in our study. In advertising, however, we \nwere cautious not to screen out too many candidates initially, so that we would not lose eligible \nparticipants who may not think they fit our criteria. Our advertisements encouraged interested \npeople to call the laboratory number and ask for the project coordinator, who would screen the \ncallers by asking them specific questions and recording the answers in an Excel database. Major \n \n \n112\n\n \nexplanation of the project details did not usually occur over the phone, but was rather deferred to \nthe recruitment meeting, where I could be more thorough and present the ideas and reasons for \nthe study more fully. \n The screening spreadsheet was computer based and had a column for each of the \ninclusion criteria. For the CIHR Senior Study, the criteria were the following: \n Age: 60-80 years \n Residence status: self-sufficient, community dwellers \n Ac tivity level: sedentary \n BMI: 27-34.9 \n Waist circumference: >88cm for women, >102cm for men \n Weight stable: change not greater than ±2 kg for 6 months prior to study \n N on-smokers \n Non -diabetic \n For women: no hormone replacement therapy within 3 months \nOther medical restrictions were noted, recording the dosage of the medication and how long the \nparticipant had been taking it. The candidate was also asked about intended medication \nchanges. The following questions were typical during these phone conversations: \n Are you having any joint/mobility concerns? \n Have you ever been prescribed nitroglycerine (spray, patch or sublingual tablet)? \n Has your doctor ever said that you have cardiovascular disease? \n Have you ever experienced angina? \n Have you had a heart attack, stroke, or bypass surgery? \n Have you ever had a stress test? How long ago? What were the results? \nOur medical team requested that we screen out the following during the telephone screening \nprocess: \n1. Anyone with angina \n2. A cardiac history unless approved by Dr. Kilpatrick \n3. Diabetics taking medication for glucose control \n \n \n113\n\n \n4. Prednisone – it affects glucose/insulin levels \n5. Blood pressure meds, specifically beta blockers: metoprolol, atenolol, propranolol, sotolol \n6. Hydrochlorothiazides if over 50mg – only allowed if dose remains constant \n7. Cholesterol meds (which we began allowing in Sept 2003): lipitor (atorvastatin), zocor \n(simvastatin), pravacol (pravastatin), niacin, crestor, lipidil \n8. Any new medications – must wait 4-6 weeks before undergoing pre testing \n The medications column was included last in the screening spreadsheet to allow for a \nlong list of medications and explanations for those medications. Any questionable medications \nwere highlighted and sent to Dr. Hudson for individual approval. Screening over the phone was \ndone so that ineligible people would not be invited to the recruit meeting and be disappointed \nwhen we didn’t allow them into the study. A column for subject status (called, not called, not \navailable until next Thursday, etc) was also in the spreadsheet, so that the project manager and I \ncould both operate from the same sheet and not duplicate efforts when or the other was not \navailable to do phone work. \n \n7.1.5. Orientation meetings \n When candidates successfully passed the eligibility criteria, orientation meetings were \nscheduled. I conducted all of these meetings personally since the initial overview presentation \nwas vital to the seniors’ understanding of the project and was often pivotal in their decision-\nmaking. It was preferable to have five or so candidates meet together in the downstairs \nconference room of the PEC, room 154. In actuality, we rarely had five in one meeting, and \nmeetings were often performed with one or two potential participants in my office when \nscheduling of the conference room proved difficult. \n The orientation meeting educated each candidate fully as to the procedures performed, \nthe time commitment required, and the potential risks and benefits for involvement in the study. I \nwas careful to hold no detail back and to present the information as concisely as possible. An \nexample of the PowerPoint presentation used for orientation meetings in the CIHR Seniors study \nis available in section 7.1.13., Appendix 5. \n \n \n114\n\n \n The three documents given the subjects upon arrival to the meeting are listed below and \ncopies of these documents are found in the appendices: \n1. Orientation Meeting Information Sheet (section 7.1.13, Appendix 6) \n2. Informed Consent (section 7.1.13, Appendix 7) \n3. Medical Questionnaire (section 7.1.13, Appendix 8) \nIn the final minutes of the orientation session, I would explain each of the above documents and \nwhat the potential participant should do with them. The information sheet was turned in and used \nfor recording the screening anthropometrics (height, weight, and waist circumference). The \ninformed consent was to be read carefully with a spouse or friend before it was signed and \nreturned to the project coordinator. The medical questionnaire was filled out by the potential \nparticipant and taken to a personal physician for approval. \n While some physicians had seen their senior patients for yearly check-up recently \nenough, most of the potential participants’ physicians preferred performing a complete physical \nbefore giving signed approval. The signed paperwork and in some cases the physical, which in \nprevious trials had been covered as a standard medical visit by the Canadian health care system, \nwas no longer covered due to recent legislation. We instructed the seniors to bring the receipts \nfor such fees into the project coordinator for reimbursement. The fees varied from a $20 \npaperwork fee to well over $200 in some cases. \n \n When performing a larger orientation meeting, I would have the project coordinator \nand/or a few graduate students available at the meeting to help me conduct anthropometric \nscreening measurements on the candidates in the laboratory. Otherwise I would personally \nperform the following on interested candidates after the meeting: \n1. Waist circumference – usually done in the wet lab for privacy. This measurement was \noften done over the top of clothes with the tape should be positioned horizontally at the \niliac crest. Those candidates who were “close” to the abdominal obesity cutpoints were \nasked if they wouldn’t mind submitting to another measurement wearing loose-fitting \nQueen’s athletic shirt and shorts for this measurement. \n \n \n115\n\n \n2. Weight – in kilograms with clothes on (shoes off) on the lab scale. \n3. Height – by the wall-mounted Holtain Limited to the nearest centimeter. \n The measurements were recorded on the information sheet (section 7.1.13, Appendix 6). \nBMI was calculated immediately by dividing kg body weight by height in meters squared. \nBecause we measure height in centimeters, the decimal was shifted 2 columns to the left before \nsquaring height. \n Before inclusion into the study, these information sheets were examined carefully (by Dr. \nHudson, if necessary, for medications) to screen out any candidates who do not fit the inclusion \ncriteria. When a medication list did not match either the version received over the phone or the \nlist provided in the medical questionnaire, the project coordinator investigated the discrepancies. \n \n7.1.6. Nutritional meetings \n Having handed in the information sheet, a signed consent, and having at least a \nscheduled appointment to see a physician, participants began meeting with the study nutritionist \nfor the nutritional run-in period. Key messages during these first few meetings were the following: \n1. This is a physical activity intervention, not a weight loss program \n2. Participants are expected to maintain weight during the baseline period run-in period and \ncalorie intake throughout the course of the study \n3. Participants must be willing to participate in any of the four randomly-assigned groups \n4. Participants must inform the lab if a medication change occurs \n5. Participants must not make any changes to their current way of eating. \n \nThe nutritionist then explained Canada’s Food Guide, including the rainbow design and the focus \non variety. She reviewed the four food groups and the “other” category, identifying which food \ngroups provide major macronutrients. She explained the importance of choosing whole grains, \nbrightly-colored fruits and vegetables, low fat dairy products, and leaner meats and meat \nalternatives. She discussed unhealthy fats (saturated and trans) and identified sources. The \nparticipants were taught to quantify portion sizes and to understand measurements. They were \n \n \n116\n\n \ntaught to understand serving sizes and to identify the fat and calorie content on a label. \nParticipants were instructed and practiced using the T-factor booklet while filling out a diet record, \nwith focus on how to report a combination of foods and how to break food down to individual \ncomponents. Each run-in session concluded with a weigh-in on the laboratory scale. \n After the introductory session, participants took home a nutritional binder containing a \npicture of Canada’s food guide, a T-Factor or H book, fast food brochures on nutrition breakdown \nof food, daily food intake records, a sheet giving instructions on how to improve accuracy of diet \nrecords, and a frequently used food list. An appointment was scheduled for a return visit within \nthe next three days to assess diet records and to measure body weight. An example of one \ncompleted day of dietary recording is found in section 7.1.13, Appendix 9. \n For a period of three to sometimes five weeks, the nutritionist/project coordinator and \neach participant met 2 to 3 times per week to discuss the accuracy of the food records and to \nobtain a current body weight. The intent of this process was to determine the total calories \nrequired to keep that particular participant weight stable under “normal” or sedentary conditions. \nWhen a satisfactory calorie intake was determined, the participant was encouraged to maintain \nthat target calorie level throughout the study. Only when calorie intake and weight were both \nstable was the participant allowed to begin baseline assessments. \n After baseline testing, the nutritionist checked in regularly with exercising seniors and \nwould collect a packet of completed dietary records from each senior on a weekly basis. Seniors \nin the control group would drop in once a week to weigh in and drop of the previous week’s \ndietary records for review. Exercisers and controls alike were expected to maintain their target \ncalorie intake throughout the study. When waist circumference and/or weight changed \ndramatically to an extent unexplained by the prescribed exercise treatment, the nutritionist would \ninvestigate the issue, determine whether excessive or insufficient calorie intake was driving the \nchanges, and provide counsel accordingly. On rare occasions, the calorie target was deemed \nincorrect and needed to be adjusted. \n Along with regular monitoring of weight and checking accuracy of diet records, the \nnutritionist provided all participants with a series of educational sessions on the fundamentals of \n \n \n117\n\n \nmaintaining a healthy diet according to Canada’s Food Guide. A total of nine nutritional packages \nwere delivered during the course of the study. A summary of the goals for each nutritional \nsession is provided in section 7.1.13, Appendix 10. \n \n7.1.7. Randomization \n Our method of randomly assigning new participants into one of four treatment groups \nwas to prepare a list of assignments in random order at the beginning of the trial, and place each \nnew participant into one of two master lists (stratified by gender) in the order that he/she \ncompleted baseline testing, thus assigning treatment. Because of the potential for bias that \narises if a single person were able to schedule baseline testing (which determines placement in \nthe list) while also having access to the master list of assignments, the project coordinator and I \ndivided responsibilities. The project coordinator, who worked with the participants during the run-\nin period and determined the schedule of baseline assessments, was not allowed access to the \nrandomized treatment list. When a group of participants had progressed through baseline \nassessments and was ready to begin treatment, the project manager assigned a subject number \nto each participant by gender and by order of estimated completion of baseline testing, and \napproached me with the names and assigned numbers. My mandate was to reveal to the project \nmanager the group assignment from the master list that was associated with each participant’s \nsubject number by telling her which treatment group was associated with the subject numbers \nshe had given me. To avoid the possibility of my rearranging assignment order, I was made \naccountable by having an archival copy of the original randomized lists that was burned onto a \ncompact disk and kept in storage. \n Partway through the study, we decided that married couples should be assigned to the \nsame group to avoid the potential for “treatment envy” or the likelihood that one member in the \nrelationship might compete with the other, even subconsciously, to achieve similar benefits \ndespite undergoing different treatments. To maintain integrity of the randomization, the project \nmanager decided which member of a couple I was to randomize, and then the spouse would also \nassume that randomized assignment. \n \n \n118\n\n \n The randomized lists were generated before the study began. In an Excel spreadsheet, I \ncreated 100 group assignments (25 of each treatment) in one column. In the adjacent column, I \ninserted “=rand()”. This function assigns a computer-generated random number between 0 and 1 \nin each cell. I then sorted both columns by random number in ascending order, thus shuffling the \ngroup assignments randomly. In a separate spreadsheet, I performed the same operation again \nfor the other gender. To the left of the group assignments, I entered a column for subject \nnumber: 001 through 100 for women, and 101 through 200 for men. After these procedures, I \ncreated the archival copy. \n \n7.1.8. Assessments \n The following subsections (7.1.8.1 through 7.1.8.12) summarize the laboratory \nprocedures followed for the assessments performed on Senior Study participants and constitute \nmy laboratory manual as a graduate student. \n \n 7.1.8.1. Anthropometrics \n Anthropometric measurements should be recorded on the Anthropometric Data \nCollection Form (see 7.1.13, Appendix 11). \n \nWeight and Height \nAnthro Weight (kg): on Detecto scale \nStanding Height (cm): stand with heels against metal plate below Holtain Limited hung on wall in \ndry lab. Instruct subject to stand tall and take a deep breath in, record measurement \ngiven on dial. \nAcromion Height (cm): have subject sidestep so that the R acromion process is at the edge of the \nmeasurement board. Deep breath in. \nArm length (cm): with tape, measure acromion to longest fingertip \nSitting Height (cm): seat subject on green-topped table (73.3 cm tall), deep breath in. \n \n \n119\n\n \nKnee Height (cm): measure from heel to the top of the knee, with both foot and knee flexed to 90 \ndegrees. \n \nSkinfolds (mm) \nMark the midpoint on the lateral side of the upper arm between the acromion and olecranon \nprocesses. \nWrap the tape around the upper arm and transfer that midpoint to the anterior (bicep) and \nposterior (tricep) surfaces of the arm \nDo the following 3 times, measuring within 4 seconds of pinch (longer results in fluid \ndisplacement in tissue): \n1. Subscapular – diagonal fold, just inferior to the inferior angle of the scapula. \n2. Tricep – vertical fold, at midpoint mark \n3. Bicep – vertical fold, at midpoint mark subject’s palm facing anteriorly \nDo these together: \n1. Mid-Axillary – subject’s R hand on left shoulder, arm elevated (ensure no trunk flexion); \nhorizontal fold on mid-axillary line at level of the xiphi-sternal junction. \n2. Iliac Crest – immediately superior to iliac crest along mid-axillary line (p.63) \n3. Abdomen – horizontal fold; 3 cm to the right of the umbilicus, 1 cm inferior \nDo these together: \n1. Thigh – mark midpoint between inguinal crease and proximal patella; vertical fold. \n2. Calf – have subject put foot on chair (90 degrees flexion), mark medial calf at widest \npoint; vertical fold. \n \nCircumference Measures (cm): \nHip: should be called “buttocks” measure – at the level of farthest posterior protrusion of the \nbuttocks. Be sure tape does not sag. \nStanding Waist, Last Rib: physically find the bottom of the ribcage. Mark it on the R side; Use \ntape -- do not compress skin and be sure the tape is horizontal. \n \n \n120\n\n \nStanding Waist, Iliac Crest: horizontally at the most superior tip of the iliac crest (palpation will \nrequire pressing in firmly with both hands laterally at subject’s waist). Mark the level on \nthe R side. Instruct subject to relax and breathe normally. If measurement changes with \nbreathing, take the measure at the end of normal exhalation. Do not compress skin with \ntape. \nDo these together: \n1. Bicep: R side, use skinfold mark; L side, create mark between olecranon and acromion \n2. Forearm: subject’s palms facing anteriorly; measure at maximal circumference \nDo these together (subject’s weight evenly on both legs): \n1. Proximal thigh: horizontally around thigh, immediately distal to gluteal furrow. \n2. Midthigh: horizontal at level of skinfold mark \n3. Distal thigh: just proximal to femoral condyles \nCalf: horizontally at skinfold mark \n \nSupine Waist, Last Rib: take subject into wet lab and have him/her recline supine on padded \ntable (put tape down before the subject lies down) with arms crossing chest. Physically \nfind last rib and measure after normal exhalation. \nSupine Waist, Iliac Crest: Physically find superior-most edge of iliac crest and measure \ncircumference vertically at that level. \n \nSaggital Diameters (cm): \nSupine, Last Rib: warm caliper arm first; place end without arm on padded table without \ndepressing vinyl, measure diameter at point of last rib marking after exhalation \nSupine, Umbilicus: move caliper inferior to umbilicus, measure after exhalation \nStanding Last Rib: insert other caliper arm and warm it; measure at last rib mark with subject \nstanding (on exhalation) \nStanding Umbilicus: move calipers inferiorly and measure horizontally at umbilicus (on \nexhalation) \n \n \n121\n\n \n \n 7.1.8.2. Functional fitness \n The functional fitness test outcomes should be recorded on the FFT Data Sheet (7.1.13, \nAppendix 12). Instructions for the testing procedure are summarized from the Senior Fitness \nTest Manual, a book produced in 2001 by Roberta Rikli and Jessie Jones, who developed this \nbattery of tests. The functional fitness test was a battery of 6 physical tests performed \nimmediately following the anthropometrics measurements. \n \n1. 30-second chair stand \na. Equipment needed \ni. Stopwatch \nii. Stable chair, no arm rests, seat height 17 inches \nb. Protocol \ni. Place back of chair against wall \nii. Have subject sit in the middle of the chair, back straight, feet flat on the \nfloor about shoulder-width apart, arms crossed at wrists and held against \nchest \niii. At your signal of “go,” the subject rises to a full stand, then returns to \nseated position \niv. Subject repeats movement as many times as possible within 30 seconds \nc. Scori ng \ni. Administer only one trial \nii. Count number of stands in 30 seconds \n \n2. Arm curl \na. Equipme nt \ni. Stopwatch \nii. Stable chair \n \n \n122\n\n \niii. 5-lb dumbbell for women, 8-lb for men \nb. Protocol \ni. Have subject sit on the chair, back straight, feet flat on floor, shifted \nslightly to the dominant side of the seat to allow for arm movement \nii. Subject holds the dumbbell in the dominant hand, arm hanging down \nbeside chair in a handshake grip \niii. On your signal of “go,” the subject lifts and lowers the weight as fast as \npossible (yet in a controlled manner) \niv. Hand position should be facing the chest in full flexion, then return to \nhandshake in extension \nv. Subject repeats movement as many times as possible within 30 seconds \nc. Scori ng \ni. Administer only one trial \nii. Count the number of curls completed in 30 seconds \n \n3. Chair sit-and-reach \na. Equipme nt needed \ni. Stable chair, placed against a wall for stability \nii. 18-inch ruler \nb. Protocol \ni. Have subject sit on the edge of the chair, with one foot flat on the floor \nand the other leg extended with foot flexed (toe pointing up) \nii. Subject slowly reaches forward, bending at the hips, and slides the \nhands (one on top of the other with tips of middle fingers even) down the \nextended leg in an attempt to touch the toes or reach beyond them \niii. If the extended knee starts to bend, the subject should sit back slowly \nuntil the knee is straight before you record a score \nc. Scori ng \n \n \n123\n\n \ni. After giving the subject two warm-up practices, administer two test trials \nand record the better test score \nii. Measure the distance from the tips of the middle fingers to the top of the \nshoe to the nearest half-inch (or cm) \niii. If the reach is short of the toes, record the distance as a minus (-) score; \nif the fingers touch the toes, record a score of “0”; and if the reach is past \nthe toes, record the distance as a plus (+) score \n \n4. B ack scratch \na. Equipme nt needed \ni. 18-inch ruler \nii. Perhaps a an ink pen to aide in positive measures \nb. Protocol \ni. In a standing position, keeping the back as straight as possible, the \nsubject reaches one hand over the shoulder and down the back (elbow \nup, palm down) and reaches the other hand (palm facing up) behind the \nback and up as far as possible in an attempt to touch or overlap the \nmiddle fingers of each hand \nc. Scori ng \ni. After giving the subject two warm-up practices, administer two test trials \nand record the better test score to the nearest half-inch (or cm) \nii. Measure the distance of overlap (positive (+) score) or distance between \nthe tips (negative (-) score) of the middle fingers; fingertips touching \nreceives a “0” score \n \n5. Eight-foot up-and-go \na. Equipme nt needed \ni. Stopwatch \n \n \n124\n\n \nii. Stable chair, placed against a wall in a clear, unobstructed area \niii. Cone, placed exactly 8 feet (measured from the back of the cone to the \nfront edge of the chair) in front of the chair \nb. Protocol \ni. Subject sits in the middle of the chair with feet flat on the floor and hands \non thighs \nii. On your signal of “go,” the subject pushes off and walks (but does not \nrun) as quickly as possible around the cone, then walks back and sits \ndown \nc. Administer one practice and two test trials. Record the better test time to the \nnearest 1/10th of a second. \n \n6. Six-minute walk \na. Equipme nt \ni. Stopwatch \nii. 4 cones in a 20 x 5-yard rectangle, with 6 cones or other markers \nshowing 5-yard increments along the long sides \nb. Protocol \ni. Give each subject a marked Popsicle stick and instruct each to track \nhis/her own laps by moving a thumb to uncover the lap number written \nsequentially on the stick \nii. On your signal of “go,” the subject walks as fast as possible (no running) \naround the course as many times as he or she can within the six-minute \ntime limit \niii. Administrator should “call out” when there are 3, 2, and 1 minutes \nremaining \niv. Subjects should walk around the course for another minute to cool down \nc. Scori ng \n \n \n125\n\n \ni. Give the subject a practice trial on a day prior to the test; on test day, \nadminister only one trial. \nii. The score is the total number of yards walked in six minutes to the \nnearest 5-yard indicator \n1. Each lap = 50 yds; each subsequent cone passed = 5 yds \niii. If necessary, the subject may rest and start again during the six minutes, \nbut the clock should keep running \n \n7. 2-minute step (Used instead of six-minute walk because of limited space) \na. Equipme nt \ni. Stopwatch \nii. Tape measure and piece of masking tape for a wall marker. \nb. Protocol \ni. Find midpoint of the thigh (already marked if anthropometrics done \npreviously) and place the masking tape on an adjacent wall to mark the \nstepping height \nii. On the “go” signal, subject begins stepping in place, raising each knee to \nthe indicated height. Do not allow the subject to run. \nc. Scori ng \ni. The score is the number of full steps completed in 2 minutes (counted \neach time the right knee reaches the target height). \n \n 7.1.8.3. Glucose tolerance \n We screened our participants for undiagnosed diabetes by having them undergo a 2-hour \noral glucose tolerance test (OGTT) at our metabolic facilities in the Hotel Dieu Hospital. \nParticipants were instructed to eat a normal to high-carbohydrate meal the evening before, \nfollowed by a 12-hour fast prior to testing. I would meet participants personally at 8:00 a.m. at the \nBrock Street entrance of the Hotel Dieu and escort them to our laboratory on the third floor. \n \n \n126\n\n \nThere introduced them to the study nurse, who would seat them and prepare to draw fasting \nblood samples from a retrograde venous catheter she inserted into an antecubital vein. The \nseniors were given a specially-prepared drink containing exactly 75g of glucose and were asked \nto drink it all in less than 10 minutes. When they had finished drinking, a “0-time” blood sample \n(5mL volume) was taken from the catheter. Samples were taken every 30 minutes thereafter until \n120 minutes had passed. During this time, I took the opportunity to answer any more questions \nthey had about the trial or any upcoming tests. For most, however, I spent a majority of the two \nhours processing plasma samples for the Hoffman-LaRoche study, which will be described in \nsection 7.1.8.13. We had a small collection of reading material or movies available for the \nparticipants to pass the time until the end of the test, after which the nurse removed the catheter \nand fed the them a light snack. I escorted the participants to the front doors of the hospital. \n Using a YSI glucose analyzer, the nurse determined blood glucose for each of the \nsamples taken at 30-minute intervals. The two most important samples for diagnosing Type 2 \ndiabetes are the fasting or “0-time” sample and the sample taken 2 hours after ingestion of the \nglucose drink. Fasting samples which were greater than 7.0 mmol/L or a 2-hour glucose level \ngreater than 11.1 mmol/L is diagnostic of diabetes, according to the 1999 World Health \nOrganization (WHO) diabetes criteria. If either of these cutpoints were exceeded, Dr. Hudson \nwas notified and he communicated the finding to the participant’s personal physician. While \ndiagnosis of diabetes at baseline was considered cause for exclusion from the study, all six of the \nseniors found to be diabetic with this test continued participation in the study in an exercise \nintervention. We performed a repeat OGTT on one of the diabetic participants after completing \nthe trial, and his 2-hour blood glucose level was reduced from 12.3 to 10.6 mmol/L (slightly below \nthe diabetes threshold) as a result of 6 months of resistance training. \n After separating out the plasma by centrifugation, samples from the OGTT were stored at \n-80ºC in a deep freezer located in our laboratory at the Hotel Dieu Hospital. \n \n \n \n \n \n127\n\n \n 7.1.8.4. Cardiorespiratory fitness test (VO2max) \n Measuring changes in aerobic capacity requires a comparison of maximal performance \non a graded exercise test. For seniors who have never been on a treadmill and are \nunaccustomed to pushing themselves physically, obtaining meaningful results can prove difficult. \nDuring the run-in period, I familiarized each senior with the treadmill and assess his/her ability \nand balance while they demonstrated a few minutes of walking on the treadmill (usually just after \nthe functional fitness and anthropometrics tests). For some, this required more than one session \nof practice. The more they comprehended the test and what was required of them, the better the \nparticipants would respond when encouraged to exercise “to fatigue” during the test. \n VO 2max tests were performed once a week, on an evening when Dr. Kathie Kilpatrick \ncould attend (usually Monday nights). We scheduled a half hour to 45 minutes per participant, \nand often had 3-4 tests per session. The seniors changed into Queen’s athletic shirt and shorts, \nand wore a pair of comfortable shoes suitable for brisk walking or jogging. We gave them a Polar \nheart rate monitor to wear so that we could record heart rates every 20 seconds throughout the \ntest. The test usually lasted 12-15 minutes, beginning with a relatively brisk pace at level grade, \nincreasing grade to 2% at the 3rd minute, and then further increasing the grade by 1% every odd \nminute thereafter. Heart rates were observed by a graduate student, who held a receiver watch \nwhile standing close to the participant, and who recorded them on a data sheet (see section \n7.1.13., Appendix 13). \n Breath-by-breath analysis of respiratory gases was also recorded throughout the test. \nThe following is the step-by-step process of operating the Vmax machine and other computers \nused in our laboratory for data collection and analysis of this test: \n \nStartup \nTurn the power on to the Vmax console and laptop. \nAllow 30 minutes of warming time before calibration and testing. \nThe Vmax program automatically loads upon startup. If the computer was already on, locate the \nVmax program icon and double-click it. \n \n \n128\n\n \n \nPatient Demographic Information \nBe aware that any new calibration data or test data will be added to the current patient file.You \ndon’t want that unless your subject is doing back-to-back exercise tests – not likely. You have \ntwo choices: \n1. Make a New Patient File \na. Select “2 New Study” on the Vmax Main Menu \nb. Enter the subject’s information \ni. ID \nii. Date – computer will automatically generate today’s date \niii. DOB – enter/select birthdate; Age is calculated automatically \niv. Gender – drop-down list \nv. Race – choose from list \nvi. Height – either inches or centimeters \nvii. Weight – enter today’s weight (kg or lbs) \nviii. Physician – select Kathie, None, or Big Bob \nix. Tech – select your name \nx. Medication – enter up to 5 medications \nc. Select “F3” to store the information and return to the Main Menu \n2. Retrieve a Previous Patient \na. Select “2 New Study” on the Vmax Main Menu \nb. Press “F1” to search for previous patient’s demographic data \nc. The “Last Name” Data Window will automatically be selected when the Patient \nFile Search Box is initially displayed \nd. Type the subject’s last name (not case sensitive) \ne. Select “F1” to begin the search \nf. Select the desired subject name with the mouse \ng. Select “F2” to run a new VO2 test on the subject \n \n \n129\n\n \nh. Change any information (likely weight will change in these studies, perhaps age) \ni. Select “F3” to store the information and return to the Main Menu \n \nFlow Volume Calibration \nSelect “1 Flow Sensor Calibration” on the Main Vmax Menu. \nThe Mass Flow Sensor Zero Box will be displayed. \nAttach the calibration syringe to the Mass Flow Sensor. \nPress “F1” to start calibration. \nStroke the syringe 2 times to purge the Mass Flow Sensor with room air. \nSelect “Space Continue” \nExcessive movement of the Mass Flow Sensor or the Sensor Cable during calibration can affect \n your accuracy and success at calibration: Ensure that airflow is minimal around Vmax. \nA ten-second timer will count down to zero before continuing to the Zero routine. \nThe Mass Flow Sensor will be automatically calibrated to zero gas flow. \nWhen the Zero routine is complete, the Flow Volume Calib Screen will be re-displayed. \nCalibration Strokes \n With the syringe piston initially in, move the piston in and out for 5 full strokes. \n The display will not show the first full stroke \n A screen with flow ranges will show whether you have averaged a certain stroke speed \n Be sure to turn all ranges from yellow to green with the allotted strokes \n Strokes should be done smoothly and consistently: don’t bang the syringe! \n Hint: for slow strokes, twist the syringe head slightly as you go – keeps it from sticking \n Keep each stroke within 3-6 LPS (0.5-1.0 second stroke duration) \nVerification Strokes \n Perform 5 more strokes. \n At least one of the last 4 should have an average flow rate of < 0.5 LPS \n At least one of the last 4 should have an average flow rate of > 3.0 LPS \n The red dotted lines should help you achieve these requirements. \n \n \n130\n\n \nIf you failed the Verification Criteria (±3% of known piston volume) then start again: Press “F1” \nPress “F3” to accept calibration values. \nRemove the syringe. \n \nVerification only (used between consecutive tests) \nSelect “F2” on the Flow Volume Calibration Screen. \nAttach the calibration syringe to the Mass Flow Sensor using the calibration adapter. \nPerform 6 strokes of the syringe piston (flow rate between 20-720 LPM) \n At least one of the last 4 should have an average flow rate of < 0.5 LPS \n At least one of the last 4 should have an average flow rate of > 3.0 LPS \n The red dotted lines should help you achieve these requirements. \nIf a Warning Message Box appears, you generally have to perform the complete Cal. Procedure \nRemove the syringe. \n \nGas Analyzer Calibration \nSelect “4 Exercise/Metabolic Test” from the Main Menu \nSelect “Exercise Protocol”, then Press “F1” \nUse the tool to turn the Span 1 and Span 2 valves on completely (2 full turns counterclockwise) \nConnect sample line (braided) to the Calibration Fitting on the front of the Pneumatics Module. \nSelect “F1” to initiate the O2 and CO2 analyzer calibration sequence \nBoth analyzers will initially sample 3 gas concentrations and calculate correction factors (step 1): \n 16% O2, 4% CO2 (Cal 1 gas) \n 26% O2, 0% CO2 (Cal 2 gas) \n 20.94% O2, 0.05% CO2 (room air) \nThe correction factors are then verified by sampling the same three gas concentrations (step 2) \nThe Verification sequence (step 2) is displayed graphically in the O2% vs. Time Window and the \nCO2% vs. Time Window. \nThe values are updated at the end of the verification sequence. \n \n \n131\n\n \nIf you get a warning, follow directions. Do not test someone until this calibration is successful. \nReconnect the sample line to the sample fitting on the Mass Flow Sensor. \nPress “F3” to accept calibration values and begin test. \n \nVerification only (used between consecutive tests) \nConnect sample line (braided) to the Calibration Fitting on the front of the Pneumatics Module. \nSelect “F2 Verify” to initiate the O2 and CO2 analyzer verification sequence \nIf you get a warning, complete a full Gas Analyzer Calibration procedure. \nReconnect the sample line to the sample fitting on the Mass Flow Sensor. \nPress “F3” to accept calibration values and begin test. \nTest screen will pause until you have the subject hooked up and start the VO2max test \n \nEquipment Check \nYou’ll need a clean mouthpiece and spit drain connected to the Mass Flow Sensor \nThe spit drain is assembled by stuffing gauze in the drain and sealing the end with tape \nWrap a clean pad around the forehead section of the headpiece. \nSnap the headpiece onto the Mass Flow Sensor and carefully lay aside so it will not fall. \nHave a heart rate monitor and receiver (watch) ready to give to the subject \nHave two extra pieces of tape ready for the subject’s nose and to secure the lines to the treadmill \ndisplay panel \n \nSubject Preparation \nThoroughly explain the entire procedure to the subject, including: \na. stop mechanisms for treadmill \nb. subject should not try to talk – use hand signals instead \nc. subject should terminate test if feels pain in chest or dizziness \nFit the heart rate monitor snugly around the subject’s ribcage (about at braline) \nEnsure that the receiver (watch) reads a normal heart rate \n \n \n132\n\n \nHave the subject familiarize him/herself with the treadmill and warm up for at least 5 minutes \nTreadmill should be at 0% grade and a speed that induces a HR of about 135 BPM \n Use the speed you determined (in practice sessions) for the treadmill test speed \nStretch the major leg muscles with the subject in preparation for the test \nFit the headgear snugly and adjust the wires so that the mouthpiece is supported \nTape the tubes (with some slack toward the subject) to the display panel on the treadmill \nPlace a nose clip on the subject (may require tape first if subject will sweat profusely) \n \nMaximal Graded Exercise Test \nSimultaneously select “F8” and the Start button on the treadmill. \nImmediately adjust the treadmill to the desired speed. \nManually record HR every 20 seconds throughout the test \nProvide encouragement to the subject, reassurance, and step-by-step explanations \nThe ramp protocol is included as an appendix to this section \nInstruct the subject to press the stop button or grab hold of railings with both hands as a signal to \nstop the test. \nBe watching for signs of fatigue and be ready to offer a steadying hand at the subject’s back \nDo the following upon completion of the test: \nSelect “Exit/Pause” on the Top Menu \nSelect “Y to End Test” \nData collection will terminate, and the Exercise/Indirect Calorimetry End of Test Comments Box \nwill be displayed. \nDisconnect subject from breathing circuit and perform your routine post-test subject care \n \nCleaning Equipment \nDetach headpiece from breathing circuit. \nRun a beaker full of water and add proper amount of cleaning solution \nDetach the Mass Flow Sensor and gently place it into the solution \n \n \n133\n\n \nRemove the tape and gauze from the spit drain and discard \nPlace the mouthpiece and spit catch in the solution as well \nBEWARE: leaving the Mass Flow Sensor in a cleaning solution for too long may damage it! \nNot leaving it in long enough may be damaging in the long run too: \n Let it soak for 10 minutes, then VERY GENTLY rinse \nRemove forehead pad from headpiece, and repeatedly saturate with soapy water and rinse. \nLeave all breathing circuit equipment on the towel to dry \nWash, rinse, and thoroughly dry the heart rate monitor. Lay it out on the towel for the next test. \n \nFormatting File and Saving for Data Entry (immediately after testing) \nFrom Main Menu, select “4 Exercise/Metabolic Test” \nSelect “1 Tabular Edit” \nYou’ll need to generate a one-page summary; change the Average section from None to 20 Sec. \nSelect “F5” to print the file (you really don’t print with this selection) \nA Print To File Window appears, with “*.prn” highlighted \nChange the “*.prn” to “<subjectlastname>.prn” \nChange the Drive from C: to A: and insert a floppy disk. Press OK. \nRemove the floppy. \nHit Esc twice to return to Main Menu \nExit the Vmax program and shut the computer down \n \nFinding File, Formatting and Saving for Data Entry (when other tests have since occurred) \nFrom Main Menu, select “A Find a Patient” \nType the last name of the subject in the available field \nSelect “F1” \nTests completed on that subject will appear. Click on the appropriate test. \nSelect “F3” to retrieve patient data. The Main Menu will appear. \nFollow the directions above in Formatting File and Saving for Data Entry \n \n \n134\n\n \n \nData Entry \nInsert the floppy that has the subject’s VO2max data on it. \nOn Viewsonic, go to Lance’s file. \nOpen folders: Queens PhD → CIHR Seniors → VO2max results \nSelect folder for subject’s cohort, and find name. An Excel worksheet will appear. \nClick on the appropriate tab: Pre, Mid, or Post. \nCheck to see that the name is correct and enter the test date. \nFile, open. View “All Files” \nSelect “3½ floppy A:\\<subject_name>.prn”; press OK. \nChange option from “Fixed width” to “Delimited”; press Next. \nChoose “Tab” and “Space” delimited; press Finish. \nDrag and right click the entire data set from 00:00:20 to the last interval of testing \n(Check to see that the last few intervals are really valid data points) \nCopy the highlighted area \nClose the “3½ floppy A:\\<subject_name>.prn” \nClick on cell “A8” and Paste. \nEnter HR values you from the VO2max data sheet. Double-check for errors. \nClick on each of the yellow boxes and change all “_99” values to the number of the last row of \ndata for this test. Example “_69” \nFormulas will generate valid numbers to be used for updating the lab’s stand-alone computer. \nSave changes, Exit. \n \nUpdating The Stand-Alone Computer \nIn the Results section of the VO2 datasheet, find the “kcal/HR” formula output. \nDouble-check that the row numbers represent the data set. \nWrite the Slope and Intercept numbers shown onto a piece of paper. \nWalk over to the stand-alone computer in the main lab room. \n \n \n135\n\n \nOn the desktop, select the icon representing the subject’s cohort. \nFind the subject’s worksheet and the current date. \nClick on the kcal column of the next exercise day. \nInput the numbers into the formula shown in the cell window: \n=((Slope*R#)-Intercept)*Q# Where R# = mean HR during exercise \n And Q# = minutes exercised \nChange the “Eq(Equation) Source” to represent the latest test VO2 test performed: Pre, Mid, Post \nCopy a few more days with the updated formula, Save changes, Exit. \n \nPaperwork \nPrint out a hard copy of the VO2max summary for the current VO2max test. \nStaple it to the front of the heart rate record. \nInsert the test into the cohort folder under the label “VO2max” \nSort alphabetically by subject’s last name and then by chronology. \n \nAn example of the VO2max summary data printout is given in section 7.1.13., Appendix 14. \n Eac h VO2max test in the senior study was evaluated by standard criteria. A true \nmaximum was achieved when two of the three criteria were met. \n1. A plateau in oxygen consumption was observed despite further increases in workload \n2. Respiratory exchange ratio (VCO2 expired / VO2 consumed) was greater than 1.1. \n3. Maximal heart rate was greater than 85% of age-estimated maximum: 208 – 0.7 (Age). \n \n 7.1.8.5. Magnetic resonance imaging \n Body composition was assessed in the Senior Study by whole body magnetic resonance \nimaging (MRI). Whole body MRI is considered by many to be a gold standard technique for \ndetermining whole body muscle and total and regional fat deposition. Through Dr. Ross’s \nconnections with the Queen’s University medical school and with Kingston General Hospital \n \n \n136\n\n \n(KGH), we had access to a 1.5 Tesla magnet for testing of seniors before and after their 6-month \ninterventions. \n The project coordinator made appointments for whole body testing with the MRI \ntechnicians at KGH. These appointments were made outside of the normal hours of medical use \non the magnet, and were usually on Saturday mornings. A graduate student met the seniors at \nthe main entrance of KGH and escorted them to the imaging department. The seniors changed \ninto hospital gowns to eliminate clothing-related artifact in the images. In a process that took 30-\n40 minutes, the technician performed at least 11 scans (including scouts) to acquire 45-47 cross-\nsectional images of each participant. The whole body acquisition protocol and scan \nspecifications are detailed in section 7.1.13., Appendix 15. \n The acquired images were burned to compact disk and taken back to an image analysis \ncomputer at Queen’s University. For each set of scans, I examined the images, identified the 45-\n47 images to be used for analysis, arranged them sequentially from inferior (foot images) to \nsuperior (finger images), and adapted a program (or script) for the computer to retrieve the \nimages in sequence for tissue analysis. An example of the script file can be found, in part, in \nsection 7.1.13., Appendix 16. Using the table coordinates obtained during scan acquisition, I \ncalculated the spacing between the femoral head image and the adjacent superior image, and the \nspacing between the humeral head image and the adjacent inferior image: the only gaps in our \nwhole-body protocol that are usually not 4 cm. The spacing between the 45-47 images is used \nfor interpolating total tissue volume from the tissue areas observed on each 1 cm-thick image. \nThe worksheet used to arrange the images and to calculate the two variable gap distances is in \n7.1.13., Appendix 17. Procedures for calculating gap distances in abnormal situations (how to \ndeal with overlapping images, etc.) are given in 7.1.13., Appendix 18. \n Determination of tissue area (muscle, fat, organ, etc.) on each image was accomplished \nusing specially-designed image analysis software called Slice-O-Matic, a product of Tomovision \n(Montreal, Canada). A technician viewed the cross-sectional image and identified muscle, fat, \nand other lean tissues shown in the image, tracing the gray-level image and tagging the visible \ntissue area with specific colors. A completely analyzed mid-thigh image, for example, would have \n \n \n137\n\n \ntag colors identifying lower extremity bone, muscle, lean tissue (large veins, nerves, etc.), \nintramuscular fat, and subcutaneous fat, and the voxel area of the tag labeling each tissue could \nbe quantified, indicating the volume of tissue found in that cross-section of the body that was 1 \ncm thick. If the images were contiguous, simply adding the voxels of a specific tissue tag \nthroughout the body would yield whole body tissue volume. However, since the images were not \ncontiguous, but rather placed 5 cm apart, the 4 cm of body tissue between images was \ninterpolated mathematically using data from adjacent images. See section 7.1.13., Appendix 19 \nfor a visual representation of inter-image interpolation and formulas used for the volume \ncalculations. \n Using voxel summary data from the 45-47 images on each whole body scan, I used \nExcel spreadsheets to run interpolation formulas and calculate whole body tissue volumes. \nBecause each tissue varies in density, I employed tissue-specific conversions to express volumes \nas masses (in kilograms). For example, skeletal muscle and adipose tissue volumes were \nconverted to masses by multiplying them by 1.04 and 0.92, respectively. \n \n 7.1.8.6. Magnetic resonance spectroscopy \n Magnetic resonance spectroscopy (MRS) can be used to quantify the adipose tissue \ndeposition within skeletal muscle. Because intramuscular triglyceride levels appear to affect \nmetabolic function and play a role in insulin resistance, we intended to perform an MRS \nassessment of intramuscular triglyceride in anterior tibialis muscles of the seniors before and after \nthe 6 month intervention. Encountering some technical difficulty, we only collected MRS data on \napproximately half of our sample. \n The MRS test required a 40-minute extension of the time spent in the imaging unit on the \nday of the MRI. The test required essentially the same conditions, but was a different application \nof the magnet, and only a specially-trained technician could perform the procedure. Since the \nresults of the MRS acquisition will not be discussed in this dissertation, the procedures of this test \nwill not be provided in detail. \n \n \n \n138\n\n \n 7.1.8.7. Computed tomography \n Computed tomography (CT) images of liver and thigh were used in the senior study to \nassess the quality of hepatic and skeletal muscle tissue, respectively. The travel of x-ray \nparticles emitted by a CT scanner is attenuated as the particles pass through more dense bodily \ntissues; because liver and muscle tissue are more dense than fat, they have comparatively higher \nattenuation values. Under conditions of high visceral adiposity or insulin resistance, both liver \nand muscle tissue are often infiltrated with lipid and decrease in attenuation value. Although CT \ncannot directly quantify lipid content of lean tissue, it measures the extent of lipid infiltration and \nprovides an in vivo and non-invasive assessment of metabolic risk. \n The Senior Study used CT images at mid-thigh and chest (at the T12-L1 intervertebral \nspace) for analysis of muscle and liver tissue quality, respectively. The measured variables at \nmid-thigh were the following: \n1. Adipose tissue area (total, deep, and subcutaneous) \n2. Low attenuation skeletal muscle area \n3. Normal attenuation skeletal muscle area \n4. Mean attenuation of skeletal muscle \nThese variables were measured in the liver: \n1. Mean liver attenuation \n2. Mean spleen attenuation \n3. Liver-to -spleen ratio \n \nMeasurement Device \nAquilion TSX-101A Whole-Body X-Ray CT Scanner \nfrom Toshiba Medical Systems (New York, NY), \nlocated at Hotel Dieu Hospital, Kingston, Ontario. \n \n \n \nCT scanner at HDH \nKinsman CT Suite \n \n \n139\n\n \nMeasurement Procedures \nPreparing the participant \n1. The participant was met by a graduate student 10 minutes prior to the appointment in the \nmain lobby of the Hotel Dieu Hospital and then escorted to the Kinsman CT Suite, level 0. \n2. The graduate student provided the participant with appropriately-sized Queen’s athletic \nshorts to change into in the washroom located in the CT Suite. \n3. The participant was asked to remove all metal or other artifact-inducing materials. \n \n \n \n \n \n4. The graduate student marked an “x” \non the participant’s skin at the \nmidpoint of the right thigh. This was \nperformed by having the participant stand with full body weight on the left leg, relaxing \nthe right leg so that both hip and knee joints are in slight flexion. The graduate student \nthen used a plastic tape measure to assess thigh length anteriorly from the inguinal \ncrease to the base of the patella. When midpoint was determined, a clear mark was \ndrawn on the skin of the participant’s anterior mid thigh. \n \nGraduate student measures \nmid-thigh mark \nPreparing the Aquilion computer \n The graduate student provided the radiology technologist with a CT requisition form \nwhich had been completed by the project coordinator and signed by the study physician (see \nsection 7.1.13., Appendix 20). The technologist entered the subject’s Pre test ID number where it \nasked for ID and the Pre test ID number preceded by “ZZ” where it asked for name. Beside \n“Attending Physician” the technologist typed in ROSSPROTOCOL. With this information, the \ncomputer automatically performed thigh and abdominal scans under the following technique: \n \n \n140\n\n \n1. Thigh – 120 kV, 250 mA, LL, 480 FOV \n2. Abdominal scout – 100 kV, 250 mA, approximately 320 mm \n3. Liver – 120 kV, 250 mA, LL, 480 FOV \n \nPerforming the scan: Thigh \n The technologist instructed the participant to lie supine on the examination table with feet \npointed into the barrel of the CT scanner and the right mid-thigh mark exposed. The technologist \nadjusted the table until the laser guide superimposed the mid-thigh mark. Two 10mm-thick \nimages were obtained, centered 5mm to either side of the mark, as shown on the following \ndiagram: \n \n \n \n \n \n \n \n+10mm \n-10mm \n0 X \nR Leg L Leg \n \nPerforming the scan: Liver \n The participant was instructed to follow the recorded message to “breathe in and hold \nyour breath” at the appropriate times. During this timed breath hold, a “scout” scan of the \nparticipant’s lumbar vertebrae was performed for the purpose of land-marking the T12-L1 \nintervertebral space. This scout was performed at 100 kV, 10 mA, and has an approximate \nlength of 320 mm. The technologist located the L5 vertebra and counted up to the T12-L1 \nintervertebral space. The image acquisition box was positioned at the center of this space to \nobtain two 10mm-thick cross-sectional images at the T12-L1 intervertebral space. The scan was \nthen performed during another breath hold. \n \n \n \n141\n\n \n \n \nLocating the T12-L1 \nintervertebral space \nusing a scout image \n \n \n \n \n \n \n \n Like in most radiological procedures, there is some health hazard associated with CT. \nHowever, the total exposure of this entire procedure was below 1.5 mSv, which is well below the \n5 mSv/year considered the upper “safe” limit. \n \nData transfer \n All images acquired were immediately sent to the Galileo imaging database at the Hotel \nDieu Hospital. The Galileo system has a pre-programmed link to an FTP site on the firewall of \nthe Ross Laboratory at Queen’s University. Within 24 hours, I retrieved all scans and copied \nthem into a designated folder behind the Ross Laboratory firewall. Images were transferred in a \ncondensed format. I unzipped each file, saved a copy of the raw (condensed) CT images, and \nstored the viewable images on a folder labeled by the scan ID number. I visually inspected each \nimage on the Slice-O-Matic software to ensure quality of acquisition, number of scans obtained, \nand proper image labeling. \n \nData backup \n Raw (unanalyzed) images were burned onto compact disks and stored in the CT section \nof the black binder labeled “Senior Images.” A secondary backup was created at the same time \nand stored at my off-campus apartment. Scans were analyzed as described in the Data Analysis \nsection of this protocol, and new tag files were created. Analyzed material was stored on the \n \n \n142\n\n \nlocal hard drive of the analysis computer, which was backed up daily by an automated system \nonto another hard drive stored in a different room and locked under a different key – available \nonly to the principle investigator and our computer maintenance technician. When at least 50 \nnew scans have been analyzed, 2 copies of the raw images and associated tag files were burned \nonto separate DVDs: one of them was for me to hold onto, and the other was an archival copy, \nstored separately. When the study was complete, the images were removed from the local \nanalysis computer to free it up for future projects, and there still remained at least 2 copies of the \ncomplete data. \n Database files containing the image analysis results were transferred to an Excel \nspreadsheet for compilation of all the data, and were subsequently transferred into the Senior \nStudy Database in Access format. All data were consistently backed up by the automated \nsystem and archived every other week on DVDs as per the database protocol. \n \nData Analysis \nMid-thigh images \n While in Slice-O-Matic, all images from one subject’s pre or post data acquisition were \nopened (identified by test ID number): File → File open → Shortcut to Senior CT → ID number. \nSince the Senior Study subjects have 4 contiguous 10mm images, and we only analyzed two of \nthem, the middle two images were chosen by pressing F12 and examining the Z axis numbers of \nthe individual images. Images are segmented using standard threshold values: \n Adipose tissue: -200 to 0 HU \n Low density muscle: 1 to 30 HU \n High density muscle: 31 to 150 HU \n Bone: >150 HU \n \nRaw segmentation is then touched up by the analyzer according to this protocol: \n1. Edit the low density areas out of the femoral bone (label as bone) and the high density \nareas tagged as bone within the muscle (label as high density muscle). \n \n \n143\n\n \n2. Edit the high density areas (skin) out of the subcutaneous AT. \n3. Change the tag for subcutaneous AT to differentiate it from the sub-fascial \n(intermuscular) AT. \n4. See raw and analyzed thigh images that follow: \n \nExample of mid-thigh image analysis: \n \n \n \n \n \n \n \n \n \n \n \n \n \nLiver Images \n Of the liver images acquired (early in the study there were sometimes 4-8 images instead \nof just two), the one in which the spleen has the greatest volume is chosen for analysis. I \nattempted to match the appearance of pre and post images on each subject as well to ensure \nimaging of the same liver/spleen regions. \n \nRevising assessment of liver fat \n In all of our previous studies, liver and spleen had been analyzed using sample “regions \nof interest” from the CT image, attempting to find representative areas of the liver or spleen from \n \n \n144\n\n \nwhich we could gather attenuation data. The regions of interest were often placed near the outer \nedge of the liver (perhaps so that they would correlate better with liver biopsy data) and the \nanalyzer needed to be wary that the region of interest did not contain any areas of \ninhomogeneity, like vessels or fatty deposits. When I began analyzing the senior livers in this \nway, I noticed that my subjective placement of these regions of interest had a great impact on the \nattenuation outcomes. I attempted to develop a less subjective approach to my analysis, and \narrived at a few questions that I felt needed to be answered. \n1. What region of the liver or spleen best represents the whole organ? \n2. Is that region relatively consistent throughout all subjects? \n3. Does choosing a different vertical positioning of the scan also affect attenuation? \n \n After tossing around a few ideas, Dr. Ross, Jennifer Kuk and I decided to perform an \nanalysis of the Cooper CT scans, to which we had access in our laboratory, to answer some of \nthose questions. Our work resulted in a published manuscript in the Journal of Applied \nPhysiology (see section 7.2.0), providing evidence to support a few adjustments to the \nmethodological approach to proper acquisition and analysis of CT liver data. Our work helped us \nto recommend a bony landmark (the T12-L1 intervertebral space) to target when acquiring \nimages of the liver, minimizing radiation exposure while also increasing the likelihood of imaging \nthe spleen simultaneously. We also found that while there are some regions of the liver which \nare inhomogeneous from the rest across a population, these regions do not differ widely from the \nwhole. Thus, the most reliable, repeatable, and objective measure of liver attenuation was to \nsample the entire liver visible within an image instead of sampling specific regions of interest. \n Following the protocol recommended in our methodology paper, we began obtaining liver \nimages at the level of T12-L1. I used the entire visible liver and spleen for attenuation values on \nthat image instead of choosing regions of interest. Here are a few tips for performing the \nanalyses: \n \n \n145\n\n \n1. When tracing the liver and spleen on the images, avoid tagging clear to the edge. Leave \na few millimeters of liver near the borders, since the borders often have \nuncharacteristically low attenuation values. \n2. Avoid including major vessels as part of the liver. \n3. If possible, have only one person do the analyses on pre and post images to avoid \nincorporating inter-analyzer error into change scores. \n \n 7.1.8.8. Hyperinsulinemic Euglycemic Clamp \n The hyperinsulinemic euglycemic clamp (or “the clamp” as we like to call it) is the gold \nstandard for quantifying insulin resistance. It measures the amount of glucose necessary to \nmaintain normal glucose levels while compensating for a known infusion of insulin, and indicates \nthe subject’s level of peripheral insulin resistance. In order to obtain reliable results in this test, \nthe following things must be accounted for and controlled in each participant: \n1. Acute physical activity – any exercise performed within 24-48 hours of the clamp may \nincrease insulin sensitivity. We asked the participants to not engage in any exercise for \n3-4 days prior to the initial clamp, and we scheduled the last exercise intervention \nsession between 24-36 hours of the post clamp. The last 24 hours before the clamp was \na rest day; they were not to do exercise of any kind. We also had them arrive at the \nHotel Dieu Hospital as rested and relaxed as possible: we paid their cab fare when \nneeded so they wouldn’t be driving, and asked them to not shower or brush their teeth. \nWe encouraged them to just “roll out of bed” and get in the cab. \n2. Nutritional state – depleted muscle glycogen stores increase insulin sensitivity. The \nparticipants fasted for 12 hours prior to the clamp, but to ensure complete restoration of \nmuscle glycogen prior to the fast, we devised a meal plan for them to follow the night \nbefore with plenty of carbohydrate to “top them up.” The meal they recorded for the pre \nclamp was re-issued (we provided them with a photocopy of their dietary record) and they \nwere asked to follow the same dietary pattern for the post clamp. \n \n \n146\n\n \n3. Anxiety and muscle activity – Immediately before and during the clamp, it is essential to \nminimize muscle contraction, which provides an alternative route for glucose disposal \nfrom blood than insulin mediated glucose disposal. When participants are nervous or \nfidgety during the test, glucose disposal is falsely elevated. I did anything I could to calm \nthe nerves of the seniors before the clamp. I phoned each one the night before the \nclamp to reassure them that I would be there in the morning, offered a wake-up call, met \neach one personally at the entrance to the hospital, and remained with them through the \n“needles” and the beginning of the clamp. Although I was usually processing blood \nsamples or doing other testing during the duration of the clamp, I checked in with the \nparticipants regularly to answer questions and keep them at ease. \n \n Many tests are performed on the morning of the clamp, and I needed to be prepared \nahead of time and ensure proper operation of equipment for it to run smoothly. Before testing \nbegan for the Senior Study, I made a checklist of things to prepare the night before each clamp to \nhave with me in the morning: \n1. The key to the Hotel Dieu Laboratory – we only had one key available to the students for \nthe metabolic unit, and forgetting it meant alerting the hospital night security to come and \nopen our door since we were there in the morning before regular hospital operating \nhours. \n2. Hotel Dieu ID badge – the Hotel Dieu closes at 8:00 p.m. and doesn’t re-open until 6:00 \na.m. My ID badge opened the electronic locks on the main entrance and was essential to \ngetting the participant into the hospital at 5:15 a.m. \n3. Anthropometrics data sheet – we needed the height measurement (same pre value as \npost) taken in the lab to calculate body surface area for determining the appropriate \namount of insulin to infuse. \n4. Clamp binder with phone numbers – in case the participant, nurse, or physician fails to \narrive, contact numbers were needed for wake-up calls or cancellation notices. \n \n \n147\n\n \n5. Queen’s University athletic shirt and shorts the right size – for the weigh-in and for ease \nin performing the other tests, I had to have a clean set of appropriately-sized “grays” with \nme. \n6. Money for lunch – for more than half of the study, I had to buy the participant’s lunch after \nthe clamp. They needed to consume a solid meal and have blood glucose levels \nelevated before being discharged from the unit. In the last two years of testing, the café \ndownstairs allowed me to run an account with them, which alleviated the need to have \ncash on hand for the clamps. \n \nThe following is the timeline I followed on the morning of the clamp: \n5:05 Arrive at the Brock Street entrance of the Hotel Dieu Hospital \n5:15 Meet the participant and escort to the clamp room \n5:20 Instruct participant to change into shirt and shorts in the clamp room and meet back in \nthe hall. Meanwhile, prepare the standing multi-frequency bio-impedance computer; \nenter essential data. \n5:30 Perform bio-impedance (bioelectrical impedance) measures. \n5:35 Instruct participant to return to clamp room, get into bed, and try to relax or sleep. Ensure \nthe senior has sufficient blankets to maintain comfortable temperature. Retrieve more if \nnecessary. In an adjacent room, prepare all of the clamp documentation, including the \nbody surface area calculation using formulas and the weight from the bio-impedance \nscale. Print separate copies of the clamp data sheet (section 7.1.13., Appendix 21) for \nthe physician and for the nurse. Pull a desk into the hall for the physician and place the \ndata sheets on it. Arrange a writing table outside the clamp room for the nurse, and on it \nplace the other copy of the datasheet; fill out the blood gases and lipid profile requisition \nforms (section 7.1.13., Appendix 22) and set them also on the nurses table. \n5:55 Enter the clamp room and begin quietly calibrating and preparing the Deltatrac (used for \nobtaining basal metabolic rate (BMR) and clamp calorimetry) machine. \n \n \n148\n\n \n6:05 Take blood pressure manually and/or set up the BPtru blood pressure machine and take \nresting blood pressure. Record the mean measurements on the back of the \nAnthropometrics datasheet, which is the clamp morning data collection sheet (section \n7.1.13., Appendix 11). \n6:15 Plug in 2-4 heating pads to begin warming the participant’s arms to bring out the veins for \nthe nurses. Install the hood over the participant and begin measuring breathing gases for \n30 minutes. Remain in the room, but quiet to ensure that the Deltatrac is working \nproperly and that the participant does not fall asleep during the measurement. Set up the \nsupine multi-frequency machine (Tanita prototype) and measure bio-impedance on the \nhand and foot. Record the readings from the screen by hand onto the datasheet. \n6:45 Remove the hood, stop the Deltatrac, keep the printout, and do a backup of the electronic \ncopy of the BMR reading. Introduce the participant to the nurse and aid her as she sets \nup equipment and finds the two veins for intravenous sites. \n7:00 Retrieve the insulin from the refrigerator and place it on the physician’s desk along with a \nneedle and saline bag. \n7:15 Turn on the temperature-controlled centrifuge and set it for a single cycle. If there is a \nRoche sample to be processed (see section 7.1.8.13.), prepare the tubes. \n7:30 Clamp test begins. Make sure that the participant is comfortable, and set up a selected \nmovie or set the radio station to meet the participant’s preferences (the participant must \nbe awake, yet relaxed throughout a three-hour test wherein he/she must be supine. Non-\nstimulating distractions are extremely helpful.) Begin spinning Roche samples, if \nnecessary. \n9:45 Recalibrate the Deltatrac. Prepare for 30 minute clamp calorimetry when the physician is \ncertain that the participant is “clamped” and will continue to be so for the next 30 minutes. \nWithout eliciting any movement or excessive talking, obtain a lunch request from the \nparticipant. Essentials of this meal include a large fruit juice, a piece of fruit, and a \nhealthy, substantial main course (soup and sandwich). Install the hood and begin testing \ngases at the physician’s request – around 10:00. \n \n \n149\n\n \n10:30 Have lunch ready to be served by the end of the clamp – never earlier than 10:30, and \noften later if participant wasn’t “clamped” by 10:00. Remove the hood, congratulate the \nparticipant on successful completion of the test, and serve lunch. \n10:50 The participant is not allowed to leave until at least 30 minutes after lunch is completed \nand blood glucose readings indicate normal for post-prandial state. While waiting, \nadminister the SF-36 questionnaire (section 7.1.13., Appendix 23) to the participant. \n11:30 Escort the participant to the main entrance. Re-affirm upcoming appointments for testing \nor for exercise session appointments if the clamp was the final test. \n \n 7.1.8.9. Bioelectrical Impedance \n In keeping with our purpose as a body composition laboratory, we perform many different \nmethods of assessing body fat and muscle. Bioelectrical impedance is a method that became \ncommercially available in the mid 1980’s, and some of Dr. Ross’s own research as a student and \nearly career was related to this measurement method. Because of his interest in bioelectrical \nimpedance, and because of our ability to compare other methods with the “gold standard” of \nwhole body multi-slice MRI, we routinely assess study participants with various types of \nbioelectrical impedance machines – some of them prototypes. \n Bioelectrical impedance is a method of measuring body fat using current electrodes for \napplying a constant current through a human body and voltage electrodes for detecting a voltage \ndrop caused by bioelectrical impedance of the human body. Some of these electrodes took the \nform of “foot to foot” pads which the subjects stood on, often while obtaining a standard weight \nmeasurement before the clamp. Other machines had “hand to hand” and “foot to foot” \ncapabilities that extended measurements also to “hand to foot” measurements, most were \nperformed in standing position, but another was supine with stick-on electrodes. \n When the senior study began, each participant was tested by no fewer than four \nbioelectrical impedance machines. When we obtained two more machines from Tanita \nCorporation (Japan) and another stopped functioning, we reassessed the situation and phased \nout a couple of machines that were obtaining parallel measurements. Through all of this, \n \n \n150\n\n \nhowever, we have a wealth of bioelectrical impedance data on the senior participants that could \nbe used for an interesting side project comparing bioelectrical impedance to other standards of \nbody composition assessment. \n The impedance measurements were obtained using the following protocol: \nWhile the subject is changing into greys at the clamp: \n Pull the scales out from underneath the desk. \n Check each one to be sure it works. (Turn both on, press start) \nCheck with the subjects to see whether they have had anything to eat or drink. \nHave participant take socks off and stand on Tanita machine with Japanese writing on it (this was \na whole body assessment prototype). Subject holds the “guns” in the proper hands (L and R), \narms straight out, no moving. \nPress display; write results next to the corresponding number on the back of the Anthropometrics \nData Collection Form (section 7.1.13., Appendix 11). \n \nTurn on Tanita machine with English writing on it. Select Adult. \nType in height from Standing Height entry on Anthropometric Data Collection Form (Anthros \nsheet) \nWait for the “Stand On” arrow to flash. \nRecord the weight (kg) into the “Clamp Weight” space on the Anthros sheet \nStaple the TBF-305 analyzer receipt onto the Anthros sheet as well. \n \nUnplug and carry the multi-frequency equipment to the bedside chair. \nPlug it in. Turn on the laptop. \nHave the subject lie down on the bed with hands not touching the sides of his/her body \nCut the electrode pads in half. You’ll need 8 per subject. \nPut the pads on the dorsal surface of the feet and hands: \n Feet – joint space of the ankle and a finger-width from the base of the toes \n Hands – joint space of the wrist and a finger-width from the base of the fingers \n \n \n151\n\n \nPut the rest of the electrodes away and fold the flap over on the package so they don’t dry out. \nClick on the shortcut to multi-frequency \nFile, Open \nType last name, Enter \nAttach the clips to the little black box (1 pair of leads to a terminal). \nTest; see “z standard check” and make sure that numbers appear. If not, readjust and try again. \nType in “Arm-arm” and attach clips: \n Red = proximal \n Black = distal; “blood towards the heart, dirt at the fingertips” \nPress Start \nWhen numbers appear, press PrtSc (Print screen) on the laptop. \nGo to Paint on the desktop. \nCtrl V to paste, select Yes. \nMinimize Paint screen. \nRepeat for “whole body” and “leg-leg.” \nRemove electrode pads and discard. \nRecord data onto the multi-frequency data sheet from each minimized Paint window. \nClose each window without saving. \n \n Similar instructions were followed for the newer machines, with some simplification of \ndata management. For instance, the new standing multi-frequency machine required no hand-\nentering of impedance values; rather, data was stored in Excel spreadsheets. I helped Bill Pierce \nwrite a program that would convert the data from spreadsheets into a single database at the end \nof the study, which I then transferred into the Senior Study data, indexed by subject number. \n \n 7.1.8.10. Basal Metabolic Rate and Clamp Calorimetry \n For nearly half of the data collection in the Senior Study, the machine that measures \nmetabolic rate and clamp calorimetry was not operational, and I came to know the operator and \n \n \n152\n\n \ntechnician manuals for it quite well. In memory of those numerous hours of frustration, here are \nthe instructions for operating the Deltatrac machine when it was measuring expired gases \ncorrectly: \n \nShortly after bio-impedance data have been collected, the subject should be lying in bed and \npreparing for BMR readings with the hood. Be sure that the subject has been lying undisturbed \nfor at least 20 minutes. \nBe sure that the Deltatrac is plugged in. \nCheck the gauge on the side (through the makeshift hole that Ken cut); be sure pressure is up. \nPress the Cal button. \nChoose 1 Gas. \nPress Patient Data \n You will need to provide: gender, DOB, height (cm), weight (kg) \nPress 4 Save; “data accepted” \nPress 4 again for Normal Screen \nPull out the hood (or canopy) \nInstruct the subject to not talk but relax for 30 minutes. No sleeping! \nTuck the plastic in around pillow \nPress Start \nEnsure that the printer is generating a minute-by-minute hard copy \nMonitor the progress, ensuring that the RER is within acceptable physiological levels \n… Press Stop, End. \nTurn on computer, attach cord to laptop (you’ll likely have to press Stop, End again) \nGo to Deltatrac on desktop \nPress any key \nF9 to start \nPress 2 Snd data on Deltatrac \nSelect Y to edit header or summary. \n \n \n153\n\n \nType in <subject_lastname> <pre or post> <bmr> \nEnter through until Esc = Exit; hit Esc. \nOn the C drive, open the Deltatrac folder, then tests. \nClick on the old lotus file with the highest number or date on it .prn \nAdjust the name so that it is left justified in the appropriate cell. \nCheck that all columns are there (30 columns or so) \nSave file as <subject last name, first initial>, as the latest version of Excel, and in the appropriate \nfolder (Seniors pre / post) \nCheck that the saved spreadsheet is intact where you put it. \nGo back to the Tests folder and delete all of the recent tests sent. \nDisconnect laptop from the Deltatrac \nClear all data on the Deltatrac \nLabel printout as BMR (or Clamp Cal) and file in binder back at the lab. \n \nThe clamp cal is done exactly like the BMR, but only when the subject has been completely \nclamped (usually more than 3 hours later). Before you put the subject under hood, however, \nobtain a lunch order for the participant that you will buy from the deli downstairs for lunch. \n \n 7.1.8.11. Blood Pressure \n When the subject has been lying down for at least 15 minutes on the morning of the \nClamp, pull out the blood pressure cuff and take a reading. Wait for 1 minute and take another \nreading. Record these measurements in the space provided on the Anthropometrics Data \nCollection Form. \n Partway through the study, we had a new automated blood pressure machine made \navailable to us. The instructions for this “BPtru” machine are as follows: \n In addition to the manual readings, hook up the automatic blood pressure machine, and \nallow it to take 6 readings (2 minute spacing) and record the mean blood pressure. Explain the \nmachine to the participant; ensure that the cuff is comfortably placed around the upper left arm, \n \n \n154\n\n \nwith the lower edge of the cuff proximal to the antecubital area of the arm. Remain in the room \nwith the subject through the first measurement, and then leave the room to reduce the “white coat \nsyndrome” effect. Record the measurements on the Data Collection form. \n \n 7.1.8.12. Blood Lipids / Blood Gases \n As mentioned earlier, requisition forms (section 7.1.13., Appendix 22) were prepared for \nthe nurse before the clamp. During the pre-clamp fasting blood draw, a sample was taken in a \nspecial tube and sent to the blood analysis lab (CORELAB) at KGH for analysis of plasma lipids. \nA printout of the lipid profiles were sent to the Rapid Response Lab printer at the Hotel Dieu \nHospital, where the technicians saved them for me (or later, one of the Proactive staff) to come \nby and pick up every few days. I took these printouts back to my office for data entry and \nsubsequent filing. \n To reaffirm that the venous sample site (the hand) was sufficiently heated to increase \nblood flow so that venous blood more closely approximated arterial blood, a sample was taken \npartway through the clamp for analysis of the blood gases. The sample was put on ice \nimmediately and a courier was called to deliver the tube to the CORELAB as quickly as possible. \nThe CORELAB technicians phoned us (usually within a half hour) to give the results, which I \nrecorded on the clamp data sheet. If the oxygen content was lower in the sample (below 0.90), \nwe would adjust the heating pads, wait at least 10 minutes, and then do another sample. If the \noxygen content was high, we were confident that our glucose readings on the venous samples \nwere not artificially low due to glucose disposal occurring upstream of the sample site. \n \n 7.1.8.13. Hoffman-LaRoche Blood Samples \n In an effort to secure sufficient funding to carry out the study, Dr. Ross agreed to provide \npre and post blood samples from the senior study to a pharmaceutical company, Hoffman-\nLaRoche. Involvement in the “Roche” study was purely voluntary, and some participants opted \nout (usually on principle), although the sample amount was rather minimal. The project \ncoordinator or I explained the study to the participants, and a separate consent form (section \n \n \n155\n\n \n7.1.13., Appendix 24) was signed before the morning of the oral glucose tolerance test. Pre \nsamples were usually taken the morning of the OGTT, and post samples were usually taken on \nthe morning of the post clamp. All of the handling of these Roche samples was done by me (with \nsome help from Diana Hall early on in the study); the sample processing was not to interfere with \nthe nurses properly performing the clamp or OGTT. The following are instructions for the \nhandling and processing of the Roche samples: \n \nSamples must be placed immediately on ice and cooled before spinning. All steps of this \nprotocol must be carried out in order and as quickly as possible, to ensure maximum sample \nquality and to prevent proteolysis. If samples must sit – always keep them sitting on ice. \n1. FOR PRE SAMPLE ONLY: One 6ml tube must be gently mixed by inversion and frozen \nas soon as possible at –80ºC in the HDH Senior Study freezer. Label with pre/post test \nID # and place in a zip-lock bag. \n2. Place remaining 9x6ml tubes carefully in temperature-controlled centrifuge. Balance the \nrotor by placing samples of equal level opposite each other. Use the “blank” (water-filled \ntube from the rack at the side of the centrifuge) to balance the 9th tube. Spin at 1500g for \n15min @ 4º C. \n3. Locate a pre-stocked bag of tubes in the drawer of Lance’s desk and label all tubes with \nthe subject’s test ID #. \n4. When the cycle is completed, draw off plasma layer from each 6mL sample tube using a \ntransfer pipet– leave approx 2mm in each to ensure no carryover of cells. Transfer to 4 \nx15ml polypropylene tubes. Be certain all tubes contain the same sample amount to \nassist in balancing. Cap tightly and place these tubes in the centrifuge - balancing the \nrotor – and spin at 3000g for 30min @ 4º C. \n5. Label 5-6 cryotubes with subject’s assigned pre/post test ID#. When centrifuge finishes \nits spin, carefully remove tubes from the rotor, one at a time. Gently remove each tube to \nnot disturb the layers. \n \n \n156\n\n \n6. Transfer plasma supernatant from all 4 tubes, with a pipette, to a large (50ml) conical \ntube, leaving any sediment behind (leave the bottom 2/3 of each tip of the conical tubes). \nThis is now a pooled sample from all the original tubes. Cap, mix by gentle inversion, \nand transfer with a pipette to labeled cryotubes. Place these tubes together in a zip-lock \nbag and place in freezer at -80º C. \n7. Record the name of the subject and the date in the sample key in Lance’s desk. \n8. All spills must be diluted with chlorine bleach (Javex) and wiped up immediately. \n \n Twice during the study, I packaged and shipped the Roche samples to the headquarters \nin New Jersey. Funding from these samples made possible the purchase of a new -80º C freezer \nto replace our old one and helped immensely in providing wages for essential study personnel. \n \n7.1.9. Exercise Interventions \n Participants randomized into any of the three exercise arms of the study underwent \ntraining specific to their given intervention. For all but a few of the participants, I delivered initial \norientation of the equipment, gave them instructions on safety, and explained what was expected \nof them as exercisers in our laboratory. I did this introductory session personally to ensure that \nall were given uniform instruction. I also trained all exercise monitors to ensure that the \nguidelines were uniformly followed and enforced. My rationale in taking a personal role in this \naspect of the study was not that I have superior knowledge of exercise implementation and form \n(on the contrary, the monitors that we employed were as capable or more so in that regard), but \nthat if all participants were exposed to the same instruction and guidelines throughout duration of \nthe study, the interventions would be as uniform as possible. Sections 7.1.9.1 and 7.1.9.2 \ndescribe the points of training provided the seniors as they began their specific exercise sessions. \n Regardless of the exercise group, all senior participants were encouraged to wear \nappropriate clothing. Queen’s issue shirt, shorts, and socks were available, but not required. \nSince these clothes were laundered for the participants and they were provided with a drying \ntowel each time they came, most took advantage of this service. All were required to wear \n \n \n157\n\n \nappropriate shoes. Semi-private changing rooms with lockers and showers were available as \nthey came into the research area of the Physical Education Centre, and we provided locks and \nkeys for them to secure their belongings. \n The seniors were given extraordinary latitude in making appointments for exercise \nsessions. For the first half of the study, we offered to monitor their exercise at their convenience \nany time from 7 a.m. to 7 p.m., 7 days a week. We found that the seniors tended to like to \nexercise in groups and do most of their sessions in the mornings, which cut down our monitoring \ncosts significantly. Toward the end of the study, we encouraged incoming seniors to continue the \ntradition of exercising in small groups, which they adhered to gladly. \n \n 7.1.9.1. Aerobic Exercise \n For each aerobic exercise session, we obtained a starting heart rate and then obtained a \nsteady state exercise heart rate every 5 minutes thereafter. Participants were instructed to go to \nthe anthropometrics room each time, where they would find a Polar heart rate monitor. These \nmonitors consisted of a T31 transmitter, which was strapped to their chests, and an A1 wrist \nreceiver, which they strapped to their wrists like a watch. After telling the exercise monitor the \nstarting heart rate, participants would step onto one of three treadmills and begin 5 minutes of \nwalking warm up. The five minute walking warm up was designed to elevate heart rate from a \nnon-exercise rate to nearly the exercise range. Target exercise heart rate ranges were specific to \neach participant, calculated from the most recent VO2max test, and written on the weekly \nexercise session record. Participants were encouraged to choose a speed and grade after the 5 \nminute warm up that would elevate their heart rates into the exercise range. Once within the \nrange, participants could maintain or adjust walking/jogging speed and treadmill grade as desired \nevery five minutes after telling the monitor the “steady state” heart rate for that exercise interval. \nAll exercise heart rates and treadmill speed and grade associated with those heart rates were \nrecorded by the exercise monitor onto the weekly exercise session record (section 7.1.13., \nAppendix 25). \n \n \n158\n\n \n As one might expect, there was some variance in perceived difficulty of the moderate \nexercise. Some exercisers needed more prodding than others to “pick up the pace” to elevate \ntheir heart rates sufficiently. Others needed to be reminded to not get too intense as their \ncompetitive natures drove them on to “improve” the calories burned each day or move on to a \ngreater treadmill speed or grade. Most, however, required little coaching and gentle reminders \nwere sufficient to have them continue to increase work rate gradually as their cardiorespiratory \nfitness improved. Despite the seemingly variable response, nearly all treadmill exercisers were \nable to maintain an exercise intensity that was high-moderate during the 30-minute treadmill \nsessions. \n A five minute walking cool down at the end of each session was also performed, \ndesigned to return the exercise heart rate back to near-starting levels. Participants were \nencouraged, but not required to stretch upon completion of exercise. Participants washed and \nrinsed the transmitter and chest straps at the sink in the anthropometrics room and hung them out \nto dry in preparation for the next group of seniors. \n \n 7.1.9.2. Resistance Exercise \n A five minute warm up consisting of treadmill walking or stationary cycling began each \nresistance exercise session. Participants were then accompanied by an exercise monitor down \nthe stairs to the Queen’s exercise facilities to perform nine resistance exercises, mostly on \nNautilus machines. The following are a list of exercises and the “proper techniques” encouraged \nfor each one: \n1. Chest Press – The initial fitting of the machine consisted of adjusting the seat height to \nallow for full arm extension. Seat height was recorded on the resistance exercise session \nrecord (section 7.1.13., Appendix 25) and maintained at that height throughout the \nintervention. Participants were taught to keep head, back, and shoulders against the \nseat, relax all unrelated muscles, and breathe out slowly during arm extension. Breathing \nin occurred during eccentric motion, as the hands returned to nearly chest level. \nRepetitions continued until volitional fatigue. Resistance weight was increased after 15 \n \n \n159\n\n \nrepetitions were performed with good form. A few of the subjects did not fit the Nautilus \nChest Press machine, and performed a bench press on a nearby Universal machine. \n2. Leg Extension – Initial fitting consisted of determining whether a spacer was needed to \nmove the knee closer to the axis of rotation of the leg extension machine. Use of a \nspacer was recorded on the data sheet and maintained throughout the intervention. \nParticipants were taught to maintain proper posture, breathing, and repetition rate as they \nhad learned previously. Some seniors with kyphotic spinal columns had difficulty resting \ntheir heads against the straight seat back. A “neutral” head position was allowed as long \nas movement (especially neck flexing) did not occur concurrent to repetition motion, and \na few seniors brought a rolled towel to support their necks in this position during exercise. \nSome seniors experienced knee pain with open circuit leg extension, and substituted leg \nextensions for leg press on a nearby Universal machine. \n3. Shoulder Raise – Initial fitting consisted of adjusting the seat height so that the axis of \nrotation of the machine arms aligned with the shoulder axes. Seat height was recorded \nand maintained throughout the intervention. Participants were taught to keep the entire \nback and head against the seat back or in a neutral position while raising the elbows to \nshoulder height. Technique on this machine was difficult for some, and special attention \nwas drawn toward only using elbows, not wrists or hand grips, to accomplish the \nexercise. Performing the proper breathing seemed counter-intuitive for most, and had to \nbe coached well into the intervention. A few women were unable to perform this exercise \nwith no weight added, and were taught to use 1 or 2lb dumbbells while performing a \nlateral arm raise until they could progress to the machine. \n4. Leg Flexion – No fitting was required on this machine. While lying prone on the bench, \nparticipants were taught to curl their heels against the resistance of the machine for as \ngreat a range of motion as possible. Participants learned to keep hips pressed into the \nbench to avoid any lower back extension, to breathe properly, and to watch the weight \nrack for feedback on their range of motion. \n \n \n160\n\n \n5. Superpullover/Lat pulldown – Initial fitting on the superpullover machine entailed setting \nthe seat height so that the axis of rotation of the arm bar was aligned with the shoulder \njoint. Seat height was recorded and used throughout intervention. Participants were \ntaught to keep head and back straight against the seat and to not allow back or neck \nflexion during arm motion. Repetition rate and proper breathing were reinforced. Those \nwho were uncomfortable using this machine (usually those with smaller frames) opted for \na lat pulldown from a kneeling position at a nearby Universal machine. For the lat \npulldown, participants were encouraged to lean back slightly and maintain back posture \nwhile pulling the hanging bar to just below their chins, performing a motion similar to a \nchin-up, with elbows out. \n6. Triceps Extension – Seat adjustment was made and maintained so that when the elbow \nrested on the machine’s elbow pad, it was equal to shoulder height. Participants were \ninstructed to position hands in a “karate chop” position so as not to bend the wrist, and \nextend the arm in a slow-motion “chop” while breathing out. Repetition rate, breathing, \nand eliminating head movement were all reinforced. \n7. Arm curls – Using one of our dumbbell weights, participants stood squarely, held the \nweight in one hand to the side, and then curled the weight upward toward the shoulder. \nParticipants were taught to minimize body (shoulder or back) movement, to maintain the \nposition of the upper arm, and to breathe out slowly during the concentric contraction. \nWhen a few men exceeded 20 repetitions on each arm with our heaviest dumbbells \n(25lbs), they opted for a Nautilus “preacher curl” machine to increase resistance. \n8. Abdominal Crunches – On floor mats, participants performed one set of abdominal \ncrunches to fatigue, adjusting the difficulty throughout the intervention by arm or leg \npositioning. Instruction was given and reinforced to minimize neck flexion. Proper \nbreathing was emphasized. \n9. Pushups – Participants performed one set of pushups to fatigue, adjusting the difficulty \nby placing the hands on a wall, a tabletop or bench, or the floor. Emphasis was placed \non flexing the core to maintain a rigid body, completing nearly 90 degrees of motion at \n \n \n161\n\n \nthe elbow, and breathing properly throughout. Many of the men and some of the women \nprogressed to floor pushups before completion of the study. \n \n The participants were encouraged, but not required, to stretch as a method for cooling \ndown after their resistance exercises. All weights and repetitions were documented in the \nresistance exercise session record (section 7.1.13., Appendix 26). The seniors were encouraged \nto become self-sufficient in setting the seat heights and machines according to the specifications \non their data sheets, but often received help with these tasks by the exercise monitor. Wherever \npossible, the exercise monitor provided encouragement to the seniors to push themselves to \nfatigue/failure while maintaining proper form on each exercise. \n Similar to the aerobic exercisers, the ability to comply to exercise guidelines (to push to \nfatigue in weight lifting, for example) was variable between subjects. Because volitional fatigue is \na subjective endpoint that often incorporates psychological barriers, the exercise monitors often \nneeded to provide daily support and encouragement to some, whereas others were self-\nmotivated. Our goal was for the resistance exercisers to perform repetitions to failure, so the \nexercise monitors tailored their interaction with the exercisers as needed to attain the desired \noutcome. \n \n7.1.10 Data Management \n When I began this project, I could see immediately that the sheer volume of data \ncollected would be unwieldy and difficult to manage in multiple Excel spreadsheets, as had been \ndone in previous trials in our laboratory. This trial also contained more than double the \nparticipants of any other trial previously conducted, and thus required a new data management \nstrategy. Truly, a study of this magnitude should have had a dedicated data manager, ideally not \nthe project coordinator, principal investigator, statistical analyst, or the managing graduate \nstudent, whose vested interest in the study outcomes could be a source of bias to the end results. \nHowever, since we were on a limited budget and since this was a project intended to provide \ngraduate students (and in particular, me) with hands-on experience while attending an \n \n \n162\n\n \neducational institution, I essentially took the role of data manager. With some pointers from a few \nexperienced database users around campus, like Celine Zakos and Bill Pierce, I began designing \na Senior Study database in Microsoft Access with the intent to incorporate data from the \nnumerous Excel spreadsheets, DEXA output, and hand-entered variables I was accumulating. \n One of my first steps in database management was to create a unique subject number \nfor each participant, as described in Randomization: section 7.1.7. My purpose in selecting a \nsubject number instead of a name was to be able to remove proper names entirely from any data \nanalysis: for participant confidentiality and for ease in managing the data coming in from all \nsources. I also needed to assign a unique number, instead of proper names or the subject \nnumber, for pre and post imaging and all other clamp or freezer samples that would be sent out of \nour laboratory or for which easy identification of the participant might influence analysis. We \ndecided that two testing ID numbers would be assigned each participant: one for pre testing, and \none for post. This would facilitate blinded analysis of freezer samples and MRI or CT images. \nOnly for data entry would these numbers be associated with a name, and then only as verification \nthat data was being entered for the appropriate subject. \n With these numbering systems in place, I created data tables for the various hand-\nentered data and linked them by subject number to the data from Excel spreadsheets and other \ndatabase forms I imported into the Access database. This allowed me to create Access queries \nwhich would call up any variable I needed from all of the linked databases for any or all \nparticipants. I also learned how to program my statistical package (SAS 9.1) to tap right into an \nAccess query so that I wouldn’t have to import data every time I wanted to investigate \nrelationships or run statistics. I created forms in Word and WordPerfect for results packages, \npulling data directly out of the Access database to present exercise-induced changes in readable \nformat for graduated participants. \n Hand-entering data is often a source of error in studies. For all hand-entered data, I \ncreated a system of routine checks that were completed before ever using the values for \nanalytical purposes. On my desk, I had a basket for hard copies of datasheets to be entered. \nUsing forms I created in Access, I called up the appropriate data entry form, linked to a subform \n \n \n163\n\n \nthat allowed me to scroll through subject names and all associated ID numbers, forcing me to \nverify that the data was being entered for the proper participant. I established data parameters \non some of the important entries so that I would be notified if a possibly “incorrect” value had \nbeen entered. After each form had been filled, I checked the hard copy against what I had typed \nto check for errors. When I had entered the data from each hard copy, it was placed in a binder \nspecific to testing (Anthropometrics, VO2max, Functional Fitness, Questionnaires, Medical Forms, \netc), which contained all of the current participants’ data. These binders were stored on a \nbookshelf in my office, allowing me easy access to data from participants currently in the \nintervention phase. When a subject was completed, I removed the data for that participant from \neach of the binders, and, with another person (usually one of the exercise monitors), rechecked \nall of the hand-entered values before filing the hard copies away in the Senior Study filing cabinet. \nI created the Access data entry forms in a manner that allowed me to see pre, mid and post \nvalues along the same visual line while inspecting the data -- as one another method of data \nchecking. I re-investigated all obviously non-physiological changes I observed. After these \nroutine checks, I created the results packages for the seniors and their physicians (see the \nfollowing section), a process that occasionally brought to light abnormal values because of their \npresentation in a comparative format. The final check of hand-entered values was when all data \nhad been compiled, and statistics could be run on data normality to detect any outliers. \n Data compiled during imaging analysis often requires calculations and manipulations that \nare most easily accomplished in Microsoft Excel. I managed all of the MRI data from a single \nExcel workbook, which was formatted such that each pre or post MRI was indexed by test ID \nnumber. A summary spreadsheet created the final database, linking important calculated tissue \ntotals from the appropriate pre and post tests, and was imported into Access by subject ID \nnumber. The CT data were also compiled similarly. I had graduate students check formulas and \nperform random checks from as many angles as possible to ensure the integrity of the imaging \ndata. \n Electronic backup was performed routinely throughout the duration of the study, and \nstored on a hard drive of a computer that could only be accessed by the principal investigator or \n \n \n164\n\n \nour laboratory’s computer manager. I also periodically burned the data onto DVDs and kept them \nin a data storage binder in the Senior Study file cabinet. I stored extra copies of these backup \nDVDs at my residence, away from the Queen’s laboratory. \n \n7.1.11 Results Packages \n Upon completion of their post testing schedule, participants were told that they would be \nreceiving a results package (sometimes called a feedback package) by mail that contained some \nof the important results and interpretation of personal health improvements induced by exercise \nas measured by the study outcomes. Because it was easier to create these packages in groups \ninstead of one at a time, I often did a batch of them every 3-4 months instead of giving them out \nimmediately. \n Early on, I put together a form that included some of the key health-related variables from \nthe study, some explanation about desirable ranges, and encouragement to stay active. I did not \ninclude variables that required substantial analysis or would hold up the turnaround time on the \nfeedback packages, like MRI and CT. I instead emphasized measures with a direct health or \nclinical message, like waist circumference, cardiorespiratory fitness, insulin resistance, and \nfunctional fitness. I included the original DEXA output forms from KGH, made a copy for the \nparticipant’s physician, and kept a copy for the participant’s laboratory file. For most of the study \nparticipants, I provided a CD that contained their whole body MRI images. The study \ncoordinator/nutritionist helped me by including some nutritional and health pamphlets, and we put \ntogether a nice congratulatory paper, printed on nice paper that could be framed, acknowledging \nthe efforts of each participant. We prefaced this package with a letter expressing gratitude to the \nparticipant for his/her involvement in the study. An example of a results package including a \nletter, summary of results, DEXA form, and congratulatory paper are found in section 7.1.13., \nAppendix 27. The physician was sent a copy of the summary of results and DEXA forms along \nwith a preface letter encouraging referrals to the study. Examples of the four types of letters, \nspecific to each intervention group, are found in section 7.1.13., Appendix 28. \n \n \n \n165\n\n \n \n7.1.12. Statistical Analyses \n In randomized controlled trials, intervention-induced changes are compared against the \nchanges (or lack of changes) observed in a control group. An efficacy trial investigates the effect \nof one intervention versus another, investigating the specific benefits achieved when a protocol or \ntreatment is strictly adhered to. In contrast, an effectiveness trial investigates how well an \nintervention is adhered to when it is given as a recommendation, and the ability to comply with \nthat recommendation is measured. The Senior Study is designed as an efficacy trial, \ninvestigating the health benefits derived from strict adherence to different exercise modalities \nover a six month period. Under ideal circumstances, randomly assigned groups are produced \nwhich do not differ in any baseline variable, and treatment-induced changes are then compared \nbetween groups, within which all subjects will have adhered completely to their respective \nprotocols. Ideal circumstances happen in theory and in non-human laboratory studies; in reality, \ndeaths in families, work-related moves, technical errors in testing procedures, and even subjects’ \nloss of interest thwart the model efficacy study. Some researchers choose to disregard subjects \nwho do not comply with the protocol or cannot finish, which is arguably in-keeping with an efficacy \ndesign. Increasingly, however, an “intent-to-treat” analysis is now viewed as a desirable method \nof dealing with missing values in these cases. Under an intent-to-treat analysis, all subjects who \nwere initially randomized into a group are still considered, either using a “last observation carried \nforward” procedure, or some other means of estimating missing values, assuming those values \nare missing at random. The dropout rate in the Senior Study was approximately 20%; those who \ndropped out were not found to be characterized differently than those who completed the study, \nand were considered “missing at random.” Thus, we chose a multiple imputations procedure that \nestimated the missing values randomly, based on the multivariate normal distribution of the data \nwithin each gender-specific intervention group. Analysis of variance (ANOVA) was used to \ndetermine differences between means of the treatment groups at baseline. Treatment-related \nchanges in outcomes were adjusted for baseline values in an analysis of covariance (ANCOVA). \nThe ANCOVA model was extended to include gender and treatment-by-gender interaction to \n \n \n166\n\n \ndetermine whether the effects of treatment varied by gender. Tukey post hoc tests with \nadjustment for multiple comparisons were performed to determine the differences between \ninterventions. P values of <0.05 were considered significant. All analyses were performed using \nSAS software, version 9.1 (SAS Institute, Cary, NC). \n Performing the multiple imputation procedure was a work that took nearly a year to \nperfect and accomplish. Dr. Miu Lam, a biostatistician at Queen’s University, helped me \nunderstand and perform the procedure, and wrote code for the more difficult portions of the \nanalysis. Section 7.1.13., Appendix 29 contains a sample of the SAS code used to perform the \nmultiple imputations modeling on changes in body weight, with variable names of “wk1wt,” \n“wk24wt,” and “Wtc,” to describe the mean body weight in kilograms obtained during the first and \nlast weeks and the difference between those two means, respectively. Section 7.1.13., Appendix \n30 contains the multiple imputations output for changes in body weight, including an example of \nthe missing data patterning analysis in the RE women, an example of one of the 10 imputation \noutputs, and the summary of the 10 multiple imputations with post hoc analyses using both \nBonferroni and Tukey methods to determine significance between the groups. The control, \nresistance only, aerobic only, and combined resistance and aerobic groups were coded as 0,1,2, \nand 3, respectively. \n \n \n167\n\n \n \n \n \n \n \n \n \n \n \n7.1.13. Procedural Appendices \n \n \n168\n\n \n \n \n \n \n \n \n \n \n \nAppendix 1: Newspaper Advertisements \n \n \n169\n\n \n \n \n \n Exercise Study for Senior Men & Women \n \nResearchers at Queen's University are looking \nfor overweight, inactive men and women, 60-80 \nyears old, to volunteer for an exercise study \nlooking at the effects of aging, body fat and \nphysical activity on risk factors for heart disease \nand diabetes. \n \nIf you are interested in participating or would like \nmore information, please contact Ann-Marie \nKungl at (613) 533-6000 Ext. 75118. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nExercise Study for Senior Men & Women \n \nResearchers at Queen’s University are looking for Men and Women between the ages of 60-80 \nyears old who are not exercising regularly to volunteer for an exercise study. \nHere are some comments from our participants: \n \n \n \n \n \n “This program offers an “It’s the best way to learn about “I am most grateful to \nthese \n enjoyable environment to nutrition and exercise… to ma ke wonderful people for the \n help me achieve physical your senior life healthier” opportunity to improve \n wellbeing and healthy eating” my fitness and health” \n \nIf you are interested in participating please call Shelley Atkinson at 533-6000 Ext. 75118 \n \n \n \n \n170\n\n \n \nExercise Study for Senior Men & Women \n \nResearchers at Queen’s University are looking for Men and Women between the ages of 60-80 \nyears old who are not exercising regularly, to volunteer for an exercise study. \n \nHere are some comments from our participants: \n \n \n \n \n \n \n“The participants benefit… “As an arthritis sufferer I feel “The one-on-one supervision \n Exercise research benefits… so much better after joining has helped to keep me \n The staff is very encouraging. the program. My quality of motivated. I feel great!” \n What more could you want?” life has greatly improved.” \n \n \n \n \n environment has helped me to stay \n committed to my exercise program.” \n \n \nIf you are interested in participating please call Shelley Atkinson at 533-6000 Ext. 75118 \nCall now; limited space available. \n \n “The pleasant and encouraging \n \n \n171\n\n \nExercise Study for Senior Men & Women \n \nResearchers at Queen’s University are looking for Men and Women between the ages of 60-80 \nyears old who are not exercising regularly to volunteer for an exercise study. \n \nHere are some comments from our participants: \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nIf you are interested in participating, please call Amanda McDougall at 533-6000 ext 75118. \nLast chance! Call now. \n \n \n \n \n“I love the atmosphere… \nWhat a great way to get \nin shape!” \n \n \n“I couldn’t ask for a \nbetter program to keep \nme motivated.” \n \n \n“The staff is very helpful \nand encouraging.” \n \n \n“The pleasant and \nencouraging atmosphere \nhas helped me to stay \ncommitted to my \nexercise program.” \n \n \n“This program has \nhelped me to improve \nmy diet, health, and \nfitness. I recommend it!” \n \n“The participants benefit… \nExercise research benefits… \nThe staff is very encouraging. \nWhat more could you want?” \n \n \n“As an arthritis sufferer I feel \nso much better after joining \nthe program. My quality of life \nhas greatly improved.” \n \n \n“The one-on-one supervision \nhas helped to keep me \nmotivated. I feel great!” \n \n \n172\n\n \n \n \n \n \n \n \n \n \n \nAppendix 2: Promotional Articles Written by Senior Participants \n \n \n173\n\n \nGO FOR IT \n \n I saw an ad in the Whig-Standard last spring: \"Exercise Study for Senior Men & Women.\" \nResearchers at Queens University were looking for overweight, inactive men and women \nbetween the ages of 60-80 as volunteers. The purpose of the study was to look at the effects of \naging, body fat and physical activity on risk factors for heart disease and diabetes. \n At that time, I was just turning 60 and I fit the criteria. I gave them a call, then met with the \nresearchers at the School of Physical and Health Education at Queen’s University. They were \nvery friendly and gave me extensive information about the study. \n At the beginning and end of the program, all participants go through very important tests \nat Kingston General and Hotel Dieu hospitals. These ‘before’ and ‘after’ tests give researchers \nand you incredibly valuable information about your body and health. \n During the study you are always under the supervision of nutritionists, doctors and grad \nstudents. You meet many fellow volunteers and the environment is really fun. \n I completed my program last January. Those seven months were one of the best \ninvestments I have ever made for my health. Also, knowing that you are contributing to a very \nimportant study is a great feeling. \n I strongly encourage everyone to volunteer for this study. Call Ann-Marie Kungl at (613) \n533 6000, ext.75118 today. You will thank me later… \n \nBora HINCER \n \n \nPublished in Kingston This Week, 2003 \n \n \n \n \n174\n\n \nI have recently completed my participation in an exercise study at Queen's designed especially \nfor those of us who are over 60 and perhaps somewhat overweight, and I'd like to tell you about \nmy experiences during the six months that I was enjoying the program. Yes, enjoying ... after my \ninitial discoveries of how far and fast I could walk and how strong I wasn't, I was very pleasantly \nsurprised at how quickly my strength, my endurance, and my general energy level improved. I \nwas constantly encouraged by all the friendly Team members to push myself a little further, and I \nrealized that I was constantly exceeding what I had previously thought were my limits. Usually I \nexercised in the company of other participants, and lots of lively discussions occurred between \nthe huffing and panting, and some good friendships were made. \n \nNo specific diets are involved during the study, and you continue to eat and drink as you would \nnormally, though gentle suggestions for improving one or other aspects of your intake are made \nwhen necessary. Despite increasing my strength and joie de vivre, I managed to lose some \nweight and could pull my belt in a couple of notches by the end of the program, though weight \nloss is not its primary purpose. The timing of one's exercise is very flexible, to allow for the work \nschedule of those like myself who are still working, and to fit in with the schedules of some busy \nretirees. \n \nI had a lot of fun during the study and found it extremely interesting, providing me as it did with a \nlot of information about the general status of my health and metabolism (my glucose metabolism \nhad improved by a reassuring 47% by the time I completed the program, for example). I'd like to \nrecommend this study to any of you who are interested in improving your level of fitness and \nstrength, and perhaps losing a little weight. If you enter, I can assure you that you'll learn a lot \nabout yourself, and that you'll feel a lot better as a result. The challenge now is to keep \nexercising on a regular basis! \n \nPeter Froud, FFR, FRCPC \n \nFor more information on this Exercise Study for Seniors, call 533-6000 ext 75118. \n \n \nPublished online at RAQ – Retirees Association of Queen’s, 2004 \n \n \n175\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nAppendix 3: Study Poster \n \n \n \n176\n\n \n \n \n \n177\n\n \n \n \n \n \n \n \n \n \n \nAppendix 4: Promotional Article by Pat Galasso \n \n \n \n178\n\n \nA Question of Good Health \nFrom Levity to Longevity \n \nBy Pat Galasso \n \nThose of us who attended the presentation by Dr. Bob Ross, Ph.D., Professor of Physical and \nHealth education at Queen’s, and cross-appointed in the Department of Medicine (Division of \nEndocrinology and Metabolism), were both entertained and educated. We are beholden to the \nvolunteers who run the Learn and Linger program for scheduling this important presentation on \nWednesday, January 21. The room was packed. \n With humour and conviction, Dr. Ross portrayed a picture of our age group. The majority \nof us, it seems, are exercising less, or are simply less active, and are adding to our fat while \nlosing muscle mass. He also pointed out that there has been a substantial increase in \ndegenerative disease in our age group. \n In a review of the literature on overweight and obesity, Dr. Ross cited a study of \nthousands of subjects in Denmark which showed that waist circumference was a strong, \nindependent predictor of disease and death. Simply wrapping a tape measure around our waists \n(level with the top of our hip bones) can be much more informative than stepping onto a bathroom \nscale! Having a waist circumference of greater than 88 and 102 centimeters for women and men, \nrespectively, is considered obese and can dramatically increase our chances of contracting \ndegenerative disease and/or dying prematurely. The message to seniors is quite clear. Based \non the evidence, and our position on the lean to obese scale, we would be wise to play the odds \nand do something now to diminish our middles. \n Dr. Ross also showed cross-sections of MRI slides of the thigh of a 25-year-old and a \nsenior. In the younger person, the muscles were a solid shade of colour indicating solid muscle, \nwhereas with the senior, the muscles were highly marbled with fat. This means that obese \npeople don’t just carry their fat subcutaneously, but that fat is distributed throughout their bodies \nwithin the muscles and surrounding their organs. \n As founding Dean of Human Kinetics at the University of Windsor, now retired, it was my \nrole to evaluate faculty performance. I can state unequivocally that the applied nature and superb \nquality of Dr. Ross’ work has always appealed to me. Through this he is attempting to benefit \nsociety in general. \n In order to address the impact of obesity and how to deal with it, Dr. Ross has acquired \nmajor grants, along with his colleagues, and with the help of grad students, he is attempting to \ndetermine the best way to reduce waist circumference measures, and by implication to improve \nhealth and increase longevity. \n To succeed, this major research project requires subjects. You could not learn more \nabout your health indicators than to be involved in this study. Tell your friends about it, and \nplease call 533-6000 #75118, and speak to Ann-Marie. \n \n \nText published in Vista, March 2004 \n \n \n179\n\n \n \n \n \n \n \n \n \n \n \nAppendix 5: PowerPoint Presentation Used for Orientation Meetings \n \n \n180\n\n \n \n \n \n \n \n \n \n \n \n \n181\n\n \n \n \n \n \n \n \n \n \n \n \n182\n\n \n \n \n \n \n \n \n \n \n \n \n183\n\n \n \n \n \n \n \n \n \n \n \n184\n\n \n \n \n \n \n \n \n \n185\n\n \n \n \n \n \n \n \n \n \n \nAppendix on Sheet 6: Orientation Meeting Informati\n \n \n186\n\n \n \n \n187\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \nAppendix 7: Informed Consent \n \n \n188\n\n \n \n \nITLE: Prevention and treatment of abdominal obesity and related \ninsul \n \nRINCIPAL INVESTIGATOR: \n \n/ \ne, Division of Endocrinology and \nMetabolism \nKingston, Ontario, K7L 3N6 \n533-6583 \n \nobert Hudson, M.D., Ph.D., FRCPC \nio, K7L 3N6 \n33-2973 \n \n \n \n \n \n \n CONSENT TO VOLUNTEER FOR PARTICIPATION IN A STUDY\n \n \n \nT\nin resistance in elderly men and women\n \nP\nRobert M.J. Ross, Ph.D. \nQueen’s University \nSchool of Physical and Health Education\nMedicin\n \nCO-INVESTIGATORS: \n \nChris Boesch, M.D., Ph.D. \nUniversity of Berne \nSwitzerland \n \nR\nKingston General Hospital \nMedicine, Division of Endocrinology and Metabolism \nKingston, Ontar\n5\n \n \n189\n\n \n You are invited to participate in a research study on the influence of \naging and exercise on abdominal fat and insulin resistance. The follow\nbrief is intended to provide you with the details you should be aware of prior \nto your consent as a part\ning \nicipant in this study. Please read the following \nformation carefully and feel free to ask any question that you may have. \nhe increase in fat in the abdominal region is at \nast in part responsible for the increased insulin resistance. A reduction in \ns \n \n resistance, we \nlso know that muscle fat content is increased in individuals who exercise on \n, \n \nme \nle \nng \n resistance is unknown. This is especially true for \nolder persons. \nin\n \nBACKGROUND INFORMATION \n \nMany elderly people have problems keeping their blood glucose \n(sugar) levels normal, a condition referred to as “insulin resistance” by \nscientists and medical doctors. Although the reasons associating aging with \ninsulin resistance are unclear, t\nle\nphysical activity with aging may also contribute to an increase in insulin \nresistance. \nRecent studies have shown a relationship between muscle lipid (fat) \ncontent and insulin resistance in young healthy individuals and persons with \ndiabetes. This is important as the amount of fat within the muscle increase\nwith aging. Thus, muscle fat may partially explain why insulin resistance\nincreases with age. However, at this time it is unknown whether or not \nmuscle fat content is related to insulin resistance with aging. \nAlthough muscle fat content is associated with insulin\na\na regular basis. This is important because individuals who exercise on a \nregular basis are very insulin sensitive (opposite to insulin resistance). Thus\nit appears that an increase in muscle fat content does not always suggest a \nperson will become insulin resistant. An important question to ask then is\nwhether the muscle fat in insulin resistant (e.g., sedentary elderly) and \ninsulin sensitive (e.g., physically active elderly) individuals follows the sa\npattern. We will also be looking at whether the normal insulin sensitivity \nseen in physically active elderly persons is due to changes in skeletal musc\nfat content. \nExercise is thought to be a good thing to do for reducing both \nabdominal fat and insulin resistance. However, whether aerobic (e.g., \nwalking) or resistance-type exercise (e.g., weight lifting) is best for reduci\neither is unknown. Further, whether the two forms of exercise combined \n(aerobic and resistance exercise) is better than either one alone for reducing \nabdominal fat and insulin\n \n \n190\n\n \nTherefore, you are invited to participate in a study to assess the \nlationships between exercise, abdominal fat, muscle fat, and insulin \nresista\n \nDURES \n in \n \nin \nf the \nontrol Group: For the entire study the men and women in this group will \nss or exercise. \np \nre\nnce. We hope that the results of this study will provide a better \nunderstanding of the reasons for the age-related increase in insulin \nresistance. In addition, we hope to determine whether regular exercise, and \nmore importantly what type of exercise, can prevent the insulin resistance\ncommon to the aging process. As insulin resistance is a major predictor of \ndiabetes and cardiovascular disease, these results may have important \nimplications for developing ways to prevent and treat diabetes and \ncardiovascular disease in elderly persons. \n \nEXPLANATION OF PROCE\n \nPre-participation screening \n \nYou will be required to have a medical exam prior to participation\nthis study. The examination will be performed by your family physician. In \naddition to the medical examination, you will have a fasting blood test to \nmeasure your blood sugar levels. This procedure is explained in further \ndetail on page seven (7) of this form. \n \nStudy Protocol \n \nThe study will be approximately 7 months in duration. The exercise\npart of the study will last 6 months. The 6-month exercise period will be \npreceded by a 3-4 week weight maintenance period -- thus the duration of \nthe study will be about 7 months in total. By volunteering to participate \nthis study, your name will be selected by chance and placed into one o\nfollowing four groups: (1) Control - no exercise, (2) Aerobic (walking) \nexercise, (3) Resistance (weights) exercise, (4) Aerobic and Resistance \nexercise. \n \nC\nconsume a diet that will maintain bodyweight. Thus there will be no weight \nlo\n \nAerobic Exercise Group: As a participant in the aerobic exercise grou\nyou will be asked to perform walking type exercise on a motorized treadmill \nfor 30 minutes, 5 times per week, at about 65% of your cardiovascular \nfitness level (e.g., brisk walking) for the duration of the 6 month treatment \n \n \n191\n\n \nperiod. During each exercise session we will measure your heart rate ev\n5 minutes using an automated heart rate monitor. All of your exercise \nsessions will be by appointment and performed under supervision within our \nlaboratory\nery \n at Queen’s. \nResist oup you will be \nsked to perform a series of 10 exercises, 3 times per week, for the duration \nof the\n. \n \n you will perform an exercise regimen that combines resistance \nnd aerobic exercise. The resistance exercise program will be the same as \nthat de dition, the aerobic \nxercise will be performed at the same intensity as the aerobic only group \n(~65%\naerobic \nise \n A \nill explain to you the role of nutrition in this study. A session \nill take place at the beginning of the study, with several additional sessions \nplanned throughout to help you follow the dietary plan. If someone else \nshops for your food or prepares your meals, or if you share those tasks with \nsomeo\nn of \ne study we will ask you to maintain this caloric \nintake. In other words, eat an amount of food that would normally maintain \nyour b perience will be the result of \nn increase in exercise. \n \nance Exercise Group: As a participant in this gr\na\n 6 month treatment period. Eight of the exercises will be performed \nusing Nautilus strength training equipment and 2 using your own body \nweight (e.g., sit-ups). All resistance exercise sessions will be supervised by \na qualified undergraduate or graduate level student and performed within Dr\nRoss’ laboratory at Queen’s. \n \nAerobic and Resistance Exercise Program Combined: As a participant in\nthis group,\na\nscribed for the resistance exercise only group. In ad\ne\n of your cardiovascular fitness for 30 minutes), but is reduced to 3 \ndays of the week. Most exercisers should be able to perform both an \nand a resistance session in a single laboratory visit, so the total (6) exerc\nsessions can be performed on 3 days per week at Queen’s. \n \nNutrition: All study participants will follow a similar dietary pattern.\nnutritionist w\nw\nne else, that person is invited to meet with the nutritionist as well. \nYou will be required to record the food you eat each day for the duratio\nthe study. All of your meetings with the nutritionist will be in Dr. Ross’s \nlaboratory within the Physical Education building at Queen’s. \nAt the beginning of the study, using the diet records that you \ncomplete, the number of calories required to maintain your body weight will \nbe determined. During th\nody weight. Thus any weight loss you ex\na\n \n \n \n \n192\n\n \nMagnetic Resonance Imaging \n \nMagnetic resonance imaging (MRI) is a method for imaging or \ncreatin\n of \nr and \nnt \ned MRI questionnaire to determine if there is any \nreason why you should not have the MRI exam. \n \nAs mentioned, the MRI procedure is very similar to a scanner \nexami e \n or have questions, you can be removed from \ne machine if necessary. The whole procedure takes about 35 minutes and \nwill be\n \nMagnetic Resonance Spectroscopy \n \nt \n \n omputerized tomography or CT is another method that will be used \nto obta\no \ng pictures of body structures or organs. MRI gives images in slices \ncomparable to those produced by x-ray tomography (e.g., CT scan). One\nthe primary advantages of MRI is that it does not employ x-rays or other \nforms of radiation. Instead, a large magnet, a radio transmitter/receive\na computer are used to gather chemical information from the body, and to \nproduce images or pictures of internal anatomy. No harmful effects have \nbeen associated with MRI under existing conditions of use. It is importa\nthat you fill out the enclos\nnation. You will be placed on a table and moved smoothly into th\nscanner. A loud-speaker within the magnet makes it possible for you to \nkeep in constant contact with the staff. At all times the operator can see and \nhear you and if you need help\nth\n performed by appointment at Kingston General Hospital. \nMagnetic resonance spectroscopy (MRS) works the same way that \nMRI does. You will be positioned in the magnet as in the MRI test. The \ndifference is that MRS does not provide pictures of the body. Instead, the \nradio signal emitted from the body is used to provide information abou\nwhere the fat is positioned within your muscle. In other words, MRI \nprovides pictures of muscle and fat, which tell us about the quantity of \nmuscle and fat. Information obtained using MRS tells us something about \nthe quality of muscle. As with MRI, the MRS procedure will be performed \nat Kingston General Hospital and will take about 30 minutes to complete. \n \n Computerized Tomography (CT) \n \nC\nin information about the quality of your muscle and your liver. \nUnlike MRI, CT provides pictures of the muscle and liver that can be used t\ndetermine the amount of fat in your liver and muscle. Specifically, two CT \nimages of your mid-thigh will be obtained to measure the amount of fat in \n \n \n193\n\n \nthe muscle; one CT image of the liver will be obtained to determine the \namount of fat in the liver. You will be asked to lie on an exam table while \nthe CT scan is being performed. The entire CT procedure will take about 10 \nminutes. \n \nDual Energy X-Ray Absorptiometry (DEXA) \n \nle. \nyou \n still for approximately 10 minutes. The \ndiation exposure involved with this test is approximately equivalent to one \nappointment \nnd be performed within the Department of Radiology at Kingston General \nHospi\nus sites on \n \nn’s \nis is a very simple and safe procedure requiring no more than 5 \ninutes to complete. While you lie on your back, 2 electrodes will be \nlaced ur right hand and foot. Two of the electrodes will \ntroduce an alternating current that you can’t feel into the body, while the \nother 2\nbe obtained at \ne Hotel Dieu Hospital. \nFitness \n \ntreadm h \nDEXA measures whole body fat, bone quality, and skeletal musc\nFor this test you lie on your back on a table. The scanner moves above \nmeasuring the transmission of X-rays from a source under the table. During \nthis procedure you are asked to lie\nra\npercent of a chest X-ray. This measurement will take place by \na\ntal. \n \nAnthropometry (Skinfolds and Circumferences) \n \nMany circumference measurements will be taken at numero\nyour body. These measures can be used to derive estimates of body \ncomposition. In addition, through the use of skinfold calipers, skinfold \nthickness will be measured at 8 different sites on your body. The\nanthropometric measurements require about one hour to complete and will \nbe obtained at the School of Physical and Health Education, Quee\nUniversity. \n \nBioelectrical Impedance \n \nTh\nm\np on the surface of yo\nin\n record the resistance. The results are used to determine body \ncomposition. The bioelectrical impedance measurements will \nth\n \nAssessment of Cardiovascular \nWe will measure your cardiovascular fitness (endurance) using a \nill procedure. The test will begin at a level you can easily accomplis\n \n \n194\n\n \nand w\nmay s he \ntest because of personal feelings of fatigue or discomfort. \nhe treadmill test involves risks comparable to any strenuous exercise \nsitu e, \nfaintin l be \nmade \nobserv\nin the \nonce a e \nxercise training period. \n \nweeks\nefined as the maximal resistance that could be moved through the full range \nof \n \nid (fat) \ntests) \n \ne \ndone a \nsugar \nOral G \nfast. Y\novernight fast (no eating after 7pm the night before). The first step of this \ntest will involve a venipuncture with a needle and the removal of about 30 \nml s \nproced n \nadditio\n(like a \nsugar \narm fo\nafter having not exercised on the prior 3 days. This procedure will also be \nerformed at Hotel Dieu Hospital. Having arrived at the hospital you will be \nask ) will \nill be advanced in stages, depending on your capacity to do so. We \ntop the test at any time because of signs of fatigue or you may stop t\nT\nation. They include very rare instances of abnormal blood pressur\ng, disorders of the heartbeat, and heart attack. Every effort wil\nto minimize your risk by preliminary medical examination and \nation during the test. A graduate student will conduct your fitness test \npresence of a physician. You will perform the exercise test 3 times: \nt the beginning, once after one month, and once at the end of th\ne\n \nAssessment of Muscular Strength \nImprovement in muscular strength will be assessed before and at \n 8, 16 and 24 using a 3-repetition maximum (3RM) test. The 3RM is \nd\nmotion for 3 repetitions. \nLaboratory measurements (blood glucose (sugar) and lip\nThe measurement of how much sugar and fat are in your blood will b\nt Hotel Dieu Hospital. To determine your ability to manage blood\nyou will be asked to perform two (2) separate tests. The first test, an \nlucose Tolerance Test or OGTT, will be performed after an overnight\nou will be asked to arrive at the hospital at about 8am after an \n (3 tablespoons) of blood from a vein in your arm. The only risk from thi\nure is possible local pain and bruising at the time of the blood test. I\nn, you will be asked to drink a fluid that contains 75 grams of sugar \nn orange drink). At 30-minute intervals for 2 hours after drinking the\nsolution, a small amount of blood will be taken from a vein in your \nr the purpose of measuring the amount of sugar in the blood. \n \nThe second test will also be performed after an overnight fast, and, \np\ned to lie comfortably on a bed for about 4 hours. Catheters (needles\n \n \n195\n\n \nbe pla\ncathet\nrate de y 5-10 \ninutes during this procedure a small amount of blood will be taken from a \nvein in \nain \nuld \nointments and Time Requirements \nat \nent \nitals: one 21/2-hour \nappoin l); one 6-\n \nl); \nieu Hospital); and one 15-minute \nappoin\ns will be scheduled at a time that is convenient for you. Further, \neach of these tests (excepting the oral glucose tolerance test) will be \nperformed twice, once at the beginning and once at the end of the treatment \nperiod. \n \n Risks and Benefits \n \nYou will gain no direct benefit through participation in this study. \nParticipation may involve some risks. The known risks are: \n \n1) Insertion of a catheter in your arm or hand vein may cause bruising, \nbleeding, soreness or infection. \n \n2) Computerized Tomography (CT). Participation in this research study \nwill involve a small radiation exposure (1.0 RAD or 2.0 RAD) from \nced in a vein on the top of one hand and in a vein in your arm. A \ner in the arm vein will be used to give glucose (sugar) and insulin at a \nsigned to keep your blood sugar level normal for 3 hours. Ever\nm\n your hand to measure blood sugar to ensure that it remains normal. \nA physician will monitor this procedure at all times. \nThe purpose of these tests is to determine your ability to maint\nnormal blood sugar levels (insulin sensitivity). Reduced sensitivity to \ninsulin is a complication of aging and may be associated with diabetes \nmellitus, high blood pressure, and other health problems. These tests sho\nnot have any lasting side effects. \n \n Summary of App\n \nFor the testing you will be required to make a 1-hour appointment \nthe Queen’s University Physical Education Centre to complete the \nanthropometry and functional fitness tests, and another ½-hour appointm\nfor the cardiovascular fitness test. We will arrange five appointments for \nyou at Kingston General and Hotel Dieu Hosp\ntment for the oral glucose tolerance test (Hotel Dieu Hospita\nhour appointment for the bioelectrical impedance, insulin sensitivity, and\nblood lipid/cholesterol tests (Hotel Dieu Hospital); one 1½-hour \nappointment to complete the MRI and MRS (Kingston General Hospita\none 10-minute CT test (Hotel D\ntment for the DEXA test (Kingston General Hospital). All of these \nappointment\n \n \n196\n\n \nthe CT scan to a small region of your thighs and chest (liver). For \ncomparison, a radiation worker is allowed 5 RADS of whole body \n \nts. Thus the DEXA \nexam adds approximately half the daily background radiation. \n \n \nres \n4) MRI or MRS has certain conditions which would exclude you from \nparticipating in this study. These include cardiac pacer, aneurysm \nclip, cochlear implant, intra-uterine device (IUD), shrapnel, \nneurostimulators or other metal devices. Metal objects present in the \nbody could be moved by the large magnet involved in the MRI, and \nbiological effects have been reported from being in a magnet. If you \nexperience a fear of the confined space while in the magnet, you can \nterminate the study. Trained personnel are always in attendance \nduring these studies. \n \nspital in \nwhich your sensitivity to insulin is measured) is the development of \nhypoglycemia (blood sugar which is too low). Because we give you \nglucose (sugar) throughout the test, and, your blood sugar levels are \nmeasured every 5 to 10 minutes, the likelihood of your having a low \nblood sugar is very low. The symptoms of low blood sugar include \nincreased sweating, fast heart rate, feeling shaky and/or hungry. In \nvery rare cases when your blood sugar levels fall to low, seizures or \ndeath may occur. \n \n6) The exercise test may cause muscle soreness or fatigue. In any \nexposure per year. \n \n3) The effective dose (the term used to describe your exposure to \nradiation) that you will receive during the Dual Energy X-ray \nAbsorptiometry (DEXA) exam is approximately 5 microsieverts. The\naverage background radiation that you are exposed to on a daily basis \nis estimated to be approximately 10 microsiever\n For CT and DEXA, there is no known minimum level of radiation \nexposure that is recognized as being totally free of the risk of causing\ngenetic defects or cancer. However, the risk associated with the \namount of radiation exposure you will receive from these procedu\nis considered to be very low and comparable to other everyday risks. \n \nsuch movement could cause serious injury. Fear of closed spaces is \nalso a reason you would be excluded from the study. No serious \n5) The risk of receiving insulin (as in the test at Hotel Dieu Ho\n \n \n197\n\n \nindividual there is a minute risk of a heart attack or death from the \nexercise test. A trained paramedic or medical doctor will be present. \nhis will help to ensure that \nou have not been exposed to a procedure in another study that may \nld \nnderstand that this study is a research study and may not be of direct \nenefit to you. If requested, a report will be generated for your medical \n \nCONFIDENTIALITY \n \nAll information obtained during the course of this study is strictly \nconfidential and your anonymity will be protected at all times. Your \ninformation will be kept in locked files and will be available only to Dr. \nRobert Ross and those working within his laboratory. Your identity will not \nbe revealed in any description or publication. \nIn the event you that you are injured as a result of the study \nprocedures, medical care will be provided to you until resolution of the \nmedical problem. By signing this consent form, you do not waive your legal \nrights nor release the investigator(s) and sponsors from their legal and \nprofessional responsibilities. \nFinancial remuneration will not be provided to you for participation in \nthis study. \n \nIf you develop chest pain the test will be stopped immediately. \n \nYou should inform the investigators if you have participated in any \nother research study during the previous year. T\ny\ninfluence your ability or eligibility to participate in this one. You shou\nu\nb\nrecord, which will include any information important for your medical care. \n \n \n198\n\n \nVOLUNTARY CONSENT \n \nI have been given an opportunity to ask any questions concerning the \nprocedures. All of my questions regarding the research project have been \nsatisfactorily answered. I understand that my test results are considered \nconfidential and will never be released in a form that is traceable to me, with \nthe exception of my family physician or me. I do understand that I am free \nto deny consent if I so desire, and may withdraw from the study at any time \nwithout prejudicing current or future medical care. \n \nShould I have any questions about the study, I know that I can contact \nany of the following: Dr. Robert Ross (533-6583), Dr. Robert Hudson (533-\n2973), Dr. Janice Deakin, Head, School of Physical and Health Education \n(533-6601), Dr. Donald Medicine (533-6327), \nor Dr. Albert Clark, Chair of the Ethics Review Board at Queen’s (533-\n6081). A copy of this consent form will be provided me for my records. My \nsignature below means that I freely agreed to participate in this study. \n \n \n \n \n \n_____________________ _____________________________ \n Date: Volunteer’s Signature \n \n \n \n \n_____________________________ \n Witness’ Signature \n \nBrunet, Head, Department of\n \n \n199\n\n \nSTATEMENT OF INVESTIGATO \n \nI, or one of m t the nature \nf the above r wledge, the \nubject understands clearly the nature of the study and demands, benefits, \nnd risks involved to participants in this study. \n Principal Investigator’s Signature Date \n_________________________________ _____________ \n \nR\ny colleagues, have carefully explained to the subjec\nesearch study. I certify that, to the best of my knoo\ns\na\n \n \n \n \n_\n \n \n200\n\n \n \n \n \n \n \n \n \n \n \nAppendix 8: Medical Questionnaire \n \n \n \n201\n\n \n \n \nSchool of Physical and Health Education \n \n \n \n \n \n \n \n \n \n \nMEDICAL QUESTIONNAIRE FOR RESEARCH STUDY \nAND RELATED INSULIN RESISTANCE IN ELDERLY MEN AND \nWOMEN \nipant\n \n \n \n \n \nPREVENTION AND TREATMENT OF ABDOMINAL OBESITY \n \n \n \nTo the study partic : Please answer all questions in sections 1 and 2 of \no the physician\nthis form. Have your family doctor fill out section 3. \n \n \nT : Please fill out section 3 of this form (pages 4-6). \npatient. If the results of recent tests are readily available that might prove \nuseful to study personnel while dealing with the participant, please include \nthat information in this questionnaire. \n \nPlease note that we will pay all costs for completing this questionnaire. \nPlease bill your patients directly and we will reimburse them accordingly. \nCompleting this form may not require a medical re-evaluation of your \n \n \n202\n\n \nSECTION 1: PERSONAL DATA (please print) \n \nName: _______________________________________ \n \nDate of Birth: _________________________________ \n \nDate: ________________________________________ \n \n \n \nSECTION 2: MEDICAL HISTORY \n Yes No \n. Has your doctor ever said you have heart trouble? ___ ___ \n. D ress\n. D el fain\nD. H ever t\n high blood pressure? ___ ___ \n \n. Is ason\n s rcise\n \nF. D e \n \n ii. Nerves or brain ___ ___ \ns ___ ___ \n ete \n v. Muscles, joints, or bones ___ ___ \n vi. Other (please list) \n____\nG. Pl\nA\n \no you get pain, p ure, or tightness in your chest? ___ ___ B\no you often fe t or experience dizziness? ___ ___ C\nas you doctor old you that you have \n \nE there a good re , not mentioned above, why you \nhould avoid exe ? ___ ___ \no you have, or hav you ever had, problems with any of the following? \n Yes No \n i. Heart or blood vessels ___ ___ \n \n iii. Breathing or lung\n iv. Hormones, thyroid, or diab s ___ ___ \n \n_ ________________________________________________________ \nease list any serious injuries suffered, or surgeries you have had. \n \n \n203\n\n \n_____________________________________________________________ _____________________________________________________________ _____________________________________________________________ _____________________________________________________________ \n \nH. If you have had surgery, was any metal (e.g., pins or screws) left in your \nbody ____\n? \n_________________________________________________________ _____________________________________________________________ _____________________________________________________________ \n____________________________________________________________ _ \n \n \nI. Are you presently taking any medications? If yes, please list. \n _____________________________________________________________ _____________________________________________________________ \n _____________________________________________________________\n \n \n_______\n \n ______________________________________________________ \n \n. Are you presently undergoing physiotherapy, or any other sort of \nm\n \nIf ye\n____\n \n \nJ\ntreat ent? \n \ns, please list. \n _________________________________________________________ _____________________________________________________________ _____________________________________________________________ \n______________________\n _______________________________________ \n \n \n204\n\n \nSECTION 3: MEDICAL REFERRAL \n \nPhysician: The applicant is considering participation in a research study that is \ninvestigatin .g., \nabdominal fat), cardiovascular fitness, glucose tolerance and insulin resistance. As a \nparticipant in this study, your patient would undergo a cardiovascular fitness \nappra e\nealth risk. We will forward any test results to you at \n \nA brie \nQuest\natien\nealth Education, Queen’s University (533-6583). \n___________ \n_____________________________________ \n________________ \nastrointestinal ________________________________________________ \ne\n \nf\n \ng\nh) Skin ________________________________________________ \n \n_______________________________________ \n \nII. Physical Examination \n \nBlood Pressure: _____________ Pulse: _________________ \n \nCardiovascular: _____________________________________________________ \n \nRespiratory: ________________________________________________________ \n \nHead and Neck: _____________________________________________________ \ng the effects of exercise modality on changes in body composition (e\nisal (s e explanation on page 7) and a number of other tests to assess body \ncomposition and metabolic h\nyour patient’s request. \nf describing the details of the study is appended to the back of the Medical\nionnaire. Should you have any questions regarding the participation of your \nt in this project, please contact Robert Ross Ph.D., School of Physical and p\nH\n \nI. Review of Systems – please include diagnoses \n \na) Cardiovascular _____________________________________\n \nb) Respiratory ___________\n \nc) Neurological ________________________________\n \nd) G\n \n) Genitourinary ________________________________________________ \n) Endocrine ________________________________________________ \n) Musculoskeletal ________________________________________________ \n \ni) Gynecological _________\n \n \n \n \n205\n\n \n \n MSK: _____________________________________________________________ \n \n \n____ \n_____________________________________ \n \n b ____________ WBC ____________ Plts _____________ \n___ \n _____________ Triglycerides ____________ Uric Acid _____________ \n_ \n______________ \n____________________________________________ \n____________________________________ \n________ \n__ \nAbdomen: __________________________________________________________\n \nNeurological: ___________________________________________________\n \n12-lead ECG results: (not mandatory) \n \n______________________________\n \n \n \nIII. Laboratory findings (not mandatory) Date of Test(s): ___________\n \nH\n Total Cholesterol __________ HDL __________ Chol:HDL ratio _________\nLDL \n TSH ______________ Glucose _____________ fasting \u0000 random \u0000 \n 75 g OGTT @ 120 min ______________\n \nIV. Additional abnormalities of which you are aware __________\n \n_______________________\n \n_______________________________\n \n \nV. Current medications and doses \n_______________________________\n \n___________________________________________________________________ \n \n_________________________________________________________________\n \n \n \n \n206\n\n \nVI. On the basis of your knowledge and medical evaluation of the applicant, you \nu\n_ icipation in a fitness appraisal supervised by a physical education \n____ Participation in a fitness appraisal only when a physician or paramedic is \n present, or \n____ Participation in a fitness appraisal is not recommended \nNote: An explanation of the fitness appraisal protocol, as well as absolute and \nrelative contraindications to exercise testing, is provided on page 7 of this form. \n \n \n \nPhysician’s Name: _________________________________________ \n \nPhysician’s Signature: _________________________________________ \n \nDate: ____________________________ \n \nPhone Number: _________________________________________ \n \nAddress: \n__________________________________________________________________\n__________________________________________________________________ \n_______________________________________________________________________ \n \nThank you very much for your help. \nWe hope that this study and its results will be beneficial to you and your patient. \nwo ld recommend (mark the appropriate answer): \n \n___ Part\n graduate, or \n \n \n207\n\n \nAppraisal of Cardiovascular Fitness (VO2max test) \n \nCardiovascular fitness is assessed using a maximal oxygen uptake (VO2max) test, \nwhich is routinely employed within the labor tory of the study investigators. The \ntreadmill walking test begins at a level the study participant can easily accomplish \n(comfortable walking pace with no incline) and is slowly increased in intensity (by \nincreasing treadmill incline) until the participant reaches volitional fatigue. We may stop \nthe test at any time because of signs of fatigue or the subject may stop the test because of \npersonal feelings of fatigue or discomfort. \n \nThe maximal oxygen uptake test involves risks comparable to a very strenuous \nexercise situation. Every effort is made to m ize the risk by preliminary medical \nexamination and close observation during the test by physical education graduate \nstudents and a physician. \n \na\ninim\n \nAmerican College of Sports Medicine Contraindications to Exercise \nTesting \n \nAbsolute Contraindications \n1. A recent change in the resting ECG suggesting infarction or other acute cardiac \nevents \n2. Recent complicated myocardial infarction \n3. Unstable angina \n4. Uncontrolled ventricular dysrhythmia \n5. Uncontrolled atrial dysrhythmia that compromises cardiac function \n6. Third-degree A-V block \n7. Acute congestive heart failure \n8. Severe aortic stenosis \n9. Suspected or know dissecting aneurysm \n10. Active or suspected myocarditis or pericarditis \n11. Thrombophlebitis or intracardiac thrombi \n12. Recent systemic or pulmonary embolus \n13. Acute infection \n14. Significant emotion distress (psychosis) \n \nRelative Contraindications \n1. Resting diastolic blood pressure >120 mm Hg or systolic blood pressure >200 mm \nHg. \n2. Moderate valvular heart disease \n3. Known electrolyte abnormalities (hypokalemia, hypomagnesemia) \n4. Fixed-rate pacemaker (rarely used) \n5. Frequent of complex ventricular ectopy \n6. Ventricular aneurysm \n7. Cardiomyopathy, including hypertrophic cardiomyopathy \n \n \n208\n\n \n8. Uncontrolled metabolic disease (e.g., diabetes, thyrotoxicosis, or myxoedema) \n9. Chronic infectious disease (e.g., mononucleosis, hepatitis, AIDS) \n10. Neuromuscular, musculoskeletal, or rheumatoid disorders that are exacerbated by \nexercise \n11. Advanced or complicated pregnancy \n \n \n209\n\n \n \n \n \n \n \n \n \n \n \nAppendix 9: Daily Dietary Record \n \n \n \n210\n\n \n \n \n \n211\n\n \n \n \n \n \n \n \n \n \n \n \nAppendix 10: Goals for Nutrition Sessions \n \n \n212\n\n \nSenior Study Nutrition Package Goals \n \n \nPackage 1: Canada’s Food Guide to Healthy Eating \nGoals: \n1. Provide an overview of Canada’s Food Guide and Guidelines for Healthy Eating. \n2. Educate participants about the importanc of variety, balanced meals and moderation. \n3. Help participants to recognize their own eating habits and to see healthy alternatives. \n \n \nPackage 2: Hidden Fat \nGoals: \n1. Recognize the higher fat food choices in ach food group and be aware of hidden fat. \n2. Identify healthy, lower fat options of various foods. \n3. Include hidden fat sources on the diet re\n \n \nPackage 3: Types of Fat \nGoals: \n1. Recognize fat as an essential nutrient \n2. Introduce the different types of fats of and learn about which foods they are found in. \n3. Understand how the different types of fats affect heart health, targeting the reduction of \nsaturated and trans fat. \n4. Clarify the ‘cholesterol’ issue: \n- recognize the difference between blood cholesterol and cholesterol found in food. \n- realize that different kinds of dietary fats have different effects on blood \ncholesterol \n5. Introduce trans fatty acids \n \n \nSession 2: Understanding Food Labels \nGoals: \n1. Educate participants on the regulations governing food labels in Canada. \n2. Increase participants understanding of food labels by teaching them to find nutrition \ninformation in the “Nutrition Facts Table” and the ingredient listing and use this \ninformation to make healthy food choices. \n3. Provide recommended daily allowances for various nutrients: cholesterol, sodium, fibre, \nand protein \n4. Introduce nutrition claims on food packages and help participants recognize misleading \nclaims. \n \nPackage 5: Eating Out \nGoals: \n1. Recognize breakfast as an important meal to start the day. \n2. Provide healthy snacks ideas. \n3. Learn that fast foods tend to be high in fat and salt, and low in fiber. \n4. Educate participants on how to make healthy choices when eating out. \n \nPackage 6: Meat & Alternatives \nGoals: \n1. Participants should choose 2-3 servings from the meat and alternative food group each \nday. \n2. Understand that meat and alternatives provide many essential nutrients, including \nprotein. \n3. Understand that red meat can be high in saturated fat; by choosing leaner meats and \nusing low-fat cooking methods, red meat can fit into a healthy diet. \ne \n e\ncords. \n \n \n213\n\n \n4. Provide practical suggestions for buying and preparing lean meat. \n5. Encourage pa ore often. \n \ncip\n2. Introduce the two types of fiber, their effects on health and the different foods they are \nfound in. \n3. Encourage participants to consume 25-35 grams of fiber per day; provide ideas on how \nto achieve this as well as ways to decrease the discomfort that is usually associated with \nincreased fiber intake. \n \nackage 8: Fruit & Vegetables \nicip\nart to \ntica\nduc fere as a \nk o t of\n \nalci ce in \ning es s\ners wha of this \nce different food m-rich \nchoices more often. \nrticipants to choose poultry, fish and meat alternatives m\nPackage 7: Fiber \nGoals: \n1. Educate parti ants on the importance of fiber in the diet. \n \nP\nGoals: \n1. Educate part ants on the importance of consuming fruit and vegetables. \n2. Encourage p icipants to consume 5-10 servings of fruit and vegetables daily, and\nprovide prac l suggestions on how to achieve this. \n3. Intro e dif nt kinds of fruit and vegetables and to provide ways of eating them\nsnac r par a meal. \n \n \nPackage 9: Calcium\nGoals: \n1. Recognize c um as an important part of a healthy diet; in particular, its importan\nkeep bon trong and healthy. \n2. Und tand t osteoporosis is and the role that calcium plays in the prevention \ncondition. \n3. Introdu s that contain calcium and urge participants to make calciu\n \n \n \n214\n\n \n \n \n \n \n \nAppendix 11: Anthropometric Data Collection Form \n \n \n \n \n \n \n \n \n215\n\n \nSeniors Anthropometric Data Collection Form \nName: ________________________________ Test: PRE Mid8 Mid16 POST \nGender: M F Date: _____________________ Student: ____________ \n \n \n \n \n \nSkinfolds (mm) 1 2 3 mean \nSubscapular _________ _________ _________ _________ \nTricep \nBicep _________ _________ _________ _________ \nMid-Axillary _________ _________ _________ _________ \nIliac Crest _________ _________ _________ _________ \nAbdomen _________ _________ _________ _________ \nThigh _________ _________ _________ _________ \nCalf _________ _________ _________ _________ \n \nCircumference Measures (cm): \nHip: 1 2 mean \n _______ _______ _______ \n 1 2 mean \nWaist (standing) Last Rib: _______ _______ _______ \n Iliac Crest: _______ _______ _______ \nWaist (supine) Last Rib: _______ _______ _______ \n Iliac Crest: _______ _______ _______ \n \n 1 2 mean 1 2 mean \nBicep: R ______ ______ ______ L ______ ______ _______ \nForearm: R ______ ______ ______ L ______ ______ _______ \nThigh: Proximal R ______ ______ ______ L ______ ______ _______ \n Medial R ______ ______ ______ L ______ ______ _______ \n Distal R ______ ______ ______ L ______ ______ _______ \nCalf: R _______ _______ _______ L _______ _______ ________\nAnthro Weight: _____________ kg Arm Length: _____________ cm \nStanding Height: _____________ cm Sitting Height: _____________ cm \nAcromion Height: _____________ cm Knee Height: _____________ cm \n \n_________ _________ _________ _________ \n \n \n216\n\n \n Clamp Morning Data Collection \n \n_ Test ID: _______ \nGender: M F Today’s Date: \nSubject Name: ____________________\n________________ \nB: __________________ \n \n 2. _________ / _________ mmHg \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nDO _\nAge: ______ Height: _______ cm \nBlood Pressure: 1. _________ / _________ mmHg \n \n \n \nFat _______ TBW _______ \nWhole Body Impedance _______ \nWhole Body \nBio-Impedance Measurements \n \nTanita Segmental (BC-418) \n Weight ______ %\n \n RL ______ LL ______ RA ______ LA ______ \n \nSupine Multifrequency \n Z Phase \n4 Hz Rinf \n8 Hz Ro/Re \n16 Hz Ri \n32 Hz Beta \n64 Hz Fc \n128 Hz R \n256 Hz X \n512 Hz \n \n \n \n217\n\n \n \n \n \n \n \n \n \n \n \nAppendix 12: Functional Fitness Test Data Sheet \n \n \n218\n\n \nFunctional Fitness Data Collection Form \nge: __________ \nDate: ___________________ Time: ___________ Tester: ________________ \ny/month/year) \n________________________________________________________________________ \n1. 30-sec chair stand \nHave subject try one stand, rest, and then perform one 30-second trial. \n \nN of stands: ____________ \n \n2. Arm curl \nUse subject’s dominant arm (circle one): Right Left \nExplain full range of motion and position of wrist in up and down position. Have \nsubject practice one or two curls, rest, and hen pe\n \nN of controlled curls: ____________ \n \n3. 2-Minute Step Test \nM dpoint ween ASIS nd patella on wall adjacent to \nsubject as a guide for the knee height when stepping (no running). \n \nN of time arker: ____________ \n \n4 r sit-an reach \n plain le ositioning and remind bject rm the test slowly and ithout \nbending the extended leg. Perform two tests for practice, and then record two actual \nt ircle the est score. \n \nTrial 1: ____________ (cm) Trial 2: ____________ (cm) \n \n5. Back Scratch \nHave the subject try either elbow up and choose the better one ( cle): Right Left \nGive the subject two practice stretches and then record measurem\nt Circle the best score. \n \n al 1: _ _________ cm) : ____ _______ (c ) \n \n6. 8 ft up-and-go \nExplain that the subject should not run, and give one practice trial. \nCircle the score the better o ials.\n \n Trial 1: ____________ (sec) Trial 2: ____________ (sec) \nSubject Name: _________________________________ Pre 8 wks \nTest: \n 16 wks Post \n \nGender: M F A\n \n(da\number\n t rform one 30-second trial. \number\nark mi bet a . Put a piece of tape\number s the right knee reaches the m\n. Chai d-\nEx g p su to perfo w\nrials. C b\n \ncir\nents from two actual \nrials. \nTri __ ( Trial 2 _ m\n of f two tr \n \n \n219\n\n \n \n \n \n \n \n \n \n \n \nAppendix ercise Test 13: Heart Rate Record for Graded Maximal Ex\n \n \n220\n\n \nMaximal Oxygen Consumption Test -- Seniors Study PRE MID POST \n \nParticipant Name: ___________________________ Date: _________________ \nParticipant ID: Senior_______ Weig ht (kg): ____________ \nHeight (cm): _______ Speed (mph): ___________ \nDOB: ____________________________ Teste r: ________________ \nAge-predicted HRmax: _______________ \nTime \n(min) \nGrade \n(%) \nHR \n(bpm) Time \n(min) \nGrade \n(%) \nHR \n(bpm) \n00:00 0 12:00 \n00:20 12:20 \n00:40 12:40 \n01:00 13:00 7 \n01:20 13:20 \n01:40 13:40 \n02:00 14:00 \n02:20 14:20 \n02:40 14:40 \n03:00 2 15:00 8 \n03:20 15:20 \n03:40 15:40 \n04:00 16:00 \n04:20 16:20 \n04:40 16:40 \n05:00 3 17:00 9 \n05:20 17:20 \n05:40 17:40 \n06:00 18:00 \n06:20 18:20 \n06:40 18:40 \n07:00 4 19:00 10 \n07:20 19:20 \n07:40 19:40 \n08:00 20:00 \n08:20 20:20 \n08:40 20:40 \n09:00 5 21:00 11 \n09:20 21:20 \n09:40 21:40 \n10:00 22:00 \n10:20 22:20 \n10:40 22:40 \n11:00 6 23:00 12 \n11:20 23:20 \n11:40 23:40 \n \n \n221\n\n \n \n \n \n \n \n \n \n \n \nAppendix 14: VO2max Summary Data Sheet \n \n \n222\n\n \n \n \n \n223\n\n \n \n \n \n \n \n \n \n \n \nAppendix 15: Whole Body MRI Acquisition Protocol \n \n \n224\n\n \nWhole Body MRI Acquisition Protocol \n Ross et al. 1992 and 1996 \n \nSummary \n \nThe purpose of this protocol is to acquire T1-weighted images the entire length of the body (with \n4 cm slice gaps between slices). These images will be analyzed to determine total body fat and \nmuscle content. \n \nProtocol \n \nSpecifications: \n Axial multi-slice spin-echo TR/TE = 210ms/17ms \n FOV = 48cm (LR) x 36cm (AP) (i.e. 48cm FOV with rectangular FOV at 75%) \n 7 axial slices of 10mm thickness and 40mm slice gap (i.e. 50mm center to center) \n 0.5 or 1.0 NEX \n \n1. Place subject in the prone position feet first and landmark at approximately L4-L5. \n2. Acqui re localizers: \na. Saggitals (to find L4-L5) \nb. Coronals (to find head of femur) \n3. Acquire 7 axial T1W SE images from L4-L5 down (towards feet) with the breath hold \nT1W sequence. Breath hold will be approximately 0.26 seconds at 0.5 NEX. \n4. Reposition the patient couch and acquire 7 T1W axial slices starting at the femoral head \ngoing towards the feet. \n5. Reposition the patient couch such that the next 7 T1W axial slices can continue to be \nacquired with a 4cm slice gap. \n6. Repeat step 5 until the entire length of the legs are acquired. (1/2 FOV if possible at \nextremities) \n7. Reposition patient prone and head first with arms over the head and landmark at \napproximately L4-L5. \n8. Acqui re localizers: \na. Saggitals (to find L4-L5 again) \nb. Coronoals (to find head of right humerus) \n9. Acquire 7 axial T1W SE images from L4-L5 upwards (toward head) with the breath hold \nT1W sequence. \n10. Reposition patient couch and acquire 7 more T1W SE images continuing (towards the \nhead) with a 4cm slice gap with the breath hold T1W sequence. \n11. Reposition patient couch and acquire 7 T1W SE images starting at the humeral head \n(going towards the fingers) with a 4cm slice gap. \n12. Reposition the patient couch such that the next 7 T1W axial slices can continue to be \nacquired with a 4 cm slice gap. \n13. Repeat step 12 until the entire length of the arms is acquired. \n \n \n225\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n226\n\n \n \n \n \n \n \n \n \n \n \nAppendix 16: MRI Script File \n \n \n227\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nImages proceed from inferior to superior, arranged sequentially…. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n228\n\n \n \n \n \n \n \n \n \n \n \nAppendix 17: MRI Script Record \n \n \n \n229\n\n \n \n \n230\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nMRI Script Record 1. \n \nScript File \n \nSE1: (scout) \nSE2: (L4-5↓) \nSE3: (FH↓) \nSE4: (35cm below FH [knee]) \nSE5: (70cm below FH [toes]) \nSE6: (scout) \nSE7: (scout) \nSE8: (L4-5↑) \nSE9: 35cm above L4-5) \nSE10: (HH↑) \nSE11: (35cm above HH [fingers]) \nSE12: \nSE13: \nSE14: \nSE15: \n2. \n6. \n7. \n8. \n9. \n10. \n11. \n12. \n13. \n14. \n15. \n16. \n17. \n18. \n19. \n20. \n21. \n22. \n23. \n24. \n25. \n26. \n27. \n28. \n29. \n30. \n31. \n32. \n33. \n34. \n35. \n36. \n37. \n38. \n39. \n40. \n41. \n42. \n43. \n44. \n45. \n46. \n47. \n \nName: 3. \nDate: \n \nL4-5: \nFH: \nL4-5: \nHH: \n \n \nIn 35cm above L4-5, use: \n<400 = 1 image → 45 \n400-450 = 2 images → 46 \n>450 = 3 images → 47 \nTest ID: \nLine 21 \n \nL4-5: \nFH:\nLine 31, 32, or 33 \n \nL4-5: \nHH: \nPartial Volume Adjustments \n4. \n5. \n\n \n \n \n \n \n \n \n \n \n \nAppendix 18: MRI Partial Volume Anomalies Guide \n \n \n231\n\n \nPartial Volume Adjustments: Anomalies \n \nOverlapping Images in Order \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nLine 21 \nL4-5: S 9 \nFH: I 97 \nLine 31 \nL4-5: I 7 \nHH: S 348 \n \nIn MRI summary spreadsheet, change image thickness on \nthe respective partial volume (subtract amount of overlap \nfrom 1.0 cm) and delete truncated cone portion (from “+” sign \nonward) of volume equation. \n \nLine 21: \nPV 21 =B24*0.6 ((SUM(B24:B25)+SQRT(B24*B25))/3)*1.3 \n \nLine 31:\n \n \n \n \n \n24 \n23 \n21 \n20 \n19 \n+\n \n))/3)*2 \nLine 32:\nPV 31 =B34*0.5+((SUM(B34:B35)+SQRT(B34*B35\n 22 \n \nPV 32 =B35*0.6 ((SUM(B35:B36)+SQRT(B35*B36))/3)*2 \n \nLine 33:\n+\n \nPV 33 =B36*0.5+((SUM(B36:B37)+SQRT(B36*B37))/3)*2 \nLine 32 \nL4-5: I 37 \nHH: S 369 \nLine 33 \nL4-5: \nHH: \n \n24 2424\n25 \n33 \n34 \n31 32 \n25\n34\n3233 \n31\n25\n35 \n36 \n3334 \n \n \n232\n\n \nOverlapping Images Out of Order \n \n \n \n \n \n \n \n \n \n \n \n \nLine 21 \nL4-5: I 41 \nFH: I 138 \n \n22 21\n20 \n19 \nIn MRI summary spreadsheet, enter zeros for area 22 and \npartial volume 22. Adjust the spacing for partial volume 21 \nso that it reflects the distance between images 21 and 23. \n \nArea 22 = 0 \nPV 22 = 0 \nPV 21 =B24*1+((SUM(B24:B26)+SQRT(B24*B26))/3)*3.7 \n \nApply the same rules to cases where image 22 appears \ncompletely before image 21. \n \n24 \n23 \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n233\n\n \n \n \n \n \n \n \n \n \n \nAppendix 19: MR me Calculations I Tissue Area and Whole Body Volu\n \n \n \n234\n\n \n \n \n235\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \nA \n \nppendix 20: CT Requisition Form\n \n \n236\n\n \n \n \n237\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n237\n\n \n \n \n \n \n \n \n \n \n \nAppendix 21: Clamp Data Sheet \n \n \n238\n\n \n \n \n239\n \n\n\n \n \n \n240\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \nAppendix 22: Blood Gases and Lipid Profile Requisition Forms \n \n \n \n241\n\n \n \n \n242\n \n \n \n\n\n \n \n \n243\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \nix 23: Medical Outcomes Survey -- SF-36 \n \n \n \nAppend\n \n \n244\n\n \nMedical Outcomes Survey (MOS) \n \nName: Date: ____________________ \nInstructions: This survey asks for your views about your health. This information \n to do our usu \nactivities. \n \n answer as indicated. If you unsure\nabout how to answer a question, please give the best answer you can. \n _ _ _\n \nwill help keep track of how you feel and how well you are able y al\nAnswer every question by circling the are \n_ \n \n1. In General, would you say your health is: \nent \n2 Very Good \n2. Compared to one year ago, how would you rate your health in general now? \n \nar ago \n2 Somewhat better now than one year ago \n3 About the same as one year ago. \n \n4 Somewhat worse now than one year ago \n \n5 Much worse now than one year ago \n \n \n1 Excell\n3 Good \n4 Fair \n5 Poor \n \n \n1 Much better now than one ye\n \n \n \n \n245\n\n \n3. The following items are about activities you might do during a typical day. Does your health\nnow limit you in these activities? If so, how much? \n \n \n \nAct es \nCircle one numb line \n \nYes, \nlimited a \nlot \nYes, \nlimited a \nlittle \nNo, not \nlimited \nat all \niviti\ner on each\na. Vigorous act as running, lifting heavy \nobje cipating in strenuous sports \n \n1 \n \n2 \n \n3 \nivities, such \ncts, parti\nb. Moderate act as moving a table, pushing a \nvacuum cleaner playing golf \n \n1 \n \n2 \n \n3 \nivities, such\n, bowling, or\n \nc. L g or carrying groceries \n \n \n1 \n \n2 \n \n3 iftin\n \nd. Climbing several flights of stairs \n \n \n1 \n \n2 \n \n3 \n \ne. Climbing one flight of stairs \n \n \n1 \n \n2 \n \n3 \n \nf. B ing, kne ng \n \n \n1 \n \n2 \n \n3 end eling or stoopi\n \ng. Walking more than a mile \n \n \n1 \n \n2 \n \n3 \n \nh. Walking several blocks \n \n \n1 \n \n2 \n \n3 \n \ni. Walking one block \n \n \n1 \n \n2 \n \n3 \n \nj. Bathing or dressing yourself \n \n1 \n \n2 \n \n3 \n \n \n246\n\n \n4. During the past 4 weeks, have you had any of the following problems with your work or other \nregular activities as a result of your physical health? \n \nCircle one numb line Yes No er on each\na. C own on t of time you spent on work or other activities \n1 \n \n2 ut d the amoun\n \nb. A mplish you would like \n \n1 \n \n2 cco ed less than\nc. Were limited in the kind of work or other activities 1 2 \n \nd. Had difficulty performing the work or other activities (for example it \ntook extra effort). \n \n1 2 \n \n \n have you h d any of t follow blems rk or oth r \nmotion roblem (Such a eeling depressed or \nmber on each line Yes No \n5. During the past 4 weeks,\nregular daily activities as a result of an\na\ny e\nhe\nal p\ning pro with your wo\ns f\ne\ns, \nanxious)? \n \nCircle one nu\na. Cut down the amount of tim\nactivities \ne you spent on work or other \n \n 1 \n \n \n 2 \n \nb. Accomplished less than you would e \n \n 1 2 \n lik\n \n \n \nc. Didn’t do work or other activities as carefully as usual \n \n 1 \n \n \n \n \n 2 \n \n \n \n247\n\n \n6. During the past 4 weeks, to what extent has your physical health or emotional problems \ninterfered with your normal social activities with family, friends, neighbors, or groups? \n \n1 Not at all \n \n2 Slightly \n \n3 Moderately \n \n4 Quite a bit \n \n5 Extremely \n \n \n \n \n2 Very Mild \n \n4 Moderate \n \n7. How much bodily pain have you had during the past 4 weeks?\n1 None \n \n \n3 Mild \n \n5 Severe \n6 Very severe \n \n \n \n \n248\n\n \n8. During the past 4 weeks, how much did pain nterfere with your normal work (Including both \nwork outside the home and inside the home and housework)? \n \n1 Not at all \n \n2 A little bit \n \n3 Moderately \n \n4 Quite a bit \n \n5 Extremely \n \n9. These questions are about how you feel and how things have been with you during the past 4 \nweeks. For each question, please give the one answer that comes closest to the way you have \nbeen feeling. How much time during the past few weeks: \n \n \nCircle one number on each line \n \nAll of \nthe \ntime \nMost of \nthe time \nA \ngood \nbit of \nthe \ntime \nSome \nof the \ntime \nA little \nof the \ntime \nNone \nof the \ntime \n i\na. Did you feel full of pep? 1 2 3 4 5 6 \n \nb. Have you been a very nervous \nperson? \n1 2 3 4 5 6 \nc. Have you felt so down in the \ndumps that nothing could cheer \nyou up? \n1 2 3 4 5 6 \nd. Did you feel calm and \npeaceful? \n1 2 3 4 5 6 \n \ne. Did you have a lot of energy? 1 2 3 4 5 6 \n \nf. Have you felt downhearted and \nblue? \n1 2 3 4 5 6 \ng. Did you feel worn out? 1 2 3 4 5 6 \n \nh. Have you been a happy \nperson? \n1 2 3 4 5 6 \n \ni. Did you feel tired? 1 2 3 4 5 6 \n \n \n \n \n249\n\n \n1\np\n0. During the past 4 weeks how much of the time has your physical health or emotional \nroblems interfered with your social activities (like visiting with friends, relatives, etc.)? \n \n2 Most of the time \n \n3 Some of the time \n \n4 A little of the time \n \n5 None of the time \n \n \n11. How true or false is each of the following sentences for you? \n \nCircle on number on each \nline \nDefinitely \nTrue \nMostly \nTrue \nDon’t \nKnow \nMostly \nFalse \nDefinitely \nFalse \n1 All of the time \n \na. I seem to get sick a little \neasier than most people \n \n1 \n \n2 \n \n3 \n \n4 \n \n5 \nb. I am as healthy as \nanybody I know \n \n \n1 \n \n2 \n \n3 \n \n4 \n \n5 \nc. I expect my health to get \nworse \n \n1 \n \n2 \n \n3 \n \n4 \n \n5 \nd. My health is excellent \n \n \n1 \n \n2 \n \n3 \n \n4 \n \n5 \n \n \n \n \n250\n\n \n \n \n \n \n \n \n \n \n \nAppendix 24: Informed Consent for Hoffmann-LaRoche Study \n \n \n251\n\n \n \nCONSENT TO VOLUNTEER FOR PARTICIPATION IN A STUDY \n \n \n \nTITLE: Prevention and treatment of abdominal obesity and related \ninsulin resistance in elderly men and women \n(Clinical Research Study) \n \n \nPRINCIPAL INVESTIGATOR: \n \nRobert M.J. Ross, Ph.D. \nQueen’s University \nSchool of Physical and Health Education/ Medicine, Division of \nEndocrinology and Metabolism \nKingston, Ontario, K7L 3N6 \n533-6583 \n \n \nCO-INVESTIGATORS: \n \nChris Boesch, M.D., Ph.D. \nUniversity of Berne \nSwitzerland \n \nRobert Hudson, M.D., Ph.D., FRCPC \nKingston General Hospital \nMedicine, Division of Endocrinology and Metabolism \nKingston, Ontario, K7L 3N6 \n533-2973 \n \n \n \n \n \n252\n\n \nPURPOSE OF THE STUDY \nYou are being asked to join, by your ow n choice, a clinical research study \nthat is part of t he exercise study for wh ich you have agreed to participate. \nParticipation in t his second st udy i n NOT obligatory and you are free to \ndeny parti cipation without com promising participation in the exer cise and \nobesity reduction study. \nSo that you can decide whether or not y ou want to take part in this second \nstudy, you should understand it s possible risks and benefits enough to make \nan informed decision. Before you decide whether or not to take part, you \nshould read thi s i nformation carefully. A sk as m any questi ons as you l ike \nuntil you are completely satisfied that you understand the answers. \n \nThe purpose of this study is to look at the relationships between various \nblood factors including proteins, lipids (fats), hormones, or biological \nmolecules of interest, to visceral adiposity, insulin resistance, and obesity \nrelated problems. The DNA in your blood will be used to look for blood \nfactors related to disease or lack there of. \n \nSTUDY PROCEDURES \nIf you decide to part icipate in this st udy, one 60m L blood sam ple will be \ncollected from a vein in your arm. Th is will be done once at the beginning, \nand once at the end of the study (6 m onths later). This blood sample will be \nsent to Roche Pharmaceutical for analysis. \n \nRISKS AND BENEFITS SIDE EFFECTS \nYou will gain no direct benefit th rough participation in this study. \nParticipation m ay invol ve some risks. Th ere is the risk of slight pai n or \nbruising when your bl ood is drawn for tests in t his study. You m ay feel \nsome brief discomfort from the needle in your arm. There is a sm all risk of \nbruising, bleeding, or swelling where th e needle enters the body. R arely, \nfainting or a local infection may occur. \n \n \n \n \n \n253\n\n \nCONFIDENTIALITY OF RECORDS \nYou have a right to privacy, and all in formation that is collect ed for this \nstudy is c onfidential as m uch as possi ble by law. To protect your pri vacy, \nyou will be identified only by your patient number in the study. \nYour information may be analyzed in any count ry worldwi de by Roche \nPharmaceutical or other co mpanies acting on behalf of Roche \nPharmaceutical. Roche Phar maceutical m ay then send the study results to \nHealth Authorities worldwide, and repor t results at medical meetings and in \nmedical magazines, so that other doctors can find out about the results of the \nstudy. If you leave the study, inform ation already collected about you will \nstill be used. \n \nRoche Pharmaceutical m ay need to re-a nalyze the data fro m this study at a \nlater date, and may need to carry out extra tests on samples col lected during \nthe study or perform further statistical tests on the data. In addition, it is \npossible that in the future Roche Pharmaceutical may need to co llect \nadditional data from your m edical chart/records in order to put the already \ncollected data in the proper medica l context. The approval of the \nappropriate Institutional Review Boar d or Ethical Comm ittee will be sought \nprior to collecting any additional information. \n \nRepresentatives from Roche Pharmaceu tical, Health Authorities, and your \nlocal Ethical Committee may be allowed to look at your m edical records so \nthat they can make sure that the info rmation collected is correct. If this \nhappens, it may be possible for them to identify you. \n \nStudy results will only be looked at for groups (eg patients who have the \nsame disease characteristics), and not for any individual patient. If the study \nresults show anything that coul d affect how your conditi on is managed, this \nwill only be known after m any m ore st udies are done. This is why it is \nimportant for you to unde rstand and agree that Ro che Pharmaceutical wil l \nnot be giving you or your Doctor the results of the test(s) done on your \nsample(s). The results will not have any effect on your own treatment. \n \n \n \n \n \n \n254\n\n \nNEW DISCOVERIES \nIt is possible that results from this study m ay lead to discoveries and \ninventions (eg patents) or other commercial benefits. The rights to these will \nall belong to Roche Pharmaceutical. \n \nSAMPLE STORAGE AND USE \nYour blood sample will be stored for a maximum of 15 years after the end of \nthis study as part of a sam ple bank, and may be made available only for \nfuture research in the field of obesity. This research may include extra tests \non your sa mple and analysis of inform ation about you that was collected as \npart of the exercise and obesit y study. The research may take several years \nto com plete, but if successful, m ay lead to earlier diagnosis and better \ntreatment of obesity and related di seases. The blood sam ples will be \ndestroyed no later than 15 years after the end of this study. \n \nMEDICAL TREATMENTS FOR INJURIES \nYou will not have to pay fo r any clinic visits or fo r any of the tests required \nby the study. If you develop a problem related to the study, which requires \nmedical attention, you will be exam ined by your physician and medical care \nwill be given. Roche Pharmaceutical will pay for the cost of medical \ntreatment for any inj ury that is a dire ct result of the study procedures when \nthey have been performed as it states in the st udy protoc ol. No other \ncompensation will be offered. \nIn the event you that you are injured as a result of the study procedures, \nmedical care will be provided to you until resolution of the medical problem. \nBy signing this consent form, you do not waive your legal rights nor release \nthe investigator(s) and sponsors from their legal and professional \nresponsibilities. \n \nFinancial remuneration will not be provided to you for participation in this \nstudy. \n \n \n \n \n \n \n \n255\n\n \nVOLUNTARY CONSENT \n \n An opportunity has been provided to you to ask any question \nconcerning the procedures. All your questions regarding the research project \nhave been satisfactorily answered. Your test results are considered \nconfidential and will never be released in a form that is traceable with the \nexception of your family physician or yourself. You are free to deny \nconsent if you so desire, and may withdraw from the study at any time \nwithout prejudicing current or future medical care. \n \n Should you have any questions about the study you are encouraged to \ncontact any of the following: Dr. Robert Ross (533-6583), Dr. Robert \nHudson (533-2973), Dr. Janice Deakin, Head, School of Physical and Health \nEducation (533-6601), Dr. John McCans, Head, Department of Medicine \n(533-6327), or Dr. Albert Clark, Chair of the Ethics Review Board at \nQueen’s (533-6081). A copy of this consent form will be provided to you \nfor your records. The signature below means that you freely agree to \nparticipate in this study. \n \n \n____________________________ _____________________________ \n Date Volunteer’s Signature \n \n______________________________ \n Witness’s Signature \n \n \n \n \n \n \nSTATEMENT OF INVESTIGATOR \n \nI, or one of my colleagues, have carefully explained to the subject the nature \nof the above research study. I certify that, to the best of my knowledge, the \nsubject understands clearly the nature of the study and demands, benefits, \nand risks involved to participants in this study. \n \n___________________________________ ______________ \n Principal Investigators Signature Date \n \n \n256\n\n \n \n \n \n \n \n \n \n \n \nAppendix 25: Aerobic Exercise Session Record \n \n \n \n257\n\n \n \n \n258\n\n\n \n \n \n \n \n \n \n \n \n \nAppendix 26: Resistance Exercise Session Record \n \n \n259\n\n \n \n \n260\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n \n \n \n \n \n \n \n \n \n \nAppendix 27: Results Package for Participants \n \n \n \n261\n\n \n \n \n262\n \n \n \n \n \n \nDear Jane, \n \nThank you for participating in the Queen's Senior Exercise Study. Without \nyour diligent efforts and commitment, this project would never be possible. \nThe information that we obtained from you and your fellow participants \nduring testing will enable us to help other Seniors become more healthy and \nreduce the risk of developing diabetes. \n \nWe hope that your involvement in this project has brought you to a new \nsense of awareness of your health and inspired you to continue with more \nhealthy habits throughout your life. Enclosed is a summary of the results of \nmost of the tests you underwent in our lab. They are accompanied by brief \nexplanations of the importance of each outcome, but please contact us if you \nwant further information or find any of your results difficult to understand. \n \nBrought on by popular demand and purely for interest's sake, we have \nincluded a CD which contains a presentation of the cross-sectional images of \nyour whole body obtained by magnetic resonance imaging (MRI) \ntechnology at the conclusion of the study. If you would like an explanation \nor further help with this CD, please contact Lance. \n \nOnce again we thank you for being part of our lives as you participated in \nthe Senior Exercise Study. We hope that the coming years will bring you \nand your loved ones health and happiness. Please keep in touch. We would \nlove to hear from you! \n \nSincerely, \n \n \n \nShelley Atkinson Lance Davidson \nQueens phone: 533-6000 ext 75118 Queen's phone: 533-6000 ext 75118 \nHome phone: 544-7340 Home phone: 542-7434 \nE-mail: atkins@post.queensu.ca E-mail: 1led@qlink.queensu.ca \nSchool of Kinesiology and Health \nStudies \nQueen's University \nKingston Ontario Canada\n\n\n \n \n \n \nTest Results \nfor \n \nJane Doe \n \na graduate of the \n \nQueen's University \nSenior Exercise Study \nin the Ross Laboratory \n \n \nCompleted \nOctober 2004 \n \n \n263\n\n \nThe following is a description of the variables that were measured during the \nQueen's Senior Exercise Study. A brief explanation of the importance of \neach test is included with your final test results, as well as normative and \nchange data where applicable. We hope that you will find this summary \nuseful and informative. \n \n \n \nThe composition of your body, particularly the ratio of fat to lean tissue \n(muscle, bone), has a marked impact on your health and capacity for \nmobility and function into later years. Excess body fat is associated with \nmany different risk factors, including high blood pressure, heart disease, \ndiabetes, stroke and cancer. The general population tends to gain weight at a \nrate of about a pound per year from age 30 to 50 (for men) and age 30 to 60 \n(for women), stabilize for a few years, and then begin a gradual decline in \nweight. Unfortunately, this weight loss for people in their later years is \nowed to degeneration of muscle mass and bone, not reduction of fat. \nBecause weight loss in the senior population usually reflects a reduction of \nthe very tissues that keep them mobile and living independently, indexes of \nbody fatness and muscle composition are more useful in determining health \nrisk than simply measuring body weight. \nDuring this study, your body composition was measured in a variety of \nways, including bioelectrical impedance (BIA), anthropometry \n(circumferences and skinfolds), dual-energy x-ray absorptiometry (DEXA) \nand magnetic resonance imaging (MRI). Of these measurement methods, \nMRI is the most accurate for quantifying differences in fat and muscle, but \nbecause the other methods are more widely used, standards for comparison \nare more readily available. Following are your body composition outcomes \nwith tables for comparison against a health or population standard. \nBioelectrical Impedance \nImpedance reflects the body's inherent resistance to an electrical current. \nMuscle acts as a conductor of the electrical current; adipose tissue acts as a \nresistor. Using the impedance values we collected from you in the study, \nyour body fat percent (or the percentage of your body that is fat versus \nmuscle, bone, fat-free tissue or water) was estimated. \nBody Composition \n \n \n264\n\n \nYour body fat percentage at the beginning of the study was 38.4%. At the \nconclusion of the study, it was 37.8%. \nThe following are guidelines for determining health risk by body fat \npercentage in males and females in your age range. \n \nAnother helpful tool in determining health risk is to see your percentile \nranking among your fellow seniors. Since no percentile rankings currently \nexist for Canadian seniors, these are data from a Swiss population: \n Percentile Rankings \nGender Age 5th 10th 25th 50th 75th 90th 95th\n55-64 12.0 13.8 17.7 22. 8 26.4 29.1 30.6 \n54-74 14.6 17.2 19.8 24. 2 27.6 30.7 32.6 Men \n75-84 15.5 18.0 21.1 25. 2 28.0 30.3 31.2 \n55-64 21.4 24.4 28.3 32. 5 36.0 39.4 40.5 \n54-74 24.4 27.3 31.4 36. 0 39.9 42.4 44.4 Women \n75-84 25.9 29.1 32.8 36. 9 40.4 44.2 45.2 \n \nAnthropometry \nAlthough excessive body fat is a health hazard, the distribution of body fat is \nperhaps even more important. Fat storage in the trunk region is more of a \nhealth risk than fat distributed on the limbs. One of the more meaningful \nmeasurements that can be collected with anthropometry is waist \ncircumference taken at the level of the iliac crest. We recommend working \ntoward a waist circumference of less than 80 cm, since measurements \n \n \n265\n\n \ngreater than this are associated with increased health risk (a waist \ncircumference greater than 88cm (in women) and 100 cm (in men) is \nassociated with a substantial increase in risk). You began the study with a \nwaist circumference of 94 cm. Your final waist circumference, measured at \nthe level of the iliac crest, was 88 centimeters(cm). \n \nDual-Energy X-Ray Absorptiometry (DEXA) \nDEXA uses two X-ray beams that differ in intensity. The extent to which \nthe two beams are diffracted by bone and soft tissue allows for \ndifferentiation of muscle and fat as well as bone mineral density (BMD). \nYour body fat percentage as determined by DEXA was 36.5% before you \nbegan the study; after, it was 34.9%. Often in research literature, DEXA is \nconsidered a standard by which bioelectrical impedance and anthropometric \nmeasures are verified. You may use your DEXA body fat percentage score \nin the tables on the previous page to reaffirm your current health risk and \ndetermine your ranking in a representative senior population. \n \nThe most common use of DEXA is for determining bone mineral density in \nscreening for the development of osteoporosis. Bones naturally become \nthinner as you grow older, because existing bone is broken down faster than \nnew bone is made. As this occurs, bones lose minerals (such as calcium), \nand their structure is compromised, making them weaker. This bone \nthinning, called osteopenia, can develop into a condition called osteoporosis, \nand most commonly occurs in post-menopausal women. Diagnosis of \nosteoporosis is done by comparing your bone mineral density to population \nvalues. Having a z-score that is -2.5 or lower (2.5 standard deviations below \nthe population mean of young adults) is cause for concern and medical \nconsultation. \n \nThere are currently no population means determined for men. Because most \nscreening is performed specifically on the areas of the body where bone loss \nis first apparent (hip and lower spine), and this whole body bone density test \nrepresents mineral density throughout your body as a whole, you may wish \nto seek out further and more specific diagnostic testing if your score \napproaches higher risk. A copy of your results for the DEXA test is \nappended to this document.\n \n \n266\n\n \n \n \nInsulin Sensitivity \nInsulin is a hormone produced by the body in the pancreas. It is mainly \nimportant for the storage of glucose and prevents excessive glucose levels in \nthe blood. Chronic overeating and lack of exercise can tax insulin's ability \nto regulate blood glucose levels, and eventually leads to hyperinsulinemia, a \nrisk factor in the development of Type II (non-insulin dependent or adult \nonset) diabetes mellitus and cardiovascular disease. In Type II diabetes, the \nbody's cells become progressively less sensitive to insulin, causing higher \nlevels of insulin and glucose in the blood. By practicing moderation in diet \nand developing good exercise habits, you can improve the effectiveness of \ninsulin in your body and take steps to prevent the onset of Type II diabetes. \nThe Oral Glucose Tolerance Test and the Euglycemic Clamp are used to \nevaluate your insulin sensitivity. \nOral Glucose Tolerance Test (OGTT) \nTo evaluate your tolerance to a glucose load, you were given an orange \ndrink (75g glucose) after 12 hours of fasting. Your blood glucose was \nmeasured every half hour. A fasting glucose (See 0 min in table below) of \n5.6 mmol/L or greater has recently been used by the American Diabetes \nAssociation as an indication of impared glucose tolerance. Of perhaps \ngreater clinical importance is the 2-hour plasma glucose level (See 120 min \nbelow), which, if found to be greater than 11.1 mmol/L, is diagnostic for \nType II diabetes. \nThe results of your OGTT are summarized below in mmol/L: \ne 0 min 30 min 60 min 90 min 120 minTim \nGlucose 5.3 9.8 9.7 8.9 6.1 \n \n \nT glycemic Clamphe Hyperinsulinemic Eu \n\"The clamp,\" as we call it for short, measures how effectively insulin helps \nt take glucose out of the blood. As mentioned earlier, high blood \ninsulin (hence the name Hyperinsulinemic) into your blood and then infuse \nMetabolic Variables \nhe muscles\nsugars put you at risk for disease. In this test, we infuse a measured dose of \n \n \n267\n\n \nglucose until your blood glucose stabilizes at a normal level (Euglycemic). \nThe rate of glucose infusion during the last 30 minutes of the test determines \ninsulin sensitivity. If high levels (7.5 mg/kg/min or higher) are required, the \npatient is insulin-sensitive. Very low levels (4.0 mg/kg/min or lower) \nsuggest that the body is resistant to insulin action. Levels between 4.1 and \n7.4 mg/kg/min are indetermined and might point at \"impaired glucose \ntolerance\", considered an early form of insulin resistance. It is thought that \nweight loss and exercise can help to increase your insulin sensitivity, thereby \ndecreasing your risk of developing Type II diabetes. \nYour insulin sensitivity at the beginning of the study as indexed by your \nglucose disposal rate was 6.01 mg/kg/min. After the study, your glucose \ndisposal was 10.71 mg/kg/min. \n \nBlood Lipids \nExcess cholesterol in the blood is a risk factor for atherosclerosis and heart \ndisease. Cholesterol found in the body can come from either the diet or \norgan production (mainly the liver). The total amount of cholesterol in the \nblood is not as important as the type of cholesterol with regard to health risk. \nHigh density lipoprotein (HDL) is known as the \"good cholesterol\" because \nit removes cholesterol from the blood. In contrast, low density lipoprotein \n(LDL) is \"bad cholesterol\" because it generates deposits on blood vessel \nwalls. For this reason, it is beneficial to have high levels of HDL and low \nlevels of LDL cholesterol in the blood. Modest reductions in blood \ncholesterol can be accomplished by lowering the intake of animal fats in \nyour diet. \n \nFractions \n (mmol/L) \nRecommended\nRanges \nYour results \nbefore the study \nYour results at the \nend of the study \nHDL > 0.9 1.45 1.55 \nLDL < 3.4 3.5 3.7 \nTotal cholesterol < 5.2 6.2 6.1 \nTriglycerides 0.55-3.30 2.66 1.76 \n \n \n268\n\n \nA physically inactive lifestyle can be a primary cause of frailty in older \nyears, and has shown to be on a par with chronic disease as a cause of \ndisability. Studies show that increased physical activity, even when begun \nlater in life, results in improved physical fitness and functional capacity. \nDuring this study, you performed at least two maximal exercise tests. Your \ncapacity to utilize oxygen to continue exercise during the last few moments \nof these tests was an objective measure of your fitness. \nAt the beginning of the study, your maximal oxygen consumption was 30.3 \nmilliliters per kilogram of body mass per minute. This corresponds to a \nfitness level of very good in your age group. Your final test was 37.4 \nmL/kg/min, corresponding to a fitness level of excellent in your age group, \nor equal to an average 27 year old! \n \nYou also performed a series of 6 functional tests designed to assess your \nability to perform basic \"independent living\" activities. The following is a \ntable expressing your results and percentile ranking compared to others your \nage. \n Beginning \nScore \nPercentile\nRanking \nEnding \nScore \nPercentile \nRanking \nChair Stand \n(stands) \n12 30th 20 90th \nArm Curl \n(repetitions) \n14 35th 20 80th \n2-Min Step \n(steps) \n82 35th 126 95th \nChair Sit-&-Reach \n(inches beyond toes) \n-2.16 15th 2.16 50th \nBack Scratch \n(inches fingers overlap) \n2.7 85th 4.05 90th \n8-Foot Up-&-Go \n(seconds) \n5.28 50th 4.22 80th \n \nFitness and Functionality \n \n \n269\n\n \n \n \n270\n \n\n \n \n \n271\n \n\n\n \n \n \n272\n\n\n \n \n \n273\n\n\n \n \n \n \n274\n\n \n \n \n \n \n \n \n \n \n \nAppendix 28: Results Package Letters for Physicians \n \n \n275\n\n \nDr. David Hemmings \n464 Princess Street \n \n \n physically active lifestyle. \n \nKingston, Ontario \nK7L 1C2 \n \nAugust 13, 2004 \nDear Dr. Hemmings: \n \nThank you for supporting your patient, John Doe, in becoming involved in our Senior \nExercise Study at Queens University. John’s experience with us has not only made him \nmore aware of his health, but has contributed to a dataset which we hope will further \ncurrent knowledge regarding the prevention and treatment of obesity and related co-\nmorbidities. \n \nJohn was randomized into the control group of this intervention trial, which required him \nto not change his previous level of physical activity over a 24-week period so that his \ndata could be compared with other seniors randomized into exercise groups. Throughout\nthe study, he maintained a healthy, isocaloric diet with the help of a nutritionist. He \nsuccessfully completed the trial and has been encouraged to begin an exercise routine so \nthat he may enjoy the health benefits of a\n \nEnclosed is a copy of the results summary given to John upon his completion of the \nstudy. In addition, we have included a copy of the results from dual energy x-ray \nabsorptiometry (DEXA) scans performed for the purpose of collecting body composition \ndata. We hope that this information will be useful to you as his primary caregiver. \n \nYour support as a physician and encouragement to become physically fit were essential \nto John’s involvement in our study, and we are grateful for the contribution he has made. \nIf you encounter other seniors under your care who meet the basic criteria for this study \nand would benefit from becoming physically active, please pass along our contact \ninformation. We welcome new participants! \n \nIf you have additional questions or comments, please contact Dr. Robert Ross at \n(613)533-6583 or me at the number below. \n \nThank you, \n \n \nLance E. Davidson \nDoctoral Candidate \nQueens University \n(613)533-6000 ext75118 \n \n \n276\n\n \nDr. Colleen Webster \nreet \n \nr: \n \nnclosed is a copy of the results summary given to Jane upon her completion of the \nsition \nour support as a physician and encouragement to become physically fit were essential \n. \n you have additional questions or comments, please contact Dr. Robert Ross at \n(613)533-6583 or me at the number below. \n \nhank you, \nance E. Davidson \n118 \n312 - 797 Princess St\nKingston, Ontario \nK7L 1G1 \n \nAugust 13, 2004 \nDear Dr. Webste\n \nThank you for supporting your patient, Jane Doe, in becoming involved in our Senior \nExercise Study at Queens University. Jane’s experience with us has not only made her \nmore aware of her health, but has contributed to a dataset which we hope will further \ncurrent knowledge regarding the prevention and treatment of obesity and related co-\nmorbidities. \n \nJane was randomized into the resistance exercise group, which required her to complete a \ncircuit of nine resistance exercises in our Queen’s laboratory three times per week for \napproximately 24 weeks. Throughout the intervention, she maintained a healthy, \nisocaloric diet with the help of a nutritionist. She successfully completed the exercise \ntraining and should continue to see health benefits as she strives to maintain a physically\nactive lifestyle. \n \nE\nstudy. In addition, we have included a copy of the results from dual energy x-ray \nabsorptiometry (DEXA) scans performed for the purpose of collecting body compo\ndata. We hope that this information will be useful to you as her primary caregiver. \n \nY\nto Jane’s involvement in our study, and we are grateful for the contribution she has made\nIf you encounter other seniors under your care who meet the basic criteria for this study \nand would benefit from becoming physically active, please pass along our contact \ninformation. We welcome new participants! \n \nIf\nT\n \n \n \nL\nDoctoral Candidate \nQueens University \n(613)533-6000 ext75\n \n \n \n277\n\n \nDr. Trevor Thompson \n945 Gardiners Rd \nKingston, Ontario \nK7M 7H4 \n \nAugust 13, 2004 \n \nDear Dr. Thompson: \n \nThank you for supporting your patient, Jane Doe, in becoming involved in our Senior \nExercise Study at Queen’s University. Jane’s experience with us has not only made her \nmore aware of her health, but has contributed to a dataset which we hope will further \ncurrent knowledge regarding the prevention ent of obesity and related co-\nmorbidities. \n \nJane was randomized ired her to perform \nmoderate (about 60-75% of her maximal heart rate for 30-40 min) treadmill exercise in \nour laboratory at Queen’s five times per week for approximately 24 weeks. Throughout \nthe study, she maintained a healthy, isocaloric diet with the help of a nutritionist. She \nsuccessfully completed the exercise training and should see health benefits as she strives \nto maintain a physically active lifestyle. \n \nEnclosed is a copy of the results summary given to Jane upon her completion of the \nstudy. In addition, we have included a copy of the results from dual energy x-ray \nabsorptiometry (DEXA) scans performed for the purpose of collecting body composition \ndata. We hope that this information will be useful to you as her primary caregiver. \n \nYour support as a physician and encouragement to become physically fit were essential \nto Jane’s involvement in our study, and we are grateful for the contribution she has made. \nIf you encounter other seniors under your care who meet the basic criteria for this study \nand would benefit from becoming physically active, please pass along our contact \ninformation. We welcome new participants! \n \nIf you have additional questions or comments, please contact Dr. Robert Ross at \n(613)533-6583 or me at the number below. \n \nThank you, \n \n \n \nLance E. Davidson \nDoctoral Candidate \nQueen’s University \n(613)533-6000 extension 75118 \nand treatm\n into the aerobic only exercise group, which requ\n \n \n278\n\n \nDr. William Beck \n125 Lakeview Ave. \nKingston, Ontario \nK7M 3T6 \n \nr. Beck: \npporting your patient, John Doe, in becoming involved in our Senior \ns experience with us has not only made him \n to a dataset which we hope will further \nrrent tion and treatment of obesity and related co-\nd resistance exercise group, which required him \n do m ximal heart rate for 30-40 min) treadmill exercise \nine resistance exercises in our Queen’s laboratory three \neeks. Throughout the intervention, he maintained \n a nutritionist. He successfully completed the \nercis see health benefits as he strives to maintain a \nnclos y given to John upon his completion of the \nincluded a copy of the results from dual energy x-ray \nns performed for the purpose of collecting body composition \n you as his primary caregiver. \ne physically fit were essential \nor the contribution he has made. \n the basic criteria for this study \ne pass along our contact \nformation. We welcome new participants! \nIf you h comments, please contact Dr. Robert Ross at \n13)533-6583 or me at the number below. \nTha\nal Candidate \nAugust 13, 2004 \n \near DD\n \nThank you for su\nExercise Study at Queens University. John’\ntributedmore aware of his health, but has con\ncu knowledge regarding the preven\nmorbidities. \n \nJohn was randomized into the aerobic an\noderate (about 60-75% of his mato\nas well as complete a circuit of n\nes ptim er week for approximately 24 w\na healthy, isocaloric diet with the help of\nex e training and should continue to \nphysically active lifestyle. \n \nE ed is a copy of the results summar\nstudy. In addition, we have \nscaabsorptiometry (DEXA) \n hopedata. We that this information will be useful to\n \nYour support as a physician and encouragement to becom\nto John’s involvement in our study, and we are grateful f\nIf you encounter other seniors under your care who meet\nand would benefit from becoming physically active, pleas\nin\n \nave additional questions or \n(6\n \nnk you, \n \n \n \nLance E. Davidson \nDoctor\nQueen’s University \n(613)533-6000 extension 75118 \n \n \n279\n\n \n \n \n \n \n \n \nSAS Code for Intent-to-Treat Analysis \n \n \n \n \nAppendix 29: \n \n \n280\n\n \nPROC IMPORT = WORK.Seniors OUT\n DATATABLE= \"Subject Characteristics\" \n DBMS=ACCESS REPLACE; \n DATABASE=\"C:\\Documents and Settings\\Administrator\\My \nDocuments\\Queen's PhD\\Senior Study\\Seniors Data.mdb\" ; \n SCANMEMO=YES; \n USEDATE=NO; \n SCANTIME=YES; \nRUN; \n \nDATA Seniors; \nSET Seniors; \n \n*DELETE NEWLY-DIAGNOSED DIABETICS; \n IF ID = 3 THEN DELETE; \n IF ID = 29 THEN DELETE; \n IF ID = 57 THEN DELETE; \n IF ID = 72 THEN DELETE; \n IF ID = 114 THEN DELETE; \n IF ID = 116 THEN DELETE; \n \n*DELETE \"Non-randomized\"; \n IF ID = 63 THEN DELETE; \n IF ID = 80 THEN DELETE; \n IF ID = 109 THEN DELETE; \n IF ID = 140 THEN DELETE; \n IF ID = 32 THEN DELETE; \n IF ID = 58 THEN DELETE; \n IF ID = 112 THEN DELETE; \n \n*SEX and GROUP codes; \n Sexnum = 9; \n IF Sex = 'F' THEN Sexnum = 0; \n IF Sex = 'M' THEN Sexnum = 1; \n GRPnum = 9; \n IF GROUP = 'C' THEN GRPNUM = 0; \n IF GROUP = 'RE' THEN GRPNUM = 1; \n IF GROUP = 'AE' THEN GRPNUM = 2; \n IF GROUP = 'RAE' THEN GRPNUM = 3; \n \n*create body weight change variable; \n Wtc = wk24wt - wk1wt; \nRUN; \n \nPROC SORT DATA=Seniors; *Sort by randomized group; \nBY Grpnum Sexnum; \nRUN; \n \nPROC mi data=Seniors seed=1305417 nimpute=10 out=seniors_mi; \nBY Grpnum Sexnum; \nVAR wk24wt wk1wt; \nRUN; \n \nDATA grpsex31; set seniors; /* Grpnum=3 and Sexnum=1 has 14 \n observations with complete data -- excluded in MI */ \nIF grpnum=3 and sexnum=1; /* Make 10 copies indexed by _Imputation_ \n of these 14 observations */ \n \n \n281\n\n \nDO _Imputation_ = 1 to 10; \nOUTPUT; END; \nRUN; \n \nDATA seniors_mi; set seniors_mi grpsex31; /* combine the imputed data \n with the complete portion of the data */ \nRUN; \n \nDATA seniors_mi; set seniors_mi; \n * Need to recreate the change for the imputed data; \n Wtc = wk24wt - wk1wt; \nRUN; \n \nPROC SORT DATA=seniors_mi; by _Imputation_; \nRUN; \n \n /* Perform 10 ANCOVA for the 10 imputed data sets */ \nPROC mixed data=seniors_mi; *ANCOVA - controlling for baseline; \nBY _Imputation_; \nCLASS GRPnum; \nMODEL Wtc = GRPnum wk1wt / solution covb; \nLSMeans grpnum / adjust=tukey diff; \nODS OUTPUT lsmeans=grp_lsm diffs=grp_diffs; \nRUN; \n \n /*LSmeans with imputed data*/ \nPROC MIanalyze parms=grp_lsm; by sexnum; \nCLASS GRPnum; \nMODELEFFECTS GRPnum; \nRUN; \n \n /*Summary of pairwise differences*/ \nDATA grp_diff; set grp_diffs; /* data set with pairwise LSmean \n differences and SE */ \nVari = StdErr*StdErr; \nKEEP _Imputation_ GRPNUM _GRPNUM Estimate DF Vari; \nRUN; \n \nPROC MEANS DATA=grp_diff n mean var; /* summarize 10 imputations -- \n means (variances) of the LSmean differences */ \nCLASS grpnum _grpnum; \nVAR estimate df vari; \nOUTPUT OUT=grp_diff2 n=m mean=est edf vi var=estv; \n /* est average parameter estimate (pairwise lsmean difference) */ \n /* vi average within imputation variance */ \n /* estv between imputation variance */ \nRUN; \n \nDATA grp_diff2; set grp_diff2; \nIF _type_=3; /* Only the pairwise mean differences kept in data set */ \nt = vi + (1 + 1/m)*estv; \nstatistic = est/sqrt(t); /* Test statistic for pairwise comparison */ \nq_stat = sqrt(2)*statistic; /* Tukey's studentized range statistic */ \nr = ((1+1/m)*estv)/vi; /* relative variance incr due to nonresponse */ \nvmdf = (m - 1)*(1+1/r)**2; \nlambda = (r + 2/(vmdf+3))/(r+1); /* fraction of missing information */ \ngamma = (1 + 1/m)*estv/t; /* degrees of freedom */ \n \n \n282\n\n \nv0df = (1 - gamma)*edf*(edf+1)/(edf+3); \nvmdf1 = 1/(1/vmdf + 1/v0df); /* adjusted degrees of freedom in case r \n is small and vmdf is large */ \npvalue1 = min(1, (1 - cdf('T', abs(statistic), vmdf1))*2*6); \n /* 2-tailed bonferroni adjusted for 6 comparisons*/ \npvalue2 = 1- probmc(\"range\", abs(q_stat), ., vmdf1, 4); \n /* Tukey's adjusted p-values */ \nKEEP grpnum _grpnum m est edf vi estv t statistic r vmdf lambda v0df \n vmdf1 pvalue1 pvalue2; \nRUN; \n \nPROC PRINT DATA=grp_diff2; \nRUN; \n \n \n \n \n \n283\n\n \n \n \n \n \n \n \n \n \n \n \nAppendix 30: Multiple Imputations Output for Changes in Body Weight \n \n \n284\n\n \n \n The SAS System 08:30 Thursday, June 28, 2007 149 \n------------------------------------ GRPnum=1 Sexnum=0 -------------------------------- \n The MI Procedure \n Model Information \n Data Set WORK.SENIORS \nCMC \n Initial Estimates for MCMC EM Posterior Mode \n \n Group wk24wt wk1wt Freq Percent wk24wt wk1wt \n _TYPE_ _NAME_ wk24wt wk1wt \n MEAN 77.891438 78.938095 \n93511 82.939321 \n -----------------Variance----------------- \n Total DF \n 5.053173 18.24 \n Multiple Imputation Variance Information \n wk24wt 0.001156 0.001155 0.999885 \n \n--\n \n \n \n \n \n \n Method M\n Multiple Imputation Chain Single Chain \n \n Start Starting Value \n Prior Jeffreys \n Number of Imputations 10 \n Number of Burn-in Iterations 200 \n Number of Iterations 100 \n Seed for random number generator 1261520860 \n \n Missing Data Patterns \n \n ---------Group Means-------- \n \n \n 1 X X 20 95.24 77.670000 78.725000 \n 2 . X 1 4.76 . 83.200000 \n \n \n EM (Posterior Mode) Estimates \n \n \n \n \n COV wk24wt 88.3\n COV wk1wt 82.939321 79.814563 \n \n \n Multiple Imputation Variance Information \n \n \n Variable Between Within \n \n wk24wt 0.005303 5.047340 \n \n \n \n Relative Fraction \n Increase Missing Relative \n Variable in Variance Information Efficiency \n \n \n \n \n285\n\n \n \n The SAS System 08:30 Thursday, June 28, 2007 150 \n \n \n \nor 95% Confidence Limits DF \n \n wk24wt 77.884010 2.247926 73.16574 82.60228 18.24 \n \n wk24wt 77.746028 77.991931 0 34.65 <.0001 \n-------------------------------------- GRPnum=1 Sexnum=0 -------------------------------- \n The MI Procedure \n \n Multiple Imputation Parameter Estimates\n \n Variable Mean Std Err\n \n \n Multiple Imputation Parameter Estimates \n t for H0: \n Variable Minimum Maximum Mu0 Mean=Mu0 Pr > |t| \n \n \n \n286\n\n \n \n \n The SAS System 08:30 Thursday, June 28, 2007 160 \n \n------------------------ \n \n \n Standard \n Effect GRPnum Estimate Error DF t Value Pr > |t| \n Intercept -2.5695 1.0999 131 -2.34 0.0210 \n GRPnum 0 2.7134 0.4712 131 5.76 <.0001 \n GRPnum 2 -0.4336 0.4378 131 -0.99 0.3239 \n Covariance Matrix for Fixed Effects \n Row Effect GRPnum Col1 Col2 Col3 Col4 Col5 Col6 \n 3 GRPnum 1 -0.08708 0.09872 0.1944 0.09852 -0.00013 \n Type 3 Tests of Fixed Effects \n Effect DF DF F Value Pr > F \n GRPnum 3 131 19.66 <.0001 \n Effect GRPnum Estimate Error DF t Value Pr > |t| \n GRPnum 0 0.3307 0.3511 131 0.94 0.3480 \n GRPnum 1 -0.7815 0.3095 131 -2.53 0.0128 \n GRPnum 2 -2.8162 0.3053 131 -9.22 <.0001 \n <.0001 \n------------------------------------- Imputation Number=1 -------\n \n The Mixed Procedure \n Solution for Fixed Effects \n \n \n \n \n GRPnum 1 1.6011 0.4409 131 3.63 0.0004 \n \n GRPnum 3 0 . . . . \n wk1wt 0.002187 0.01242 131 0.18 0.8605 \n \n \n \n \n \n \n 1 Intercept 1.2098 -0.07883 -0.08708 -0.09757 -0.01309 \n 2 GRPnum 0 -0.07883 0.2220 0.09872 0.09853 -0.00023 \n \n 4 GRPnum 2 -0.09757 0.09853 0.09852 0.1917 -0.00001 \n 5 GRPnum 3 \n 6 wk1wt -0.01309 -0.00023 -0.00013 -0.00001 0.000154 \n \n \n \n \n Num Den \n \n \n \n wk1wt 1 131 0.03 0.8605 \n \n \n Least Squares Means \n \n Standard \n \n \n \n \n GRPnum 3 -2.3826 0.3139 131 -7.59 \n \n \n \n \n287\n\n \n \n The SAS System 08:30 Thursday, June 28, 2007 161 \n \n------------------------------------- Imputation Number=1 ------------------------------- \n The Mixed Procedure \n Differences of Least Squares Means \n Standard \n \n \n \n \n \n \n Effect GRPnum _GRPnum Estimate Error DF t Value Pr > |t| Adjustment Adj P \n \n GRPnum 0 1 1.1123 0.4680 131 2.38 0.0189 Tukey-Kramer 0.0866 \n GRPnum 0 2 3.1469 0.4655 131 6.76 <.0001 Tukey-Kramer <.0001 \n GRPnum 0 3 2.7134 0.4712 131 5.76 <.0001 Tukey-Kramer <.0001 \n GRPnum 1 2 2.0347 0.4348 131 4.68 <.0001 Tukey-Kramer <.0001 \n GRPnum 1 3 1.6011 0.4409 131 3.63 0.0004 Tukey-Kramer 0.0023 \n GRPnum 2 3 -0.4336 0.4378 131 -0.99 0.3239 Tukey-Kramer 0.7552 \n \n \n288\n\n \n \n \n The SAS System 08:30 Thursday, June 28, 2007 189 \n \n The MIANALYZE Procedure \n \n \n PARMS Data Set WORK.GRP_LSM \n Number of Imputations 10 \n Multiple Imputation Variance Information \n Parameter GRPnum Between Within Total DF \n GRPnum 3.000000 0.005060 0.104532 0.110098 3521.6 \n Relative Fraction \n GRPnum 0 0.048823 0.047009 0.995321 \n GRPnum 3.000000 0.053245 0.051092 0.994917 \n \n \n Multiple Imputation Parameter Estimates \n \n Model Information \n \n \n \n \n -----------------Variance----------------- \n \n GRPnum 0 0.005803 0.130747 0.137130 4153.4 \n GRPnum 1.000000 0.029603 0.101595 0.134158 152.77 \n GRPnum 2.000000 0.006022 0.098872 0.105497 2282.6 \n \n \n Multiple Imputation Variance Information \n \n \n Increase Missing Relative \n Parameter GRPnum in Variance Information Efficiency \n \n \n GRPnum 1.000000 0.320518 0.252445 0.975377 \n GRPnum 2.000000 0.066999 0.063612 0.993679 \n \n \n Parameter GRPnum Estimate Std Error 95% Confidence Limits DF \n \n GRPnum 0 0.280685 0.370311 -0.44532 1.00669 4153.4 \n Parameter GRPnum Minimum Maximum \n \n \n \n Multiple Imputation Parameter Estimates \n \n \n GRPnum 0 0.185363 0.387468 \n Multiple Imputation Parameter Estimates \n \n t for H0: \n Parameter GRPnum Theta0 Parameter=Theta0 Pr > |t| \n \n GRPnum 0 0 0.76 0.4485 \n \n \n289\n\n \n \n The SAS System 08:30 Thursday, June 28, 2007 190 \n \n The MIANALYZE Procedure \n \n \n Multiple Imputati n Parameter Estimates \n \n Parameter GRPnum Estimate td Error 95% Confidence Limits DF \n \no\nS\n GRPnum 1.000000 -0.644884 0.366275 -1.36850 0.07874 152.77 \n GRPnum 2.000000 -2.752293 0.324802 -3.38923 -2.11535 2282.6 \n GRPnum 3.000000 -2.324532 0.331810 -2.97509 -1.67397 3521.6 \n \n \n Multiple Imputati n Parameter Estimates \n \n Parameter GRPnum Minimum Maximum \n \n \n GRPnum 2.000000 -2.875482 -2.640898 \n GRPnum 3.000000 -2.446468 -2.219368 \n \n Multiple Imputation Parameter Estimates \n \n t for H0: \n Parameter GRPnum Theta0 Parameter=Theta0 Pr > |t| \n \n GRPnum 1.000000 0 -1.76 0.0803 \n GRPnum 2.000000 0 -8.47 <.0001 \n GRPnum 3.000000 0 -7.01 <.0001 \n \no\n \n GRPnum 1.000000 -0.970474 -0.438463 \n \n \n290\n\n \n \n The SAS System 08:30 Thursday, June 28, 2007 191 \n \n The MEANS Procedure \n \n N \n GRPnum _GRPnum Obs Variable N Mean Variance \n \nƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ \n 0 1 10 Estimate 10 0.9255684 0.0468495 \n DF 10 131.0000000 0 \n Vari 10 0.2322449 0.000562820 \n \n 2 10 Estimate 10 3.0329782 0.0101547 \n DF 10 131.0000000 0 \n Vari 10 0.2297699 0.000550888 \n \n 3 10 Estimate 10 2.6052162 0.0100214 \n DF 10 131.0000000 0 \n Vari 10 0.2354520 0.000578472 \n \n 1 2 10 Estimate 10 2.1074098 0.0408193 \n DF 10 131.0000000 0 \n Vari 10 0.2005170 0.000419546 \n \n 3 10 Estimate 10 1.6796478 0.0295065 \n DF 10 131.0000000 0 \n Vari 10 0.2061843 0.000443597 \n \n 2 3 10 Estimate 10 -0.4277620 0.0088933 \n DF 10 131.0000000 0 \n Vari 10 0.2033151 0.000431337 \n ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ \n \n \n The SAS System 08:30 Thursday, June 28, 2007 192 \n \n Obs GRPnum _GRPnum m est edf vi estv t statistic \n \n 1 0 1 10 0.9256 131 0.23224 0.046850 0.28378 1.73747 \n 2 0 2 10 3.0330 131 0.22977 0.010155 0.24094 6.17895 \n 3 0 3 10 2.6052 131 0.23545 0.010021 0.24648 5.24755 \n 4 1 2 10 2.1074 131 0.20052 0.040819 0.24542 4.25398 \n 5 1 3 10 1.6796 131 0.20618 0.029506 0.23864 3.43831 \n 6 2 3 10 -0.4278 131 0.20332 0.008893 0.21310 -0.92664 \n \n Obs r vmdf lambda v0df vmdf1 pvalue1 pvalue2 \n \n 1 0.22190 272.90 0.18753 105.610 76.144 0.51808 0.31173 \n 2 0.04861 4187.36 0.04682 123.062 119.549 0.00000 0.00000 \n 3 0.04682 4499.36 0.04515 123.273 119.986 0.00000 0.00000 \n 4 0.22393 268.87 0.18897 105.435 75.736 0.00036 0.00034 \n 5 0.15742 486.53 0.13954 111.494 90.707 0.00532 0.00483 \n 6 0.04812 4270.58 0.04635 123.121 119.671 2.13586 0.79064 \n \n \n291\n\n \n \n \n \n \n \n \n \n \n \n7.2.0. Associated Appendix: Liver Fat Methodology Paper \n \n \n \n292\n\n \n \n \n \n293\n\n \n \n \n \n294\n\n \n \n \n \n \n295\n\n \n \n \n \n \n296\n\n \n \n \n \n297\n\n \n \n \n \n \n \n \n \n \n \n7.3.0. List of Publications and Abstracts \n \n \n298\n\n \n \n \n299\nPEER-REVIEWED MANUSCRIPTS \n \nKuk JL, Davidson LE, Hudson R, Kilpatrick K, and Ross R. “Effect of dietary fat intake on the \nrelationship between liver fat and insulin sensitivity in sedentary, abdominally obese older \nmen” Submitted to Appl Physiol Nutr Metab, 2007. \n \nKilpatrick K, Kuk JL, Davidson LE, Hudson R, Ross R. “Skeletal muscle mass is not related to \nglucose tolerance or insulin sensitivity in overweight and obese men and women” In press at \nMed Sci Sports Exer, 2007. \n \nDavidson LE, Kuk JL, Church T, and Ross R. “Measurement of liver fat by computed \ntomography” J Appl Physiol. 100(3):864-8, 2006. \n \nLee SJ, Kuk JL, Davidson LE, Hudson R, Kilpatrick K, Graham TE, and Ross R. “Exercise \nwithout weight loss is an effective strategy for obesity reduction in obese individuals with and \nwithout type 2 diabetes” J Appl Physiol. 99(3):1220-1225, 2005. \n \n \nPEER-REVIEWED PRESENTATIONS \n \nDavidson LE, Kuk JL, McMillan K, Janiszewski P, Hudson R, Kilpatrick K, Ross R. “Influence \nof Exercise Modality on Skeletal Muscle, Fat, and Functional Fitness in Older Men and \nWomen: A Randomized Controlled Trial” CSEP Conference, Toronto, Ontario, November \n2007. \n \nDavidson LE, Kuk JL, Ross R. “Morphologic and Metabolic Adaptations to Resistance and/or \nAerobic Exercise in Abdominally Obese Older Men and Women: A Randomized Controlled \nTrial” NAASO Conference, New Orleans, LA, October 2007. \n \nDavidson LE, Kuk JL, Hudson R, Kilpatrick K, and Ross R. “Effect of dietary fat intake on the \nrelationship between liver fat and insulin sensitivity in sedentary, abdominally obese older \nmen” NAASO Conference, Boston, MA, October 2006 \n Published abstract: Obesity Research, 14:A147, 2006. \n \nDavidson LE, Hudson R, Kilpatrick K, Ross R. “Novel assessment of hepatic steatosis by \ncomputed tomography” CSEP Conference, Ottawa, Ontario, October 2005. \nPublished Abstract: Can J Appl Physiol, 30:S20, 2005. \n \nDavidson LE, Kuk JL, Ross R. “Independent relationships among abdominal adipose \ndepots, liver fat, cardiorespiratory fitness, and insulin resistance in abdominally obese older \nmen and women” NAASO Conference, Vancouver, BC, October 2005. \nPublished Abstract: Obesity Research, 13:A126, 2005. \n \nDavidson LE, Kuk JL, Ross R. “Liver volume as a marker of hepatic fat in men” NAASO \nConference, Las Vegas, NV, October 2004. \nPublished Abstract: Obesity Research, 12:A137, 2004. \n \nDavidson LE, Janssen I, Hudson R, Kilpatrick K, Ross R. “Insulin resistance corresponds to \nobesity rather than aging in women” OEP Conference, Barry, Ontario, January 2004. \n \nWatts M, Davidson LE, Lee SJ, Hudson R, Kilpatrick K, Ross R. “Abdominal adiposity, \nskeletal muscle composition, liver fat and insulin resistance in obese men” OEP Conference, \nBarry, Ontario, January 2004. \n \n\n \n \n \n300\nDavidson LE, Janssen I, Hudson R, Kilpatrick K, Ross R. “Age-related reduction in glucose \nuptake is explained by corresponding increase in obesity, not aging per se” CSEP \nConference, Niagara-on-the-Lake, Ontario, October 2003. \nPublished Abstract: Canadian Journal of Applied Physiology, Z8:S45, 2003. \n \nDavidson LE, Peterson T, Tucker L. “Television viewing habits and measured \ncardiorespiratory fitness in 277 women” National ACSM Conference, St. Louis, MO, May \n2002. \nPublished Abstract: Medicine and Science in Sports and Exercise, 34(5):S66, 2002 \n \nDavidson LE, Peterson T, Bailey B, LeCheminant J, Tucker L.“Objectively measured \nchanges in physical activity predict changes in abdominal fat: a prospective 20-month study” \nNAASO Conference, Quebec City, October 2001. \nPublished Abstract: Obesity Research, 9(Suppl 3): 2001. \n \n \nBOOK CHAPTERS \n \nKuk JL, Saunders TJ, Davidson LE, Ross R. “Age-related Changes in Total and Regional \nFat Distribution” in Aging and Human Body Composition: Medical Measurement and \nTherapeutic Applications. Humana Press, 2007."
  },
  "outcomes": {
    "primary": [
      "body-composition",
      "hypertrophy",
      "vo2"
    ],
    "intervention_weeks": 29,
    "primary_human": "body_comp; muscle_mass; strength; function"
  },
  "bucket": "C",
  "notes": "Older Korean women with sarcopenic obesity; ~12 weeks of supervised RT vs control; outcomes include DXA body comp and physical performance tests."
}